program - CardioFocus

Transcription

TCT2011
T r a n s c at h e t e r
Cardiovascular
Therapeutics
program
The World’s Premier Interventional Experience
November 7-11, 2011
The Moscone Center · San Francisco, CA
www.tctconference.com
Hypertension
Innovation
Endovascular
Innovation
Innovating for life.
Leading the Way
Medtronic is leading the way in interventional medicine.
From groundbreaking technologies to novel therapies and more,
we’re pioneering a path to the future.
For distribution in the USA only. © 2011 Medtronic, Inc. All rights reserved. Printed in USA. 9/11
Transcatheter Valve
Innovation
Coronary Stent
Innovation
Table of Contents
Overview
TCT for Surgeons, Nurses/Technologists, and Fellows ................................. 4
Directors and Organizers. . ........................................................................... 6
Acknowledgements.. ................................................................................... 8
Commercial Support Acknowledgement. . ................................................... 13
Special Activities.. ..................................................................................... 14
ACC and CRF Joint Initiative..................................................................... 16
Learning Labs and Edited Taped Cases..................................................... 18
CME/CE Information................................................................................. 19
TCT 2011 Awards..................................................................................... 20
TCT Week at a Glance.............................................................................. 21
Breakout Symposium II. Working in Today’s Cath Lab. . ........................... 59
Breakout Symposium III. Business Development and Operations.. ........... 59
Scientific Symposia
Surgical, Interventional, and Hybrid Procedures (Part 1):
Coronary Revascularization. . ................................................................. 59
Peer-Reviewed Research
Poster Abstract Sessions. . .................................................................... 60
Challenging Cases Video Abstracts....................................................... 79
Oral Abstract Sessions......................................................................... 82
Scientific Symposia (Continued)
Device-Based Approaches for Heart Failure:
Recent Developments and New Directions. . ........................................... 88
Faculty
International Faculty. . ................................................................................ 24
TCT Advisory Faculty................................................................................ 30
United States Faculty................................................................................ 32
Endovascular Intervention (Part 2)......................................................... 89
Hot Topics in Interventional Cardiology:
ACC.11 Highlights for the Interventional,
Invasive, and General Cardiologist. . ....................................................... 89
Identifying the High-Risk Patient and Lesion:
From Vulnerable Plaque to Ischemia and Viability................................... 90
Live Case Sites and Operators.................................................................. 39
Left Atrial Appendage Closure:
Indications, Devices, and Techniques.................................................... 91
Monday
Next Generation Drug-Eluting Stents
and Bioabsorbable Scaffolds.. ............................................................... 92
Board Review Course with Self-Assessment in
Interventional Cardiology (Part 1)........................................................... 42
The Valvular Heart Disease Summit (Part 2):
Mitral Valve Therapies........................................................................... 93
TCT for Nurses and Technologists
Translational Research and First-in-Human
Studies for Emerging Cardiovascular Technologies................................. 93
20th Annual Cardiovascular Nurse and Technologist Symposium............ 42
RCIS Review Course............................................................................ 43
Scientific Symposia
Special Sessions
Chronic Total Occlusions: Basic and Expert Techniques.. ........................ 43
Endovascular Intervention (Part 1)......................................................... 45
Interventional Innovation: Novel Therapies
and The “Best” New Device Concepts for 2011..................................... 46
Left Main and Bifurcation Stenting:
An Advanced Operator’s Workshop....................................................... 48
Transradial Angiography and Intervention:
From Basic to Advanced. . ..................................................................... 94
Strategies for Cardiovascular Repair: Stem Cells and Beyond................. 49
The Drug-Eluting Stent Summit: Appropriate
Utilization of Current Generation Devices............................................... 50
Aortic Valve Therapies.......................................................................... 52
PFO and ASD Closure: Evolving Indications,
Patient Selection, Devices, and Technique............................................. 53
Special Twilight Sessions
Featured Clinical Research I. Transcatheter
Valve and STEMI/Heart Failure Therapies............................................... 54
New Patients for New Interventional Therapies. . ..................................... 54
Partnership Session: Angioplasty Summit-TCTAP. . ................................. 55
Evening Programs. . ............................................................................... 146
SCAI ELM Program in Partnership with ACC and CRF............................ 95
Japan-US Synergies for Medical Device Innovation:
A Harmonization by Doing (HBD) Educational Symposium...................... 95
Presentation Theater South.................................................................. 150
Featured Clinical Research II.
Drug-Eluting Stent vs. Stent Studies. . .................................................... 96
How to Treat Complex Lesions. . ............................................................ 96
Partnership Session: CIT in Partnership with TCT:
Challenging Cases in Clinical Practice................................................... 97
Partnership Session: TCT Russia: Focused
Session on Endovascular and Structural Heart Disease.......................... 97
Wednesday
Breakfast Meetings............................................................................... 152
Main Arena. . .......................................................................................... 100
How to Treat Theater: Coronary Artery Disease.................................... 101
How to Treat Theater: Endovascular and Structural Heart Disease...... 102
Tuesday
2
Challenging Case Multiplex
Challenging Case Theater................................................................... 103
Board Review Course with Self-Assessment
In Interventional Cardiology (Part 2)....................................................... 58
International Society-Sponsored Case Theater..................................... 103
Maintenance of Certification (MOC) Course.. ........................................ 104
TCT for Nurses and Technologists
Morning Spotlight Sessions
Breakout Symposium I. The Great Debates. . .......................................... 58
program ·
T r a n s c at h e t e r C a r d i o va s c u l a r T h e r a p e u t i c s
Core Training Curriculum in Clinical Research . . ..................................... 104
TCT2011
Deep Dive: Stroke Prevention Therapies.............................................. 105
Innovative Surgical Techniques and Technologies................................. 106
International Debating Chamber: Interventional Cardiology on Trial........ 106
Presentation Theaters. . ......................................................................... 155
Lunchtime Activities
Hot Topics......................................................................................... 107
Learn the Technique........................................................................... 109
Afternoon Spotlight Sessions
Aortic Endografts and Aneurysm Repair.. ............................................. 111
Integrating IVUS and FFR to Improve PCI Outcomes............................ 112.
Next Generation Transcatheter Mitral Valve Therapies. . ......................... 112
Optimizing Use of Today’s Antithrombotic and
Antiplatelet Drugs in ACS, PCI, and Atrial Fibrillation............................ 113
Valvular and Structural Heart Disease.................................................. 114
Cardiovascular
Therapeutics
Next Generation Optical Intravascular Imaging:
OCT and NIR Spectroscopy................................................................ 133
Optimizing Primary PCI for STEMI (Part 2):
Drugs, Devices, and Techniques.. ........................................................ 133
Partnership Session: Brazilian Society of
Interventional Cardiology (SBHCI) and Gi2: Transcatheter
Aortic Valve Replacement and Complex Coronary Intervention.............. 134
Partnership Session: p-c-i Live in Partnership with TCT:
Practical Aspects of Coronary, Valvular, and
Electrophysiologic Interventions.......................................................... 134
Practicalities and Pitfalls of Platelet Function Testing............................ 135
TCT Mediterranean. . ........................................................................... 135
Friday
Clinical Cardiovascular Genetics and
the Era of Personalized Medicine.. ....................................................... 114
Main Arena. . .......................................................................................... 138
Featured Clinical Research III. Drug-Eluting Stents,
Drug-Coated Balloons, and PCI Pharmacology.................................... 115
Partnership Session: JIM at TCT......................................................... 115
Focus on India: Interactive Case Review and Panel Discussion............. 115
Korean Interventional Cardiology Summit. . ........................................... 115
Special Circulation Journal Session:
The Most Important Interventional Papers from the Last Year. . .............. 116
Thursday
Controversies in Interventional Cardiology:
The Skeptic’s Corner.......................................................................... 140
Difficult Patients in Interventional Cardiology:
The Art of Clinical Decision-Making..................................................... 141
TAVR Site Readiness: Organizing and Training Your
Site to Prepare for TAVR..................................................................... 142
Main Arena. . .......................................................................................... 120
Maintenance of Certification (MOC) Course.. ........................................ 124
Special Sessions
FDA Town Hall Meeting. . ..................................................................... 125
From Clinical Trials Evidence to Clinical Practice:
Unraveling the Issues.. ........................................................................ 126
Next Generation Transcatheter Aortic Valve Therapies.......................... 126
Optimizing Primary PCI for STEMI (Part 1): The Systems Approach....... 127
Tough Calls in the Cath Lab: Are You Up to the Challenge?.................. 127
Presentation Theaters. . ......................................................................... 160
Lunchtime Sessions
Hot Topics......................................................................................... 128
Learn the Technique........................................................................... 129
Deep Dive: Interventional Hypertension. . .............................................. 131
Drug-Coated Balloons: Clinical Data and Applications.......................... 132
Satellite Symposia
Monday
Evening Programs.............................................................................. 146
Tuesday
Breakfast Meetings. . ........................................................................... 147
Presentation Theater South. . ............................................................... 150
Wednesday
Presentation Theater North................................................................. 155
Thursday
Presentation Theater North................................................................. 160
Friday
Poster Abstracts Map........................................................................... 166
Moscone Center Map.. .......................................................................... 168
www . t c t c o n f e r e n c e . c o m
3
TCT for Surgeons, Nurses/
Technologists, and Fellows
TCT for Surgeons: Creating and
Securing the Future
20th Annual Cardiovascular Nurse
and Technologist Symposium
Monday
Monday
Aortic Valve Therapies.......................................................................... 52
20th Annual Cardiovascular Nurse and
Technologist Symposium...................................................................... 42
Tuesday
Coronary Revascularization................................................................... 59
Tuesday
Breakout Symposium I. The Great Debates. . .......................................... 58
Mitral Valve Therapies........................................................................... 93
Breakout Symposium II. Working in Today’s Cath Lab. . ........................... 59
Breakout Symposium III. Business Development and Operations.. ........... 59
Wednesday
Innovative Surgical Techniques and Technologies................................. 106
Aortic Endografts and Aneurysm Repair.. ............................................. 111
Valvular and Structural Heart Disease.................................................. 114
RCIS Review Course............................................................................ 43
Special TCT Sessions for
Cardiology Fellows
Monday
Tuesday
Wednesday
MOC Course Interventional Cardiology 2011
Update Module Review, 8:05 am .......................................................... 104
Update Module Review, 10:15 am ........................................................ 104
Update Module Review, 12:00 pm ........................................................ 104
ACC Fellows Session I. Advanced Training in
Valvular Heart Disease........................................................................ 107
Thursday
Update Module Review, 8:05 am .......................................................... 125
Update Module Review, 10:15 am ........................................................ 125
Update Module Review, 12:00 pm ........................................................ 125
ACC Fellows Session II. Advanced Training in
Structural (Non-valve) Heart Disease................................................... 128
4
program ·
5 Reasons to Attend
1
Late Breaking
Clinical Science
TCT2011
Cardiovascular
Therapeutics
Late Breaking Trials
A cornerstone of every TCT, late breaking trials are presented in the Main Arena and are typically the initial worldwide
presentation of clinical trials, impactful single-center or multicenter registries, or important follow-up data from major
randomized trials and first-in-man experiences with novel devices or drugs.
A major highlight from last year’s TCT, the Special Twilight Sessions are can’t-miss evening sessions that highlight
featured clinical research and presentations on the hottest topics in a more casual setting with hors d’oeuvres.
Dedicated Oral, Poster, and Challenging Cases Video Abstract Presentations
TCT 2011 will feature a four-and-a-half hour block dedicated to oral and poster abstract presentations and, new this
year, challenging cases video abstracts. This will provide the opportunity to interact with peers in an intimate setting
for critical review of science.
2
Practical
Knowledge
“How to Treat” Live Case Theaters
For practitioners desiring a state-of-the-art review of contemporary interventional practice, TCT’s “How to Treat”
Live Case Theaters are there to provide step-by-step approaches to basic and advanced interventions, covering
a broad knowledge base as well as numerous new techniques and tips and tricks to improve care for patients
with cardiovascular disease.
Challenging Case Multiplex Theater
Over 400 physicians submit their most challenging cases to be presented at TCT, with the most remarkable
cases to be presented in the Challenging Case Multiplex Theater and published in Catheterization and
Cardiovascular Interventions.
3
Networking With
Colleagues
4
Focused
Educational
Activities
TCTMD Connect
TCTMD Connect is an online professional media network designed and developed just for you—the interventional
cardiovascular professional. Along with your free membership to TCTMD (www.tctmd.com), you can now network
with colleagues, blog about issues and updates relevant to you and your practice, and collaborate by uploading and
downloading images, presentations, and cases.
14th Annual Self-Assessment Course for Interventional Cardiology
This interactive course will include didactic and case presentations, image interpretation, and multiple choice (single
best answer) questions to prepare you for your exam or enhance your overall understanding of interventional
cardiology.
20th Annual Cardiovascular Nurse and Technologist Symposium
The Annual Nurse and Technologist Symposium provides a forum for discussion of the latest advances in
interventional, pharmacologic, structural heart, and endovascular strategies for the management of the
cardiovascular patient.
TCT for Surgeons: Creating and Securing the Future
TCT for Surgeons is an in-depth course focusing on novel and advanced surgical techniques for surgeons
interested in the most contemporary surgical techniques and catheter-based approaches.
5
Interactive Meeting
Technology
CRF Meetings Mobile App
Keeping up to date with news and the best sessions at TCT has never been easier with our free app for the iPhone
and iPad: Up-to-the-minute information on TCT, with extensive program, exhibitor, and faculty search tools, add
integration with your mobile calendar. The free TCT mobile app is available from iTunes using the keyword “TCT”.
A mobile Web site is available for those not using Apple products.
Smart Tags
With only your mobile device, access detailed information on the go, which include slides from late breaking trials
and other presentations, exhibitor details and locations, and useful tips on San Francisco and the Moscone Center.
Download the free app at http://gettag.mobi from your mobile device.
5
Directors and
Organizers
Directors
Scientific Committee
Martin B. Leon, MD
David H. Adams, MD
Gregg W. Stone, MD
Dominick J. Angiolillo, MD, PhD
Josef Bartunek, MD, PhD
Eric R. Bates, MD
Co-Directors
Olivier F. Bertrand, MD, PhD
George D. Dangas, MD, PhD
Deepak L. Bhatt, MD, MPH
William A. Gray, MD
William E. Boden, MD
Roxana Mehran, MD
Steven F. Bolling, MD
Gary S. Mintz, MD
Russell A. Brandwein, RPA-C
Ralph G. Brindis, MD, MPH
Associate Directors
Todd J. Brinton, MD
Bruce R. Brodie, MD
Alexandre Abizaid, MD, PhD
Daniel Burkhoff, MD, PhD
Gary M. Ansel, MD
Jacques Busquet, MD
Robert O. Bonow, MD
Josep Rodés-Cabau, MD
Antonio Colombo, MD
Christopher P. Cannon, MD
Ted Feldman, MD
Louis A. Cannon, MD
Run-Lin Gao, MD
John D. Carroll, MD
Bernard J. Gersh, MB, ChB, DPhil
David A. Cox, MD
Anthony H. Gershlick, MD
Michael E. Crawford, MD
Juan F. Granada, MD
Frank J. Criado, MD
Liliana R. Grinfeld, MD
Mark A. de Belder, MD, MA
Eberhard Grube, MD
Bernard de Bruyne, MD, PhD
Ziyad M. Hijazi, MD, MPH
Elazer R. Edelman, MD, PhD
David R. Holmes Jr, MD
David P. Faxon, MD
Alice K. Jacobs, MD
William F. Fearon, MD
Michael R. Jaff, DO
Francisco Fernandez-Aviles, MD, PhD
Barry T. Katzen, MD
Peter J. Fitzgerald, MD, PhD
Dean J. Kereiakes, MD
William J. French, MD
Ajay J. Kirtane, MD, SM
James A. Goldstein, MD
Alexandra J. Lansky, MD
Christopher B. Granger, MD
Michael J. Mack, MD
J. Aaron Grantham, MD
Akiko Maehara, MD
Giulio Guagliumi, MD
Ian T. Meredith, MBBS, PhD
Michael Guiry, RPA-C
David J. Moliterno, MD
Paul A. Gurbel, MD
Jeffrey W. Moses, MD
Christian W. Hamm, MD
Masahiko Ochiai, MD, PhD
Martial Hamon, MD
John A. Ormiston, MB, ChB
Kishore J. Harjai, MD
Seung-Jung Park, MD, PhD
Marian C. Hawkey, RN
LeRoy E. Rabbani, MD
Mark Reisman, MD
David J. Hildick-Smith, MD
Patrick W. Serruys, MD, PhD
W. Craig Hooper, PhD
Sigmund Silber, MD
Nancy Houston Miller, BSN, RN
Varinder P. Singh, MD
Yong Huo, MD
Robert J. Sommer, MD
Yang-Soo Jang, MD, PhD
Paul S. Teirstein, MD
Peter Juni, MD
Renu Virmani, MD
Aaron V. Kaplan, MD
John G. Webb, MD
Saibel Kar, MD
Giora Weisz, MD
John W. Karanian, PhD
Harvey D. White, MD
Sanjay Kaul, MD
Mathew Williams, MD
Morton J. Kern, MD
Stephan Windecker, MD
6
program ·
Ran Kornowski, MD
Hans Krankenberg, MD
Mitchell W. Krucoff, MD
Massoud A. Leesar, MD
Thierry Lefevre, MD
JoAnn Lindenfeld, MD
James B. McClurken, MD
John A. McPherson, MD
Marie-Claude Morice, MD
Hilary Nierenberg, NP, MPH
E. Magnus Ohman, MD
Semih Oktay, PhD
Jeffrey W. Olin, DO
Manish A. Parikh, MD
Helen Parise, ScD
Amit Patel, MD, MS
Ileana L. Pina, MD
Stuart J. Pocock, PhD
Jeffrey J. Popma, MD
Matthew J. Price, MD
Sunil V. Rao, MD
Vivek Y. Reddy, MD
Evelyn S. Regar, MD, PhD
Bernhard Reimers, MD
Mark Reisman, MD
Charanjit S. Rihal, MD
Ivan C. Rokos, MD
Dierk Scheinert, MD
Allan Schwartz, MD
Warren Sherman, MD
Georgios Sianos, MD, PhD
Horst Sievert, MD, PhD
Martina Kelly Speight, RN, BSN
H. Robert Superko, MD
David Taggart, MD, PhD
Guillermo Tearney, MD, PhD
Holger Thiele, MD
Martyn R. Thomas, MD
Craig A. Thompson, MD, MMSc
Leif Thuesen, MD
Jonathan M. Tobis, MD
Zoltan G. Turi, MD
E. Murat Tuzcu, MD
Alec Vahanian, MD
Marco Valgimigli, MD
Ron Waksman, MD
Gerald S. Werner, MD, PhD
Janet F. Wyman, MSN, ACNS-BC
Paul Yock, MD
Christopher K. Zarins, MD
Thomas Zeller, MD
Bram D. Zuckerman, MD
Organizational Committee
Andrea Abizaid, MD, PhD
Fernando Alfonso, MD, PhD
Somjot S. Brar, MD
Stephen Balter, PhD
Antonio L. Bartorelli, MD
Lee N. Benson, MD
Joseph Carrozza, MD
Christina A. Chadwick, RN, MSN
Michael B. Collins, MD
Joseph S. Coselli, MD
Nick Curzen, PhD
John S. Douglas Jr, MD
Michael E. Farkouh, MD, MSc
Frederick Feit, MD
Philippe Genereux, MD
Ulrich Gerckens, MD
A. Marc Gillinov, MD
Cindy L. Grines, MD
Howard C. Herrmann, MD
James B. Hermiller Jr, MD
Richard R. Heuser, MD
John McB. Hodgson, MD
Leo Nelson Hopkins, MD
Kurt Huber, MD
Alice K. Jacobs, MD
David E. Kandzari, MD
Osamu Katoh, MD
Susheel Kodali, MD
Raghu Kolluri, MD
Bon-Kwon Koo, MD, PhD
Edward M. Kreps, MD
Frederick Kushner, MD
Glenn N. Levine, MD
Scott Lim, MD
Brij Maini, MD
Tift Mann, MD
D. Christopher Metzger, MD
Philip M. Meyers, MD
Issam D. Moussa, MD
Srihari S. Naidu, MD
Manesh R. Patel, MD
Mahmood K. Razavi, MD
John F. Rhodes, MD
Binoy K. Singh, MD
Thomas D. Stuckey, MD
Clemens von Birgelen, MD, PhD
Bonnie H. Weiner, MD, MSEC, MBA
David O. Williams, MD
Bernhard Witzenbichler, MD
TCT2011
Associations and
Affiliations
American Association for
Thoracic Surgery
American College of Cardiology
ASEAN Federation of Cardiology
Association on Cardiovascular
Interventions of the Polish
Cardiac Society
Belgian Working Group of
Interventional Cardiology
Brazilian Society of
British Cardiovascular
Intervention Society
Canadian Association of
Cardiac Society of Australia and
New Zealand
Cardiology Society of India
CardioVascular Research
Foundation Asia
China Interventional Therapeutics
Chinese Society of Cardiology
Cardiovascular Intervention
Association of Thailand
Chinese Society of Cardiology
Circulation: Cardiovascular
Interventions
TCT International
Advisory Committee
Argentina
Rubén Piraino, MD
Australia and New Zealand
James Cameron, MD
Belgium
Glenn Van Langenhove, MD, PhD
Brazil
Alexandre Abizaid, MD
Canada
Erick Schampaert, MD
Chile
Oscar A. Mendiz, MD
China
Dayi Hu, MD
Croatia
Aleksander Ernst, MD, PhD
Czech Republic
Petr Kala, MD, PhD
Denmark
Anders Junker, MD
Leif Thuesen, MD
Colegio Argentino de Cardioangiologia
Intervencionista
Croatia Working Group of
Iran Heart Association
Singapore Cardiac Society
Israeli Working Group on Interventional
Society for Cardiovascular
Cardiology/The Israel Heart Society
Interventional Cardiology,
Italian Society of Invasive Cardiology
Croatian Cardiac Society
Japanese Association of
Czech Working Group of Interventional
Cardiology of the Czech Society
of Cardiology
Danish Group of Interventional
Cardiology
Dutch Society of Interventional
Cardiology
Dutch Working Group on
Egyptian Society of Cardiology
Finland Working Group on
Greece Working Group on
Heart Association of Thailand Under
the Royal Patronage of
His Majesty the King
Hellenic Cardiological Society
International Society of
Endovascular Specialists
Therapeutics
Joint Interventional Meeting
Journal of the American College
of Cardiology
Korean Society of Cardiology
Malaysian Interventional
Cardiology Society
Cardiologia Intervencionista
Society of Invasive Cardiovascular
Professionals
Spanish Working Group on
Spanish Society of Angiology and
Vascular Surgery
Stanford Biodesign
Morocco Working Group on
Swedish Working Group on Coronary
Nordic-Baltic Study Group of
Heart Disease
Swedish Working Group on PCI/
Swedish Society of Cardiology
p-c-i Live
Swiss Society of Cardiology
Pediatric Interventional Cardiac
TCT Mediterranean
Symposium
Preventive Cardiovascular
Nurses Association
Russian Society of Endovascular
Surgery
Endovascular Therapy
Cardiology and Angiology
and New Zealand
Sociedad Latin Americana de
Mexican Society of Cardiology
Russian Society of Interventional
Cardiac Society of Australia
Angiography and Interventions
Sociedad de Cardiologia
Intervencionista de Mexico
Cardiovascular Intervention and
International Symposium on
Interventional Council of the
Cardiovascular
Therapeutics
TCT Russia
Turkish Working Group of
Working Group on Interventional
Cardiology and Acute Coronary
Syndrome/The Swiss Society
of Cardiology
Saudi Arabia Cardiology
Interventional Group
Science Innovation Synergy
Egypt
Latin America
Spain
Mohamed Sobhy, MD
Oscar A. Mendiz, MD
Marc Cairols, MD
Europe
Malaysia
Josefina Mauri, MD
Carlo Di Mario, MD
Rosli Mod Ali, MD
Sweden
Finland
Mexico
Göran Olivecrona, MD
Karl Andersen, MD, PhD
Jose Luis Leyva Pons, MD
Frederik Schersten, MD
Greece
Carlos Martínez-Sánchez, MD
Switzerland
Lambros Michalis, MD
Morocco
Giovanni Battista Pedrazzini, MD
Georgios Parcharidis, MD
Abdelhamid Moustaghfir, MD
Thailand
Iceland
Poland
Sarana Boonbaichaiyapruck, MD
Karl Andersen, MD, PhD
Waldemar Banasiak, MD
Yingnoi Uboldejpracharak, MD
India
Russia
Turkey
Samuel K. Mathew, MD
Bagrat G. Alekyan, MD
Muzaffer Degertekin, MD, PhD
Iran
Zaza Kavteladze, MD
United Kingdom
Feridoun Noohi, MD
Saudi Arabia
Mark A. de Belder, MD
Israel
Mohammed Balghith, MD
Ran Kornowski, MD
Serbia
Italy
Miodrag Ostojic, MD
Antonio Colombo, MD
Singapore
Bernard Kwok, MD
Japan
South Korea
Takeshi Kimura, MD
Chong Yun Rhim, MD
Masahiko Ochiai, MD
7
Acknowledgments
The TCT program development and organization
Laura A. McKeown
is a year-round effort. Many people play important
Editorial Services
Medical Writer/Editor
roles that ensure the success of TCT by contributing
Thomas Mortimer
their experience and expertise. The Cardiovascular
Editorial Services
Proofreader
Research Foundation wishes to give special thanks
Cody Pietras
to all those who have worked tirelessly and with
Web Sites
great dedication to our mission.
Consultant
Leonard Posso
Graphic Designer
Marketing and Creative Services
Planning Group
Johnnie White, CMP
Elizabeth Burke
Executive Director
Executive Assistant
Meetings and Educational Services
Stephen Cannarelli
Caitlin C. Cox
Senior Design Manager
Senior Medical Writer/Editor
Editorial Services
Jeff Chamlee
Elizabeth Coyle
Service Coordinator
Multimedia Manager
Senior Meeting Planner
Web Sites
Meeting Planning
Irma Damhuis
William A. Himmelsbach,
MPH, FACHE
President and Chief Executive Officer
Matthew P. Pazaryna
Chief Financial Officer
Donald L. Abrams, Esq
General Counsel
Johnnie White, CMP
Executive Director
Industry Relations
Administrative
Support Staff
Abby Rees
Nancy Collins
Program Coordinator
Gabriella Gallo-Cisak
CME Program Development
Diane Salerno-Madrid
Program Project Manager
Adam Saunders
E-Marketing and Customer
Clinical Trials Center
Rasha Aaskar
Maria Alfonso
Greg Simsic
Sinan Biro
Kim Dalton
Consultant
Sonia Burgher
Director
Isabel Corral
External Relations
Editorial Services
Denise Tong
Ecaterina Cristea
Josh Hartman
Alexander Damhuis
Associate
Director
CME Coordinator
Web Sites
Lisa Hathaway Stella, CMP
Christina DiFrancesco
Senior Copy Editor
Director
Senior Coordinator, Grants
Editorial Services
Industry Relations
Industry Relations
Jason Kahn
Scott Allan Wallick
Rosa De Jesus
Ossen Delbrun
Marina Dizik
Champika Djurkovic
Ovidiu Dressler
LaTosha Eligon
Todd Worms
Monica Embacher
Tara Donegan
Project Manager
Martin Fahy
Manager, Academic Content
Meeting Planner
Raza Hijazi
Editorial Services
Meeting Planning
Margaret Zetts
Cecilia Jade Hart
Fun Lee, CMP
Michelle Gan
Program Coordinator
Director
Senior CME Coordinator
Meeting Planning
Ted Silverstein
Stephanie Gutch
Director
Manager, Operations and Content
Web Sites
Todd Wagner
Katie Herrion
Katharine Lymberis
Manager, Print Production
Senior Associate
Catalin Mindrescu
Industry Relations
Gary S. Mintz, MD
Colleen Whelan
Guadalupe Hogarty, CMP
Gopinathan Mohan
Director
Senior Meeting Planner
Sophia Papamitrou
Meeting Planning
Helen Parise, ScD
Michael Houk
Multimedia Designer
Yael L. Maxwell
Editorial Services
8
Tricia Rawh
Management Team
Senior Management Group
program ·
Irene Hueter
Jaclyn Jacobson
Elena Konovalova
Laura LaSalle
Wangyue Liu
Sarah Luijpers, PMP
Mitchel Lustre
Nicoleta Pavlovici
Khary Perry
Ecaterina Prepelita
Eugene Salgado
Raquel Sanchez
Shawnalee Vassell
Stepahnie Wolin
Sarah McDaniel
Douey Wright
Program Planner
Ke Xu
Yuliya Yureneva
TCT2011
Finance
Yuliya Bogomolny
Jenni Kong
Eileen Morales
Cheryl Turnbull
Human Resources
Kelli O’Toole
Emilia K. Valtcheva
Office Services
Aryel Flores De Valgaz
The Jack H. Skirball
Center for Cardiovascular
Research
Juan Carbonell
Francy Castro
Carlos Fernandez Ceballos
Yan-Ping Cheng
Gerard B. Conditt
Duane Dennis
Jennifer Duffy
Juan F. Granada, MD
Anguo Gu
Jaime Guzman
Greg L. Kaluza, MD, PhD
Information Technology
Jennifer McGregor
Patricia Mount
Louis Cruz
Athanasios Peppas
Richard Han
Armando Tellez, MD
Alain Moise
Kathy Troyan
Anthony Napoli
Alyssa Wagner
Kimberly White
External Relations
Irma Damhuis
Judy Romero
Geng-Hua Yi
Cardiovascular
Therapeutics
Factoid Faculty
Elissa Altin, MD
Usman Baber, MD
Louise Buchanan, MD
Adriano Caixeta, MD, PhD
Bimmer E. Claessen, MD, PhD
Jose Costa, MD
Daniel Silva Chamié de Queiroz, MD
Isaac George, MD
Philip Green, MD
Diaa Hakim, MD
Vishal Kapur, MD
Farhan Khawaja, MD
Thosaphol Limpijankit, MD
Jorge Magallon, MD
Vinod Patel, MD
Elias Sanidas, MD
Georgios Vlachojannis, MD
Tadayuki Yakushiji, MD
Jennifer Yu, MD
Board of Directors of the
Cardiovascular Research
Foundation
Eric B. Woldenberg, Esq
Office of Legal Affairs
Donald L. Abrams, Esq
Quality Assurance
Chairman
William A. Himmelsbach,
MPH, FACHE
President and Chief Executive Officer
Joseph G. Beck
Whitney Petrie
Colette Y. Gardner
Maria Rossolino
Arthur J. Pergament
Eric A. Rose, MD
Marvin L. Woodall
9
Acknowledgments
Columbia University
Medical Center
AnnMarie Kelly
Delita Glori-Feri, RN
Rose Ang, RN
Eileen Madison
Denise Groff, RN
Samantha Allen
Faculty
Enid Montalvo
Dennis Sta. Maria, RN
Scott Cooper, RN
Dora Mussenden
Derrrick Horne, RN
Serge Sabo Sr.
Diane Pearson
Ellen Moreno, RN
Sheehan Raab
Jackie Price-Saunders
Ellen Pitiger, RN
Sheri Pinto, RN
Brenda Puentes
Emil Osorno, RN
Siobhan Reilly, RN
Aura Adelhaydy Ramirez
Eufemia Penaflor, RN
Soojin Horland, RN
Fernando Ramirez
Evaine Iral-Fallurin, RN
Stephanie Quach Luc, RN
Catherine Reyes
Fall Fatou-Khady
Stephen Balter, PhD
Jacqueline Rosenthal
Felicia Leon
Tamara Grazette, RN
Evelyn Rendon
Gerard Cowles, RN
Tamara Van Gelder
Tiesha Ruiz
Gleonisi Ramirez
Tina Jones
Toni Russo
Greta Martin
Viola King
Diane Salerno-Madrid
Harold Stella
Vivian Tamara
Jeanie Sohn
Hilda Devlin, RN
Woodley Perpignan, RN
Alina Sokolinskaya
Holly McCall, RN
Yang Fang
Annicia Thomas
Hongge Wei
Yovana Chardon
Samantha Tsiolis
Isidro Gonzalez
Yvette Reyes
Jaime Crist, RN
Zaira Marcelino
Jan Greenfield, RN
Zoraya Boissard
Mark A. Apfelbaum, MD
Braulio Flores, MD
Alexander Gorodnitskiy, MD
William A. Gray, MD
Rebecca Hahn, MD
Nellie Kalcheva, MD
Ajay Kirtane, MD
Susheel Kodali, MD
Edward Kreps, MD
Martin B. Leon, MD
Manish Parikh, MD
LeRoy E. Rabbani, MD
Norbert Rainford, MD
Abdollah Sedighi, MD
Clinical Research Staff
Warren Sherman, MD
Angelica Castaneda, BS
Binoy Singh, MD
Diane Weber Cannone, BA
Varinder Singh, MD
Vasiliki Chantziara, MD
Kate Dalton, MS
Gregg Stone, MD
Zumara de la Cruz, BS
Giora Weisz, MD
Eunice Dilone
Mathew Williams, MD
Ahmed Hassanein, MD
Ashlee Mattone, BS
Clinical Instructors
Andy Morales, MD
Benoit Daneault, MD
Gordian Ndubizu, BS
Isaac George, MD
Lauren Privitera, MPH
Elana Y. Koss, MD
Jean-Michel Paradis, MD
Fernando Sosa, BS
Philip Green, MD
Niurka Suero, BA, MA
Vishal Kapur, MD
Joyce Ann Thomas, BS
Farhan Khawaja, MD
Giora Weisz, MD
Jorge Magallon, MD
Treena Williams, ME
Tamim Nazif, MD
Prabhdeep Sandhu, MD
Wilson Arango, FNP- BC
Russell Brandwein, PA-C
Marian Hawkey, RN
10
Rachel Yoo, MA
Cath Lab
Clinical Staff
Tiffany Wongh, PA-C
Elaine Rodriguez, MPH
Sowmya Shree, MD
Fellows
Susan Schnell, ACNP-c
Yasir Qureshi, MD
Alex Castillo
Alla Ogii-Landis, RN
Andrew Stefanski
Annelle Williams
Araceli Limbaga, RN
Barbara Stock, RN
Beatriz Custodio
Administrative Staff
Betty Yu-Chong, RN
Regina Amelko
Brian Aquino, RN
C. Jeanette Bermeo
Brian Padilla
Donna Brown
Byron Johnson
Rosie Calcano
Christine Carthy, RN
Beth Carraturo
Christopher Bechtel
Veronica Garcia
Claudia Echeverry
Tiffany Gibney
Danielle Thompson
Charlette Gomez
David Borsh, RN
Yemilet Gonzalez
Debbie Donaldson
Stacy Hall
Debbie Maccaro
Bevi James
Deborah Plant, RN
Suzanne Jakubiak
Deirdre Conlon, RN
Rona Kahn
Del Mundo, Regel, RN
program ·
Janice Sbarro
Jhan Nunez
Joanna Castro
Jodi Conway, RN
Joel De Jesus
Kathleen Casey, RN
Kelle Brocker, RN
Kelly Light, RN
Ketevan Telia
Lenny Guzman
Leslyn Hall
Lihua Fang
Louis Lopez
Lu Kan Gorman RN
Margaret Griffin, RN
Maria Lourdes Tan-Uy,RN
Maria Mamuri, RN
Maria Younessian, RN
Maria-Cristina Beltran, RN
Maricar Jordana, RN
Mary Egan, RN
Melanie Diaz, RN
Melissa Pusterla, RN
Michael De Leon, RN
Michael Sgarella
Michele Foley, RN
Michelle Lindquist, RN
Michelle Murray, RN
Miriam Candaroma, RN
Moira Smith RN
Myriam Medrano
Nenita Generales, RN
Noel Castor, RN
Norma Ennis
Osama Amine
Patrick Hayford
Patrick Kline, RN
Paul Kelley, RN
Phyllis Rodriguez
Rene Ambrona
Rodello Diamante
Ronald Rigor, RN
Physician Assistants
Alicia Adams, RPA-C
Sean Ahearn, RPA-C
Anna Akker, RPA-C
Gretchen Andersen, RPA-C
Michael Bergman, RPA-C
Priscilla Binsack, RPA-C
Russell Brandwein, RPA-C
Mario Buss, RPA-C
Kamman Chan, RPA-C
Tara Collins, RPA-C
Pilar Dolcimascolo, RPA-C
Galina Dumchin, RPA-C
Marian Elbert, RPA-C
Jessica Forman, RPA-C
Neisha Hariprashad, RPA-C
Seing Houy, RPA-C
Nancy Copeland-Kelley, RPA-C
Kristin Maidhof, RPA-C
Irina Pilosova, RPA-C
Michael Querijero, RPA-C
Eileen Redmond, RPA-C
Sofia Romero, RPA-C
Jamie Shein, RPA-C
Mindy Sporn, RPA-C
Bethany West, RPA-C
Kayin Wu, RPA-C
TCT2011
Abstract Reviewers
The TCT Course Directors and the
Abstract Selection Committee,
which was chaired by Gary S. Mintz,
MD, wish to express their sincere
appreciation to all the physicians
who selflessly donated their time and
expertise as TCT Abstract Reviewers.
J. Dawn Abbott, MD
Andrea Abizaid, MD
Takashi Akasaka, MD
Fernando Alfonso, MD
Steven Almany, MD
John Ambrose, MD
Zahid Amin, MD
Dominick Angiolillo, MD
Gary M. Ansel, MD
David Antoniucci, MD
Robert Applegate, MD
Stephen Balter, MD
Adrian Banning, MD
Gerald Barbeau, MD
Colin Barker, MD
Jozef Bartunek, MD
Theodore A. Bass, MD
Eric R. Bates, MD
Mark Bates, MD
Kevin Beatt, MD
Jorge Belardi, MD
Keith Benzuly, MD
Nirat Beohar, MD
Daniel Berman, MD
Daniel Berrocal, MD
Olivier Bertrand, MD
Anuj Bhasin, MD
Deepak Bhatt, MD
John Bittl, MD
William Boden, MD
Steven Bolling, MD
Raoul Bonan, MD
J.J.R.M. (Hans) Bonnier, MD
Alessandro S. Bortone, MD
Bruce Bowers, MD
Somjot Brar, MD
Jeffrey Breall, MD
Stephen Brecker, MD
Sorin Brener, MD
Carlo Briguori, MD
Emmanouil Brilakis, MD
Ralph Brindis, MD
Jeffrey Brinker, MD
Bruce R. Brodie, MD
Maurice Buchbinder, MD
Robert Byrne, MD
Christopher P. Cannon, MD
Louis A. Cannon, MD
Davide Capodanno, MD
Blase Carabello, MD
Mauro Carlino, MD
John Carroll, MD
Joseph P. Carrozza, MD
Paul N. Casale, MD
Charles E. Chambers, MD
Seemant Chaturvedi, MD
Shaoliang Chen, MD
Stanley Chetcuti, MD
Alaide Chieffo, MD
Kenneth Chin, MD
Leslie Cho, MD
Michael W. Cleman, MD
Marc Cohen, MD
David Cohen, MD
Mauricio Cohen, MD
Tyrone Collins, MD
Antonio Colombo, MD
Jose A. Condado, MD
Jose De Ribamar Costa, MD
David Cox, MD
Michael Crawford, MD
Fernando Cura, MD
Nick Curzen, MD
Donald Cutlip, MD
Charles J. Davidson, MD
Jose M. De La Torre Hernandez, MD
Robbert De Winter, MD
Larry S. Dean, MD
Gregory Dehmer, MD
Ali Denktas, MD
Germano Di Sciascio, MD
Nabil Dib, MD
Stefanie Dimmeler, MD
Daniel Diver, MD
Simon R. Dixon, MD
Douglas Drachman, MD
Henricus J. Duckers, MD
Vladimir Dzavik, MD
Holger Eggebrecht, MD
Stephen G. Ellis, MD
Raimund Erbel, MD
Andrejs Erglis, MD
David Erlinge, MD
Steven M. Ettinger, MD
Peter Fail, MD
Tony Farah, MD
Michael Farkouh, MD
Dave Faxon, MD
Frederick Feit, MD
Ted Feldman, MD
Dmitriy Feldman, MD
Fausto Feres, MD
Francisco Fernandez-Aviles, MD
Michael Fifer, MD
Hans R. Figulla, MD
Tim A. Fischell, MD
Gregory Fontana, MD
Robert Freedman, MD
William French, MD
Shmuel Fuchs, MD
Lawrence Garcia, MD
Hector Garcia-Garcia, MD
Eulogio Garcia, MD
Kirk Garratt, MD
Efrain Gaxiola, MD
Junbo Ge, MD
Jon George, MD
Anthony Gershlick, MD
Gary Gershony, MD
Ian Gilchrist, MD
Linda Gillam, MD
Robert Giugliano, MD
Dietmar Glogar, MD
Sheldon Goldberg, MD
Steven Goldberg, MD
Mark Goldberger, MD
Paul C. Gordon, MD
Evelyne Goudreau, MD
Neil Goyal, MD
Juan F. Granada, MD
Christopher Granger, MD
William A. Gray, MD
Liliana Grinfeld, MD
Luis Gruberg, MD
Marek Grygier, MD
Luis A. Guzman, MD
Jaap N. Hamburger, MD
Michalis Hamilos, MD
Yaling Han, MD
George Hanzel, MD
Jan Harnek, MD
Robert Harrington, MD
Michael Haude, MD
Jose Henriques, MD
Michel Henry, MD
Timothy D. Henry, MD
David J. R. Hildick-Smith, MD
Jonathan Hill, MD
Willibald Hochholzer, MD
Rainer Hoffmann, MD
Ralf Holzer, MD
Myeong-Ki Hong, MD
Stephen Hoole, MD
Craig Hooper, MD
Eric Horlick, MD
Phillip Horwitz, MD
Dongming Hou, MD
Thomas Ischinger, MD
Alice K. Jacobs, MD
Michael R. Jaff, MD
Farouc Jaffer, MD
Ik-Kyung Jang, MD
Lisa Jennings, MD
Allen Jeremias, MD
Neeraj Jolly, MD
Sanjit Jolly, MD
Christoph Kaiser, MD
Petr Kala, MD
Greg L. Kaluza, MD
Soo-Jin Kang, MD
Hsien-Li Kao, MD
Samir Kapadia, MD
Aaron Kaplan, MD
Adnan Kastrati, MD
Barry Katzen, MD
Upendra Kaul, MD
Henning Kelbaek, MD
Dean Kereiakes, MD
R. Stefan Kiesz, MD
Young-Hak Kim, MD
Hyo-Soo Kim, MD
Nicholas Kipshidze, MD
Ajay J. Kirtane, MD
Neal Kleiman, MD
Lloyd Klein, MD
Raghu Kolluri, MD
David Kong, MD
Jacques Koolen, MD
Ran Kornowski, MD
Jan Kovac, MD
Zvonimir Krajcer, MD
Henry Krum, MD
Aaron Kugelmass, MD
Michael Kutcher, MD
Vincent On-Hing Kwok, MD
Jean-Marc Lablanche, MD
Antoine Lafont, MD
Roger Laham, MD
Gervasio Lamas, MD
Cardiovascular
Therapeutics
John Lasala, MD
Azeem Latib, MD
Bonello Laurent, MD
Michel Le May, MD
Guy LeClerc, MD
Michael Lee, MD
Massoud Leesar, MD
Pedro Lemos, MD
Jonathan Leor, MD
Norman Lepor, MD
Amir Lerman, MD
Michael Lim, MD
Hugo Londero, MD
Robert Lookstein, MD
Chaim Lotan, MD
Kapildeo Lotun, MD
Tom Mabin, MD
Lindsay Machan, MD
Akiko Maehara, MD
Francesco Maisano, MD
Ganesh Manoharan, MD
Steven Manoukian, MD
Jack Martin, MD
Pedro Martinez-Clark, MD
Julinda Mehilli, MD
Roxana Mehran, MD
Maurizio Menichelli, MD
D. Chris Metzger, MD
Erich Minar, MD
Michael Mooney, MD
Pedro Moreno, MD
J. Brent Muhlestein, MD
Brad Munt, MD
Toshiya Muramatsu, MD
Subbarao Myla, MD
Srihari Naidu, MD
Massimo Napodano, MD
Franz-Josef Neumann, MD
Thach Nguyen, MD
Stephen Nicholls, MD
Andrzej Ochala, MD
Masahiko Ochiai, MD
Takao Ohki, MD
Goran Olivecrona, MD
William O’Neill, MD
Charles D. O’Shaughnessy, MD
Miodrag Ostojic, MD
Igor Palacios, MD
David Paniagua, MD
Keyur Parikh, MD
Seung-Jung Park, MD
Raghotham Patlola, MD
Wes Pedersen, MD
Carlos Pedra, MD
Marc Penn, MD
John Petersen, MD
Harry R. Phillips, MD
Nicolo Piazza, MD
Augusto Pichard, MD
Nico Pijls, MD
Duane Pinto, MD
Michael Poon, MD
Francesco Prati, MD
John Puskas, MD
Shakeel Qureshi, MD
Leroy Rabbani, MD
11
Acknowledgments
Sunil Rao, MD
Sudhir Rathore, MD
Simon Redwood, MD
Jon Resar, MD
Expedito Ribeiro, MD
Charanjit Rihal, MD
David Rizik, MD
Josep Rodes-Cabau, MD
Jason Rogers, MD
Ivan Rokos, MD
Eric Roselli, MD
Jamil Saad, MD
Robert D. Safian, MD
Francesco Saia, MD
Luigi Salemme, MD
Giuseppe Sangiorgi, MD
Teguh Santoso, MD
Gennaro Sardella, MD
Lowell Satler, MD
Jorge Saucedo, MD
Bruno Scheller, MD
Paul Schoenhagen, MD
Joachim Schofer, MD
Helmut Schuhlen, MD
Gerhard Schuler, MD
Allan Schwartz, MD
Amit Segev, MD
Hubert Seggewiss, MD
Victor Serebruany, MD
Ashok Seth, MD
Samin Sharma, MD
Marc Shelton, MD
Warren Sherman, MD
Mehdi Shishehbor, MD
Dirk Sibbing, MD
Robert Siegel, MD
Horst Sievert, MD
Ulrich Sigwart, MD
Sigmund Silber, MD
Frank Silvestry, MD
Tomasz Siminiak, MD
Daniel Simon, MD
Richard Smalling, MD
Mohamed Sobhy, MD
Robert Sommer, MD
Amanda Sousa, MD
Vankeepuram Srinivas, MD
Eugenio Stabile, MD
Terje Steigen, MD
Satoru Sumitsuji, MD
Robert Superko, MD
Maarten J. Suttorp, MD
Corrado Tamburino, MD
Huay-Cheem Tan, MD
Jean-François Tanguay, MD
Mitsuyasu Terashima, MD
Martyn Thomas, MD
Christopher Thompson, MD
Leif Thuesen, MD
Henry Ting, MD
Carl L. Tommaso, MD
Pim Tonino, MD
Sam Tsimikas, MD
Thomas Tu, MD
E. Murat Tuzcu, MD
Kinzo Ueda, MD
Barry Uretsky, MD
Marco Valgimigli, MD
12
program ·
Glenn Van Langenhove, MD
Stefan Verheye, MD
Francesco Versaci, MD
Renu Virmani, MD
Clemens Von Birgelen, MD
Marco Wainstein, MD
Ron Waksman, MD
Darren Walters, MD
Thomas Walther, MD
Jie Wang, MD
Sergio Waxman, MD
Bonnie H. Weiner, MD
Neil J. Weissman, MD
Giora Weisz, MD
Peter Wenaweser, MD
Brian Whisenant, MD
Robert Whitbourn, MD
Christopher White, MD
Harvey White, MD
Michael Wholey, MD
Robert L. Wilensky, MD
Mathew Williams, MD
David Williams, MD
Peter Wilmshurst, MD
B. Hadley Wilson, MD
Jochen Wöhrle, MD
Wojciech Wojakowski, MD
S. Chiu Wong, MD
Bo Xu, MD
Alan Yeung, MD
Hiroyoshi Yokoi, MD
Andreas Zeiher, MD
David Zhao, MD
Late Breaking Trial and
First Report Reviewers
Steven Bailey, MD
Michel Bertrand, MD
David Cohen, MD
Antonio Colombo, MD
George D. Dangas, MD
David Faxon, MD
Ted Feldman, MD
Bernard Gersh, MD
Tony Gershlick, MD
Juan F. Granada, MD
Liliana Grinfeld, MD
Christian Hamm, MD
Adnan Kastrati, MD
Sanjay Kaul, MD
Dean Kereiakes, MD
Ajay J. Kirtane, MD
Martin B. Leon, MD
Morice Marie-Claude, MD
Roxana Mehran, MD
Ian T. Meredith, MD
Gary S. Mintz, MD
David Moliterno, MD
John Ormiston, MD
Seung-Jung Park, MD
Sigmund Silber, MD
Gregg W. Stone, MD
John G. Webb, MD
Giora Weisz, MD
Karl-Heinz Kuck, MD
Harvey White, MD
Massoud Leesar, MD
Pedro Lemos, MD
Martin B. Leon, MD
Challenging Case
Reviewers
Scott Lim, MD
J. Dawn Abbott, MD
Alexandre Abizaid, MD
Patrick Mccarthy, MD
Andrea Abizaid, MD
Roxana Mehran, MD
S. Hinan Ahmed, MD
Neil Moat, MD
Dominick Angiolillo, MD
Douglass Morrison, MD
Antonio Bartorelli, MD
Issam Moussa, MD
Theodore Bass, MD
John Ormiston, MD
Eric Bates, MD
Igor Palacios, MD
Mark Bates, MD
Seung-Jung Park, MD
Jorge Belardi, MD
Lynn Peng, MD
Lee Benson, MD
Anna Sonia Petronio, MD
John Bittl, MD
Nicolo Piazza, MD
Peter Block, MD
Duane Pinto, MD
Raoul Bonan, MD
Jeffrey Popma, MD
Emmanouil Brilakis, MD
John Reilly, MD
Jeffrey Brinker, MD
Chet Rihal, MD
Carlos Ruiz, MD
Samuel Butman, MD
Lowell Satler, MD
Blase Carabello, MD
Robert Schainfeld, MD
Charles Chambers, MD
Joachim Schofer, MD
Alaide Chieffo, MD
Gerhard Schuler, MD
Robert Chilton, MD
Robert Schwartz, MD
Mehmet Cilingiroglu, MD
Allan Schwartz, MD
Mauricio Cohen, MD
Ashok Seth, MD
Tyrone Collins, MD
Paul Sorajja, MD
Antonio Colombo, MD
Martyn Thomas, MD
Marco Costa, MD
Jonathan Tobis, MD
Charles Davidson, MD
Carl Tommaso, MD
Larry Dean, MD
Thomas Tsai, MD
Thomas Tu, MD
David Faxon, MD
E. Murat Tuzcu, MD
Ted Feldman, MD
Barry Uretsky, MD
Marc Feldman, MD
Nicolas Van Mieghem, MD
Gregory Fontana, MD
Bonnie Weiner, MD
Olaf Franzen, MD
Olaf Wendler, MD
Ian Gilchrist, MD
Brian Whisenant, MD
Steven Goldberg, MD
Thomas Zeller, MD
James Goldstein, MD
Paul Grayburn, MD
Donald Hagler, MD
Timothy Henry, MD
James Hermiller, MD
Richard Heuser, MD
Ziyad Hijazi, MD
John Hirshfeld, MD
Alice Jacobs, MD
Allen Jeremias, MD
Thomas Jones, MD
Samir Kapadia, MD
Pieter Kappetein, MD
Navin Kapur, MD
Morton Kern, MD
Carey Kimmelstiel, MD
Takeshi Kimura, MD
Ran Kornowski, MD
Michael Mack, MD
TCT2011
Commercial Support
Cardiovascular
Therapeutics
Commercial Support Acknowledgement
TCT 2011 is sponsored by the Cardiovascular Research Foundation and partially funded
through educational grants from commercial supporters.
The Cardiovascular Research Foundation strives to ensure that its programs are as educational as possible and free from bias.
To support this endeavor, TCT directors and co-directors create organizational and scientific committees to assist in educational
content development and content oversight for live cases, spotlight sessions, case reviews, practical workshops,
and scientific symposia. These sessions are developed without influence from commercial supporters.
The educational grant support of our industry colleagues, who, like the Cardiovascular Research Foundation, are dedicated to
educating medical professionals and the public to enhance patient outcomes, helps to make each TCT possible.
The Cardiovascular Research Foundation gratefully acknowledges
the TCT 2011 MAJOR BENEFACTORS:
Abbott Vascular
AstraZeneca
Boston Scientific Corporation
Cordis Cardiac and Vascular InstituteSM
Edwards Lifesciences
Medtronic CardioVascular
The Cardiovascular Research Foundation appreciates
the educational grant support for the Faculty Support
Program provided by:
ABIOMED, Inc.
AngioScore, Inc.
Biotronik
MAQUET Cardiovascular
The Cardiovascular Research Foundation gratefully acknowledges
the TCT 2011 BENEFACTORS:
ABIOMED, Inc.
Terumo Medical Corporation
TherOx, Inc.
The Cardiovascular Research Foundation gratefully
acknowledges the TCT for Surgeons: Creating and
Securing the Future MAJOR BENEFACTORS:
Abbott Vascular
The Cardiovascular Research Foundation appreciates the
educational grant support for TCT 2011 provided by:
BridgePoint Medical, Inc.
Cook Medical
Cytori Therapeutics
Direct Flow Medical, Inc.
Genzyme
Guerbet LLC
Lutonix
Mitralign, Inc.
Tryton Medical, Inc.
Valtech Cardio
W.L. Gore & Associates
The Cardiovascular Research Foundation appreciates
the educational grant support for TCT for Surgeons:
Creating and Securing the Future provided by:
Cook Medical
Direct Flow Medical
St. Jude Medical
The Cardiovascular Research Foundation appreciates the
educational grant support for the 20th Annual Cardiovascular
Nurse Technologist Symposium provided by:
Abbott Vascular
Cordis Cardiac and Vascular InstituteSM
St. Jude Medical
Disclosure Statement
It is the policy of the Cardiovascular Research Foundation to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational
activities. Commercial support from industry does not influence educational content, faculty selection, and/or faculty presentations, and, therefore,
does not compromise the scientific integrity of the educational activity.
Discussion of off-label product usage and/or off-label product use during live cases is made at the sole discretion of the faculty. Off-label product discussion and usage
are not endorsed by the Cardiovascular Research Foundation or the conference directors of this activity.
Faculty participating in continuing medical education activities sponsored by the Cardiovascular Research Foundation are required to disclose to the activity audience
any real or apparent conflicts of interest related to the content of their presentations. Faculty not complying with this policy are not permitted to participate in this activity.
(As of 9/26/2011)
13
Special Activities
Education
Challenging Case Multiplex and
Poster Presentations
Keynote Speaker: Michio Kaku, PhD
The renowned theoretical physicist,
futurist, and author Dr. Michio Kaku will be
providing the keynote address, “The Future
of Humankind,” Wednesday, November 9,
10:40 am, in the Main Arena of the Moscone
Center. Please see page 100 for the
complete listing.
Please drop off your business card at the
CRF booth in the Partnership Pavilion
on the first floor of Moscone North for a
chance to win autographed copies of Dr.
Kaku’s latest book, Physics of the Future.
There will be a book signing with Dr. Kaku
in the Partnership Pavilion on Wednesday,
November 9, at 11:30 am.
Dedicated Poster and Oral
Abstract and Challenging
Cases Video Abstracts
The presentation of original peer-reviewed
research is the basis of scientific discovery,
representing the heart of academic
medicine and offering participants
opportunities to interact with peers in an
intimate setting for critical review prior to
manuscript generation.
To emphasize TCT’s belief in the importance
of such research, all accepted abstracts will
be presented in a dedicated four-and-a-halfhour block during which there will be few
competing sessions. Abstracts, both oral
and poster, will be downloadable during
TCT in electronic format via TCTMD.com
and from the e-abstract viewing stations
located throughout the Moscone Center.
All abstracts are published in a special
supplement of the Journal of the American
College of Cardiology. Please see pages
60 and 82 for complete listings. New this
year, Challenging Cases Video Abstracts
will be presented during the Poster Abstract
Sessions. Please see page 79 for
complete listings.
Tuesday, November 8
Poster Abstract Sessions
8:00 am-10:00 am
The Challenging Case Multiplex will include
two theaters, the Challenging Case Theater
and the International Society-Sponsored
Case Theater. Over 550 physicians submitted
their most challenging coronary and
endovascular intervention and structural
heart disease cases to be presented at
TCT. The most remarkable cases will be
presented in the Challenging Case Theater
and published in Catheterization and
Cardiovascular Interventions. New this
year, Challenging Cases Video Abstracts
will be presented during the poster session
on Tuesday, 8:00 am-10:00 am. Challenging
cases will also be shown in the multiplex
organized under the auspices of numerous
international societies in the International
Society-Sponsored Case Theater. The
Challenging Case Multiplex is located in
Hall D of Moscone North. Please see pages
103, 123, and 140 for complete listings.
program ·
Hosted during the evenings of TCT Week,
Special Twilight Sessions will highlight
featured clinical research, presentations
on the hottest topics in interventional
cardiology and hosted must-see
international sessions in a more casual
setting with hors d’oeuvres. Please
see pages 54, 96, 114, and 134 for
complete listings.
Monday through Thursday, November 7-10
6:00 pm-8 :00 pm
The Moscone Center
Maintenance of Certification
(MOC) Course and ABIM
Simulation Sessions
The MOC Course will prepare you with the
2009, 2010, and 2011 update modules and
enhance your knowledge base and get you
updated for your ten-year recertification on
the ABIM and ABVM exams.
These sessions will be planned and
developed by the ACC in partnership
with CRF.
You can earn up to 30 credit points from
the home study module sessions at the
MOC Course and an additional 20 credit
points for participating in the Practice
Improvement Module (PIM). TCT can offer
you up to 50 credit points, half of the 100
credit points needed to sit for the secure
recertification examination. Please see
pages 104 and 124 for complete listings.
Tuesday, November 8
1:00 pm-6:00 pm
Hands on Hearts
ACC Educational Sessions
Co-sponsored by the American College of
Cardiology (ACC) and the Cardiovascular
Research Foundation (CRF)
Hot Topics in Clinical Cardiology: ACC.11
Highlights for the Intervention, Invasive,
and General Cardiologist (page 89)
Wednesday, November 9
12:15 pm-1:45 pm
ACC Fellows Session I. Advanced Training in
Valvular Heart Disease (page 107)
Special JACC Session: How to Write and
Evaluate Medical Journal Articles (page 109)
Thursday, November 10
12:15 pm-1:45 pm
ACC Fellows Session II. Advanced Training
in Structural (Non-valve) Heart Disease
(page 128)
ACC Practitioners Session: Innovations to
Manage, Maintain, and Expand Your
Clinical Practice (page 128)
Oral Abstract Sessions
10:15 am-12:30 pm
14
A favorite of TCT attendees, Hands on
Hearts includes actual pathological
specimens demonstrating human heart
disease as well as CT-generated casts
of human hearts prior to intervention,
ventricular septal disease, valves,
cardiomyopathies, coronary anomalies, and
special video vignettes from the bioskills
sessions presented at CRF’s Transcatheter
Valve Therapies (TVT) workshop. Please visit
the Hands on Hearts Pavilion in Hall D of
Moscone North.
Wednesday and Thursday, November 9-10
9:00 am-5:00 pm
Friday, November 11
9:00 am-12:00 pm
Learn the Technique Lunchtime
Sessions and Spotlight Sessions
New in 2011, the Learn the Technique
Lunchtime Sessions will demonstrate
step-by-step approaches to advanced
interventional techniques, relying heavily
on patient cases to showcase tips and tricks
TCT2011
to achieve success while avoiding (and,
if necessary, managing) complications.
Please see pages 109 and 129 for
complete listings.
Spotlight Sessions are a brand new
approach to the concurrent sessions from
previous TCTs and are now focused, clinical
issue-centered sessions with featured
lectures, case presentations, and special
“summary” sessions. Please see pages 104,
111, 126, 131, and 140 for
complete listings.
TCT for surgeons: Creating and
securing the future
The integrated four-day course within TCT
Week will be of special interest to cardiac
and vascular surgeons, highlighting
advanced techniques and emerging
devices specific to cardiovascular
surgery, as well as emphasizing emerging
areas of percutaneous and minimally
invasive therapies in which the surgeon
is increasingly participating or leading,
including transcatheter valve therapies and
structural heart and aortic aneurysm repair.
Please see pages 52, 59, 93, 106, 111,
and 114 for complete listings.
20th Anniversary of the
Cardiovascular Nurse
Technologist Symposium
Join us as we celebrate the 20th
anniversary of the Cardiovascular Nurse
and Technologist Symposium. The
symposium began two decades ago, when
TCT Director Martin B. Leon, MD, then at
Washington Hospital Center (Washington,
DC), invited nurses working there to share
their expertise at TCT. Please see pages 42
and 58 for complete listings.
Networking Opportunities
Partnership Pavilion
Come visit the CRF booth on the first
floor of Moscone North to learn about
the services CRF offers and also meet
representatives from the American College
of Cardiology and NewYork-Presbyterian/
Columbia University Medical Center.
For more information about each of
these organizations, please visit CRF
at www.crf.org, the ACC at
www.cardiosource.org/acc, NewYorkPresbyterian at www.nyp.org, and
Columbia University Medical Center
at www.cumc.columbia.edu.
Exhibit Hall Opening and Reception
Please join us at the opening of the Exhibit
Hall in the Moscone Center for lunch at
12:00 pm on Tuesday, November 8. Also,
there will be a special cocktail reception in
the Exhibit Hall on Tuesday, November 8,
5:30 pm-6:30 pm. All are welcome!
Attendee Lounge Sponsored by
TCTMD Connect
Meet with colleagues and connect with
other professionals at the Attendee Lounge,
in Hall D of Moscone North, sponsored by
TCTMD Connect, an online professional
media network designed and developed just
for you—the interventional cardiovascular
professional. Along with your free
membership to TCTMD (www.tctmd.com),
you can now network with colleagues,
blog about issues and updates relevant
to you and your practice, and collaborate
by uploading and downloading images,
presentations, and cases.
To sign up for TCTMD Connect, please visit
www.tctmd.com/connect, and please visit
the Attendee Lounge sponsored by TCTMD
Connect in Hall D of Moscone North.
Art from the Heart
Art from the Heart is a sculpture exhibition
provided by the international awardwinning sculptor Akiva Huber. Be sure
to see Mr. Huber’s exhibition during TCT
outside Hall D in Moscone North.
Technology
Smart Tags at TCT
Smart tags are made possible through
support from Edwards Lifesciences
With only your mobile device, access
detailed information and the slides from
the late breaking trial presentations and
abstract posters. Smart tags will be located
on the signs outside the room where late
breaking trials are presented and in the
poster abstract hall. Simply download the
free app at http://gettag.mobi from your
mobile device to gain access to the late
breaking trial presentations, and download
the QR code reader for your device to gain
access to the abstract posters.
Cardiovascular
Therapeutics
CRF MEEtings App for
iPhone and iPad
The CRF Meetings App is made possible
through support from Cook Medical
Keeping up to date with news and finding
the best sessions at TCT has never been
easier with our free app. You can get up-todate information on TCT, search agendas,
exhibitors, and faculty, add sessions to your
calendar, find out what’s going on in San
Francisco, and view the Virtual TCT stream
and the new “Best Practices” feature. You
can also network with faculty and other
TCT attendees. The free CRF Meetings App
is available from iTunes with the keyword
“CRF Meetings”.
TCTMD Gold
An initiative to provide an enhanced
online educational experience to the
interventional cardiovascular community,
this TCTMD offering includes access to
multimedia versions of presentations from
TCT and other conferences, downloadable
PowerPoint slides, and a host of premium
educational content in addition to
continuous access to news and other
educational opportunities now available to
current TCTMD members. Visit the TCTMD
Gold booth during TCT to learn more about
TCTMD Gold and to take a test drive, or visit
www.tctmd.com/gold.
Virtual TCT
Virtual TCT delivers live and on-demand
viewing of the Main Arena during TCT 2011
and for 30 days after the conference. Access
to Virtual TCT is provided complimentary to
all paid TCT Week and TCT in 3 attendees.
Wednesday and Thursday, November 9-10
8:00 am-6:00 pm
Friday, November 11
8:00 am-3:00 pm
Need to Know
Meals
Lunches will be served during Scientific
Symposia (Monday), at the opening of the
Exhibit Hall (Tuesday), and during lunchtime
activities (Wednesday and Thursday).
Concession stands will be available throughout
the Moscone Center and Exhibit Hall.
15
ACC and CRF
Joint Initiative
Joint Conflict of Interest
(COI) and Relationship with
Industry (RWI) Policies of
the Cardiovascular Research
Foundation (CRF) and
the American College of
Cardiology Foundation (ACC)
planning the activity) as well as faculty. For
a live activity, each faculty is required to
check-in upon arrival; and faculty who have
not completed their RWI declarations are
not allowed to enter the CME activity. For
enduring activities, the CME product is not
published, either online or in print, until all
declarations are completed.
CRF/ACC require and collect disclosure of
relationships with industry (RWI) from all
individuals who are in a position to control
or influence educational content. This is
done annually in conjunction with all of
CRF’s meetings and educational offerings
for which CME is offered (including
TCT, CRF’s major annual educational
event) and all of ACC’s meetings and
educational offerings for which CME
is offered (including the annual ACC
scientific session). All individuals involved
in directing, planning, and delivering
educational content for CRF and ACC
(course directors, planning committee
members, faculty, staff, etc) are required
to submit RWI disclosures prior to
participation; otherwise their participation
in the event is precluded. If disclosure
of RWI information is not already on file
at the inception of a new activity, that
information is collected at confirmation of
individual participation. This information
is also confirmed and updated prior to the
development of each CME activity to ensure
that the most up-to-date information is
collected and available. Likewise, nonphysician staff are required to complete RWI
Disclosure Declaration forms.
COI Resolution
COI (RWI) Declaration
The online Required Faculty Disclosure
Declaration form requires each individual
to identify financial relationships that
he or she and/or his or her spouse or
partner have had with any organization
within the preceding 12 months or that
is anticipated in the next 12 months that
could be perceived as a relevant conflict
of interest. Any individual who does not
complete the form is not permitted to
participate; this includes course director(s)
and planners (who are then excluded from
16
program ·
Director(s) and planning committee
members are required to complete the
COI Resolution form prior to content
development. In the event that a conflict
of interest exists, the activity content is
reviewed by course director(s), planning
committee members, CME committee
members, or designees who do not have
conflicts of interest.
Speakers, Presenters, Moderators,
Panelists, and Live Case Operators who
have declared a COI or RWI are required
to complete a COI Resolution form online
to indicate that they will resolve their
conflict(s) by one or more of the following:
1.Confirming that no patient care
recommendations will be made to the
learners regarding the use of drugs or
devices from companies with which they
have a financial relationship
2. Confirming that if patient
recommendations will be made to
the learners regarding the use of drugs
or devices from companies with which
they have a financial relationship, the
conflict will need to be resolved
(see next paragraph)
3. Submitting an alternate resolution
of the conflict that is then reviewed by
the CME Committee, course director(s)
and/or planning committee, and if
acceptable, approved
4. Recommending an alternate speaker
5. Agreeing to divest themselves of the
financial relationship
Upon receipt of the COI Resolution form,
the course director(s), planning committee
members, or CME committee members or
their designees review each COI Resolution
form to determine the course of action,
if any, necessary to resolve the conflict.
Possible conflict resolution mechanisms,
based on the educational design of the
program, include using a variety of
approaches including, but not limited to:
1. Knowledge of speakers (for example, in
the past has the individual participated
in unbiased presentations, discussions,
published literature, etc)
2. Knowledge of content
3. Interview with speakers
4. Slide peer review
5. Abstract peer review
6. Replacing the presenter
For TCT and ACC annual scientific sessions
where presentations number in the
thousands, a committee is formed to
review all faculty financial relationships
to determine whether slide review is
necessary; if so, slides are reviewed prior to
presentation and, when necessary, changes
are recommended and implemented.
In July 2010, in response to an ACCME
update, sessions with industry employee
speakers are allowed to be certified under
the following circumstances:
1. The presentation is about the scientific or
discovery process itself
2. The presentation is about products that
have not yet entered the clinical arena
(including products that are under
investigation)
3. P
resentation slides are submitted at
least 2 weeks before the start of the
CME activity, and the presenter agrees
in advance to any and all modifications
requested by the CME committee
TCT2011
Disclosure to Attendees
Standard practices to ensure that faculty
financial relationships are disclosed to the
learners prior to the activity include:
1. Printed disclosure summaries
2. A COI slide prepared by the presenter
is inserted at the beginning of the
presentation. COI slide templates are
e-mailed to all faculty approximately one
month prior to the activity. Audiovisual
vendors review each presentation to
insure that a COI slide has been inserted,
and are instructed not to load or confirm
the speaker’s presentation without a valid
COI slide being present.
Additional Policies of the
Foundation
CRF requires members of the Board of
Directors, all employees, and affiliated
physicians to disclose on an annual basis
any relevant financial interests. The process
is managed and the policy is enforced
by CRF’s Compliance Oversight Review
Committee of the Board of Directors and its
Compliance Officer.
For the TCT scientific sessions, abstracts are
peer-reviewed and if accepted are presented
at the meeting and published in the Journal
of the American College of Cardiology.
Approximately 379 physicians grade the
abstracts, more than 80% of whom are TCT
Course Directors, Co-directors, or Associate
Directors, planning committee members,
or faculty, and their Disclosure Declarations
are on file. The abstract review process is
performed online, is blinded, and requests
reviewers to recuse themselves from
grading abstracts for which they may have
a COI or RWI. Ten reviewers are assigned
to grade each abstract, and the high and
low scores are discarded. This process
Cardiovascular
Therapeutics
also performed online similar to
the abstract review process.
For TCT 2011, 25 physicians graded the
Late Breaking Trial submissions. As part
of the selection process, outlier as well as
mean scores are reviewed to confirm that
grading is fair.
For all live activities except TCT, CRF has
mandatory slide review for all individuals,
even individuals who attest that
(1) recommendations will be based on
data and findings from peer-reviewed
sources or, in the absence of adequate
peer-reviewed material, will rely on the best
available evidence based medicine, and
(2) content will be fair and balanced, and if
any product specific drugs or devices are
discussed, alternative drugs or devices will
be discussed. Slides are reviewed prior to
presentation, and when necessary, changes
are recommendedand implemented.
Faculty members at all CRF educational
events are instructed to verbally
communicate to the audience the
RWIs displayed on the COI slide. CRF’s
audiovisual vendor has developed a system
that requires that the COI slide cannot be
advanced until a sufficient time has elapsed
to allow it to be read by the audience.
was selected to mitigate the effect of any
one individual who may have a conflict of
interest. Late Breaking Clinical Trial review is
17
Learning Labs and
Edited Taped Cases
Learning Labs
Learning Labs are hands-on interactive
training sessions dedicated to creating
an intimate educational atmosphere
for interaction between physicians and
health care professionals and a company’s
clinical specialist or a key opinion leader to
enhance knowledge and understanding of
treatment techniques and devices.
Learning Labs are conveniently
located in Exhibit Hall with sessions Tuesday
through Thursday, November 8-10,
during Exhibit Hall hours.
Learning Lab Sponsored
by Cordis Corporation,
a Johnson & Johnson
Company
Tuesday, November 8
12:00 pm-1:00 pm
Experience EXOSEAL™ Workshop:
Vascular Closure
Patrick A. Cambier, MD
2:30 pm-3:30 pm
How to Start a Radial Program
Wayne Batchelor, MD, MHS
Tuesday, November 8
9:00 am-10:00 am
Transradial Access and Procedural
Anticoagulation Therapies
2:30 pm-3:30 pm
3:30 pm-4:30 pm
A Nurse Perspective on Radial Approach
Jeanne Kuperberg, RN
10:00 am-11:00 am
Vascular Closure
2:00 pm-3:00 pm
Vascular Closure
3:30 pm-5:00 pm
Complex Radial PCI “Tips and Tricks”
Christopher J. Cooper, MD
Panel Discussion: How Should I Treat?
Adhir R. Shroff, MD, Oliver F. Bertrand, MD,
Christian Spaulding, MD
Learning Lab Sponsored by
Terumo Interventional Systems
and The Medicines Company
Transradial Access
and Procedural
Educating for Better Outcome
9:00 am-10:00 am
Vascular Closure
Through didactic presentations and handson simulator demonstrations, the attendee
will have the opportunity to gain exposure
and experience in the following areas:
radial access, catheter and wire selection
for various anatomical situations, tips and
tricks, and complex cases review.
12:00 pm-1:30 pm
Complex Radial PCI “Tips and Tricks”
Panel Discussion: How Should I Treat?
Adhir R. Shroff, MD, Oliver F. Bertrand, MD,
Christian Spaulding, MD
2:00 pm-3:00 pm
Vascular Closure
3:30 pm-4:30 pm
In addition, the attendee will learn about
hemostasis techniques and comparing the
TR Band™ to competitive offerings and
why patent hemostasis is preferred along
with procedural anticoagulation therapies.
This program has been developed in close
coordination with Sunil V. Rao, MD, and
Adhir R. Shroff, MD, along with a faculty
of experienced physicians in radial and
anticoagulation solutions.
18
program ·
9:30 am-10:30 am
11:00 am-12:00 pm
1:00 pm-2:00 pm
2:30 pm-3:30 pm
4:00 pm-5:00 pm
9:30 am-10:30 am
11:00 am-12:00 pm
12:30 pm-1:30 pm
Edited Taped Case
Presentations
Presentation Theater North,
Napa Valley (Located in Hall D)
A taped case demonstration consists of
capturing the following elements of an
interventional procedure performed in a
cath lab in real time:
• Narrated patient history slides and an
introduction of the case
• A wide shot of the primary operator
from across the table narrating the
demonstration
• A close-up of devices and techniques from
the foot of the table
• Live imaging capture from flouroscopy,
echo, IVUS, etc
New to TCT 2011, the Edited Taped
Cases Presentations will be presented
in the Presentation Theater North
(Napa Valley) of the Moscone Center on
Wednesday and Thursday, November 9-10.
The topics will include FFR, OCT, CHF, CTO,
and endovascular interventions.
CME/CE information
CME Accreditation and
Designation
The Cardiovascular Research
Foundation is accredited by
the Accreditation Council
for Continuing Medical Education to
provide continuing medical education
for physicians.
The Cardiovascular Research Foundation
designates this live activity for a maximum
of 54.75 AMA PRA Category 1 Credits™.
Physicians should claim only the credit
commensurate with the extent of their
participation in the activity.
One contact hour equals 60 minutes
of learning time. This does not include
Breakfast Meetings, Evening Symposia,
or other specialty programs such as
Hands on Hearts.
Documentation of awarded credit is
provided for registered attendees in
exchange for completed online activity
evaluations. Certificates of attendance are
provided to all registered attendees in
their meeting bags.
CE Accreditation and
Designation
The American College of
Cardiology Foundation (ACCF) is
accredited as a provider of
continuing nursing education by
the American Nurses Credentialing Center’s
Commission on Accreditation.
The ACCF designates TCT 2011 educational
activity for a maximum of 54.75 contact
hours. Requirements for successful
completion are attendance at TCT 2011
and completing the evaluation tool. Each
nurse/nurse practitioner attendee may
only claim a maximum of 54.75 contact
hours, commensurate with the extent of
their separate or combined successful
completion in the activities.
Non-Endorsement of Products
Accredited status does not imply
endorsement by the American Nurses
Credentialing Center or the American
College of Cardiology Foundation of
any commercial products displayed in
conjunction with this activity.
Off-Label Use
ACCF requires that all faculty disclose their
intent to discuss any unlabeled/unapproved
uses of drugs and/or devices during
their presentations.
Learning Objectives
By the end of this symposium, participants
should be able to:
•Discuss the results from important
clinical trials and evidence-based
medicine to guide management of
patients with atherosclerosis and
structural heart disease
•Incorporate new interventional
technologies and procedures into the care
of patients with complex coronary and
endovascular disease
•Integrate advances in diagnostic
evaluation and therapeutics to
patients with carotid and peripheral
arterial disease
•Describe appropriate pharmacologic
management in the care of patients
undergoing diagnostic arteriography and
interventional therapies before, during,
and after catheterization
Target Audience
This symposium is designed for
interventional cardiologists, radiologists,
clinical cardiologists, basic scientists,
vascular medicine specialists, surgeons,
nurses, cath lab technicians, and other
health care professionals with a special
interest in the field of interventional and
vascular medicine.
Activity Evaluation
Online evaluation will address content,
presentation, possible bias, and future
educational needs.
TCT2011
Cardiovascular
Therapeutics
Disclosure Statement
It is the policy of the Cardiovascular
Research Foundation to ensure balance,
independence, objectivity, and scientific
rigor in all of its sponsored educational
activities. Commercial support from
industry does not influence educational
content, faculty selection, and/or faculty
presentations, and, therefore, does not
compromise the scientific integrity of the
educational activity.
Discussion of off-label product usage and/
or off-label product use during live cases is
made at the sole discretion of the faculty.
Off-label product discussion and usage
are not endorsed by the Cardiovascular
Research Foundation or the conference
directors of this activity.
Faculty/planners participating in continuing
medical education activities sponsored by
the Cardiovascular Research Foundation are
required to disclose to the activity audience
any real or apparent conflicts of interest
related to the content of their presentations.
Faculty/planners not complying with this
policy are not permitted to participate in
this activity.
Program Sponsorship
This symposium is sponsored by the
Cardiovascular Research Foundation.
This symposium is co-provided by the
American College of Cardiology Foundation.
Program Support
This symposium is partially funded through
educational grants from commercial
supporters. The Cardiovascular Research
Foundation ensures that its programs are
educational and meet the needs of the
target audience.
To support this endeavor, the directors and
co-directors of TCT create organizational
and scientific committees to assist in
educational content development and
content oversight for live cases, concurrent
sessions, case reviews, abstract sessions,
practical workshops, and scientific
symposia. These sessions are
developed without influence from
commercial supporters.
19
TCT 2011 awards
TCT 2011 Awards
Please join us in the Main Arena for the
presentation of the following awards:
TCT Career
Achievement Award
Wednesday, November 9 at 11:15 am
Thomas J. Linnemeier Spirit of
Interventional Cardiology Young
Investigator Award
Geoffrey O. Hartzler Master
Clinical Operator Award
Friday, November 11 at 10:50 am
Thursday, November 10 at 11:00 am
1994
Geoffrey O. Hartzler, MD
2003
2009
Eberhard Grube, MD
1995
David R. Holmes, MD
2004
Farouc Jaffer, MD, PhD
2010
Osamu Katoh, MD
1996
2005
Giuseppe De Luca, MD
Takahiko Suzuki, MD
1997
John B. Simpson, MD
2006
Alaide Chieffo, MD
2011
Horst Sievert, MD
1998
Antonio Colombo, MD
2007
Wojciech Wojakowski, MD, PhD
1999
Julio C. Palmaz, MD
2008
Mehdi H. Shishehbor, DO, MPH
2000
Donald S. Baim, MD
2009
Robert A. Byrne, MD
2002
William W. O’Neill, MD
2010
Colin M. Barker, MD
2003
J. Eduardo M.R. Sousa, MD, PhD
2011 Finalists
Masaki Awata, MD
2004
Eugene Braunwald, MD
2005
James T. Willerson, MD
Robert W. Yeh, MD
Thomas T. Tsai, MD
2006
Paul Yock, MD
2007
Barry T. Katzen, MD
2008
Seung-Jung Park, MD
2009
Spencer B. King III, MD
2010
Alain G Cribier, MD
2011
Eric J. Topol, MD
20
program ·
Hideo Tamai, MD
21
FRIDAY, 11/11
THURSDAY, 11/10
WEDNESDAY, 11/9
TUESDAY, 11/8
MONDAY, 11/7
SUNDAY, 11/6
am
Breakfast Meetings
Breakfast Meetings
Breakfast Meetings
Breakfast Meetings
7:30
am
am
9:00
am
9:30
am
10:00
am
10:30
am
11:00
pm
1:00
pm
1:30
pm
2:00
pm
2:30
TCT for Surgeons
Scientific Symposia
Presentation
Theaters
pm
3:30
pm
4:00
pm
4:30
How to Treat Theater: Endovascular Disease
Learn the Technique
Lunchtime Sessions
TCT for Surgeons
Spotlight Sessions
Hot Topic
Lunchtime Sessions
Learn the Technique
Lunchtime Sessions
Exhibit Hall
Presentation
Theaters
FDA Town Hall Meeting
How to Treat Theater: Coronary Artery Disease
Main Arena
Spotlight Sessions
Main Arena
Spotlight Sessions
How to Treat Theater: Structural Heart Disease
Maintenance of Certification (MOC) Session
TCT for Surgeons
Exhibit Hall
Spotlight Sessions
Spotlight Sessions
Presentation
Theaters
Hot Topic
Lunchtime Sessions
Exhibit Hall
TCT for Surgeons
Scientific Symposia
pm
5:30
pm
6:00
pm
6:30
pm
7:00
Exhibit Hall
Reception
Twilight Sessions
Twilight Sessions
Twilight Sessions
pm
7:30
Twilight Sessions
Registration: All Attendees and Exhibitors
pm
5:00
Main Arena
Lunch in Exhibit Hall
Maintenance of Certification (MOC) Session
pm
3:00
Registered Cardiovascular Invasive Specialists (RCIS) Review Course
Self-Assessment for Interventional Cardiology (Part 2)
Oral Abstracts
20th Annual Nurse and Technologist Symposium
TCT for Surgeons
Poster Abstracts
pm
12:30
Registration: All Attendees and Exhibitors
pm
12:00
Self-Assessment for Interventional Cardiology (Part 1)
am
11:30
20th Annual Cardiovascular Nurse and Technologist Symposium
am
8:30
am
8:00
Week at a Glance
7:00
TCT2011
pm
8:00
pm
9:00
pm
9:30
Evening Programs
Evening Programs
Evening Programs
Evening Programs
pm
8:30
THE MOSCONE CENTER
SAN FRANCISCO, CA
November 7-11, 2011
C A R D I O VA S C U L A R
RESEARCH
F O U N D AT I O N
A Passion for Innovation
Pioneering New Therapies for
the Treatment of Heart Disease
More than 81 million people live with heart disease
worldwide. Many of them will benefit from
interventional procedures developed or refined by
the Cardiovascular Research Foundation (CRF) . . . .
WE INVESTIGATE
Early Stage Technologies During Preclinical Research
WE EVALUATE
Promising New Therapies by Designing and Implementing
Multiple Phases of Human Clinical Trials
WE EDUCATE
Medical Professionals and the Public to Enhance
Patient Outcomes
Visit us at the Partnership Pavilion on the first floor of Moscone North.
International Faculty
Instituto Dante Pazzanese de Cardiologia
São Paulo, Brazil
University of Milan
Milan, Italy
Stephen J.D. Brecker, MD
St. George’s Hospital
London, United Kingdom
Paulo Caramori, MD, PhD
Hospital São Lucas-PUCRS
Porto Alegre, Brazil
Andrea Abizaid, MD, PhD
São Paulo, Brazil
Jozef Bartunek, MD, PhD
Cardiovascular Center, OLV Hospital
Aalst, Belgium
Carlo Briguori, MD, PhD
Clinica Mediterranea
Naples, Italy
Mauro Carlino, MD
San Raffaele Hospital
Milan, Italy
Sergey A. Abugov, ScD
BV Petrovsky Russian Centre of
Science of Surgery
Moscow, Russia
Jeroen J. Bax, MD
Leiden University Medical Center
Leiden, The Netherlands
Fabio S. Brito, MD, PhD
Albert Einstein Hospital
São Paulo, Brazil
Didier Carrie, MD, PhD
Hôpital de Ranueil
Toulouse, France
Kevin J. Beatt, MBBS, PhD
Mayday University Hospital
Miroslav Brtko, MD
Charles University Prague
Hradec Kralove, Czech Republic
Luiz Antonio Carvalho, MD
Hospital Pro-Cardiaco S/A
Rio de Janeiro, Brazil
Jorge A. Belardi, MD
Instituto Cardiovascular de Buenos Aires
Buenos Aires, Argentina
Elchanan Bruckheimer, MBBS
Schneider Children’s Medical Center
Petach Tikva, Israel
Graham A. Cassel, MD
Milpark Hospital
Johannesburg, South Africa
Ivo Bernat, MD
University Hospital Pilsen
Pilsen, Czech Republic
Gill L. Buchanan, MD
San Raffaele Scientific Institute
Milan, Italy
Renzo Cecere, MD
McGill University Health Centre
Montreal, Canada
Daniel H. Berrocal, MD
Hospital Italiano de Buenos Aires
Wacin Buddhari, MD
King Chulalongkorn Memorial Hospital
Bangkok, Thailand
Pavel Cervinka, MD, PhD
Masaryk Hospital
Ústí nad Labem, Czech Republic
Colin Berry, BSc, MBChB, PhD
Golden Jubilee National Hospital
Glasgow, United Kingdom
Lutz Buellesfeld, MD
Bern University Hospital
Bern, Switzerland
Albert W. Chan, MD
Royal Columbian Hospital
New Westminster, Canada
Olivier F. Bertrand, MD, PhD
Institut Universitaire de Cardiologie et de
Pneumologie de Québec
Quebec City, Canada
Siro Buendia, MD
Son Espases Palma de Mallorca
Palma de Mallorca, Spain
Charles Chan, MD
Gleneagles Medical Centre
Singapore
Christopher E. Buller, MD
St. Michael’s Hospital
Toronto, Canada
Asim Cheema, MD
St. Michael’s Hospital
Toronto, Canada
Rafael Beyar, MD, DSc
Rambam Medical Center
Haifa, Israel
Francesco Burzotta, MD
Institute of Cardiology, Catholic
University of the Sacred Heart
Rome, Italy
Shao Liang Chen, MD
Nanjing First Hospital of Nanjing
Medical Center
Jiangsu, China
Henning Rud Andersen, MD
University of Aarhus
Aarhus, Denmark
Giancarlo Biamino, MD, PhD
Clinica Montevergine
Mercogliano, Italy
Jacques Busquet, MD
Clinique Chirurgicale Val d’Or
Paris-Saint Cloud, France
YunDai Chen, PhD
Chinese PLA General Hospital
Beijing, China
Careggi Hospital
Florence, Italy
Klaudija Bijuklic, MD
Hamburg University
Cardiovascular Center
Hamburg, Germany
Pawel E. Buszman, MD, PhD
American Heart of Poland
Katowice, Poland
Anson Cheung, MD
St. Paul’s Hospital
Vancouver, Canada
Robert A. Byrne, MB, BCh
Deutsches Herzzentrum
Munich, Germany
Bernard R. Chevalier, MD
Institut Cardiovasculaire Paris Sud
Massy, France
Adriano Caixeta, MD, PhD
Hospital Israelita Albert Einstein
São Paulo, Brazil
Paul T.L. Chiam, MD
National Heart Center Singapore
Singapore
Alisson L. Calver, MD, MBBS, MD
Wessex Cardiothoracic Centre
Southampton, United Kingdom
Alaide Chieffo, MD
Milan, Italy
Edoardo Camenzind, MD
University Hospital of Geneva
Geneva, Switzerland
Kenneth Chin, MBBS
Pantai Hospital
Kuala Lumpur, Malaysia
Marcelo Jose de Carvalho Cantarelli,
MD, PhD
Bandeirantes Hospital
São Paulo, Brazil
Yoon Sin Chong, MD
Serdang Hospital
Kajang, Malaysia
Takashi Akasaka, MD, PhD
Wakayama Medical University
Wakayama, Japan
Remo Albiero, MD
Clinica San Rocco di Franciacorta
Brescia, Italy
Bagrat Alekyan, MD
Bakoulev Center for Cardiovascular
Surgery/RAMS
Moscow, Russia
Dimitrios Alexopoulos, PhD
Patras University Hospital
Patras, Greece
Fernando Alfonso, MD, PhD
Hospital Universitario San Carlos
Madrid, Spain
Yaron Almagor, MD
Shaare Zedek Medical Center
Jerusalem, Israel
Ibrahim R. Al-Rashdan, MD
Chest Disease Hospital,
Ministry of Health
Safat, Kuwait
Aleksander Araszkiewicz, MD
Poznan University of Medical Sciences
Poznan, Poland
Magaly Arrais dos Santos, MD, PhD
São Paulo, Brazil
Yasushi Asakura, MD
Toyohashi Heart Center
Toyohashi, Japan
Panayiotis Avraamides, MD
Cyprus Society of Cardiology
Nicosia, Cyprus
Masaki Awata, MD
Kansai Rosai Hospital
Amagasaki, Japan
Vinay K. Bahl, MD, DM
All India Institute of Medical Sciences
New Delhi, India
Amal Kumar Banerjee, MD, DM
Advanced Medical Research Institute
Kolkata, India
Adrian P. Banning, MD
John Radcliffe Hospital
Oxford, United Kingdom
Mauricio R. Barbosa, MD
Biocor Hospital
Nova Lima, Brazil
24
program ·
Otavio Berwanger, MD
São Paulo Cardiac Hospital
São Paulo, Brazil
Josef Bis, MD
Charles University Prague
Hradec Kralove, Czech Republic
Daniel J. Blackman, MD
Leeds General Infirmary
Leeds, United Kingdom
Wolfgang Bocksch, MD, PhD
Tubingen University Hospital
Tubingen, Germany
Jose Ary Boechat, MD
Sociedade Brasileira de Hemodinâmica e
Cardiologia Intervencionista
Raoul Bonan, MD
Montreal Heart Institute
Montreal, Canada
Laurent Bonello, MD
Hôpital Universitaire Nord
Marseille, France
Sarana Boonbaichaiyapruck, MD
Ramathibodi Hospital, Mahidol University
Bangkok, Thailand
Alessandro S. Bortone, MD, PhD
Interventional Lab Cardiac Surgery
University of Bari
Bari, Italy
Warren J. Cantor, MD
Southlake Regional Health Center
Newmarket, Canada
Ferrarotto Hospital
Catania, Italy
Piera Capranzano, MD
Ferrarotto Hospital
Catania, Italy
Evald H. Christiansen, PhD
Aarhus University Hospital
Aarhus, Denmark
Sanjay Kumar Chugh, MD, DM
Fortis Escorts Heart Institute
New Delhi, India
Bimmer E. Claessen, MD, PhD
University of Amsterdam Academic
Medical Center
Amsterdam, The Netherlands
TCT2011
Cardiovascular
Therapeutics
Eric A. Cohen, MD
Sunnybrook Health Sciences Centre
Toronto, Canada
Giuseppe De Luca, MD
Eastern Piedmont University
Novara, Italy
David Erlinge, MD, PhD
Lund University Hospital
Lund, Sweden
Hector M. Garcia-Garcia, MD, PhD
Thoraxcenter, Erasmus Medical Center
Rotterdam, The Netherlands
Antonio Colombo, MD
Columbus Hospital/San Raffaele Hospital
Milan, Italy
Muzaffer Degertekin, MD, PhD
Yeditepe University
Istanbul, Turkey
Aleksander Ernst, MD, PhD
Clinical Hospital Center Zagreb
Zagreb, Croatia
Jorge Gaspar, MD
National Institute of Cardiology
Mexico City, Mexico
Stéphane Cook, MD
Swiss Cardiovascular Center
Fribourg, Switzerland
Peter den Heijer, MD
Amphia Hospital Breda
Breda, The Netherlands
Javier Escaned, MD, PhD
Hospital ClÌnico San Carlos
Madrid, Spain
Efrain Gaxiola, MD
Jardines Hospital de Especialidades
Jalisco, Mexico
Thierry Corcos, MD
American Hospital of Paris
Neuilly-sur-Seine, France
Jean-Pierre Dery, MD, MHS
Quebec Heart and Lung Institute
Quebec, Canada
Miroslaw Ferenc, MD
Heart Center Bad Krozingen
Bad Krozingen, Germany
Lei Ge, MD
Shanghai Zhongshan Hospital
Shanghai, China
Roberto Corti, MD
University Hospital Zurich
Zurich, Switzerland
Walter Desmet, MD
Katholieke Universiteit
Leuven, Belgium
Fausto Feres, MD
São Paulo, Brazil
Ulrich J. Gerckens, MD
Hospitial St. Petrus
Bonn, Germany
Jose de Ribamar Costa Jr, MD
São Paulo, Brazil
Carlo Di Mario, MD
Royal Brompton Hospital
University of Leicester
Leicester, United Kingdom
Ricardo A. Costa, MD
São Paulo, Brazil
Germano Di Sciascio, MD
Campus Bio-Medico University
Rome, Italy
Francisco Fernandez-Aviles, MD, PhD
Hospital General Universitario
Gregorio Marañón
Madrid, Spain
Brian Courtney, MD, MSEE
Schulich Heart Program
Toronto, Canada
Stefanie Dimmeler, PhD
University of Frankfurt
Frankfurt, Germany
Bodo Cremers, MD
Klinik für Innere Medizin III
Homburg, Germany
Mirko Doss, MD
JW Goethe University Frankfurt
Frankfurt, Germany
Alain G. Cribier, MD
Hôpital Charles Nicolle
Rouen, France
Henricus J. Duckers, MD, PhD
Erasmus Medical Center
Fernando Cura, MD, PhD
Instituto Cardiovascular de Buenos Aires
Dariusz Dudek, MD, PhD
Jagiellonian University
Krakow, Poland
Nick Curzen, PhD
Southampton University Hospitals
Southampton, United Kingdom
Timothy C. Dy, MD
Chinese General Hospital and
Medical Center
Manila, Philippines
Maciej Dabrowski, MD
Institute of Cardiology
Warszawa, Poland
Joost Daemen, MD, PhD
Sameer Indravadan Dani, MD
Apollo Hospital International Ltd.
Ahmedabad, India
Mikael Danielewicz, MD
PCI-unit Karlstad
Karlstad, Sweden
Justin Davies, MBBS, MRCP, PhD
Imperial College London NHS Trust
Periklis Davlouros, MD
Patras University Hospital
Patras, Greece
Vladimir Dzavik, MD
Peter Munk Cardiac Centre,
University Health Network
Toronto, Canada
Franz R. Eberli, MD
Triemli Hospital Zurich
Zurich, Switzerland
Guering Eidt-Lidt, MD
Instituto Nacional de Cardiologia
Mexico City, Mexico
Helene Eltchaninoff, MD
Rouen, France
Knut Endresen, MD, PhD
Oslo University Hospital
Oslo, Norway
Mark A. de Belder, MD, MA
The James Cook University Hospital
Middlesbrough, United Kingdom
Thomas Engstrom, MD, DMSci, PhD
The Heart Centre, University
of Copenhagen
Copenhagen, Denmark
Bernard De Bruyne, MD, PhD
Cardiovascular Center Aalst
Aalst, Belgium
Raimund A. Erbel, MD
University Duisburg-Essen
Essen, Germany
Antonio Carlos Campos de Carvalho, MD
National Cardiology Institute
Oktay Ergene, PhD
State Hospital in Izmir
Izmir, Turkey
Jose M. de la Torre Hernandez, MD, PhD
Hospital Universitario Marques
de Valdecilla
Santander, Spain
Andrejs Erglis, MD, PhD
P. Stradins Clinical University Hospital
Riga, Latvia
Hans R. Figulla, MD
Friedrich-Schiller Universitat
Jena, Germany
Massimo Fineschi, MD
Le Scotte Hospital, University
Hospital of Siena
Siena, Italy
Thierry A. Folliguet, MD
Institut Mutualiste Montsouris
Paris, France
Olaf Franzen, MD
Rigshospitalet Copenhagen
Copenhagen, Denmark
Douglas G. Fraser, MD
Manchester Heart Centre
Manchester, United Kingdom
Guosheng Fu, MD
Sir Run Run Shaw Hospital
Zhejiang, China
Xianghua Fu, MD
Second Hospital of Hebei
Medical University
Shijiazhuang City, China
Rié Fukaya, MMS
Pharmaceuticals and Medical
Devices Agency, Japan
Tokyo, Japan
Anthony Fung, MBBS
Vancouver General Hospital
Vancouver, Canada
Alfredo R. Galassi, MD
Ferrarotto Hopsital
Catania, Italy
Daljeet S. Gambhir, MD, DM
Kailash Hospital and Heart Institute
New Delhi, India
Vladimir Ganyukov, MD
Scientific Research Institute for
Cardiovascular Diseases
Kemerovo, Russia
Run-Lin Gao, MD
Fu Wai Hospital
Beijing, China
Eulogio J. Garcia, MD
Hospital Clinico San Carlos
Madrid, Spain
Georges Ghanem, MD
Clemenceau Medical Center
Beirut, Lebanon
Robert J. Gil, PhD
Central Clinic Hospital
Warsaw, Poland
Dietmar H. Glogar, MD
University of Vienna
Vienna, Austria
Matthias Götberg, MD, PhD
Skane University Hospital
Lund, Sweden
Roger M. Greenhalgh, MD
Charing Cross Hospital
Liliana R. Grinfeld, MD
CENPEC
Ladislav Groch, MD
University Hospital St. Anna
Brno, Czech Republic
Eberhard Grube, MD
University Hospital Bonn
Bonn, Germany
Marek Grygier, MD, PhD
University Hospital in Poznan
Poznan, Poland
Ospedali Riuniti Di Bergamo
Bergamo, Italy
Victor Guetta, MD
Heart Institute Chaim Medical Center
Tel-Hashomer, Israel
Vivek Gupta, MD, DM
Indraprastha Apollo Hospitals
New Delhi, India
Maoto Habara, MD
Toyohashi, Japan
Marcelo Halac, MD
Hospital Italiano de Buenos Aires
Michalis Hamilos, MD
University Hospital of Heraklion
Crete, Greece
Kerckhoff Clinic
Bad Nauheim, Germany
25
Martial Hamon, MD
University Hospital of Caen
Caen, France
Keiichi Igarashi, MD, PhD
Hokkaido Social Insurance Hospital
Sapporo, Japan
Osamu Katoh, MD
Kusatsu Heart Center
Toyohashi, Japan
Takashi Kubo, MD, PhD
Wakayama, Japan
Yaling Han, MD
Shenyang Northern Hospital
Shenyang, China
Koji Ikeda, PhD
Pharmaceuticals and Medical
Devices Agency
Tokyo, Japan
Upendra Kaul, MD
Fortis Hospital
Karnataka, India
Karl-Heinz Kuck, MD
Asklepios Hospital St. Georg
Hamburg, Germany
Zaza Kavteladze, MD
The Centre of Endosurgery
and Lithotripsy
Moscow, Russia
Sreenivas Arramraju Kumar, MD, DM
CARE Hospitals
Hyderabad, India
Claude Hanet, MD
University of Louvain Medical School
Brussels, Belgium
Jan Harnek, MD, PhD
Lund, Sweden
Thomas A. Ischinger, MD, PhD
Kardiologie im Zentrum
Munich, Germany
Michael Haude, MD
Lukaskrankenhaus Neuss
Neuss, Germany
Gonzague Issenmann
Stentys
Paris, France
Paul J. Hauptman, MD
BioControl Medical
Yehud, Israel
Christoph Hehrlein, MD
University Hospital Freiburg
Freiburg, Germany
Stefan K. James, MD
Uppsala Clinical Research Center, Uppsala
University Hospital
Uppsala, Sweden
Lars Hellsten, MD
Landstinget Gävleborg
Gävle, Sweden
Yang-Soo Jang, PhD
Yonsei University Health System
Seoul, South Korea
Jose P.S. Henriques, MD, PhD
Academic Medical Center
Lisette Okkels Jensen, MD, DMSci, PhD
Odense University Hospital
Odense, Denmark
Michel Henry, MD
Cabinet de Cardiologie
Nancy, France
Ulf Jens Jensen, MD
Karolinska University Hospital
Stockholm, Sweden
Yudi Her Oktaviono, MD
Dr Hospital Soetomo
Surabaya, Indonesia
Young-Hoon Jeong, MD, PhD
Gyeongsgang National
University Hospital
Jinju, South Korea
Felipe Hernandez, MD
Hospital 12 de Octubre
Madrid, Spain
Elvin Kedhi, MD
Maasstad Ziekenhuis
Henning Kelbaek, MD
Rigshospitalet
Kobenhavn, Denmark
Thomas Kellerth, MD
Örebro University Hospital
Örebro, Sweden
Joerg Kempfert, MD
Kerckhoff Clinic Bad Nauheim
Hyo-Soo Kim, MD, PhD
Seoul National University Hospital
Seoul, South Korea
Young-Hak Kim, PhD
Asan Medical Center
Seoul, South Korea
Masashi Kimura, MD
Toyohashi, Japan
Takeshi Kimura, MD
Kyoto University Hospital
Sakyo-ku, Japan
Indulis Kumsars, MD
Pauls Stradins Clinical University Hospital
Riga, Latvia
Vincent On-Hing Kwok, MD
Hong Kong Sanatorium & Hospital
Hong Kong, China
Jean-Claude Laborde, MD
St George’s Hospital
Antoine Lafont, MD
Hôpital European Georges Pompidou
Paris, France
Irene M. Lang, MD
University of Vienna
Vienna, Austria
Rudiger Lange, MD, PhD
German Heart Center Munich
Munich, Germany
Jens Flensted Lassen, MD, PhD
Aarhus, Denmark
Azeem Latib, MB, BCh
EMO Cuore Columbus
Milan, Italy
Florin Laubenthal, MD
Alfried Krupp Krankenhaus
Essen, Germany
Nigel Jepson, MD
Prince of Wales Hospital
Sydney, Australia
Pawel Kleczynski, MD, PhD
University Hospital in Krakow
Krakow, Poland
Gillian A. Jessurun, MD, PhD, MBA
Scheper Ziekenhuis Emmen
Emmen, The Netherlands
Merril L. Knudtson, MD
Libin Cardiovascular Institute of Alberta
Calgary, Canada
Jonathan M. Hill, MD, MRCP
King’s College Hospital
Sanjit S. Jolly, MD
McMaster University
Hamilton, Canada
Karel T. Koch, MD, PhD
Academic Medical Center Amsterdam
Jose Luis Lazaro Castillo, MD
Hospital General Centro Médico
Nacional La Raza
Mexico City, Mexico
Lynne Hinterbuchner, RN, DGKS
Salzburg University Hospital
Salzburg, Austria
Michael Joner, MD
Deutsches Herzzentrum München
Munich, Germany
Viktor Kocka, MD
Charles University Praque
Prague, Czech Republic
Michel R. Le May, MD
University of Ottawa Heart Institute
Ottawa, Canada
Andrew Holden, MD
Auckland City Hospital
Auckland, New Zealand
Jeffrey B. Jump
Biosensors International
Morges, Switzerland
Tian-Hai Koh, MD
National Heart Center
Singapore
Guy LeClerc, MD
Centre Hospital Universitaire de Montreal
Montreal, Canada
Stephen P. Hoole, MD
Papworth Hospital
Cambridge, United Kingdom
Peter Juni, MD
University of Bern
Bern, Switzerland
Bon-Kwon Koo, MD, PhD
Seoul, South Korea
Michael Kang-Yin Lee, MBBS
Queen Elizabeth Hospital
Kowloon, Hong Kong
Eric Horlick, MD, CM
University Health Network
Toronto General Hospital
Toronto, Canada
Christoph A. Kaiser, MD
University Hospital Basel
Basel, Switzerland
Jacques J. Koolen, MD, PhD
Catharina Hospital
Eindhoven, The Netherlands
Thierry Lefevre, MD
Institut Hospitalier Jacques Cartier
Massy, France
Angela Hoye, MD, PhD
Castle Hill Hospital
Kingston-upon-Hull, United Kingdom
Petr Kala, MD, PhD
University Hospital and Medical
Faculty Masaryk University
Brno, Czech Republic
Ran Kornowski, MD
Rabin Medical Center
Jorge H. Leguizamon, MD
Argentine Society of Interventional
Cardiology
Kurt Huber, MD
Wilhelminen Hospital
Vienna, Austria
Soo-Jin Kang, MD
Asan Medical Center
Seoul, South Korea
Ioannis (John) Iakovou, MD, PhD
Onassis Cardiac Surgery Center
Athens, Greece
A. Pieter Kappetein, MD, PhD
Thoraxcenter
David J. Hildick-Smith, MD
Sussex Cardiac Centre, Brighton and
Sussex University Hospitals
Brighton, United Kingdom
26
Dan Ioanes, MD
Sahlgrenska University Hospital
Gothenburg
Gothenburg, Sweden
program ·
Jan Kovac, MD
University Hospital of Leicester
Medical Care Center
Hamburg, Germany
Henry Krum, MBBS, PhD
Monash University
Victoria, Australia
Sandra Lauck, MSN
Vancouver, Canada
Jonathon A. Leipsic, MD
Vancouver, Canada
Jose L. Leiva-Pons, MD
Hospital Central
San Luis Potosi, Mexico
Pedro A. Lemos, MD, PhD
University of São Paulo Medical School
São Paulo, Brazil
TCT2011
Cardiovascular
Therapeutics
Jonathan Leor, MD
Sheba Medical Center
Tel-Hashomer, Israel
Massimo Mancone, MD
Umberto I Hospital
Rome, Italy
Friedrich W. Mohr, MD, PhD
Heart Center Leipzig
Leipzig, Germany
Jacob Odenstedt, MD, PhD
University of Gothenburg
Gothenburg, Sweden
Maciej Lesiak, MD, PhD
University Hospital
Poznan, Poland
Jose Armando Mangione, MD
BeneficÍncia Portuguesa Hospital
São Paulo, Brazil
Marie-Angele Morel, BSc
Cardialysis B.V.
Takao Ohki, MD, PhD
Jikei University School of Medicine
Tokyo, Japan
Thorsten Lewalter, MD
Isar Heart Center
Munich, Germany
Royal Victoria Hospital
Belfast, United Kingdom
Massy, France
Hiroyuki Okura, MD
Kawasaki Medical School
Kurashiki, Japan
Lang Li, MD, PhD
Guangxi Medical University
Nanning, China
Isabelle Martin
Minvasys
Gennevilliers, France
Ralf Mueller, MD
HELIOS Klinikum Siegburg
Siegburg, Germany
Shu-Kin Li, MD
College of Cardiology
Chai Wan, Hong Kong
Martin Mates, PhD
Na Homolce Hospital
Prague, Czech Republic
Ajit Mullasari, MD, DM, DNB
Madras Medical Mission Hospital
Chennai, India
Keith G. Oldroyd, MD
West of Scotland Regional
Heart and Lung Centre
Glasgow, Scotland
Berglind Libungan, MD
Sahlgrenska University Hospital
Göteborg, Sweden
Samuel K. Mathew, MD, DM
Apollo Hospitals
Chennai, India
Michael J. Mullen, MD
University College Hospital London
Valter C. Lima, MD, PhD
Hospital São Francisco - ISCMPA
Detlef G. Mathey, MD
Hamburg University
Hamburg, Germany
David W.M. Muller, MBBS, MD
St. Vincent’s Hospital
Darlinghurst, Australia
Ramathibodi Hospital
Bangkok, Thailand
Axel Linke, MD
University of Leipzig Heart Center
Leipzig, Germany
Jian Liu, MD
Peking University People’s Hospital
Beijing, China
Xuebo Liu, MD
East Hospital, Tongji University
Shanghai, China
Hugo F. Londero, MD
Sanatorio Allende-Cordoba
Cordoba, Argentina
Chaim S. Lotan, MD
Hadassah University Hospital
Jerusalem, Israel
Shuzheng Lu, MD
Beijing An Zhen Hospital
Beijing, China
Georg Lutter, MD, PhD
University Hospital Schleswig-Holstein
Kiel, Germany
Rhona MacDonald, DPhil
Mercy Angiography Unit
Sumaira Macdonald, MBChB, PhD
Freeman Hospital
Newcastle upon Tyne, United Kingdom
Lindsay S. Machan, MD
Vancouver Hospital & Health
Sciences Center
Vancouver, Canada
Ahmed Magdy, MD
National Heart Institute in Cairo
Cairo, Egypt
Felix Mahfoud, MD
Klinik für Innere Medizin III
Homburg/Saar, Germany
Elsayed Mahmoud
Egypt
Milan, Italy
Talib Majwal, MD
Dubai Heart Center Hospital
Dubai, United Arab Emirates
Jorge Antonio Mayol Almera, MD
Universidad de la República
Montevideo, Uruguay
Margaret B. McEntegart, MD
Golden Jubilee National Hospital
Glasgow, United Kingdom
Julinda Mehilli, MD
Deutsches Herzzentrum und Medizinische
Klinik der Technischen Universitat Munchen
Munich, Germany
Ashwin Balachand Mehta, MD
Jaslok Hospital
Mumbai, India
Shamir R. Mehta, MD, MSc
Hamilton Health Sciences
Hamilton, Canada
Bernhard Meier, MD
Swiss Cardiovascular Center Bern
Bern, Switzerland
Oscar A. Mendiz, MD
Fundacion Favaloro
Maurizio Menichelli, MD
Spaziani Hospital Frosinone
Frosinone, Italy
Ajit Menon, MD, DM
Lilavathi Hospital
Mumbai, India
Monash Medical Centre Clayton
Melbourne, Australia
Antonio Micari, MD
Maria Eleonora Hospital
Palermo, Italy
Ghada W. Mikhail, MD
Imperial College Healthcare
Erich Minar, MD
Medical University Vienna
Vienna, Austria
Neil E. Moat, MD
Rosli Mohd Ali, MD
National Heart Institute
Goran K. Olivecrona, MD, PhD
Lund, Sweden
Eustaquio Maria Onorato, MD
Policlinico Universitario tor Vergata, Rome
Gussago, Italy
Yoshinobu Onuma, MD
Thoraxcenter, Erasmus Medical Center
Brad I. Munt, MD
Vancouver, Canada
Toshiya Muramatsu, MD
Saiseikai Yokohama-City Eastern Hospital
Yokohama, Japan
Christoph K. Naber, MD, PhD
Contilia Heart and Vascular Center
Essen, Germany
Masato Nakamura, MD
Toho University Ohashi Medical Center
Tokyo, Japan
Sunao Nakamura, MD, PhD
New Tokyo Hospital
Chiba, Japan
Mercy and Auckland City Hospitals
Alexander G. Osiev, MD
State Research Institute of
Circulation Pathology
Novosibirsk, Russia
Miodrag C. Ostojic, MD, PhD
Clinical Centre of Serbia
Belgrade, Serbia
Ali Oto, MD
Hacettepe University Hospital
Ankara, Turkey
Dev B. Pahlajani, MD
Breach Candy Hospital
Mumbai, India
Padova University Hospital
Padova, Italy
Alejandro O. Palacios, MD
Instito Dupuytren
Milan A. Nedeljkovic, MD
Clinical Center of Serbia
Belgrade, Serbia
Matti Jaakko Niemela, MD
University of Oulu
Oulu, Finland
Tullio Palmerini, MD
Istituto di Cardiologia/
Universita di Bologna
Bologna, Italy
Christoph A. Nienaber, MD, PhD
University of Rostock
Rostock, Germany
Keyur H. Parikh, MD
Heart Care Clinic
Ahmedabad, India
Eugenia Nikolsky, MD, PhD
Rambam Medical Center
Haifa, Israel
Jai-Wun Park, MD
Asklepios Kliniken
Hamburg, Germany
Stephane Noble, MD
Hùpitaux Universitaires de Genéve
Geneva, Switzerland
Asan Medical Center
Seoul, South Korea
James Nolan, MD, MB, ChB
University Hospital North Staffordshire
Stoke on Trent, United Kingdom
Radoslaw Parma, MD, PhD
Medical University of Silesia
Katowice, Poland
Gilberto Lahorgue Nunes, MD, PhD
Hospital Mae de Deus
Guido Parodi, MD
Careggi Hospital
Florence, Italy
Andrzej J. Ochala, MD
University Hospital
Katowice, Poland
Tejas Patel, MD, DM
TCVS Pvt Ltd
Ahmedabad, India
Showa University Northern
Yokohama Hospital
Kanagawa, Japan
Carlos Pedra, MD, PhD
São Paulo, Brazil
27
Giovanni B. Pedrazzini, MD
Cardiocentro Ticino
Lugano, Switzerland
Evelyn S. Regar, MD, PhD
Teguh Santoso, MD, PhD
Medistra Hospital
Jakarta, Indonesia
Marco A. Perin, MD, PhD
Hospital Albert Einstein
Sao Paulo, Brazil
Ospedale di Mirano
Mirano, Italy
Gennaro Sardella, MD
Policlinico Umberto I University
Rome, Italy
Anna Sonia Petronio, MD
Ospedale di Cisanello
Pisa, Italy
Expedito E. Ribeiro, MD, PhD
The Heart Institute/
University of São Paulo
São Paulo, Brazil
Rogerio Sarmento-Leite, MD, PhD
Instituto de Cardiologia do Rio
Grande do Sul
Flavio L. Ribichini, MD
Università di Verona
Verona, Italy
Kazuhiro Sase, MD, PhD
Juntendo University Medical Center
Tokyo, Japan
Gert Richardt, MD, PhD
Heart Center, Segeberger Kliniken
Bad Segeberg, Germany
Hopital du Sacre-Coeur de Montreal
Montreal, Canada
Stéphane Rinfret, MD, SM
Quebec City, Canada
Dierk Scheinert, MD
Park-Krankenhaus Leipzig
Leipzig, Germany
Gilles Rioufol, MD, PhD
Hospices Civils de Lyon,
Cardiovascular Hospital
Bron, France
Bruno Scheller, MD
Universitatsklinikum des Saarlandes
Homburg, Germany
Nicolo Piazza, MD
German Heart Center
Munich, Germany
Philippe Pibarot, DVM, PhD
Quebec City, Canada
Jan J. Piek, MD
University of Amsterdam
Ruben A. Piraino, MD
Sanatorio Plaza
Rosario, Argentina
Stuart J. Pocock, PhD
London School of Hygiene and
Tropical Medicine
Antonios A. Polydorou, MD
Evangelismos Hospital
Athens, Greece
Francesco Prati, MD
San Giovanni Hospital
Rome, Italy
Piotr Pysz, MD
Medical University of Silesia
Katowice, Poland
Shubin Qiao, MD
Beijing Fuwai Hospital
Beijing, China
Marcelo Queiroqa, MD
Cardiocenter Centro de Diag e
Trat das Doenças
João Pessoa, Brazil
Sam Radhakrishnan, MD
Schulich Heart Center,
Sunnybrook Hospital
Toronto, Canada
Maria D. Radu, MD
The Heart Centre, Rigshospitalet
Copenhagen, Denmark
Homero A. Ramirez, MD
Hospital de Cardiologia Instituto Mexicano
del Seguro Social
Mexico City, Mexico
Sudhir Rathore, MD
St Georges Hospital
Krzysztof Reczuch, MD, PhD
Wojskowy Szpital Kliniczy
Wrocław, Poland
28
program ·
Robert Roberts, MD
Ottawa, Canada
Quebec Heart and Lung Institute/
Laval University
Quebec, Canada
Alexey Protopopov, MD
Krasnoyarsk Regional
Krasnoyarsk, Russia
Simon Redwood, MD
St Thomas’ Hospital
Harald Rittger, MD
Universitätsklinikum Erlangen
Erlangen, Germany
Wolfgang Schillinger, MD
Universitatsmedizin Gottingen
Gottingen, Germany
Joachim Schofer, MD
Hamburg University
Hamburg, Germany
Peter Sick, MD
Krankenhaus Barmherzige
Brüder Regensburg
Regensburg, Germany
CardioVascular Center Frankfurt,
Sankt Katharinen
Frankfurt, Germany
Ulrich Sigwart, MD
University of Geneva
Geneva, Switzerland
Sigmund Silber, MD
Heart Center at the Isar
Munich, Germany
Tabassome Simon, MD, PhD
Hospital St. Antoine UPMC
Paris, France
Ajay Radheshyam Sinhal, MBBS, MD, DM
Flinders Medical Centre
Adelaide, Australia
Dimytri Siqueira, MD, PhD
São Paulo, Brazil
Peter C. Smits, MD, PhD
Maasstad Ziekenhuis
Derek So, MD
Ottawa, Canada
Erwin Schroeder, MD
UCL de Mont-Godinne
Yvoir, Belgium
Mohamed Sobhy, MD
Alexandria University
Alexandria, Egypt
Gerhard C. Schuler, MD
Herzzentrum Leipzig
Leipzig, Germany
Amanda G.M.R. Sousa, MD, PhD
São Paulo, Brazil
Karl-Ludwig Schulte, MD, PhD
Ev Hospital Königin Elisabeth Herzberge
Berlin, Germany
Konstantinos Spargias, MD, PhD
Hygeia Hospital
Athens, Greece
Alessandro Sciahbasi, MD
Policlinico Casilino - ASL RMB
Rome, Italy
Christian M. Spaulding, MD, PhD
Cochin Hospital/Cordis
Issy-les-Moulineaux, France
Amit Segev, MD
Chaim Sheba Medical Center
Tel Hashomer, Israel
Eugenio Stabile, MD, PhD
Clinica Montevergine
Mercogliano, Italy
Jacques Seguin, MD
CoreValve
Paris, France
Rod H. Stables, MA, DM
Liverpool Heart and Chest Hospital
Liverpool, United Kingdom
Thoraxcenter
Boris Starcevic, MD
Clinical Hospital Dubrava
Zagreb, Croatia
Francesco Saia, MD, PhD
Policlinico S. Orsola-Malpighi
Bologna, Italy
Ashok Seth, DSc
Escorts Heart Institute and
Research Centre
New Delhi, India
Christodoulos I. Stefanadis, MD
University of Athens
Athens, Greece
Shigeru Saito, MD
Shonan Kamakura General Hospital
Kanagawa, Japan
Hiroki Shiomi, MD
Kyoto University Hospital
Kyoto, Japan
Luigi Salemme, MD
Montevergine Clinic
Naples, Italy
Junya Shite, MD
Kobe University
Hyogo, Japan
Archimides Sanati, MD
Tehran University of Medical Sciences
Tehran, Iran
AHEPA University Hospital
Thessaloniki, Greece
Giuseppe M. Sangiorgi, MD
University of Rome tor Vergata
Rome, Italy
Dirk Sibbing, MD
Deutsches Herzzentrum Munchen
Munich, Germany
Alfredo Rodriguez, MD, PhD
Sanatorio Otamendi
Enrico Romagnoli, MD, PhD
Policlinico Casilino
Rome, Italy
Peter N. Ruygrok, MD
Grafton, New Zealand
Jamil Abdalla Saad, MD
Fundação Felisse Rosso
Belo Horizonte, Brazil
Manel Sabate, MD, PhD
Thorax Institute, Hospital Clinic
Barcelona, Spain
Stefan Sack, MD
Klinikum Schwabing
Munich, Germany
Terje K. Steigen, MD, PhD
University Hospital of Northern Norway
Tromso, Norway
Pieter R. Stella, MD, PhD
University Medical Center Utrecht
Utrecht, The Netherlands
Jason Stewart, MD
Västra Götalandsregionen
Vänersborg, Switzerland
Roman Stipal, MD
University Hospital
Olomouc, Czech Republic
Bradley H. Strauss, MD, PhD
Sunnybrook Health Sciences Center
Toronto, Canada
TCT2011
Cardiovascular
Therapeutics
Satoru Sumitsuji, MD
Nozaki Tokushukai Hospital/
Osaka University
Osaka, Japan
Sanjay Tyagi, MBBS, MD, DM
G.B. Pant Hospital and Maulana
Azad Medical College
New Delhi, India
Marco V. Wainstein, MD, DSc
Hospital de Clinicas de Porto Alegre
and Hospital Moinhos de Vento
Maarten J. Suttorp, MD, PhD
St. Antonius Hospital
Nieuwegein, The Netherlands
Wasan Udayachalerm, MD
King Chulalongkorn Memorial Hospital
Bangkok, Thailand
Kevin Walsh, MD
Our Lady’s Hospital for Sick Children
Dublin, Ireland
Takahiko Suzuki, MD
Toyohashi, Japan
Yasunori Ueda, MD, PhD
Osaka Police Hospital
Osaka, Japan
Simon Walsh, MD, MRCP
Belfast Trust
Tomoyuki Suzuki, MD
Sakakibara Heart Institute
Tokyo, Japan
Philip M. Urban, MD
La Tour Hospital
Geneva, Switzerland
Darren L. Walters, MBBS, MPhil
The Prince Charles Hospital
Brisbane, Australia
David Taggart, MD, PhD
John Radcliffe Hospital
Oxford, United Kingdom
Gian Paolo Ussia, MD
Ferrarotto Hospital
Catania, Italy
Thomas Walther, MD
Kerckhoff Klinik Bad Nauheim
Corrado Tamburino, MD, PhD
Ferrarotto Hospital
Catania, Italy
Alec Vahanian, MD
Hôpital Bichat
Paris, France
Haichang Wang, MD
Xijing Fourth Military Medical University
Xi’an, China
Bo Xu, MD
Cardiovascular Institute and
Fu Wai Hospital
Beijing, China
Huay Cheem Tan, MD
National University Heart Centre
Singapore
Marco Valgimigli, MD, PhD
University of Ferrara,
Cardiovasuclar Institute
Ferrara, Italy
Lefeng Wang, MD
Beijing Chaoyang Hospital
Beijing, China
Masahisa Yamane, MD
Sayama Hospital
Sayama City, Japan
Philip Wang, MBA
Microport
Shanghai, China
Hongbing Yan, MD, PhD
Beijing Anzhen Hospital
Beijing, China
Weiman Wang, MD
Peking University People’s Hospital
Beijing, China
Yuejin Yang, MD, PhD
Cardiovascular Institute and
Fu Wai Hospital
Beijing, China
Jean-François Tanguay, MD
Montreal Heart Institute
Montreal, Canada
Jurrien M. Ten Berg, PhD
St. Antonius Hospital
Nieuwegein, The Netherlands
Swee Guan Teo, MD
National University Health Centre
Singapore
Mitsuyasu Terashima, MD
Toyohashi, Japan
Christian Juhl Terkelsen, MD
Skejby, Denmark
Holger Thiele, MD
University of Leipzig Heart Center
Leipzig, Germany
Leif Thuesen, MD
Aarhus, Denmark
Ralph Toelg, MD
Herz-Kreislauf-Zentrum
Pim A.L. Tonino, MD
Catharina Hospital
Eindhoven, The Netherlands
Konstantinos Toutouzas, MD
Athens Medical School
Athens, Greece
Hendrik Treede, MD
University Heart Center Hamburg
Hamburg, Germany
Dietmar Trenk, PhD
Herz-Zentrum Bad Krozingen
Uday Trivedi, FRCS, C-Th
Royal Sussex County Hospital
Brighton, United Kingdom
Etsuo Tsuchikane, MD, PhD
Toyohashi, Japan
Heleen van Beusekom, MD
Thoraxcenter
Erasmus, The Netherlands
Frans Van de Werf, MD
University of Leuven
Leuven, Belgium
Isabelle Van Herzeele, MD, PhD
University Hospital Ghent
Ghent, Belgium
Glenn Van Langenhove, MD, PhD, MBA
Middelheim Hospital Antwerp
Antwerpen, Belgium
Nicolas van Mieghem, MD
Eramus Medical Center
Hugo Vanermen, MD
Onz-Lieve-Vrouw Ziekenhuis
Aalst, Belgium
Dobrin Vassilev, MD, PhD
National Heart Hospital
Sofia, Bulgaria
Freek W.A. Verheugt, MD
Onze Lieve Vrouwe Gasthuis
Stefan Verheye, MD, PhD
Antwerp Cardiovascular Institute,
Middleheim Hospital
Antwerp, Belgium
Paul Vermeersch, MD, PhD
AZ Middelheim
Hove, Belgium
Ernst Vester, MD, PhD
University of Düsseldorf
Düsseldorf, Germany
Clemens von Birgelen, MD, PhD
Thoraxcentrum Twente
Enschede, The Netherlands
Jeroen Vos, MD
Amphia Hospital Breda
Breda, The Netherlands
Pascal Vranckx, MD
Hartcentrum
Hasselt, Belgium
Third Division of Cardiology
Katowice, Poland
Stephen G. Worthley, PhD
The University of Adelaide
Adelaide, Australia
Yongjian Wu, MD
Fu Wai Hospital
Beijing, China
Nina C. Wunderlich, MD
CardioVascuar Center Frankfurt
Frankfurt, Germany
Yusuke Watanabe, MD
Paris, France
Jian Ye, MD
Vancouver, Canada
John G. Webb, MD
Vancouver, Canada
Hiroyoshi Yokoi, MD
Kokura Memorial Hospital
Fukuoka, Japan
Mark W.I. Webster, MB, ChB
Carlos Zabal, MD
Instituto Nacional de CardiologÌa
Mexico City, Mexico
Peter Wenaweser, MD
University Hospital Bern
Bern, Switzerland
Azfar G. Zaman, MD
Freeman Hospital
Newcastle Upon Tyne, United Kingdom
Olaf Wendler, MD, PhD
Robaayah Zambahari, MBBS
National Heart Institute
Gerald S. Werner, MD, PhD
Klinikum Darmstadt
Darmstadt, Germany
Robert J. Whitbourn, MBBS, MD, BSc
St. Vincent Hospital Melbourne
Harvey D. White, DSc
Green Lane Cardiovascular Service,
Aaron Wong, MD
National Heart Centre Singapore
Singapore
Andreas M. Zeiher, MD
University Hospital Medical Center
Frankfurt, Germany
Michael Zelizko, MD, PhD
Clinic of Cardiology IKEM
Praha, Czech Republic
Thomas Zeller, MD
Herzzentrum Bad Krozingen
Bad Kronzingen, Germany
Bern, Switzerland
Uwe Zeymer, MD
Herzzentrum Ludwigshafen
Ludwigshafen, Germany
Adam Witkowski, MD, PhD
Institute of Cardiology
Warsaw, Poland
Qi Zhang, PhD
Shanghai Ruijin Hospital
Luwan, China
Charite University of Medicine Berlin
Berlin, Germany
Ruiyan Zhang, PhD
Shanghai Ruijin Hospital
Shanghai, China
Jochen Wöhrle, MD
University Hospital Ulm
Ulm, Germany
Yujie Zhou, MD, PhD
Beijing Anzhen Hospital
Beijing, China
29
TCT Advisory Faculty
Atul Abhyankar, MD
Sunil Eshwarchand Agarwal, MD, DNB
Rajiv Agarwal, MD
Syed Ali Ahsan, MD
Ravikumar Aluri MD
Sung Gyu An, Fellow
Sambasivam Kalpathi
Ananthanarayanan, MD
Pedro Beraldo De Andrade, MD
Júlio César Machado Andrea, MD
Madeswaran Tiruchengode Angappan, MD
Syed Ali Anis, MD
Nelson Antonio Moura De Araujo, MD
José Augusto Rocha Araujo, MD
Carlos Augusto Formiga Areas, MD
Santiago Raul Arrieta, MD
José Airton De Arruda, MD
Bedson Jose Lopes De As, MD
Safiya Manzil Ashraf, MD, DM
Khurshid Aslam, MD
Parayoru Kottayil Asokan, MD, DM
Lakshmi Narayanan Aswathaman, MD
Ravi Kanth Athuluri, MD
Thankachan Varkey Attacheril, MD, DM
Guilherme Ferragut Attizzani, MD
Milind Avdhout, MD, FRCP
Harish Somasundaram Ayyappan, MD
Ju Yeal Back, MD, PhD
Rajeev Bagarhatta, MD
Shiv Bagga, MD
R. Bagirath, MD
Madan Mohan Balakrishnan, MD
Profparthasarathi Banerjee, MD
Raju Barathithasan, MD
Flavio Passos Barbosa, MD
Hemang Baxi, MD
Leonardo Gogo Beck, MD
Mrutyunjaya Behera, MD
Abhijit Belgaumkar, MD
Nirav Bhalani, MD
Naveen Bhambhri, MD
Rajeev Bhardwaj, MD
Suman Bhandari, MD
Jayesh Bhaskaran, MD
Gopalkrishna Bhat, MD
M. N. Bhat, MD
Vineet Bhatia, MD
J. S. Bhuvaneswaran, MD
Arup Das Biswas, MD
Roberto Vieira Botelho, MD
Fábio Sândoli De Brito Jr, MD
André Farinelli Lima Brito, MD
Ronaldo Da Rocha Loures Bueno, MD
Jamil Ribeiro Cade, MD
Adriano Mendes Caixeta, MD
Marcelo José De Carvalho Cantarelli, MD
Paulo Ricardo Avancini Caramori, MD
Cristiano De Oliveira Cardoso, MD
Rajneesh Carlton, MD
José Klauber Roger Carneiro, MD
Antonio Carlos De Camargo Carvalho, MD
Luiz Antonio Ferreira Carvalho, MD
Marco Tulio Villaça Castagna, MD
Hélio José Castello Jr, MD
Marinella Patrizia Centemero, MD
Gpcaptds Chadha, MD
In-Ho Chae, MD
Jei-Keon Chae, MD, PhD
Venkateshawara Rao Chaganti, MD
Subhash Chana, MD
B. B. Chanana, MD
Bharat Bhushan Chanana, MD, DM
Aniruddha Balkrishna Chandorkar, MD
30
program ·
Nishith Chandra, MD
Gopalan Bahuleyan Charantharayil, MD
Mahantesh Rachayya Charantimath, MD
S.S. Chatterjee, MD
Sanjiv Chaudhary, MD
V. C. Chauhan, MD
Áurea Chaves, MD
Kamaldeep Chawla, MD
Wook-Hyun Cho, MD
Yun-Kyeong Cho, MD
Yunseok Choi, MD, PhD
Jae-Woong Choi, MD
Arun Chopra, MD
Vikas Chopra, MD
Wilson Miguel Cecim Coelho, MD
Ricardo Alves Da Costa, MD
Rodrigo Nieckel Da Costa, MD
José Ribamar Costa Jr, MD
Luciana Constant Daher, MD
Ramakrishna Chengala
Damodara, MD, DM
Sameer Dani, MD
Dinyar Daruwala, MD
Rubens Zenobio Darwich, MD
Arvind Das, MD
Mrinal Kanti Das, MD
Ajit Desai, MD
Devang Desai, M.D
Rajendra Govindrao
Deshmukh, MBBS, MD, DnB
Shantanu Deshpande, MD
Pradeep Kumar Devan, MD
Fernando Stucchi Devito, MD
Anil Dhall, MD
Gilvan Oliveira Dourado, MD
Bipin Dubey, MD, DM
Norberto Toazza Duda, MD
Jaskaran S. Dugal, MD
Shuvo Dutta, MD
Timothy. C. Dy, MD
Rajeev Edakutty, MD
Satish Kumar Epari, MD
Arunachalam Esakkiappan, MD
Manoel Augusto Batista Esteves, MD
Ali Faizal, MD
Esmeralci Ferreira, MD
Antonio Carlos Neves Ferreira, MD
Hélio Roque Figueira, MD
Augusto Lima Filho, MD
Eulógio Emilio Martinez Filho, MD
Heitor Maurício De Medeiros Filho, MD
Moyses De Oliveira Lima Filho, MD
Wilson Albino Pimentel Filho, MD
Raul Ivo Rossi Filho, MD
Newton Fernando Stadler
De Souza Filho, MD
José Breno De Sousa Filho, MD
Louie Fischer, MD
Alberto Gomes Taques Fonseca, MD
Raimundo João Costa Furtado, MD
Ramesh Gadepalli, MD
Narayan Gadkar, MD
Gamini Galapathy, MD
Lazaro Claudovino Garcia, MD
Naveen Garg, MD
Gulab Chandra Gautam, MD
Ulisses Marquez Gianecchini, MD
Anand Gnanraj, MD
Girish S. Godbole, MD
Antonio Gilson Lapa Godinho, MD
Nagendra Prasad Golla, MD
Vitor Osorio Gomes, MD
José Maria Pereira Gomes, MD
Sreenivas Colanakuduru Gopal, MD
Sridhara Gopalasastry, MD
Aniyathodiyil Gopi, MD
Carlos Antonio Mascia Gottschall, MD
Raghu Thagachagere Rame Gowda, MD
Jasprakash Singh Grewal, MD, DM
Luiz Antonio Gubolino, MD
Ênio Eduardo Guérios, MD
Luiz Carlos Giuliano, MD
Jorge Ilha Guimarães, MD
Jose Silverio Peixoto Guimaraes, MD
Heloisa Maria Melo Silva Guimarães, MD
Surya Prakash Gulla, MD
Amit Gupta, MD, DM
Nishant Gupta, MD
Pankaj Gupta, MD, DM
Sanjiv Gupta, MD
Shashi Bhushan Gupta, MD
Suvir Gupta, MD
Jorge Luis Haddad, MD
Suhas Hardas, MD
Sivadasan P. Harikrishnan, MD
Jagdish Hiremath, MD
Shirish Hiremath, MD
Soon-Jun Hong, MD, PhD
Young-Joon Hong, MD
Biju C. Issaac, MD, DM
Prashant Jagtap, MD
Alkesh Jain, MD, DM
Amit Jain, MD
Bimit Kumar Jain, MD
Nirmal Jain, MD, DM
Sharad Jain, MD
Satej Janorkar, MD
R.K. Jaswal, MD
Rakesh Kumar Jaswal, MD
José Antonio Jatene, MD
Dong-Woon Jeon, MD
Paulo Henrique Jorge, MD
George Joseph, MD
George Johnson, MD
Johny Joseph, MD
Wilson Ambalathingal Joseph, BSC, MVS
Hasit Joshi, MD
Shishir Joshi, MD
Kannan Jothiraj, MD
João Orávio De Freitas Junior, MD
Alcides Ferreira Junior, MD
Pravin Rameshchandra Kahale, MD
Luiz Junya Kajita, MD
Annapoorna Kalia, MD
Dhamodaran Kaliyamoorthy, MD
Sanjay Kalkekar, MD
Basavraj Chandrashekhar Kalmath, MD
Chanakya Kishore Kumar
Kammaripalli, MD
G.R. Kane, MD
Tae Soo Kang, MD, PhD
Woong-Chol Kang, MD
Nitin Kansal, MD
Anuj Kapadia, MD
Ketan Kapashi, MD
Aditya Kapoor, MD
Vipul Kapoor, MD
Hashir Kareem, MD
Rajeev Karnik, MD
Chakkalakal Prahakaran Karunadas, MD
Atul Kasliwal, MD
Jamesthomas Kathalankal, MD
B. Kesavamoorthy, MD
Zakia Khan, MD
Asit Khanna, MD
Rajeev Khare, MD, DM
Dong-Kie Kim, MD
Hyong-Jun Kim, MD
Joong Sun Kim, MD, PhD
June-Hong Kim, MD
Ki-Seok Kim, MD, PhD
Pum-Jun Kim, MD, PhD
Young-Hoon Kim, MD, PhD
Yong-Giun Kim, Fellow
K. S. Kishore, MD
Tarlochan S. Kler, MD
Subramanyam Kodangala, MD
Young-Youp Koh, MD, PhD
Prabhakar Chandrashekhar Koregol, MD
Adrian Paulo Morales Kormann, MD
Deepaesh Kothari, MD
Deepak Krishnamurthy, MD
Suresh Krishnan, MD
Abhay Kumar, MD, DM
Anand Kumar, MD
Anil Kumar, MD, DM
Ganesh Kumar, MD
Krishnankutty Krishna Kumar, MD
Manoj Kumar, MD
Nanda Kumar, MD, DM
Pampana Venkata Varaha Narasimha
Markandeya Kumar, MD
Prabhat Kumar, MD
Prasana Kumar, MD, DM
Pratap Kumar, MD
Rakesh Kumar, MD
Sampath Kumar, MD
Sanjay Kumar, MD
Vijay Kumar, MD
Jabirabdullah Kutty, MD
André Labrunie, MD
Marta Moraes Labrunie, MD
Tilak Kishor Lall, MD
Ricardo Lasevitch, MD
Kalidoss Latchumanadhas, MD
Byoung-Kwon Lee, MD
Jae-Beom Lee, MD
Jae Hwan Lee, MD, PhD
Jang Hoon Lee, MD
Jong-Min Lee, MD, PhD
Sang-Chil Lee, MD
Seung Whan Lee, MD, PhD
Seung-Uk Lee, MD
Sang-Rok Lee, MD
Suhas Lele, MD
Viviana De Mello Guzzo Lemke, MD
Valter Correia Lima, MD
Antonio Augusto Guimaraes Lima, MD
Marcelo Antônio Cartaxo
Queiroga Lopes, MD
João Batista Lopes Loures, MD
Bruno Moulin Machado, MD
Garikapat Mahesh, MD
Samir Kanti Majumder, MD
Chandrashekhar Makhale, MD
C.N. Makhale, MD
Susheel Kumar Malani, MD
Ashish Kumar Malhotra, MD
Hemant Malhotra, MD
Vineet Malik, MD
Ari Mandil, MD
Luiz Alberto Rolla Maneschy, MD
José Armando Mangione, MD
Panchanatham Manokar, MD
José Antonio Marin-Neto, MD
Marcos Antonio Marino, MD
Helman Campos Martins, MD
Ganesh Mathan, MD
Navin Mathew, MD
TCT2011
Samuel Mathew, MD
Nelson Durval Ferreira Gomes
De Mattos, MD
Luiz Alberto Piva E Mattos, MD
Shafeeq Mattummal, MD, DM
Alok Mazumdar, MD
César Rocha Medeiros, MD
Vivek Mehan, MD
Haresh G. Mehta, MD
George Cesar Ximenes Meirelles, MD
Cintia Acosta Melo, MD
Ajit Menon, MD
Gaurav Minocha, MD
Ricardo Pontes De Miranda, MD
Anil Mishra, MD
H.N. Mishra, MD
Sundeep Mishra, MD
Sunilkumar Modi, MD
Bishav Mohan, MD
Keon-Woong Moon, MD
Raul Dáurea Mora Jr, MD
Marco Antonio Gonçalves De Moura, MD
Álvaro Vieira Moura, MD
Siddharth Mukerjee, MD
Ajit Mullasari, MD
Antonio Jose Muniz, MD
Viswanathan Muthukrishnan, MD
Venkatesh Anegunta Naidu, MD
Muralikrishna Nallamothu, MD
Ganesan Nambirajan, MD
Varun Shanker Narain, MD
Patnaik Amar Narayan, MD
Murugan Sankara Narayanan, MD
Sajan Narayanan, MD
Ranjit Kumar Nath, MD
Girishb Navasundi, MD
C.N. Nayak, MD
Hernando Eduardo Nazzeta, MD
Vijay Singh Negi, MD
Deborah Christina Nercolini, MD
Pedro Alves Lemos Neto, MD
Milton De Macedo Soares Neto, MD
Gilberto Lahorgue Nunes, MD
Prasanna Nyayadhish, MD
Adriano Dias Dourado Oliveira, MD
Flavio Roberto Azevedo De Oliveira, MD
Itamar Ribeiro De Oliveira, MD
Ludmilla Almeida Da Rocha
Ribeiro De Oliveira, MD
Paulo Sérgio De Oliveira, MD
Abraham Oomman, MD
Costantino Costantini Ortiz, MD
Evandro Cesar Vidal Osterne, MD
Shoaib Padaria, MD
Sreekala Padmanabhan, MD
José Nogueira Paes Jr, MD
Devkishen Pahlajani, MD
Mariappan Palanisamy, MD
Girish Meennahalli Palleda, MD
Naresh Pamnani, MD
A.K. Pandey, MD
Rashmit Pandya, MD
Manotosh Panja, MD
Yongwhi Par, MD, PhD
Gurunath Parale, MD
Jagdish Parikh, MD
Prakashvir Parikh, MD
Hun-Jun Park, MD
Jong-Pil Park, MD
Jong-Seon Park, MD
Kyoung Woo Park, MD, PhD
Yong-Whi Park, MD
Woo Jung Park, MD, PhD
Rajiv Passey, MD
Balagopalan Jayagopal Pathiyil, MD
Rajendra Patil, MD, DM
Rahul Patil, MD
Nitin Suresh Patki, MD
João Eduardo Tinoco De Paula, MD
Carlos Augusto Cardoso Pedra, MD
Mukund Penurkar, MD
Luis Amandio Coelho Pereira, MD
Marco Aurélio Magalhães Pereira, MD
Govinda Madhavan Pillai, MD
Jayakumar Balakrishna Pillai, MD
Ramakrishna Pillai , MD, DM
Brian Pinto, MD
Pawan Poddar, MD
Antenor Lages Fortes Portela, MD
Sanjay Porwal, MD
Anil Potdar, MD
Jayesh Prajapati, MD
Sergio Correa Prata, MD
Rajenakumar Premchand, MD
Mauricio Lopes Prudente, MD
C.S. Pruthi, MD
Aniket Puri, MD
Raman Puri, MD
Alexandre Schaan De Quadros, MD
Francisco Jose Araujo Chamié Queiroz, MD
Bagirath Raghuraman, MD
Asif Raheem, MD
Abdul Kasem Mohammad
Fazlur Rahman, MD
Afzalur Rahman, MD
Mahbubor Rahman, MD
Siddiqur Rahman, MD
Thachathodiyil Rajesh, MD
Pusapativenkataramachana Raju, MD
Rangaraj Ramalingam, MD
Vaidyanathan Peruvamba Raman, MD
Gian C. Rana, MD
Alok Ranjan, MD
Anand Rao, MD
M. Srinivas Rao, MD
Pratapchana Rath, MD
Rajiv Rathi, MD
Sivakumar Rathinavel, MD
Dilip Kumar Ratnani, MD
Pachakkoottathil Raveendran, MD, DM
Gupta Ravi, MD
Khandenahally Palya S. Ravindranath, MD
Anilkrishna Reddy, MD
Mandala Gokul Reddy, MD
Sujay Renga, MD, DM
Jorge Pinto Ribeiro, MD
Henrique Barbosa Ribeiro, MD
Cyro Vargues Rodrigues, MD
Kanchan Satish Roplekar, MD
Satish Murlidharrao Roplekar, MD
Sanjeeb Roy, MD
Subhanan Roy, MD
Sunil Baran Roy, MD
Jamil Abdalla Saad, MD
Arabinda Saha, MD
Uttam Kumar Saha, MD
Atul Kumar Sahi, MD
P.K. Sahoo, MD
Ashutosh Sahu, MD
Sanjib Kumar Sahu, MD
Goyal Saket, MD
Anil Saleem, MD, DM
José Ary Boechat E Salles, MD
Décio Salvadori Jr, MD
Mahenaprasad Samal, MD
Amit Sambare, MD
Fernando Mendes Santánna, MD
Harikrishnan Madhavankutty
Santhakumari, MD
Marcelo De Freitas Santos, MD
Prakash Sanzgiri, MD
Vikas Sardana, MD
Pramod Ratanchand
Sarnot, MBBS, DHE, MD
Toutem Sashikant, MD
Shireesh Sathe, MD
Antônio Luiz Secches, MD
Durgaprasadraja Sekhar, MD
Fabio Augusto Selig, MD
Rajiv Sethi, MD
Bhadresh, Shah, MD, DM
Bhaskar Shah, MD
Bhupesh Shah, MD
Chetan Shah, MD
Dhiren Shah, MD, DM
Hetan Shah, MD
Hitesh. J. Shah, MD
Jay Manojkumar Shah, MD
Prasad Shah, MD
O.M. Shankar, MD
Anil Sharma, MD
Arvind Sharma, MD
Kamal Sharma, MD
Manish Sharma, MD, DM
Mridul Sharma, MD, DM
Mridul Sharma, MD
Sunil Kumar Sharma, MD, DM
Anand Ramesh Shenoy, MD
Chirag Sheth, MD
G.G. Shetty, MD
Prabhakar Shetty, MD
Ranjan Shetty, MD
Sadanand Shetty, MD
Sreekanth Shetty, MD
Eun Seok Shin, MD, PhD
Deepak Jijabrao Shinde, MBBS, DnB
Bharat Shivdasani, MD
Jalepalli Shivkumar Rao, MD
Célia Maria Camelo Silva, MD
Eduardo Missel Silva, MD
Ricardo Cavalcante E Silva, MD
Samuel Silva Da Silva, MD
Stefan Costa Siveira, MD
Alok Kumar Singh, MD
Parminder Singh, MD
Rakesh Kumar Singh, MD
Nakul Sinha, MD
Ramanand Sinha, MD
Sudhir Chandra Sinha, MD
Dimytri Alexandre De Alvim Siqueira, MD
Paulo Rogério Soares, MD
Vinod Somani, MD
Antonio Cesar De Souza, MD
Antonio José Neri Souza, MD
Rodolfo Staico, MD
Mantravadi Sai Sudhakar, MD, DM
Jon Suh, MD, PhD
Pawan Suri, MD, DM
Satish Suryavanshi, MD
Puttam Reddy Susheel, MD
Chetan Swaroop, MD
Ajit Tambolkar, MD
Luiz Fernando Leite Tanajura, MD
Sergio Gustavo Tarbine, MD
Sunil Thanvi, MD
Luiz Eduardo Koenig Sao Thiago, MD
Manikandan Thiruvanath Variam, MD
Vinod Thomas, MD, DM, DnB
James Thomas, MD
Cardiovascular
Therapeutics
Joby Kochuparambil Thomas, MD
Pyarelal Tiwari, MD, MRCP
Nityanand Tripathi, MD
Rutvik Trivedi, MD
Sunil Trivedi, MD
Rogério Tadeu Tumelero, MD
Mir Jamal Uddin, MD
D. Vaidiyanathan, MD
Ali Faizal Valiyakath, MD
Kesava Vallabhapurapu, MD
Kiran Varghese, MD
Jagmohan Varma, MD
Manu Varma, MD
Vinicius Daher Vaz, MD
Manjunatha Bagur Venkataramaiah, MD
Krishnan Nair Venugopal, MD, DM
Puneet Kumar Verma, MD
Suresh Vijan, MD
Vinod Vijan, MD
Maniyal Vijayakumar, MD
Rajesh Vijayvergia, MD
Marco Vugman Wainstein, MD
Gagandeep Singh Wander, MD
R.D. Yadave, MD
Joo-Young Yang, MD, PhD
Shiva Kumar Yerra, MD
Sang-Yeob Yim, MD
Jung-Han Yoon, MD, PhD
Cheol-Woong Yu, MD
Alexandre Do Canto Zago, MD
Alcides José Zago, MD
31
United States Faculty
J. Dawn Abbott, MD
Rhode Island Hospital
Providence, RI
Husam H. Balkhy, MD
The Wisconsin Heart Hospital
West Allis, WI
William E. Boden, MD
Buffalo General Hospital
Buffalo, NY
Mark W. Burket, MD
University of Toledo Medical Center
Toledo, OH
Alex Abou-Chebl, MD
University of Louisville Stroke Center
Louisville, KY
Stephen Balter, PhD
Cardiovascular Research Foundation
New York, NY
Steven F. Bolling, MD
University of Michigan
Ann Arbor, MI
Daniel Burkhoff, MD, PhD
CircuLite
Saddle Brook, NJ
William T. Abraham, MD
Ohio State University
Columbus, OH
Subhash Banerjee, MD
UT Southwestern Clinical Heart Center
Dallas, TX
Johannes Bonatti, MD
University of Maryland
Baltimore, MD
David H. Adams, MD
Mount Sinai Medical Center
New York, NY
Sripal Bangalore, MD, MHA
New York University School of Medicine
New York, NY
Robert O. Bonow, MD
Northwestern University
Chicago, IL
Louis A. Cannon, MD
Northern Michigan Hospital Heart and
Vascular Institute, Petoskey Cardiology
Petoskey, MI
Tayo A. Addo, MD
UT Southwestern Clinical Heart Center
Dallas, TX
Kenneth W. Baran, MD
United Heart and Vascular Clinic
Saint Paul, MN
Brett E. Bouma, PhD
Massachusetts General Hospital
Boston, MA
Heather L. Agler, PhD
US Food and Drug Administration
Silver Spring, MD
Ravit Barkama, MD
NewYork-Presbyterian Hospital/
New York, NY
Bruce Bowers, MD
Dallas Cardiovascular Specialists
Dallas, TX
Jodi Akin, VP
Irvine, CA
Steven L. Almany, MD
William Beaumont Hospital
Boomfield Hills, MI
Caesar Alvero, AAS, RCIS
New York, NY
John A. Ambrose, MD
UCSF Fresno
Fresno, CA
Zahid Amin, MBBS, MD
Rush University Medical Center
Chicago, IL
Dominick J. Angiolillo, MD, PhD
University of Florida-Shands
Jacksonville, FL
Brian H. Annex, MD
University of Virginia
Charlottesville, VA
Gary M. Ansel, MD
Riverside Methodist Hospital
Columbus, OH
Robert J. Applegate, MD
Wake Forest University
School of Medicine
Winston-Salem, NC
Salman A. Arain, MD
Tulane University School of Medicine
New Orleans, LA
Michael Argenziano, MD
New York, NY
Herbert D. Aronow, MD, MPH
St. Joseph Mercy Hospital
Ypsilanti, MI
Vasilis Babaliaros, MD
Emory University School of Medicine
Atlanta, GA
J. Michael Bacharach, MD, MPH
North Central Heart Institute
Sioux Falls, SD
Steven R. Bailey, MD
University of Texas Health Science
Center at San Antonio
San Antonio, TX
32
program ·
Colin M. Barker, MD
Hermann Memorial Heart and
Vascular Institute
Houston, TX
Theodore A. Bass, MD
University of Florida Health
Science Center
Jacksonville, FL
Eric R. Bates, MD
University of Michigan Medical Center
Ann Arbor, MI
Mark C. Bates, MD
CAMC Vascular Center of Excellence
Charleston, WV
Joseph E. Bavaria, MD
University of Pennsylvania
Philadelphia, PA
Anthony A. Bavry, MD, MPH
University of Florida
Gainesville, FL
Nirat Beohar, MD
Columbia University Division of Cardiology
at Mount Sinai Medical Center
Miami, FL
Daniel S. Berman, MD
Cedars-Sinai Medical Center
Los Angeles, CA
Robert M. Bersin, MD
Seattle Cardiology
Seattle, WA
Andrew J. Boyle, MD, PhD
UCSF Medical Center
San Francisco, CA
Russell A. Brandwein, RPA-C
New York, NY
Somjot S. Brar, MD
Kaiser Permanente
Los Angeles, CA
Sorin J. Brener, MD
New York Methodist Hospital
Brooklyn, NY
Andreas Brieke, MD
University of Denver
Aurora, CO
Emmanouil S. Brilakis, MD, PhD
VA North Texas Health Care System and
UT Southwestern Medical Center
Dallas, TX
Ralph G. Brindis, MD, MPH
Northern California Kaiser Permanente
Oakland, CA
Todd J. Brinton, MD
Stanford University Medical Center
Stanford, CA
Bruce R. Brodie, MD
Moses Cone Heart and Vascular Center
Greensboro, NC
Thomas G. Brott, MD
Mayo Clinic
Jacksonville, FL
Ronald Caputo, MD
SJH Cardiology Associates
Liverpool, NY
Blase A. Carabello, MD
Veterans Affairs Medical Center
Houston, TX
John D. Carroll, MD
University of Colorado Denver
Aurora, CO
Joseph P. Carrozza Jr, MD
Caritas St. Elizabeth’s Medical Center
Boston, MA
Charles E. Chambers, MD
Hershey Medical Center
Hershey, PA
Paul S. Chan, MD
Saint Luke’s Mid America Heart
and Vascular Institute
Kansas City, MO
S. James Chen, PhD
University of Colorado Hospital
Aurora, CO
James H. Chesebro, MD
UMass Memorial Medical Center
Worcester, MA
W. Randolph Chitwood Jr, MD
East Carolina University
School of Medicine
Greenville, NC
Leslie Cho, MD
Cleveland Clinic
Cleveland, OH
Lorraine Choi, MD
UTMB
Galveston, TX
Karen Christman, PhD
University of California San Diego
La Jolla, CA
Foundation for Cardiovascular Medicine
San Diego, CA
Nicolas A.F. Chronos, MD
Saint Joseph’s Translational Research
Institute/American Cardiovascular
Research Institute
Atlanta, GA
Michael Buck
Abbott Vascular
Abbott Park, IL
Timothy A.M. Chuter, DM
UCSF Medical Center
San Francisco, CA
John A. Bittl, MD
Munroe Regional Medical Center
Ocala, FL
Clifford J. Buckley, MD
Scott & White Clinic
Temple, TX
Daniel G. Clair, MD
Cleveland Clinic Foundation
Cleveland, OH
Peter C. Block, MD
Emory University Hospital
Atlanta, GA
James P. Burke, MD, PhD
Lehigh Valley Health Network
Allentown, PA
Sarah Clarke, MSN, NP
Scripps Clinic and Research Foundation
La Jolla, CA
Ashley B. Boam, MSBE
Silver Spring, MD
M. Nicholas Burke, MD
Minneapolis Heart Institute Foundation
Minneapolis, MN
Joseph C. Cleveland, MD
University of Colorado Anschutz
Medical Center
Aurora, CO
Patricia J. Best, MD
Mayo Clinic
Rochester, MN
VA Boston Healthcare System and Brigham
and Women’s Hospital
Boston, MA
TCT2011
David J. Cohen, MD
Saint Luke’s Mid-America Heart Institute
Kansas City, MO
New York, NY
Mauricio G. Cohen, MD
University of Miami Hospital
Miami, FL
Tony Das, MD
Presbyterian Heart Institute-Dallas
Dallas, TX
William E. Cohn, MD
Texas Heart Institute at St. Luke’s
Episcopal Hospital
Houston, TX
Rajesh M. Dave, MD
Central Pennsylvania Cardiovascular
Research Institute
Harrisburg, PA
Gerald D. Dorros, MD, ScD
Dorros-Feuer Interventional Cardiovascular
Disease Foundation, Ltd.
Wilson, WY
New York, NY
Charles J. Davidson, MD
Northwestern Memorial Hospital
Chicago, IL
John S. Douglas Jr, MD
Atlanta, GA
Michael J. Davidson, MD
Brigham and Women’s Hospital
Boston, MA
Robert D. Dowling, MD
University of Louisville
School of Medicine
Louisville, KY
Tyrone J. Collins, MD
Ochsner Clinic Foundation
New Orleans, LA
Anthony J. Comerota, MD
Jobst Vascular Institute
Toledo, OH
Mark W. Connolly, MD
St. Joseph’s Hospital Medical Center
Paterson, NJ
University of Toledo Medical Center
Toledo, OH
Jeff Davis, RRT, RCIS
Edison State University
Fort Myers, FL
Keith D. Dawkins, MD
Boston Scientific
Natick, MA
Anthony Dawson, MSN, RN
NewYork-Presbyterian Hospital
New York, NY
Pilar Dolcimascolo, RPA-C
New York, NY
Ted Feldman, MD
Evanston Hospital
Evanston, IL
Valerian Fernandes, MD
Medical University of South Carolina
Charleston, SC
Dennis J Donohoe, MD
Durham, NC
Elazer R. Edelman, MD, PhD
Cambridge, MA
Neal L. Eigler, MD
St. Jude Medical
Sylmar, CA
Stephen G. Ellis, MD
Cleveland, OH
Gregory P. Fontana, MD
Los Angeles, CA
Prakash Deedwania, MD
UCSF Medical Center
Fresno, CA
Stephen E. Epstein, MD
Washington Hospital Center
Washington, DC
Marco A. Costa, MD, PhD
University Hospitals Case Medical Center
Cleveland, OH
Regina Deible, BSN, RN
Suburban Hospital/
Johns Hopkins Medicine
Bethesda, MD
Michael D. Ezekowitz, MB, ChB, DPhil
Lankenau Medical Center
Wynnewood, PA
Michael J. Cowley, MD
Medical College of Virginia
Richmond, VA
David A. Cox, MD
Lehigh Valley Hospital
Bethlehem, PA
Michael H. Crawford, MD
University of California, San Francisco
Medical Center
San Francisco, CA
Enrique Criado, MD
University of Michigan Health System
Ann Arbor, MI
Frank J. Criado, MD
Union Memorial Hospital/MedStar Health
Baltimore, MD
Donald Cutlip, MD
Beth Israel Deaconess Medical Center
Boston, MA
Michael D. Dake, MD
Stanford University School of Medicine
Stanford, CA
Kate Dalton, MS, RD
New York, NY
Tony J. DeMartini, MD
Prairie Cardiovascular
Springfield, IL
Ali E. Denktas, MD
University of Texas at Houston
Houston, TX
Joseph J. DeRose, MD
Albert Einstein College of Medicine
Montefiore Medical Group
Bronx, NY
Tim A. Fischell, MD
Heart Institute at Borgess Medical Center
Kalamazoo, MI
Thomas J. Fogarty, MD
Fogarty Institute for Innovation
Mountain View, CA
Nicola Corvaja, MD
Stamford Hospital
Stamford, CT
Todd D. Courtney
Silver Spring, MD
Aloke V. Finn, MD
Emory Crawford Long Hospital
Atlanta, GA
John Flack, MD, MPH
Wayne State University
Detroit, MI
Chad Cornell
Medtronic, Inc.
Minneapolis, MN
Anthony N. DeMaria, MD
University of California, San Diego
School of Medicine
San Diego, CA
Michael A. Fifer, MD
Boston, MA
Peter J. Fitzgerald, MD, PhD
Stanford, CA
Larry S. Dean, MD
University of Washington
Regional Heart Center
Seattle, WA
Maria Rosa Costanzo, MD
Midwest Heart Specialists
Naperville, IL
Cardiovascular
Therapeutics
Sammy Elmariah, MD, MPH
Boston, MA
Robert J. Freedman Jr, MD
Life Recovery Systems
Alexandria, LA
Peter S. Fail, MD
Cardiovascular Institute of the South
Houma, LA
William J. French, MD
Harbor - UCLA Medical Center
Torrance, CA
Glenna Friedman, RN
New York, NY
Valentin Fuster, MD, PhD
New York, NY
Andrew Farb, MD
US Food & Drug Administration
Silver Spring, MD
James S. Gammie, MD
University of Maryland Heart Center
Baltimore, MD
Michael E. Farkouh, MD, MSc
Mount Sinai School of Medicine
New York, NY
Lawrence A. Garcia, MD
St. Elizabeth’s Medical Center
Boston, MA
David P. Faxon, MD
Boston, MA
Neal Fearnot, PhD
Cook Group Incorporated
W. Lafayette, IN
Timothy J. Gardner, MD
Center for Heart and Vascular Health,
Christiana Care Health System
Newark, DE
Todd M. Dewey, MD
Medical City Dallas
Dallas, TX
Stanford, CA
Kirk N. Garratt, MD, MSc
Lenox Hill Hospital
New York, NY
Nabil Dib, MD, MSc
Chandler Regional and Mercy Gilbert
Medical Centers/Catholic
Healthcare West
Gilbert, AZ
Frederick Feit, MD
New York University Medical Center
New York, NY
New York, NY
Simon R. Dixon, MBChB
Royal Oak, MI
Ozgen Dogan, MD
New York, NY
David S. Feldman, MD, PhD
Abbott Northwestern/Minneapolis
Heart Institute
Minneapolis, MN
Isaac George, MD
New York, NY
Dmitriy N. Feldman, MD
NewYork-Presbyterian Cornell Hospital
New York, NY
Jon C. George, MD
Deborah Heart and Lung Center
Browns Mills, NJ
Marc D. Feldman, MD
San Antonio, TX
Mayo Clinic
Rochester, MN
33
Gary Gershony, MD
John Muir Cardiovascular Institute
Piedmont, CA
Cindy L. Grines, MD
Detroit Medical Center
Royal Oak, MI
Chicago, IL
David B. Jessup, MD
St. Joseph Hospital
Bellingham, WA
C. Michael Gibson, MD
Boston, MA
Eugene A. Grossi, MD
NYU Medical Center
New York, NY
Mark Andrew Hlatky, MD
Stanford, CA
Thomas K. Jones, MD
Seattle Children’s Hospital
Seattle, WA
Ian C. Gilchrist, MD
Penn State/Hershey Medical Center
Hershey, PA
Luis Gruberg, MD
Stony Brook University Medical Center
Stony Brook, NY
Judith S. Hochman, MD
New York University Medical Center
New York, NY
Ulrich P. Jorde, MD
New York, NY
Linda D. Gillam, MD
New York, NY
Michael Guiry, MBA, RPA-C
New York, NY
John McB. Hodgson, MD
Geisinger Health System
Wilkes Barre, PA
James D. Joye, DO
El Camino Hospital
Mountain View, CA
Paul A. Gurbel, MD
Sinai Hospital of Baltimore System
Baltimore, MD
Udo Hoffmann, MD, MPH
Boston, MA
Hitinder S. Gurm, MD
Ann Arbor, MI
Lawrence Hofmann, MD
Stanford School of Medicine
Stanford, CA
Rona G. Kahn, DS
New York, NY
Swaminatha V. Gurudevan, MD
Los Angeles, CA
David R. Holmes Jr, MD
Mayo Clinic
Rochester, MN
Lee R. Guterman, MD, PhD
Catholic Health System of Buffalo
Amherst, NY
Howard M. Holstein, JD
Department of Health, Education,
and Welfare
Washington, DC
A. Marc Gillinov, MD
Cleveland, OH
Gregory R. Giugliano, MD, SM
Baystate Medical Education and Research
Foundation
Springfield, MA
Peter J. Goadsby, MD, PhD
UCSF Medical Center
San Francisco, CA
Sheldon Goldberg, MD
Cardiology Consultants of Philadelphia
Philadelphia, PA
Steven L. Goldberg, MD
University of Washington
Seattle, WA
Mark Goldberger, MD
New York, NY
Lee Goldman, MD
New York, NY
Royal Oak, MI
Juan F. Granada, MD
The Jack H. Skirball Center for
Orangeburg, NY
Luis A. Guzman, MD
University of Florida
Jacksonville, FL
Rebecca Tung Hahn, MD
New York, NY
Adam Hansgen, BS
University of Colorado Health
Sciences Center
Aurora, CO
Joshua M. Hare, MD
Miller School of Medicine
Miami, FL
Kishore J. Harjai, MD
Guthrie Clinic
Sayre, PA
Christopher B. Granger, MD
Duke University Medical Center
Durham, NC
William T. Harrington, MD, MBA
Three Arch Partners
Portola Valley, CA
University of Missouri Kansas City and Mid
America Heart Institute
Kansas City, MO
Marian C. Hawkey, RN
New York, NY
William A. Gray, MD
New York, NY
Timothy D. Henry, MD
Minneapolis, MN
Ralf J. Holzer, MD, MSc
Nationwide Children’s Hospital
Columbus, OH
W. Craig Hooper, PhD
Centers for Disease Control and Prevention
Atlanta, GA
L. Nelson Hopkins, MD
Millard Fillmore Gates Hospital
Buffalo, NY
Phillip A. Horwitz, MD
University of Iowa Hospitals & Clinics
Iowa City, IA
Syed Hossainy, PhD
Abbott Vascular
Santa Clara, CA
Fumiaki Ikeno, MD
Palo Alto, CA
Frank F. Ing, MD
Texas Children’s Hospital
Houston, TX
Alice K. Jacobs, MD
Boston University Medical Center
Boston, MA
Michael R. Jaff, DO
Boston, MA
Ross A. Jaffe, MD
Versant Ventures
Menlo Park, CA
Paul A. Grayburn, MD
Baylor University Medical Center
Dallas, TX
St. Vincent Hospital/
The Heart Center of Indiana
Indianapolis, IN
Philip Green, MD
New York, NY
Philadelphia, PA
Robert D.B. Jaquiss, MD
Duke University
Durham, NC
Richard R. Heuser, MD
St. Luke’s Medical Center
Phoenix, AZ
Allen Jeremias, MD, MSc
Stony Brook University Medical Center
Stony Brook, NY
Ann Greenberg, MSN
Suburban Hospital
Bethesda, MD
34
Robert A. Guyton, MD
Atlanta, GA
program ·
Jo Carol Hiatt, MD
Kaiser Permanente
Pasadena, CA
Farouc Jaffer, MD, PhD
Boston, MA
Greg L. Kaluza, MD, PhD
Orangeburg, NY
Piedmont Heart Institute
Atlanta, GA
Samir R. Kapadia, MD
Cleveland, OH
Aaron V. Kaplan, MD
Dartmouth-Hitchcock Medical Center
Lebanon, NH
Navin K. Kapur, MD
Tufts Medical Center
Boston, MA
Saibal Kar, MD
Los Angeles, CA
John W. Karanian, PhD
Laurel, MD
Dimitri Karmpaliotis, MD
Atlanta, GA
Barry T. Katzen, MD
Baptist Cardiac and Vascular Institute
Miami, FL
Sanjay Kaul, MD
Los Angeles, CA
Clifford J. Kavinsky, MD, PhD
Chicago, IL
Martina Kelly Speight, RN, BSN
Stanford, CA
The Christ Hospital
Cincinnati, OH
Morton J. Kern, MD
University of California Irvine
Orange, CA
Akshay Khandelwal, MD
Henry Ford Hospital
Northville, MI
R. Stefan Kiesz, MD
San Antonio Endovascular and
Heart Institute
San Antonio, TX
TCT2011
Cardiovascular
Therapeutics
Michael S. Kim, MD
University of Washington Medical Center
Seattle, WA
Tak W. Kwan, MD
Beth Israel Medical Center
New York, NY
Glenn N. Levine, MD
Baylor College of Medicine
Houston, TX
Tift Mann, MD
Wake Heart Associates
Raleigh, NC
Carey D. Kimmelstiel, MD
Boston, MA
Elena Ladich, MD
CVPath Institute, Inc.
Gaithersburg, MD
John C. Lewin, MD
Washington, DC
Steven V. Manoukian, MD
Sarah Cannon Research Institute
Nashville, TN
Nicholas N. Kipshidze, MD, PhD
Lenox Hill Hospital
New York, NY
Roger J. Laham, MD
Boston, MA
Michael J. Lim, MD
Saint Louis University
Saint Louis, MO
Gopi Manthripragada, MD
University of California
Los Angeles, CA
New York, NY
John R. Laird Jr, MD
UC Davis Medical Center
Sacramento, CA
Scott Lim, MD
UVA Medical Center
Charlottesville, VA
James R. Margolis, MD
Jackson South Community Hospital
Miami, FL
Gervasio A. Lamas, MD
Miami Beach, FL
JoAnn Lindenfeld, MD
University of Colorado Health
Sciences Center
Aurora, CO
Jonathan D. Marmur, MD
Downstate Medical Center
Brooklyn, NY
Jacqueline Kixmiller, RN
Stanford, CA
Neal S. Kleiman, MD
Methodist DeBakey Heart and
Vascular Center
Houston, TX
Robert A. Kloner, MD, PhD
Good Samaritan Hospital
Los Angeles, CA
Susheel Kodali, MD
New York, NY
Raghu Kolluri, MD
Prairie Vascular Institute
Springfield, IL
David F. Kong, MD, AM, DMT
Durham, NC
St. Luke’s Episcopal Hospital
Houston, TX
Paul H. Kramer, MD
Liberty Cardiovascular Specialists
Liberty, MO
Edward M. Kreps, MD
New York, NY
Yale School of Medicine
New Haven, CT
Tim J. Lapp, RCIS
Lancaster General Hospital
Lancaster, PA
Kevin Larkin
TherOx
Irvine, CA
John M. Lasala, MD, PhD
Washington University School
of Medicine
St. Louis, MO
Pedro Martinez-Clark, MD
Jupiter Medical Center
Miami, FL
Laura Mauri, MD, MSc
Boston, MA
Byron K. Lee, MD
UCSF Medical Center
San Francisco, CA
Kapildeo Lotun, MD
Virginia Commonwealth University Medical
Center
Richmond, VA
James B. McClurken, MD
Temple Cardiothoracic Surgery Associates
Philadelphia, PA
Michael S. Lee, MD
UCLA Medical Center
Los Angeles, CA
Reginald I. Low, MD
UC Davis Heart Center
Sacramento, CA
Randall J. Lee, MD, PHD
San Francisco, CA
Alan Lumsden, MD
Vascular Center
Houston, TX
Massoud A. Leesar, MD
University of Cincinnati
Cincinnati, OH
Aaron D. Kugelmass, MD
Baystate Medical Center
Springfield, MA
Martin B. Leon, MD
New York, NY
Robert Kutys, MS, PA(ASCP)
Gaithersburg, MD
William L. Lombardi, MD
North Cascade Cardiology
Bellingham, WA
Tim I. Martin, RCIS
Lancaster General Hospital
Lancaster, PA
Robert A. Lookstein, MD
New York, NY
Robert J. Lederman, MD
National Heart, Lung, and Blood Institute
Bethesda, MD
Durham, NC
Michael A. Kutcher, MD
Wake Forest University Baptist
Medical Center
Winston-Salem, NC
Julie Logan, RN
San Diego, CA
Jon S. Matsumura, MD
University of Wisconsin
Madison, WI
W. Anthony Lee, MD
Lynn Heart and Vascular Institute
Boca Raton, FL
Frederick Kushner, MD
Heart Clinic of Lousiana
Marrero, LA
Jack L. Martin, MD
Methodist Hospitals, San Antonio Texas
Live Oak, TX
Frank Litvack, MD
Los Angeles, CA
Kareen Looi
Campbell, CA
Paul A. LaViolette
SV Life Sciences
Boston, MA
Prakash Krishnan, MD
New York, NY
Chad Kugler
BridgePoint Medical
Plymouth, MN
David J. Maron, MD
Vanderbilt Chest Pain Center
Nashville, TN
Richard J. Linder
Coherex Medical, Inc.
Salt Lake City, UT
Doff B. McElhinney, MD
Children’s Hospital Boston
Boston, MA
James F. McKinsey, MD
New York, NY
Michael J. Mack, MD
The Heart Hospital Baylor Plano
Plano, TX
Akiko Maehara, MD
New York, NY
Brij Maini, MD
Pinnacle Health System
Harrisburg, PA
Jane A. Leopold, MD
Boston, MA
William H. Maisel, MD, MPH
Silver Spring, MD
Norman E. Lepor, MD
Beverly Hills, CA
Raj Makkar, MD
Los Angeles, CA
Stamatios Lerakis, MD
Emory Healthcare
Atlanta, GA
Joshua Makower, MD
Stanford University
Stanford, CA
Amir Lerman, MD
Mayo Clinic
Rochester, MN
Thomas H. Maloney, MHA, RCIS
Memorial Regional Medical Center
Mechanicsville, VA
Daniel J. McCormick, DO
Hahnemann University Hospital
Philadelphia, PA
Thomas O. McNamara, MD
UCLA Medical Center
Los Angeles, CA
Edward J. McNulty, MD
Kaiser San Francisco
San Francisco, CA
Vanderbilt University
Nashville, TN
Roxana Mehran, MD
New York, NY
Davendra Mehta, MD
New York, NY
Manish Mehta, MD
Albany Medical Center
Albany, NY
35
Sameer Mehta, MD
Columbia Cedars Medical Center
Miami, FL
Sandeep Nathan, MD, MSc
University of Chicago Medical Center
Chicago, IL
Wellmont CVA Heart Institute
Kingsport, TN
Manuela Negoita, MD
Medtronic
Santa Rosa, CA
Philip M. Meyers, MD
New York, NY
Christopher M. Nelson, RN, RCIS
Sentara College of Health Sciences
Chesapeake, VA
Andrew D. Michaels, MD, MAS
St. Joseph Hospital
Eureka, CA
Robert E. Michler, MD
Montefiore Einstein Center
New York, NY
New York, NY
D. Craig Miller, MD
Stanford University Medical School
Stanford, CA
James K. Min, MD
Weill Cornell Medical College
New York, NY
David Paniagua, MD
St. Luke’s Episcopal Hospital/
Texas Heart Institute
Houston, TX
New York, NY
Duane S. Pinto, MD, MPH
Boston, MA
Hina M. Pinto, MSE
Silver Spring, MD
Dan Polcyn
Business Development Cardiovascular
Service Line
Palo Alto, CA
Vincent J. Pompili, MD
Ohio State University Medical Center
Columbus, OH
Sahil A. Parikh, MD
Cleveland, OH
Boston, MA
Alexander Nikanorov, MD, PhD
Abbott Vascular
Santa Clara, CA
Helen Parise, ScD
New York, NY
Thomas A. Ports, MD
University of California SF
San Francisco, CA
Serjan D. Nikolic
CardioKinetix, Inc.
Menlo Park, CA
Juan C. Parodi, MD
University of Miami
Pinecrest, FL
Robert S. Poston, MD
UA Sarver Heart Center
Tucson, AZ
Michelle O’Donoghue, MD, MPH
Boston, MA
Amit Patel, MD, MS
University of Utah
Salt Lake City, UT
Thomas J. Povsic, MD, PhD
Chapel Hill, NC
Patrick T. O’Gara, MD
Boston, MA
Manesh R. Patel, MD
Durham, NC
Alex Powell, MD
Baptist Cardiac and Vascular Institute
Miami, FL
E. Magnus Ohman, MD
Durham, NC
Rahul S. Patel, MD
University of Maryland Medical Center
Baltimore, MD
Abhiram Prasad, MD
Mayo Clinic
Rochester, MN
Semih Oktay, PhD
CardioMed Device Consultants
Baltimore, MD
Vinod Patel, MD
New York, NY
Scripps Clinic
La Jolla, CA
Jeffrey W. Olin, DO
Mount Sinai School of Medicine
New York, NY
Raghotham R. Patlola, MD
Lafayette, LA
University of Miami
Miami, FL
Bray Patrick-Lake
PFO Research Foundation
Boulder, CO
Lauren T. Privitera, MPH
Columbia University Medical Center, Health
Policy and Management
New York, NY
Fumiyuki Otsuka, MD
Gaithersburg, MD
Wesley R. Pedersen, MD
Minneapolis, MN
Mauro Moscucci, MD
University of Miami
Miami, FL
Kenneth Ouriel, MD
New York, NY
Lynn Peng, MD
Stanford, CA
New York, NY
Christopher D. Owens, MD
Medical Center
San Francisco, CA
Issam D. Moussa, MD
Mayo Clinic, Jacksonville
Jacksonville, FL
Francis D. Pagani, MD, PhD
University of Michigan
Ann Arbor, MI
James E. Muller, MD
InfraReDx
Burlington, MA
Igor F. Palacios, MD
Boston, MA
Michael A. Mussallem
Irvine, CA
James M. Palazzo, MBA
Paragon Health
Southlake, TX
Winthrop University Hospital
Mineola, NY
Julio C. Palmaz, MD
San Antonio, TX
Gary S. Mintz, MD
Washington, DC
Greg Mishkel, MD
Prairie Cardiovascular Consultants
Springfield, IL
University of Kentucky
Lexington, KY
Frederic H. Moll, MD
Hansen Medical
Mountain View, CA
Michael Mooney, MD
Minneapolis, MN
Pedro R. Moreno, MD
New York, NY
Nancy Morris, RN, MSN
Interventional Technologies
San Diego, CA
Masataka Nakano, MD
CVPath Institute, Inc
Gaithersburg, MD
36
Christopher D. Nielsen, MD
Medical University of South Carolina
Charleston, SC
Samir B. Pancholy, MD
Wright Center for Graduate Medical
Education and the Commonwealth Medical
College
Clarks Summit, PA
program ·
Marc S. Penn, MD, PhD
Summa Health System
Cleveland, OH
Emerson C. Perin, MD, PhD
Texas Heart Institute
Houston, TX
Alice A. Perlowski, MD
NorthShore University HealthSystem
Evanston, CA
John L. Petersen, MD
Swedish Medical Center
Seattle, WA
Harry R. Phillips, MD
Durham, NC
Augusto D. Pichard, MD
Washington, DC
Ileana L. Piña, MD, MPH
Albert Einstein College of Medicine
Bronx, NY
John D. Puskas, MD, MSc
Emory University Hospital Midtown
Atlanta, GA
Patricia M. Pye, RN, MS
Carolinas Medical Center
Charlotte, NC
Robert T. Pyo, MD
New York, NY
Michael Querijero, RPA-C
New York, NY
Ramon Quesada, MD
Baptist Cardiac and Vascular
Institute of Miami
Miami, FL
Sheehan L. Raab, RT(R), RCIS
New York, NY
Jeffrey J. Rade, MD
Johns Hopkins Heart and
Vascular Institute
Baltimore, MD
C. Venkata S. Ram, MD
Dallas Nephrology Associates
Dallas, TX
TCT2011
Cardiovascular
Therapeutics
Stephen R. Ramee, MD
Ochsner Medical Center
New Orleans, LA
Ivan C. Rokos, MD
Olive View Medical Center
Sylmar, CA
Victor L. Serebruany, MD, PhD
HeartDrug Research Laboratories
Towson, MD
David P. Slovut, MD, PhD
Montefiore Medical Center
Bronx, NY
Sunil V. Rao, MD
Durham, NC
Matthew Romano, MD
Ann Arbor, MI
Prediman K. Shah, MD
Los Angeles, CA
Mahmood K. Razavi, MD
St. Joseph Cardiac and Vascular Center
Orange, CA
Martin T. Rothman, MD, MB, ChB
Santa Rosa, CA
Mohsen Sharifi, MD
Arizona Cardiovascular Consultants
Mesa, AZ
Richard Smalling, MD, PhD
Memorial Hermann Heart and
Vascular Institute
Houston, TX
Michael J. Reardon, MD
The Methodist Hospital
Houston, TX
Serge Rousselle, DVM, DACVP
Alizee Pathology
Thurmont, MD
Samin K. Sharma, MD
New York, NY
Vivek Y. Reddy, MD
New York, NY
Stanton J. Rowe
Irvine, CA
Leslee J. Shaw, PhD
Atlanta, GA
Mark Reisman, MD
Swedish Heart and Vascular Institute
Seattle, WA
John H. Rundback, MD
Holy Name Hospital
Teaneck, NJ
Fayaz Shawl, MD
Washington Adventist Hospital
Takoma Park, MD
George R. Reiss, MD
New York, NY
Joseph F. Sabik, MD
Cleveland, OH
James R. Shay, JD, BSE
Shay Glenn LLP
San Mateo, CA
Robert D. Safian, MD
Royal Oak, MI
Marc E. Shelton, MD
Prairie Cardiovascular Consultants, Ltd.
Springfirld, IL
Sean Salmon, MBA
Medtronic
Santa Rosa, CA
Warren Sherman, MD
New York, NY
Frederic S. Rensic, MD
Boston, MA
David G. Reuter, MD, PhD
Seattle Childrens Hospital
Kirkland, WA
Matthew R. Reynolds, MD
Boston, MA
John F. Rhodes, MD
Durham, NC
Randel Richner
Neocure Group, LLC
Sherborn, MA
Mayo Clinic
Rochester, MN
Michael J. Rinaldi, MD
Sanger Heart and Vascular Institute/
Carolinas Medical Center
Charlotte, NC
Marian K. Rippy, DVM, PhD
Rippy Pathology Solutions
Woodbury, MN
David G. Rizik, MD
Scottsdale Heart Group
Scottsdale, AZ
Krishna J. Rocha-Singh, MD
Prairie Cardiovascular Consultants, Ltd.
Springfield, IL
Matthew T. Roe, MD, MHS
Duke Clinical Research Institute
Durham, NC
Campbell Rogers, MD
Cordis Corporation
Bridgewater, NJ
Jason H. Rogers, MD
Sacramento, CA
Joseph G. Rogers, MD
Duke University School of Medicine
Durham, NC
Habib Samady, MD
Atlanta, GA
Timothy A. Sanborn, MD
NorthShore University HealthSystem
Evanston, IL
Maurice E. Sarano, MD
Mayo Clinic
Rochester, MN
Jorge F. Saucedo, MD
OU Medical Center
Oklahoma City, OK
Gary L. Schaer, MD
Chicago, IL
Robert M. Schainfeld, DO
Waltham, MA
Richard A. Schatz, MD
Scripps Clinic
La Jolla, CA
Peter A. Schneider, MD
Kaiser Permanente
Honolulu, HI
Theodore L. Schreiber, MD
Cardiovascular Consultants
Warren, MI
Daniel G. Schultz, MD
Greenhealth Health LLC
Washington, DC
Allan Schwartz, MD
New York, NY
Robert S. Schwartz, MD
Minneapolis, MN
Craig R. Smith, MD
New York, NY
Richard Solomon, MD
University of Vermont
Burlington, VT
New York, NY
Paul Sorajja, MD
Mayo Clinic
Rochester, MN
John A. Spertus, MD
Mid America Heart Institute
Kansas City, MO
Robert J. Siegel, MD
Los Angeles, CA
Frank E. Silvestry, MD
Hospital of the University of Pennsylvania
Radnor, PA
Daniel I. Simon, MD
Cleveland, OH
Charles A. Simonton, MD
Abbott Vascular
Santa Clara, CA
John Sninsky, PhD
Celera
Alameda, CA
Paul A. Sobotka, MD
Hennepin County Medical Center
West St Paul, MN
Mehdi H. Shishehbor, DO, MPH
Cleveland, OH
Pamela P. Simons
St. Jude Medical, Inc.
Plymouth, MN
Wade S. Smith, MD, PhD
UCSF Medical Center
San Francisco, CA
Vankeepuran S. Srinivas, MD
Montefiore Medical Center
New York, NY
Frederick G. St. Goar, MD
Advanced Cardiovascular Specialists
Mountain View, CA
Richard S. Stack, MD
Chapel HIll, NC
Anthony E. Steimle, MD
Santa Clara Medical Center
Santa Clara, CA
John B. Simpson, MD, PhD
Sequoia Hospital
Redwood City, CA
Allan Stewart, MD
New York, NY
Binoy K. Singh, MD
Columbia University, Center for
Interventional Vascular Therapy
New York, NY
Gregg W. Stone, MD
New York, NY
New York, NY
Peter H. Stone, MD
Boston, MA
Motasim Sirhan
Elixir Medical Corporation
Sunnyvale, CA
Kristen Skelton
Edwards Lifesciences Corporation
Irvine, CA
Marvin J. Slepian, MD
University of Arizona Health
Sciences Center
Tucson, AZ
Lebauer Cardiovascular Research
Foundation
Greensboro, NC
H. Robert Superko, MD
Saint Joseph’s Translational
Research Institute
Alameda, CA
37
Lars G. Svensson, MD, PhD
Cleveland, OH
Alfredo Trento, MD
Los Angeles, CA
Brian Whisenant, MD
Intermountain Medical Center
Salt Lake City, UT
David X. Zhao, MD
Vanderbilt Heart and Vascular Institute
Nashville, TN
Gilani Syed, MD
UTMB Galveston
Galveston, TX
Thomas T. Tsai, MD, MSc
Denver Veterans Affairs Medical Center
Denver, CO
Rodney White, MD
Harbor-UCLA Medical Center
Torrance, CA
James P. Zidar, MD
Rex Healthcare
Raleigh, NC
Jacqueline E. Tamis-Holland, MD
St. Luke’s-Roosevelt Hospital
New York, NY
Sotirios Tsimikas, MD
University of California San Diego
San Diego, CA
Mark H. Wholey, MD
UPMC Shadyside
Pittsburgh, PA
David Zimrin, MD
University of Maryland Medical Center
Baltimore, MD
Atsushi Tanaka, MD
Boston, MA
Thomas M. Tu, MD
Louisville Cardiology Medical Group
Louisville, KY
Michael H. Wholey, MD
Christus Santa Rosa Medical Center
San Antonio, TX
William A. Zoghbi, MD
Houston, TX
Addis Taye Makuria, MD
Gaithersburg, MD
Mark A. Turco, MD
Washington Adventist Hospital
Takoma Park, MD
Josiah N. Wilcox, PhD
Santa Rosa, CA
Bram D. Zuckerman, MD
Silver Spring, MD
Addison A. Taylor, MD, PhD
Baylor College of Medicine
Houston, TX
Zoltan G. Turi, MD
Cooper University Hospital
Camden, NJ
Robert L. Wilensky, MD
Philadelphia, PA
Guillermo Tearney, MD, PhD
Boston, MA
E. Murat Tuzcu, MD
Cleveland, OH
Jose M. Wiley, MD
New York, NY
Faramarz Tehrani, MD
Sacramento, CA
Takahiro Uchida, MD, PhD, MSc
Natick, MA
David O. Williams, MD
Boston, MA
La Jolla, CA
Uma S. Valeti, MD
University of Minnesota
Minneapolis, MN
Michael W. Tempelhof, MD
Chicago, IL
Renu Virmani, MD
Gaithersburg, MD
Mathew Williams, MD
New York, NY
David E. Thaler, MD, PhD
Boston, MA
William W. Voda, JD
Arnold and Porter LLP
Washington, DC
Robert Thatcher, BSBA, MBA
Cardiovascular Systems, Inc.
St. Paul, MN
Szilard Voros, MD
Integrated Cardiovascular
Research Group
Atlanta, GA
Yale New Haven Hospital
New Haven, CT
Vinod H. Thourani, MD
Atlanta, GA
Craig M. Walker, MD
Houma, LA
Stephen D. Wiviott, MD
Boston, MA
S. Chiu Wong, MD
Weill Cornell Medical College
New York, NY
Larry L. Wood
Irvine, CA
Sergio Waxman, MD
Lahey Clinic
Burlington, MA
Janet F. Wyman, DNPc
ACCF Cardiac Catheterization and
Intervention Committee
Grosse Pointe, MI
Jesse Weinberger, MD
New York, NY
R. Michael Wyman, MD
Torrance Memorial Medical Center
Torrance, CA
Bonnie H. Weiner, MD, MSEC, MBA
Worcester Medical Center
Worcester, MA
Jay S. Yadav, MD
Piedmont Hospital
Atlanta, GA
UCLA Medical Center
Los Angeles, CA
Neil J. Weissman, MD
Washington, DC
Steven J. Yakubov, MD
Columbus, OH
On Topaz, MD
Charles George Veterans Affairs
Medical Center
Asheville, NC
Giora Weisz, MD
New York, NY
Robert W. Yeh, MD, MBA
Boston, MA
Eric J. Topol, MD
Scripps Clinic
La Jolla, CA
Catherine P. Wentz
Silver Spring, MD
Jennifer A. Tremmel, MD
Stanford, CA
Grayson H. Wheatley, MD
Arizona Heart Institute
Phoenix, AZ
Gary Thompson
Abbott Vascular
Santa Clara, CA
Henry H. Ting, MD, MBA
Mayo Clinic
Rochester, MN
Judy Tingley, RN, MPH
New York, NY
38
Ron Waksman, MD
Cardiovascular Research Institute
Washington, DC
Robert Winchester, MD
New York, NY
program ·
Alan C. Yeung, MD
Stanford, CA
Paul Yock, MD
Stanford, CA
Christopher K. Zarins, MD
Stanford, CA
TCT2011
LIve case sites
and operators
High-definition live case transmission sites span 21
locations around the globe. Live cases offer unique,
invaluable learning opportunities for attendees.
International
Asan Medical Center
Seoul, South Korea
Soo-Jin Kang, MD, PhD
Won-Jang Kim, MD, PhD
Young-Hak Kim, MD, PhD
Cheol-Whan Lee, MD, PhD
Jong-Young Lee, MD, PhD
Seung-Whan Lee, MD, PhD
Duk-Woo Park, MD, PhD
Seong-Wook Park, MD, PhD
Brendan Buckley, MBChB
Brigid Connor, MBDCh
Andrew Hill, MBChB
Andrew Holden, MBChB
Cardiovascular Centre,
ZNA Middelheim Hospital
Antwerp, Belgium
Carl Convens, MD
Glenn Van Langenhove, MD, PhD
Paul Vermeersch, MD, PhD
First Affiliated Hospital of
Nanjing Medical University
Nanjing, China
Shao-Liang Chen, MD
Jie Qian, MD
Shou-Jie Shan, MD
Imad Sheiban, MD
Fei Ye, MD
Jun-Jie Zhand, MD
ICPS Institut Hospitalier
Jacques Cartier
Massy, France
Hakim Benamer, MD
Thomas Hovasse, MD
Thierry Lefevre, MD
Mirano General Hospital
Mirano, Italy
Andrea Pacchioni, MD
Carlo Penzo, MD
Salvatore Sacca, MD
Francesco Versaci, MD
Park Hospital Leipzig
Leipzig, Germany
Sven Braulich, MD
Dierk Scheinert, MD
Andrej Schmidt, MD
Matthias Ulrich, MD
Quebec City, Canada
Daniel Doyle, MD
Eric Dumont, MD
Can M. Nguyen, MD
Stephane Rinfret, MD
St. Paul’s Hospital/
University of British Columbia
Vancouver, Canada
Anson Cheung, MD
John G. Webb, MD
David A. Wood, MD
Jian Ye, MD
Vinnie Bapat, MD
Philip MacCarthy, MD
Simon Redwood, MD
Chris Young, MD
Toyohashi, Japan
Osamu M. Katoh, MD
Takahiko Suzuki, MD
Cardiovascular
Therapeutics
Bonn, Germany
Atlanta, GA
Lutz Buellesfeld, MD
Eberhard Grube, MD
Lars Lickfett, MD
Georg Nickenig, MD
Nikos Werner, MD
Chuck Ballard, MD
Harold Carlson, MD
Anna Kalynych, MD
Dimitri Karmpaliotis, MD
Nicholas Lembo, MD
United States
Rush Center for Congenital and
Structural Heart Disease at Rush
University Medical Center
Chicago, IL
Los Angeles, CA
Suhail Dohad, MD
Saibal Kar, MD
Mehran Khorsandi, MD
Hooman Madyoon, MD
Raj Makkar, MD
Qi-Ling Cao, MD
Clifford Kavinsky, MD, PhD
Damien Kenny, MD
Mayo Clinic
Rochester, MN
Scripps Green Hospital
La Jolla, CA
Patricia Best, MD
Allison Cabalka, MD
Rajiv Gulati, MD
Yaron Almagor, MD
Antonio Colombo, MD
Mathew J. Price, MD,
Richard A. Schatz, MD
Curtiss T. Stinis, MD
NewYork-Presbyterian
Hospital/Columbia University
Medical Center
New York, NY
Khady Fall, MD
William A. Gray, MD
Osamu Katoh, MD
Susheel Kodali, MD
Edward M. Kreps, MD
Akiko Maehara, MD
Philip Meyers, MD
Tamim Nazif, MD
Jean-Michel Paradis, MD
Anthony Pucilo, MD
Prabhdeep Sandhu, MD
Mathew Williams, MD
Swedish Health Services
Seattle, WA
Robert M. Bersin, MD
Amish J. Desai, MD
Paul P. Huang, MD
Thomas K. Jones, MD
John Petersen II, MD
Mark Reisman, MD
University of California,
Davis Medical Center
Sacramento, CA
David Dawson, MD
Andrew T. Kwa, MD
Reginald I. Low, MD
William Pevec, MD
Jason Rogers, MD
Jeffrey Southard, MD
Garrett Wong, MD
Khung-Keong Yeo, MD
University of Colorado
Denver, CO
John D. Carroll, MD
39
TCT Comes to Miami in 2012
Save the date
OCTOber 22-26, 2012
Mi ami Bea ch Co nv en tion Cent er
MiaMi, florida
w w w. t ct con f e re n c e . c o m
TCT2011
Cardiovascular
Therapeutics
TCT for Nurses and Technologists . . ..................................42, 43
TCT for Surgeons........................................................................ 52
Scientific Symposia
Chronic Total Occlusions: Basic and Expert Techniques............................ 43
Endovascular Intervention (Part 1).............................................................. 45
Interventional Innovation: Novel Therapies and
the “Best” New Device Concepts for 2011................................................. 46
An Advanced Operator’s Workshop........................................................... 48
Strategies for Cardiovascular Repair:
Stem Cells and Beyond.............................................................................. 49
The Drug-Eluting Stent Summit: Appropriate
Utilization of Current Generation Devices................................................... 50
Aortic Valve Therapies................................................................................ 52
PFO and ASD Closure: Evolving Indications,
Patient Selection, Devices, and Technique................................................. 53
New Patients for New Interventional Therapies.......................................... 54
Partnership Session: Angioplasty Summit-TCTAP...................................... 55
·
san francisco, ca
November 7, 2011
Featured Clinical Research I. Transcatheter Valve
and STEMI/Heart Failure Therapies............................................................ 54
the Moscone Center
Monday
Interventional Cardiology (Part 1).............................................. 42
41
MOnday, November 7
Board Review Course
with Self-Assessment
in Interventional
Cardiology (Part 1)
This session is not CE accredited for nurses.
8:00 am-6:00
Room 103
pm
Central Concepts of PCI
Moderators: Tayo A. Addo, George D. Dangas
8:00 am - Medical Statistics and Trial Design:
Lessons from Recent Publications
Stuart J. Pocock
8:30 am - Radiation Principles and Safety
Stephen Balter
9:00 am - Femoral Vascular Access:
Technique, Closure Devices,
and Complications
Robert J. Applegate
9:20 am - Radial Artery Access and Closure:
Technique, Results, and Complications
Varinder P. Singh
9:40 am - Break
PCI Strategies, Indications,
Guidelines, and Outcomes
Moderators: Emmanouil S. Brilakis,
George D. Dangas
10:00 am - PCI in Stable Coronary Artery
Disease: Risk Stratification and Comparison
with Medical and Surgical Alternatives
Manish A. Parikh
10:30 am - PCI in ACS and Non-STEMI:
Guidelines and Outcomes
Emmanouil S. Brilakis
11:00 am - Primary PCI for STEMI: Guidelines,
Strategies, and Outcomes
Tayo A. Addo
11:30 am - Pharmacoinvasive Strategies
(Facilitated, Rescue, and Transfer PCI)
in STEMI
Duane S. Pinto
12:00 pm - Cardiogenic Shock and
Hemodynamic Support Alternatives
Timothy A. Sanborn
12:30 pm - Lunch Break
Interventional Pharmacology:
Guidelines and Practice
Outcomes
Moderators: Tayo A. Addo, George D. Dangas
1:30 pm - Elective (Nonurgent) PCI
Matthew J. Price
42
program ·
2:00 pm - Acute Coronary Syndromes/NSTEMI
Case Presentations and Discussion with
Integrated Audience Response
2:30 pm - PCI in STEMI
Gregg W. Stone
The Hybrid Approach to Coronary
Revascularization: Best of Both Worlds?
3:00 pm - Platelet Reactivity, Genetics,
and Thienopyridine Responsiveness
Matthew J. Price
Moderator: Thomas H. Maloney
Discussants: Caesar Alvero, Ajay J. Kirtane,
George R. Reiss, Mathew Williams
3:30 pm - Break
8:40 am - Review of the Data
George R. Reiss
Valvular and Structural
Heart Disease
8:50 am - Case Introduction
Thomas H. Maloney
Moderators: Charanjit S. Rihal, Zoltan G. Turi
4:00 pm - Essentials of Aortic Valve
Disease Hemodynamics and Intervention
with Approved Devices (Including
Related Guidelines)
Susheel Kodali
4:30 pm - Essentials of Mitral Valve Disease
Hemodynamics and Intervention with
Approved Devices (Including Related
Guidelines)
Zoltan G. Turi
5:00 pm - Essentials of Adult Congenital Heart
Disease Intervention: Diagnosis, Devices,
and Outcomes
Robert J. Sommer
5:30 pm - Specialized Structural Interventions:
Approach to HOCM, Paravalvular Leaks,
Acute MI VSD, and LAA Closure
Charanjit S. Rihal
6:00 pm - Adjourn
TCT for Nurses and
Technologists
8:00 am-5:30
Room 102
pm
20th Annual Cardiovascular
Nurse and Technologist
Symposium
Director: Marian C. Hawkey
Co-Directors: Russell A. Brandwein,
Michael Guiry, Nancy Houston Miller,
Martina Kelly Speight, Hilary Nierenberg,
Janet F. Wyman
8:00 am - Introduction and Review of
Learning Objectives
Marian C. Hawkey
8:10 am - TCT for Nurses and Technologists:
Then and Now
Moderator: Regina Deible
Discussants: Ann Greenberg,
Marian C. Hawkey, Alexandra J. Lansky,
Thomas H. Maloney, Nancy Morris,
Christopher M. Nelson
8:55 am - Initial Assessment: Cardiac Surgeon
Mathew Williams
9:00 am - Initial Assessment: Interventionalist
Ajay J. Kirtane
9:05 am - Case (Continued)
Thomas H. Maloney
9:10 am - Discussion (Continued)
9:15 am - Cath Lab Staff Perspective on
Preparedness for Hybrid Procedures
Caesar Alvero
9:25 am - Case Conclusion and
Final Comments
Adapt to DAPT
Moderator: George D. Dangas
Discussants: Russell A. Brandwein,
Matthew J. Price, Stephen D. Wiviott
9:30 am - Current Standards for
DAPT Post-DES
Stephen D. Wiviott
9:40 am - Choice and Dosing of
Thienopyridines: Does It Really Matter?
Matthew J. Price
9:50 am - Clinical Vignettes in Patients
Requiring DAPT
Russell A. Brandwein
10:00 am - DAPT of the Future
George D. Dangas
10:10 am - Discussion
Decisions in ACS/Primary PCI:
Conflicts in Quality
Moderator: Janet F. Wyman
Discussants: Hitinder S. Gurm,
Ralph G. Brindis, Akshay Khandelwal
10:20 am - Case Presentation
Janet F. Wyman
10:30 am - Decision Making
Akshay Khandelwal
10:40 am - Indications for Public Reporting
Ralph G. Brindis
TCT2011
10:55 am - Real-World Impact of
Public Reporting
Hitinder S. Gurm
2:55 pm - Discussion with Audience Q&A
11:05 am - Decision-Making in High-Risk
Patients and the Impact of Public Reporting
Transcatheter Heart Valve Therapies:
Year in Review
Moderator: Martina Kelly Speight
Discussants: Jodi Akin, Julie Logan
11:10 am - Transcatheter Heart Valve Repair
Julie Logan
11:25 am - Transcatheter Aortic
Valve Replacement
Martina Kelly Speight
11:45 am - PMA Challenges and Imperatives
Jodi Akin
11:55 am - Final Discussion
12:00 pm - Adjourn with Lunch Pick-up
Session III. The Mitral Valve: A Deep Dive
Discussants: James B. Hermiller Jr,
Tim I. Martin, J. Wesley Todd
3:05 pm - Foundational Knowledge:
Mitral Valve Anatomy, Function, and
Associated Pathology
Tim I. Martin
Session II. Regional Updates for CTO
PCI Practice
Moderators: Gerald S. Werner, Alan C. Yeung
Discussants: Alfredo R. Galassi,
Bradley H. Strauss, Craig A. Thompson,
Masahisa Yamane
9:02 am - EURO CTO Registry
Alfredo R. Galassi
9:10 am - Japan CTO Registry
Masahisa Yamane
9:18 am - US CTO Practice Trends
Craig A. Thompson
3:25 pm - Hemodynamics of Mitral Stenosis
and Mitral Regurgitation
J. Wesley Todd
9:26 am - Canadian CTO Registry
Bradley H. Strauss
3:50 pm - Future of Percutaneous Devices for
the Treatment of Mitral Regurgitation
James B. Hermiller Jr
Session III. The Toolbox and Basic
Techniques for CTO PCI
Moderators: William L. Lombardi,
Georgios Sianos
Discussants: Christopher E. Buller,
Alfredo R. Galassi, David E. Kandzari,
Jeffrey W. Moses, Masahiko Ochiai,
Sudhir Rathore, Stéphane Rinfret
Session IV. Hands on Hearts
Room 12
4:20 pm - Hands on Hearts
9:34 am - Discussion with Audience Q&A
RCIS Review Course
5:30 pm - Adjourn
Session I. Fundamental Knowledge
Discussants: Jeff Davis, Todd Ginapp,
Robert S. Schwartz, George W. Vetrovec
9:42 am - Patient Selection and Indications
for CTO PCI: A Contemporary Look
Christopher E. Buller
Scientific Symposia
9:52 am - Preprocedure Angiographic Review:
Occlusion Morphology and Collateral
Patterns: What I Look For
Sudhir Rathore
12:15 pm - Introduction and
Session Objectives
Thomas H. Maloney
12:20 pm - Basics of the Heart and
Related Structures
Robert S. Schwartz
12:40 pm - Hemodynamics of the Normal
Heart: Basic Understanding
Todd Ginapp
1:00 pm - Coronary Angiography from the
Interventional Cardiologist’s Perspective
George W. Vetrovec
1:20 pm - The Heart of the Animal Kingdom:
Comparing Human Hearts to
Multiple Species
Jeff Davis
Session II. The Aortic Valve: A Deep Dive
Discussants: Stephen M. Foster,
Susheel Kodali, Tim Lapp,
1:50 pm - Foundational Knowledge:
Aortic Valve Anatomy, Function, and
Associated Pathology
Stephen M. Foster
2:10 pm - Hemodynamics of Aortic
Stenosis and Aortic Insufficiency
Tim Lapp
Chronic Total Occlusions:
Basic and Expert Techniques
8:00 am-6:10
Room 132
pm
Session I. The Anatomy of the Chronic
Total Occlusion
Moderators: Yasushi Asakura,
Masahiko Ochiai, Stéphane Rinfret
Discussants: Masataka Nakano,
Satoru Sumitsuji, Gerald S. Werner
8:00 am - CTO Plaque Anatomy:
Histopathology and Micro CT Observations
Masataka Nakano
8:10 am - Collateral Patterns and Significance
in Coronary CTO
Gerald S. Werner
8:20 am - Use of MSCT for CTO
Procedural Planning
Satoru Sumitsuji
8:30 am - IVUS Pattern Recognition During
the CTO PCI Procedure
Yasushi Asakura
8:40 am - IVUS Image Integration During
the CTO PCI Procedure
Satoru Sumitsuji
- N o v e m b e r 7 , 2 0 11
2:35 pm - Future of Percutaneous Devices
for the Treatment of Aortic Stenosis
Susheel Kodali
monday
10:50 am - Scene from Star Trek:
The Kobayashi Maru: Kirk and Spock
Discuss the No-Win Scenario
Cardiovascular
Therapeutics
10:02 am - Patient Preparation, Vascular
Access, and Cath Lab Readiness
Stéphane Rinfret
10:12 am - Antegrade Direction 1: Guidewire
Engineering, Shaping, Selection, and
Technique
Masahiko Ochiai
10:24 am - Antegrade Direction 2: Wire and
Device-Based Coronary Reentry (with
Case Examples)
William L. Lombardi
10:36 am - Antegrade Direction 3: Wire Switch
Strategies Within the Occluded Segment
Alfredo R. Galassi
10:46 am - STAR and Mini-STAR: How to
Salvage Success While Avoiding
Complications
Jeffrey W. Moses
10:56 am - Support Matters: Guide Selection
and Support Augmentation Techniques
(Balloon Anchoring, Guideliner, and More)
Jeffrey W. Moses
11:08 am - Microcatheters, Balloons,
and Stents: Tips and Tricks
David E. Kandzari
43
MOnday, November 7
Session IV. Retrograde Intervention
Core Concepts
Moderators: Jeffrey W. Moses,
Etsuo Tsuchikane
Discussants: Tony J. DeMartini,
J. Aaron Grantham, Craig A. Thompson
Debate III. The Retrograde Approach as
an Initial Strategy for CTO PCI
11:33 am - Retrograde Step-by-Step
Approach 1: Collateral Selection and
Crossing Technique (with Case Examples)
Tony J. DeMartini
1:34 pm - Think Backwards! Retrograde
Techniques Are Essential in Many
Procedures as a Primary Strategy!
Tony J. DeMartini
11:48 am - Retrograde Step-by-Step
Approach 2: Lesion Crossing, Reverse
CART and CART Techniques, and Wire
Externalization (with Case Examples)
J. Aaron Grantham
1:42 pm - Discussion
12:03 pm - Putting It All Together: Hybrid
Antegrade/Retrograde Approaches for
CTO PCI (with Case Examples)
Craig A. Thompson
12:18 pm - JAPAN Retrograde: A Large-Scale
National Registry of the Retrograde
Approach for Recanalization of Chronic Total
Coronary Artery Occlusions
Masahisa Yamane
Session V. The Great CTO
Technique Debates
Moderators: Alfredo R. Galassi,
Sudhir Rathore
Discussants: Kenneth Chin, Thierry Corcos,
Richard R. Heuser, Vincent On-Hing Kwok,
Shigeru Saito, Bradley H. Strauss
Debate I. The Role of Parallel Wire
in 2011 and Beyond
12:38 pm - Parallel Wire Remains a Relevant
Basic Technique for CTO PCI!
Masahisa Yamane
12:46 pm - The Need for Parallel Wire No
Longer Exists in the Era of Stiff
Wires, Coronary Reentry, and
Retrograde Approach!
J. Aaron Grantham
12:54 pm - Moderated Discussion
Debate II. How Important Is it to Stay
Intraluminal During CTO PCI?
1:02 pm - Every Attempt Should Be
Made to Stay Within CTO Plaque for
Optimal Outcomes!
Gerald S. Werner
1:10 pm - The End Justifies the Means:
Use Subintimal and Subadventitial
Pathways Freely!
William L. Lombardi
1:26 pm - Antegrade First! Retrograde
Techniques Should Be Reserved as a
Final Resort!
Mauro Carlino
Session VI. CTO Failure Modes:
Unsuccessful Cases from the Masters
Moderators: Tony J. DeMartini,
David J. Hildick-Smith
Discussants: Yasushi Asakura, Yaling Han,
Osamu Katoh, Sunao Nakamura,
Ramon Quesada, Maarten J. Suttorp,
Takahiko Suzuki
1:50 pm - Why CTO PCI Fails:
A Contemporary Look
Georgios Sianos
2:00 pm - Case 1: Failed CTO - Failure
Analysis and What I’d Do Different
Yaling Han
Takahiko Suzuki
Osamu Katoh
Session VII. New Technologies for
Coronary CTO PCI
Moderators: Richard R. Heuser,
R. Michael Wyman
Discussants: M. Nicholas Burke,
J. Aaron Grantham, Dimitri Karmpaliotis,
Joachim Schofer, Georgios Sianos,
Etsuo Tsuchikane
2:40 pm - New Wire Platforms for CTO PCI:
How Are They Different, and Are They
Really Better?
Masahiko Ochiai
program ·
3:25 pm - Collagenase Update
Bradley H. Strauss
3:35 pm - Forward Looking Intravascular
Ultrasound Update
Craig A. Thompson
3:45 pm - CT Angiographic
Coregistration Update
Gerald S. Werner
Session VIII. CTO Complication
Management
Moderators: Anthony H. Gershlick,
Craig A. Thompson
Discussants: David Antoniucci, Mauro Carlino,
Charles E. Chambers, Javier Escaned,
Luis Gruberg, Osamu Katoh,
Jeffrey W. Moses, Toshiya Muramatsu,
Masahiko Ochiai, Etsuo Tsuchikane,
Darren L. Walters
4:10 pm - Radiation Safety and
Procedural Considerations
Charles E. Chambers
4:22 pm - Periprocedural Renal Injury:
Frequency, Impact, and Prevention
Luis Gruberg
4:34 pm - Coronary Perforation Primer:
Frequency, Causes, Prevention, and
Management (Pericardiocentesis,
Covered Stents, Coils, and More)
Jeffrey W. Moses
4:49 pm - Intraprocedural Thrombosis
and Ischemia
Masahiko Ochiai
4:59 pm - Device Entrapment
Javier Escaned
5:09 pm - Complications Unique to the
Retrograde Approach
Osamu Katoh
Special Session: Crossboss and
Stingray Coronary Reentry
5:24 pm - Case 4: CTO Complication - Root
Cause and Management
Etsuo Tsuchikane
2:50 pm - Review of Crossboss and Stingray
Balloon/Wire Design
Dimitri Karmpaliotis
Goran K. Olivecrona
3:00 pm - Basic Crossboss and Stingray
Technique
Joachim Schofer
Georgios Sianos
44
3:10 pm - Crossboss and Stingray
Troubleshooting: Lesion Access, Sidebranch
Redirection, Poor Reentry Targets, and More
R. Michael Wyman
6:10 pm - Adjourn
TCT2011
pm
Session I. Peripheral Arterial Disease:
Diagnosis and Imaging
Moderators: Michael R. Jaff,
Robert M. Schainfeld
Discussants: Herbert D. Aronow,
Lindsay S. Machan
8:00 am - Statins and Atherosclerotic Vascular
Disease: Which Vascular Beds Benefit?
Herbert D. Aronow
8:10 am - The Zebra in the Room: Unusual
Vascular Diseases the Interventionalist
Needs to Know
8:22 am - Selecting Imaging for PAD:
CTA, MRA, or Duplex
Lindsay S. Machan
Session II. Iliac and
Femoropopliteal Intervention
Moderators: John R. Laird Jr,
Lindsay S. Machan
Discussants: Lawrence A. Garcia,
David B. Jessup, Hans Krankenberg,
Thomas O. McNamara,
D. Christopher Metzger, Michael J. Rinaldi,
John H. Rundback, Mark H. Wholey,
Thomas Zeller
8:45 am - The Endovascular Approach to
Chronic Aortoiliac Occlusions: Methods,
Tools, and Long-term Outcomes
(And When to Opt for Surgery!)
David B. Jessup
9:05 am - All Atherectomy Devices Are Not
Created Equal: A Lesion-Specific Approach
Based on Data and Experience
Lawrence A. Garcia
9:15 am - Excimer Laser as Primary or
Adjunctive Treatment for Calcium and
Thrombus in PAD
Thomas O. McNamara
9:25 am - Update on the MARIS Registry of
1,000 Patients Treated with Nitinol Stents
Hans Krankenberg
9:35 am - Drug-Coated Balloons for
Femoropopliteal Intervention: Devices,
Trials, and Outcomes to Date
Thomas Zeller
9:50 am - Managing Iliac and Femoropopliteal
Restenosis: Incidence, Diagnostic Tools, and
Treatment Strategies
Michael J. Rinaldi
10:15 am - Endovascular Repair of Popliteal
Aneurysm: Indications, Imaging, and
Tips and Tricks
John H. Rundback
10:25 am - Unraveling the Device Spaghetti:
A Lesion-Specific Approach to SFA
Intervention
Thomas Zeller
10:37 am - Complications During Peripheral
Intervention: Characterization, Planning,
Avoidance, Recognition, and Management
Hans Krankenberg
10:52 am - Is There Value in Embolic
Protection for Lower Extremity Intervention?
Mark H. Wholey
Session III. Emerging Approaches in
Vascular Intervention
Moderators: Thomas A. Ischinger,
John H. Rundback
Discussants: Gary M. Ansel, Mark W. Burket,
William A. Gray, Michel Henry,
David B. Jessup, John R. Laird Jr,
Robert A. Lookstein, James F. McKinsey,
Manish Mehta, Antonios A. Polydorou,
Jason H. Rogers, Dierk Scheinert, On Topaz,
Craig M. Walker
11:20 am - Stent Grafts vs. Bare Metal Stents
for Occlusive SFA Disease: Three-Year
Results of the VIBRANT Trial
Gary M. Ansel
11:30 am - Twelve-Month Results from the
COMPLETE SE Study of SFA Stenting
John R. Laird Jr
11:40 am - Pedal Arteries as Important Targets
for Reconstruction in CLI
Craig M. Walker
11:50 am - Outcomes of Iliac Intervention
Using a Co-Cr Balloon Expandable Stent:
Final Results of the ACTIVE Study
William A. Gray
12:00 pm - Covered Stents for Iliac Occlusive
Disease: Twelve-Month Results of the
ICARUS Trial
John R. Laird Jr
12:10 pm - Long-term Follow-up with a
Multilayer Stent for Treatment of Renal
and Mesenteric Aneurysms
Antonios A. Polydorou
12:20 pm - Out of the Coronaries and into the
Periphery: The BridgePoint System for
Lower Extremity CTOs
David B. Jessup
12:30 pm - A Low-Profile EVAR Device with
Inflatable Sealing Rings: Primary Outcomes
from the Pivotal TriVascular Ovation Stent
Graft Trial
Manish Mehta
12:40 pm - Stenting the Popliteal Artery
Using a Woven Nitinol Stent:
Twelve-Month Outcomes from the
Leipzig SUPERA Experience
Dierk Scheinert
- N o v e m b e r 7 , 2 0 11
8:00 am-6:00
Room 131
10:00 am - Recanalizing SFA Occlusions:
Procedural Planning, Tools, Techniques,
and Expected Success Rates
D. Christopher Metzger
monday
Endovascular Intervention
(Part 1)
Cardiovascular
Therapeutics
12:50 pm - Results of a First-in-Man Study
Using a Multilayer Stent for Popliteal
Aneurysm
Michel Henry
1:00 pm - Back to the Future? Outcomes of
Brachytherapy for SFA ISR Using a Rhenium
188-Filled Balloon
Dierk Scheinert
1:10 pm - Fenestrated Grafts for Juxtarenal
AAA: Outcomes from the US Registry
James F. McKinsey
1:20 pm - Deep in the Pelvis: Indications and
Methods for Internal Iliac Artery Intervention
Mark W. Burket
1:30 pm - Deeper in the Pelvis: Status of
Pudendal Artery Stenting for Erectile
Dysfunction
Jason H. Rogers
1:40 pm - Debulking the Critical Renal
Stenosis: A New Approach to Renal
Revascularization
On Topaz
1:50 pm - Optimizing Intervention for
Renal FMD: Angiography Is Not Enough
Robert A. Lookstein
Session IV. Critical Limb Ischemia and
Infrapopliteal Intervention
Moderators: Peter A. Schneider,
David P. Slovut
Discussants: Gary M. Ansel, Raghu Kolluri,
Alex Powell, Craig M. Walker, Thomas Zeller
2:20 pm - Physiologic Testing and Adjunct
Management of Patients Undergoing
Intervention for Critical Limb Ischemia
Raghu Kolluri
2:30 pm - The Approach to Tibial Intervention
for CLI: Available Tools and Techniques, and
Which Vessels Must Be Treated?
Alex Powell
2:45 pm - DES Below the Knee in CLI: Results
from YUKON-BTK, DESTINY, and ACHILLES
Thomas Zeller
3:00 pm - Drug-Coated Balloons for
Gary M. Ansel
45
MOnday, November 7
3:10 pm - Access Isn’t Everything—It’s the
Only Thing! Tips and Tricks for Successful
Vascular Approach to the Infrapopliteal
Intervention
Craig M. Walker
Flash Debate III
5:20 pm - It’s Called New School for a Reason:
Frontline Endovascular Therapy for Patients
with SFA Disease!
Session V. Renal and
Mesenteric Intervention
Moderators: Christopher J. Cooper,
Greg Mishkel
Discussants: Mark C. Bates,
Michael J. Rinaldi, John H. Rundback,
Thomas Zeller
3:35 pm - Essential Tools and Techniques
for Renal Artery Intervention
Christopher J. Cooper
3:47 pm - Avoiding and Managing
Complications of Renal Intervention
Mark C. Bates
3:59 pm - Predicting the Response to
Intervention: Methods for Determining the
“Correct” Renal Artery Stenosis to Treat
John H. Rundback
4:09 pm - Managing the Restenotic
Renal Artery
Thomas Zeller
4:19 pm - Mesenteric Ischemia: Clinical
Presentations, Diagnosis, and Indications
for Intervention and Surgery
Greg Mishkel
5:15 pm - Old School Is the Still the Best:
Surgical Bypass Is Preferred for Long
SFA Disease!
Kenneth Ouriel
5:25 pm - Discussion and Vote
Flash Debate IV
5:30 pm - Primary Bare Metal Stenting of the
SFA Gives the Best Outcomes!
Erich Minar
5:35 pm - The Data Are Limited for Bare Metal
Stents in the SFA: They Should Be Only
Applied Selectively!
Tony Das
Flash Debate V
5:45 pm - Data Don’t Lie: Renal Artery
Intervention Is Dead in the Water!
Robert D. Safian
5:50 pm - Nonsense! Renal Artery Intervention
Is a Critically Important Component of
Patient Care, and Here’s the Proof!
Michael R. Jaff
6:00 pm - Adjourn
Session VI. Flash Debates: Round One
Moderators: Frank J. Criado, Dierk Scheinert
Discussants: Robert M. Bersin, Tony Das,
Michael R. Jaff, James F. McKinsey,
D. Christopher Metzger, Erich Minar,
Kenneth Ouriel, Robert D. Safian
Interventional Innovation: Novel
Therapies and the “Best” New
Device Concepts for 2011
Flash Debate I
Session I. Interventional Innovation:
Process, Promise, and Realities in 2011
Moderators: Martin B. Leon, Paul Yock
Discussants: Todd J. Brinton,
Elazer R. Edelman, Peter J. Fitzgerald,
Thomas J. Fogarty, Julio C. Palmaz
4:45 pm - Endovascular Repair of AAA and
TAA Should Be Performed Exclusively by the
Vascular Surgeon!
James F. McKinsey
4:50 pm - In the Future These Repairs Will
Be Percutaneous and Performed by the
Nonsurgical Interventionalist!
Robert M. Bersin
Flash Debate II
5:00 pm - Drug-Eluting Stents for SFAPopliteal Disease: The New Standard
of Care!
Michael D. Dake
5:05 pm - Drug-Eluting Stents for SFAPopliteal Disease: Not So Fast!
Tony Das
8:00 am-6:00
Room 134
pm
8:00 am - Key Elements of the Biodesign
Process: Identify, Invent, and Implement
Paul Yock
8:15 am - The Innovative Process:
Taught or Spontaneous?
Todd J. Brinton, Peter J. Fitzgerald
8:30 am - What’s Gone RIGHT! Innovation
Is Still the Cornerstone of Less Invasive
Interventional Therapy
Elazer R. Edelman
46
program ·
8:45 am - Panel Discussion: Lessons
from the Masters
Moderators: Martin B. Leon, Paul Yock
Discussants: Elazer R. Edelman,
Thomas J. Fogarty, Stephen N. Oesterle,
Julio C. Palmaz, John B. Simpson,
Richard S. Stack
9:15 am - What’s Gone WRONG! The “Death
Valley” of Medical Innovation: Current
Disturbing Trends in the United States
Martin B. Leon
9:30 am - Panel Discussion: Is There an
Innovation Crisis in the United States?
Moderators: Elazer R. Edelman,
Martin B. Leon
Discussants: Chad Cornell, Keith D. Dawkins,
Andrew Farb, Tim A. Fischell,
Paul A. LaViolette, Michael A. Mussallem,
Charles A. Simonton, Mark A. Turco
Session II. The Globalization
of Innovation
Moderators: Peter J. Fitzgerald,
Ran Kornowski
Discussants: Michael Buck, Hank Kucheman,
Paul A. LaViolette, Daniel T. Lemaitre,
Keyur H. Parikh, Sean Salmon,
Jacques Seguin, Ashok Seth, Philip Wang
10:00 am - The New Medical Innovation
Success Model: “Think Global”—Rationale,
Facts, and Trends
Peter J. Fitzgerald
Regions of Greatest Interest
10:12 am - Israel: The “Start-up Nation”
Ran Kornowski
10:22 am - Europe: Old-World Firepower
Jacques Seguin
10:32 am - India: A Sleeping Giant
Keyur H. Parikh
10:42 am - China: The 800-Pound Gorilla
Philip Wang
10:52 am - Panel Discussion: Why
Globalization Makes Sense
Ran Kornowski
Discussants: Michael Buck, Hank Kucheman,
Daniel T. Lemaitre, Keyur H. Parikh,
Sean Salmon, Jacques Seguin, Ashok Seth,
Philip Wang, Bo Xu
Session III. The Convergence of Med Tech
and Info Tech (MT Meets IT)
Dana G. Mead Jr
Discussants: Donald Casey, Neal L. Eigler,
C. Michael Gibson, William T. Harrington,
Frederick G. St. Goar, Alan C. Yeung
TCT2011
Industry Roundtable
Moderators: Juan F. Granada,
Chaim S. Lotan
11:42 am - Case Example 1: HEARTFLOW:
Combining Physiology and Imaging
Frederick G. St. Goar
11:52 am - Case Example 2: Medical iPad:
Applications and Managing Heart Failure
Neal L. Eigler
12:02 pm - Case Example 3: Cell Phone:
Integration into Medical Practice
Donald Casey
12:12 pm - Panel Discussion: Impact of IT on
Medical Care, Cost, and Clinical Outcomes
Dana G. Mead Jr
Discussants: Donald Casey, Neal L. Eigler,
C. Michael Gibson, William T. Harrington,
Frederick G. St. Goar, Alan C. Yeung
Session IV. Cath Lab of the Future
Moderators: Louis A. Cannon,
Jacques J. Koolen
Discussants: Elchanan Bruckheimer,
Samir R. Kapadia, Saibal Kar, Frederic H. Moll,
Augusto D. Pichard, Amit Segev,
Marvin J. Slepian, Giora Weisz
Advanced Imaging
12:42 pm - 3-D (and 4-D) Angiography,
Echo, and CTA Have Arrived!
John D. Carroll
12:54 pm - Case Example: REALVIEW
Holographic Imaging for Adult Congenital,
Structural, and Valvular Heart Disease
Elchanan Bruckheimer
Telemanipulation and Robotics
2:00 pm - The ICI Vision of the Most
Compelling Unmet Clinical Needs for
the Next Decade
Chaim S. Lotan
Case Model Proposition I
2:15 pm - Modulating Sympathetic Nervous
System Activity to Treat HTN and CHF
Paul A. Sobotka
2:30 pm - Case Example 1:
RF Ablation (ARDIAN)
Robert J. Whitbourn
2:37 pm - Case Example 2: Local Drug
Delivery (MERCATOR)
Christopher D. Owens
4:10 pm - Case Example 1: BACKBEAT
for HTN Therapy
Daniel Burkhoff
4:20 pm - Case Example 2: The “TIC-TAC”
Approach
Stephen N. Oesterle
4:30 pm - Case Example 3: External
Shock Therapy
Debra S. Echt
4:40 pm - Discussion: Alternative Options
for the Therapy of CHF and HTN
Chaim S. Lotan
Discussants: Daniel Burkhoff, Debra S. Echt,
Stephen N. Oesterle, Robert S. Schwartz
NonCardiovascular Transcatheter Therapies
4:55 pm - Transcatheter Less Invasive
Therapies “Gone Wild”: Breakthrough
Innovations in the Noncardiovascular Space
Juan F. Granada
2:43 pm - Case Example 3: Focused Energy
(The Gamma Knife Experience)
John Adler
5:10 pm - Case Example 1: Interventional
Orthopedics
Gary S. Fanton
2:50 pm - Discussion: Challenges,
Opportunities, and Therapeutic Approaches
of Renal Denervation Therapies
Chaim S. Lotan
Discussants: John Adler, William A. Gray,
Maurizio Menichelli, Christopher D. Owens,
Paul A. Sobotka
5:20 pm - Case Example 2: Interventional ENT
Rick Anderson
Case Model Proposition II
3:05 pm - Implantable Sensors Can Prevent
Adverse Events and Improve Management of
HTN and CHF
William T. Abraham
1:10 pm - History, Rationale, and Future
Opportunities for Telemanipulation of
Catheters and Devices
Frederic H. Moll
1:22 pm - Case Example: CORINDUS
Robotic-Assisted Angioplasty:
Current Status and Distant Vision
Giora Weisz
3:30 pm - Case Example 2: SAVACOR
Future Directions
Neal L. Eigler
1:32 pm - Panel Discussion: Dissecting
the Basic Components of the Cath Lab
of the Future
Moderators: Louis A. Cannon,
Jacques J. Koolen
Samir R. Kapadia, Frederic H. Moll,
Augusto D. Pichard, Amit Segev,
Marvin J. Slepian, Giora Weisz
- N o v e m b e r 7 , 2 0 11
Session V. Responding to the Next
Clinical Needs
In collaboration with Innovations in
Cardiovascular Interventions
monday
11:30 am - The Transforming Potential of
Combining Innovative MT and IT:
Can GE and Google Coexist and Thrive?
Peter J. Fitzgerald
Cardiovascular
Therapeutics
5:30 pm - Case Example 3: Interventional
Pulmonology
Michael T. Baker
5:40 pm - Discussion: Lessons Learned from
the Interventional Cardiology Field
Chaim S. Lotan
Discussants: Rick Anderson, Michael T. Baker,
Gary S. Fanton, Peter J. Fitzgerald
6:00 pm - Adjourn
3:20 pm - Case Example 1: CARDIOMEMS
Next Steps
William T. Abraham
3:40 pm - Discussion: The Impact of
Ambulatory Monitoring on Cost and
Clinical Outcomes
Moderators: William T. Abraham,
Juan F. Granada, Chaim S. Lotan
Discussants: Daniel Burkhoff, Neal L. Eigler,
Frank Litvack
Case Model Proposition III
3:55 pm - Novel Implantable Pacemakers and
Advances in Resynchronization Therapies
Robert S. Schwartz
47
MOnday, November 7
Left Main and Bifurcation
Stenting: An Advanced
Operator’s Workshop
8:00 am-6:10
Room 133
pm
Session I. Core Concepts
Moderators: James B. Hermiller Jr,
David E. Kandzari
Discussants: Remo Albiero, Alaide Chieffo,
Akiko Maehara, Renu Virmani
8:00 am - How Are Left Main and Non-Left
Main Bifurcations Unique, and How Should
These Observations Affect the Interventional
Approach 1: Insights from Pathology
Renu Virmani
8:10 am - How Are Left Main and Non-Left
Main Bifurcations Unique, and How Should
These Observations Affect the Interventional
Approach 2: Insights from Imaging
Akiko Maehara
8:20 am - Coronary Bifurcation Treatment:
Update from the European Bifurcation Club
Remo Albiero
8:35 am - Predictors of Restenosis and Stent
Thrombosis After One- and Two-Stent
Techniques in Left Main and Non-Left
Main Bifurcations
Alaide Chieffo
Session II. Non-Left Main Bifurcations
Moderators: Thierry Lefevre, David G. Rizik
Discussants: Carlo Briguori,
David J. Hildick-Smith, Bon-Kwon Koo,
Gary S. Mintz, Issam D. Moussa,
Stefan Verheye
9:02 am - Does PCI of Non-Left Main
Bifurcation Lesions Impair the Acute and
Late Results of Multivessel Intervention?
Insights from SYNTAX
Patrick W. Serruys
9:12 am - Technical Approach to Non-Left
Main Bifurcations: Integrated Lessons from
Nordic, CACTUS, BBC ONE, and EBC TWO
9:24 am - A Prospective, Randomized Trial of
Aggressive vs. Conservative Sidebranch
Dilation Strategies After Provisional
Stenting of Bifurcation Lesions
Hyeon-Cheol Gwon
9:34 am - When to Favor a Planned Two-Stent
Technique in Non-Left Main Bifurcations
(and Which One)?
Issam D. Moussa
9:49 am - Use of IVUS to Guide Complex
Non-Left Main Bifurcation Stenting
Gary S. Mintz
48
program ·
10:01 am - Use of FFR to Guide Complex
Non-Left Main Bifurcation Stenting
Bon-Kwon Koo
12:38 pm - Does Hybrid PCI/CABG Have
a Role for Left Main Disease?
Leif Thuesen
10:13 am - Sidebranch Preservation
Strategies 1: Debulking and Scoring
Jeffrey W. Moses
12:46 pm - Are PCI Results Improving in Left
Main Disease with Advances in Stent
Technology, Pharmacology, and Technique?
Thierry Lefevre
Strategies 2: The GLIDER Balloon
Carlo Briguori
Strategies 3: Dedicated Stents
Stefan Verheye
10:46 am - TRYTON: Design and Status
of the First US IDE Dedicated Bifurcation
Stent Trial
Martin B. Leon
Session III. Management of Complex
Non-Left Main Bifurcations:
An Operator’s Guide
Moderators: Stephen G. Ellis,
Marie-Claude Morice
Discussants: Antonio Colombo,
Fernando Cura, Jens Flensted Lassen,
Thierry Lefevre
11:01 am - My Top 10 Techniques to Surviving
Complex Non-Left Main Bifurcations
Antonio Colombo
11:16 am - Case Review 1: How Did I Treat
This Complex Non-Left Main Bifurcation?
Fernando Cura
This Complex Non-Left Main Bifurcation?
Jens Flensted Lassen
This Complex Non-Left Main Trifurcation?
Thierry Lefevre
Session IV. Left Main Revascularization:
PCI vs. CABG
Moderators: Gregg W. Stone, David Taggart
Discussants: William E. Cohn, Andrejs Erglis,
Raj Makkar, James R. Margolis,
Friedrich W. Mohr, John D. Puskas,
Corrado Tamburino
12:01 pm - PCI vs. CABG for Left Main
Disease: Today’s Data: LEMANS,
PRECOMBAT, SYNTAX LM, and the
MAIN COMPARE Registry
Young-Hak Kim
12:16 pm - Four-Year Results of the Left Main
Cohort from the SYNTAX Trial
Marie-Claude Morice
12:28 pm - Left Main PCI and CABG:
Trends from Europe
Keith G. Oldroyd
1:01 pm - Are Surgical Results Improving in
Left Main Disease, and What Is the
State of the Art?
Michael J. Mack
1:16 pm - The NOBLE Trial: Design, Status,
and Timelines
Leif Thuesen
1:26 pm - The EXCEL Trial: Design, Status,
and Timelines
Gregg W. Stone
1:36 pm - Discussion: Left Main PCI vs. CABG:
EU and US Perspectives
Session V. Risk Stratification in
Left Main Disease
Moderators: Davide Capodanno,
Seung-Jung Park
Discussants: Bernard De Bruyne,
A. Pieter Kappetein, Raj Makkar,
Marie-Angele Morel, Tullio Palmerini
1:56 pm - Outcomes of Left Main PCI:
Factors Influencing Prognosis
Raj Makkar
2:08 pm - A Primer in Calculating the
Syntax Score
Marie-Angele Morel
2:18 pm - CREDO-Kyoto PCI/CABG Registry
Cohort-2: A Large-Scale Multicenter Registry
Comparing the Outcomes of Percutaneous
Coronary Intervention and Coronary Artery
Bypass Graft Surgery in Patients with Left
Main Disease
Hiroki Shiomi
2:26 pm - How Well Do Cardiologists Calculate
the Syntax Score (and Where Are Mistakes
Commonly Made)?
Tullio Palmerini
2:36 pm - Reflections on the Ideal RiskStratification Tool: Beyond the
Syntax Score
Patrick W. Serruys
2:48 pm - Functional vs. Anatomic
Revascularization: Surgical Perspectives
A. Pieter Kappetein
Revascularization: Interventional
Perspectives
Bernard De Bruyne
TCT2011
3:33 pm - Evaluating Left Main Severity:
The Case for FFR
Michalis Hamilos
3:43 pm - Evaluating Left Main Severity:
The Case for IVUS
Stéphane Rinfret
Session VII. Left Main PCI:
Special Situations
Moderators: Run-Lin Gao, Leif Thuesen
Discussants: Adrian P. Banning,
Michael S. Lee, John A. Ormiston
4:05 pm - Left Main Intervention During
Primary PCI for STEMI: Technique
and Outcomes
Michael S. Lee
4:17 pm - Geometric Considerations and
Physical Constraints of Current DES as
it Applies to Distal Left Main Stenting
John A. Ormiston
4:29 pm - Restenosis After Left Main Stenting:
Frequency, Clinical Presentation,
Management, and Outcomes
Adrian P. Banning
4:41 pm - Is There a Need for Dedicated
Stents for the Distal Left Main Bifurcation
(and What Are the Contenders)?
Martin B. Leon
Session VIII. Case Reviews in Complex
Left Main PCI
Moderators: Antonio Colombo,
Corrado Tamburino
Discussants: Fernando Alfonso, Andrejs Erglis,
Srihari S. Naidu, Erick Schampaert,
Paul S. Teirstein
5:05 pm - How Did I Treat This Complex
Distal Left Main Bifurcation? (Part 1)
Andrejs Erglis
Distal Left Main Bifurcation? (Part 2)
Erick Schampaert
Calcified Left Main?
Fernando Alfonso
5:35 pm - How Did I Treat This Complex Distal
Left Main Trifurcation?
Paul S. Teirstein
6:10 pm - Adjourn
Strategies for Cardiovascular
Repair: Stem Cells and Beyond
8:00 am-6:00 pm
Room 123
Moderators: Jozef Bartunek,
Francisco Fernandez-Aviles, Amit Patel,
Warren Sherman
Cell-Scape 2011
Moderator: Warren Sherman
8:00 am - Symposium Overview
Warren Sherman
Session I. The Framework of
Cardiovascular Repair:
Upgrading to v.2012
Moderators: Atta Behfar, Stefanie Dimmeler,
Marc S. Penn
Discussants: Karen Christman, Silviu Itescu
8:15 am - Biomechanisms: Making Optimal
Use of What Is Known
Stefanie Dimmeler
8:30 am - Naive vs. Guided Cells for Heart
Repair: The Role for Autologous
Cardiopoietic Platforms
Atta Behfar
8:45 am - “A Cell for All Seasons”: Current
Evidence and New Concepts for the
Multipotency of Mesenchymal Cells
Silviu Itescu
9:00 am - Myocardial Matrix and Ventricular
Remodelling: Promises from Tissue
Engineering
Karen Christman
Session II. Critical Limb Ischemia:
The Vascular Infrastructure of
Regenerative Medicine
Moderators: Brian H. Annex,
Stephen E. Epstein
Discussants: Timothy D. Henry, Amit Patel,
Vincent J. Pompili, Andreas M. Zeiher
9:35 am - Strategies for Cellular Intervention in
Peripheral Vascular Disease
Brian H. Annex
9:50 am - Marrow-Derived Stem Cell Therapy
in Chronic Limb Ischemia: Focus on
Point-of-Care Processing
Vincent J. Pompili
10:05 am - Combined Delivery Options for
Cell Therapy in PAD: The PROVASA Study
Andreas M. Zeiher
10:20 am - Gene Therapy for Peripheral
Artery Disease: New Agents, Early Data
Timothy D. Henry
10:35 am - Clinical Trials for Critical
Limb Ischemia: Forging Ahead with
Phase 3 Studies
Amit Patel
Session III. Stem Cells for Cardiac Repair
in the Acute Setting
Moderators: Jozef Bartunek, Hyo-Soo Kim
Discussants: Henricus J. Duckers,
Francisco Fernandez-Aviles, Warren Sherman,
Jochen Wöhrle, Andreas M. Zeiher
- N o v e m b e r 7 , 2 0 11
3:25 pm - Limitations of Angiography in
Evaluating the Left Main Coronary Artery
Alexandra J. Lansky
5:45 pm - How Did I Treat This Complex Left
Main in This Patient with Severely Depressed
Left Ventricular Function?
Srihari S. Naidu
monday
Session VI. Left Main Assessment
Moderators: Alexandra J. Lansky,
Erick Schampaert
Discussants: Sorin J. Brener,
Michalis Hamilos, Stéphane Rinfret
Cardiovascular
Therapeutics
11:10 am - Bone Marrow Mobilization, Alone
or in Combination with Cell Transplantation,
in STEMI: Lessons from TECAM-2
Francisco Fernandez-Aviles
11:25 am - Two-Year Results of a Randomized,
Double-Blind, Placebo-Controlled Trial
(SCAMI) with Serial Cardiac Magnetic
Resonance Imaging
Jochen Wöhrle
11:40 am - Adipose Cells for STEMI: APOLLO
and ADVANCE Randomized Trials
Henricus J. Duckers
11:55 am - Bone Marrow Cell Transfer for
STEMI: The BAMI Program
Andreas M. Zeiher
12:10 pm - MAGIC Study Program: Molecular
Modification of Stem Cells in the Clinic
Hyo-Soo Kim
12:45 pm - Lunch Break
Session IV. Stem Cells for Cardiac Repair
in the Chronic Setting
Moderators: Joshua M. Hare,
Emerson C. Perin
Discussants: Jozef Bartunek, Nabil Dib,
Francisco Fernandez-Aviles, Timothy D. Henry,
Marc S. Penn
1:45 pm - Final Results at 18 Months of the
PRECISE Trial for Refractory Angina
Francisco Fernandez-Aviles
2:00 pm - SDF-1: Heart Failure and
Multisystem Applications
Marc S. Penn
2:15 pm - Refractory Angina:
The Mounting Case for Stem Cells
Timothy D. Henry
2:30 pm - Lineage-Specified Mesenchymal
Cells in Patients with Chronic Left Ventricular
Dysfunction: Lessons from the C-CURE Trial
Jozef Bartunek
49
MOnday, November 7
2:45 pm - Allogenic Cells for Chronic
Left Ventricular Dysfunction:
The US Experience and Beyond
Nabil Dib
Session V. Optimizing Delivery
and Retention
Moderators: Jonathan M. Hill, Amit Patel
Discussants: Joshua M. Hare,
Emerson C. Perin, Warren Sherman
3:20 pm - IV Delivery, Homing, and
Biodistribution: Implications for the
Clinical Setting
Joshua M. Hare
3:30 pm - Present and Future of Transcatheter
Endomyocardial Stem Cell Delivery
Emerson C. Perin
3:40 pm - Transvascular Delivery of Biologic
Agents: Techniques and Patients
Warren Sherman
3:50 pm - Surgical Delivery: Which Patients,
Which Products, and When?
Amit Patel
Session VI. Clinical Directions: New
Biologics, New Patients
Moderators: Francisco Fernandez-Aviles,
Andreas M. Zeiher
Discussants: Nicolas A.F. Chronos,
Robert A. Kloner, Randall J. Lee,
Jonathan Leor
4:15 pm - Pediatric Interventions:
Autologous Progenitors for Congenital
Myocardial Disease
Andrejs Erglis
4:25 pm - Therapeutic Impact of B-Cells
After Cardiac Ischemia
Nicolas A.F. Chronos
4:35 pm - Cardiac Surgery and Ventricular
Geometry: Clinical Experience with a
Novel Agent
Randall J. Lee
4:45 pm - Induced Pluripotent Cells and
Embryonic Stem Cells: Promises to Keep?
Robert A. Kloner
4:55 pm - Noncellular Approaches to Limiting
Infarct Expansion: How Soon, and for Which
Patients?
Jonathan Leor
50
program ·
Cell Therapy and Cardiovascular Repair
State of the Union
Moderator: Jonathan M. Hill
5:25 pm - Summary, Insights, and
Future Directions
Jonathan M. Hill
6:00 pm - Adjourn
The Drug-Eluting Stent Summit:
Appropriate Utilization of
Current Generation Devices
8:00 am-6:10
Room 104
pm
Session I. DES as a Mature Subspecialty
Moderators: Sigmund Silber, Peter Wenaweser
Discussants: Edoardo Camenzind,
Bernard R. Chevalier, David J. Cohen,
David J. Hildick-Smith, Mitchell W. Krucoff,
Jeffrey W. Moses
8:00 am - Featured Lecture: From the ESC
Firestorm to the Relatively Calm Seas of
2011: What Have We Learned?
Edoardo Camenzind
Opening Controversy: Appropriate
Utilization of BMS vs. DES
8:12 am - Today’s DES Makes BMS
Nearly Obsolete!
8:22 am - Outcomes and Economic Data
Argue for a Rational Mix of BMS and DES!
David J. Cohen
8:44 am - Moderated Industry Roundtable:
What Are the Targets to Further Improve
DES? Are Current Generation DES So Good
and Are Reimbursements Such as to Inhibit
Further Investment?
Moderators: Mitchell W. Krucoff,
Gregg W. Stone
Discussants: Keith D. Dawkins,
Jeffrey B. Jump, Campbell Rogers,
Sean Salmon, Charles A. Simonton,
Mark A. Turco
Session II. DES Selection for
Unsettled Indications
Moderators: Ian T. Meredith, Gregg W. Stone
Discussants: Christoph A. Kaiser, Elvin Kedhi,
Roxana Mehran, Maurizio Menichelli,
Flavio L. Ribichini, Manel Sabate,
Francesco Saia, Paul S. Teirstein,
Glenn Van Langenhove,
Bernhard Witzenbichler
Debate: DES vs. BMS During Primary PCI in
STEMI: Clinical Equipoise or Pathologic Fear?
8:58 am - The Case for Near Universal
DES Use!
9:06 am - The Case for Near Universal
BMS Use!
Francesco Saia
9:14 am - The Case for Selective Use!
Roxana Mehran
9:22 am - Everolimus-Eluting Stents vs. BMS
in STEMI: The EXAMINATION Trial Results
Manel Sabate
9:30 am - Do DES in STEMI Increase the Rates
of Late Stent Thrombosis Compared to
BMS? The DESERT Cooperation
Giuseppe De Luca
9:38 am - Special Lecture: Can a History Be
Accurately Taken Prior to PCI in STEMI
Sufficient to Inform BMS vs. DES Use?
The GHOST Study
Maurizio Menichelli
9:48 am - DES Use in Simple Lesions in Large
Vessels: Latest BASKET-PROVE Results
Christoph A. Kaiser
9:58 am - DES in Complex Multivessel
Disease: The SYNTAX Trial at Four Years:
Overall Results and Breakdown of
the 3VD Cohort
Patrick W. Serruys
10:10 am - DES vs. BMS in SVG Lesions:
Routine, Selective, or Rarely? Review of
Randomized and Registry Data
Glenn Van Langenhove
Two Interesting Perspectives
10:20 am - Would SYNTAX Have Shown
Equivalence Between DES and CABG
Had a Potent Second Generation Device
Been Used?
Elvin Kedhi
10:28 am - Would FAME Have Been Negative
Had Second Generation DES Been
Exclusively Used?
Ian T. Meredith
When Should Cath Plus Ad Hoc PCI
Be Allowed?
10:36 am - European Perspectives
Flavio L. Ribichini
10:46 am - US Perspectives
Paul S. Teirstein
TCT2011
11:11 am - Stent Thrombosis State of
Knowledge: Mechanisms, Frequency,
Timing, and Implications
Joost Daemen
1:31 pm - When DES Restenose: Root Causes
and Diagnostic Evaluation
Antonio Colombo
11:26 am - Does Stent Thrombosis Start
Early? Insights from Angioscopy
Yasunori Ueda
11:34 am - Differences in Early and Late
Stent Thrombosis with BMS vs DES:
Insights from OCT
Takashi Akasaka
11:44 am - Relationship Between Stent
Malapposition and Stent Thrombosis:
Effector or Innocent Bystander?
Gary S. Mintz
11:54 am - Might OCT Guidance Be
Used to Determine When It’s Safe to
Discontinue DAPT?
Giulio Guagliumi
12:06 pm - Pharmacotherapeutic
Considerations to Reduce Stent
Thrombosis 1: Appropriate Use of
Prasugrel and Ticagrelor
Dean J. Kereiakes
1:43 pm - Late Catch-up After First and
Second Generation DES: Angiographic and
IVUS Phenomena vs. Clinical Relevance
Robert A. Byrne
1:53 pm - New Insights into Strut Fracture
and DES Restenosis
David E. Kandzari
4:41 pm - Everolimus-Eluting Stents:
Three-Year COMPARE Results
Peter C. Smits
2:17 pm - Treatment of DES In-Stent
Restenosis: A Rationale Algorithm with
Emerging Evidence
Fernando Alfonso
4:56 pm - Sirolimus-Eluting Stents vs. EES:
Meta-analysis of Overall Results
Hyo-Soo Kim
2:29 pm - Use of Drug-Coated Balloons to
Treat DES In-Stent Restenosis:
First or Last Option?
Alaide Chieffo
3:04 pm - Case 2: What Is the Cause of
This DES Restenosis?
Thomas A. Ischinger
Stump the Panel Cases
This Stent Thrombosis?
Jose M. de la Torre Hernandez
This Stent Thrombosis?
Upendra Kaul
4:16 pm - Comparison of Zotarolimus-Eluting
(Resolute) and Sirolimus-Eluting Stents in
Long Coronary Artery Lesions:
The Randomized LONG-DES IV Trial
Seung-Jung Park
2:09 pm - Implications of Aneurysm Formation
After DES
Daljeet S. Gambhir
12:28 pm - Strategies to Prevent Stent
Thrombosis When DAPT Must Be
Discontinued Early
Ajay J. Kirtane
4:01 pm - Zotarolimus-Eluting (Endeavor)
Stents 2011/2012: Final Five-Year Trial
Results and Clinical Use Recommendations
for Patient Selection
David E. Kandzari
4:31 pm - Everolimus-Eluting Stents
2011/2012: Stent Design Evolution,
Clinical Trial Update
Gregg W. Stone
12:48 pm - Operator Techniques to Reduce
Stent Thrombosis
Antonio Colombo
3:46 pm - Paclitaxel-Eluting Stents 2011/2012:
New Data, Appropriate Utilization
Louis A. Cannon
2:01 pm - Implications of Peri-stent Contrast
Staining After DES
Takeshi Kimura
12:16 pm - Pharmacotherapeutic
Considerations to Reduce Stent
Thrombosis 2: DAPT Duration 6 vs. 12 vs. 24
Months: Review of Completed Trials and
Insights from the DAPT Trial Enrollment
Laura Mauri
12:38 pm - Can DAPT be Discontinued Early
with Selected DES? Insights from the SPIRIT
and XIENCE USA Trials
3:36 pm - How to Select DES:
The Pathologist’s View
Renu Virmani
Stump the Panel Cases
This DES Restenosis?
Robert J. Whitbourn
Session V. DES Program Update:
Today’s Generation
Moderators: Steven R. Bailey,
Dean J. Kereiakes
Discussants: Louis A. Cannon,
David E. Kandzari, Hyo-Soo Kim,
Martin B. Leon, Tullio Palmerini,
Seung-Jung Park, Peter C. Smits,
Gregg W. Stone, Renu Virmani,
Clemens von Birgelen
3:14 pm - How to Select DES:
Geometry, Recoil, Strut Thickness,
and Bifurcation Considerations
John A. Ormiston
- N o v e m b e r 7 , 2 0 11
Session IV. DES Restenosis: New Insights
to Mechanisms, Prevention, and Treatment
Moderators: Fernando Alfonso,
Peter J. Fitzgerald
Discussants: Robert A. Byrne, Alaide Chieffo,
Daljeet S. Gambhir, David E. Kandzari,
Upendra Kaul, Takeshi Kimura, Ajay J. Kirtane
monday
Session III. Stent Thrombosis: New Insights
to Mechanisms, Prevention, and Treatment
Moderators: Giulio Guagliumi, Paul S. Teirstein
Discussants: Takashi Akasaka, Joost Daemen,
Dean J. Kereiakes, Laura Mauri,
Gary S. Mintz, Yasunori Ueda,
Marco Valgimigli
Cardiovascular
Therapeutics
5:04 pm - Sirolimus-Eluting Stents vs. EES:
Focus on Stent Thrombosis
Tullio Palmerini
5:12 pm - Zotarolimus-Eluting (Resolute)
Stents 2011/2012: Emerging Data from
Randomized Trials and Registries
Martin B. Leon
Session VI. Emerging Noncoronary
DES Applications
Moderators: Michael D. Dake,
David E. Kandzari
Discussants: Lindsay S. Machan,
Jason H. Rogers
5:35 pm - Evolution and Current Status of
DES Use in the SFA and Below the Knee
Lindsay S. Machan
5:47 pm - Drug-Eluting Stents for the
Treatment of Erectile Dysfunction:
Results of the ZEN Trial
Jason H. Rogers
6:10 pm - Adjourn
3:26 pm - How to Select DES: Do Differences
in Polymer Coating Consistency, Defects,
and Integrity Exist (and Do They Matter)?
51
MOnday, November 7
The Valvular Heart Disease
Summit (Part 1):
Aortic Valve Therapies
8:00 am-7:00
Room 135
pm
Session I. Aortic Stenosis: Pathophysiology,
Diagnosis, and Treatment
Moderators: Robert O. Bonow,
Maurice E. Sarano
Discussants: Michael J. Davidson,
Craig R. Smith, E. Murat Tuzcu,
Robert Winchester
8:00 am - Echocardiographic Keys to
Diagnosing Aortic Stenosis: What’s
Clinically Meaningful?
Maurice E. Sarano
8:15 am - Is Aortic Stenosis an Inflammatory
Disease? New Laboratory Observations and
Clinical Implications
Robert Winchester
8:30 am - How to Manage Patients with
Aortic Stenosis: Guidelines, Controversies,
and Clinical Pearls
Robert O. Bonow
8:45 am - Surgical Results in High-Risk
Patients with Aortic Stenosis: Insights
from PARTNER
Craig R. Smith
8:58 am - Are Outcomes Improved After
Minimally Invasive Aortic Valve Surgery?
Michael J. Davidson
9:12 am - Indications, Results, and
Complications of Balloon Aortic
Valvuloplasty in the Era of TAVR: Lessons
from PARTNER and Other Experiences
E. Murat Tuzcu
9:45 am - Are Animal Studies with
Transcatheter Aortic Valves Meaningful?
Juan F. Granada
9:55 am - Analysis of Human Necropsy
Transcatheter Heart Valve Specimens: Valve
Design Differences, Durability Predictions,
and Comparison with Surgical Valves
Renu Virmani
10:15 am - TAVR Update 2011:
The Year in Review
Martin B. Leon
10:30 am - VARC-2 Update: A Revised
Roadmap for TAVR Clinical Research
Patrick W. Serruys
Provocative Debate: TAVR Clinical Use
Patterns: Disciplined Appropriate Growth vs.
Uncontrolled Inappropriate Over use
10:45 am - “Risk Creep” Is Exaggerated:
The Pie Is Growing!
Martyn R. Thomas
10:55 am - Surgery Is Being Unfairly
Cannibalized and Surgical Volumes
Are Declining!
Friedrich W. Mohr
11:05 am - Rebuttal and Discussion
Session III. TAVR:
Case Selection Considerations
Moderators: Gregory P. Fontana,
Jean-Claude Laborde
Discussants: Stephen J.D. Brecker,
Philip Green, Michael J. Mack, D. Craig Miller,
Michael J. Reardon, Lars G. Svensson
11:15 am - The Proper Use (and Abuse) of Risk
Algorithms: “New” (and Improved) STS and
EuroSCORE and Beyond
Michael J. Mack
Session II. The TAVR Era: Historical
Perspectives, Basic Concepts, and
Status Updates
Moderators: Alain G. Cribier, Michael J. Mack
Discussants: Henning Rud Andersen,
Juan F. Granada, Friedrich W. Mohr,
Patrick W. Serruys, Martyn R. Thomas,
Renu Virmani, John G. Webb
Characterizing and Defining the
“Inoperable” or “Extreme Risk”
Aortic Stenosis Patient
9:25 am - TAVR Reflections 1: Concept
Genesis and Early Animal Studies
Henning Rud Andersen
52
9:35 am - TAVR Reflections 2:
The Often Agonizing Path from
Concept to Clinical Reality
Alain G. Cribier
program ·
11:28 am - Viewpoints from PARTNER
Lars G. Svensson
11:36 am - Viewpoints from the US
CoreValve Study
Michael J. Reardon
11:50 am - Understanding the Frailty
Phenotype: Objective Criteria and
Implications for TAVR Case Selection
Philip Green
12:03 pm - When Is an Aortic Stenosis Patient
“Too Sick to Treat”? The Cohort C Patient
(with Case Examples)
D. Craig Miller
12:23 pm - Which Lower-Risk Aortic Stenosis
Patients Are Appropriate TAVR Candidates
TODAY? (with Case Examples)
Stephen J.D. Brecker
Session IV. Aortic Stenosis Clinical
Case Conundrums: How to Manage
a Patient with. . . .
Moderators: Blase A. Carabello,
D. Craig Miller
Discussants: Robert O. Bonow,
Howard C. Herrmann, Susheel Kodali,
Reginald I. Low, Ganesh Manoharan,
Josep Rodes-Cabau
12:35 pm - “Asymptomatic” Severe Aortic
Stenosis with Case Examples: Exercise
Testing and Elderly with Comorbidities
Allan Schwartz
12:50 pm - Low-Flow, Low-Gradient Aortic
Stenosis: With and Without Contractile
Reserve and Clinical Outcomes
Philippe Pibarot
1:00 pm - Low-Flow, Low-Gradient Aortic
Stenosis: Case Example
Nirat Beohar
1:10 pm - Aortic Stenosis and CAD (Simple
and Complex) with Case Examples:
AVR-CABG vs. TAVR-PCI and When Not to
Treat CAD
Session V. TAVR Evidence-Based
Medicine Corner: Consensus, Gaps,
and Controversies
Moderators: Jeffrey J. Popma, John G. Webb
Helene Eltchaninoff, Jean-Claude Laborde,
Rudiger Lange, Ian T. Meredith,
John L. Petersen, Josep Rodes-Cabau,
Stefan Sack, Nicolas van Mieghem,
Thomas Walther, Olaf Wendler
1:25 pm - Updates from the Pooled Analysis
from Multicenter Country TAVR Registries
Nicolas van Mieghem
1:35 pm - SOURCE 1, 2, and XT Registries:
Take-Home Messages and Late Follow-up
Olaf Wendler
TCT2011
2:05 pm - The Australia-New Zealand
Multicenter TAVR Registry Experience
Ian T. Meredith
2:15 pm - The Munich Heart Center
TAVR Registry: Multiple Devices and
Evolving Trends
Rudiger Lange
2:25 pm - Updates from the German Aortic
Valve Therapy Registry
Stefan Sack
2:35 pm - Milan Experiences with Multiple
TAVR Systems: Patient and Lesion Profiling
Antonio Colombo
2:45 pm - Panel Discussion: Take-Home
Messages from the Registry Data
Transapical vs. Transfemoral TAVR:
A Spirited Debate
3:00 pm - Outcome Differences Are Largely
a Reflection of Underlying Patient
Characteristics!
Thomas Walther
3:10 pm - Outcome Differences Are
Determined by Fundamental Procedural
Differences and Not Just Patient
Characteristics!
Jeffrey W. Moses
3:25 pm - Settled and Unsettled
PARTNER Issues: A Critical Analysis
of the Data
Susheel Kodali
3:38 pm - Updates from the US CoreValve
Pivotal Randomized Trial
Jeffrey J. Popma
New Clinical Indications for TAVR
3:51 pm - Balloon Expandable Sapien TAVR:
Valve-in-Valve, Bicuspid Disease, and with
Mitral Prostheses
John G. Webb
4:01 pm - Self-Expanding CoreValve TAVR:
Valve-in-Valve, Bicuspid Disease, and
Aortic Regurgitation
Jean-Claude Laborde
Intermediate Risk Patients:
Updates from. . . . .
Session VII. TAVR Complications:
A “No-Holds Barred” Appraisal
Moderators: Nicolo Piazza,
Josep Rodes-Cabau
Discussants: Philippe Genereux,
Linda D. Gillam, D. Craig Miller, John G. Webb
4:16 pm - PARTNER 2
Martin B. Leon
4:21 pm - SURTAVI
Patrick W. Serruys
Session VI. TAVR Procedural
Considerations: Screening, Access,
Techniques, and Adjunctive Technologies
Moderators: Raj Makkar, E. Murat Tuzcu
Discussants: Lutz Buellesfeld, Alain G. Cribier,
Mirko Doss, Eberhard Grube,
Rebecca Tung Hahn, Susheel Kodali,
Jean-Claude Laborde, Jonathon A. Leipsic,
Augusto D. Pichard, Michael J. Reardon
Advanced Imaging
4:30 pm - An Overview of Advanced Imaging
Modalities for TAVR Screening and
Procedures
Lutz Buellesfeld
4:40 pm - Echo Before and During TAVR:
A Screening Tool and for Intraprocedural
Decision-Making
Rebecca Tung Hahn
4:50 pm - CTA Is Indispensable for TAVR
Screening and Procedure Planning:
What Every Interventionalist and Surgeon
Should Know
Jonathon A. Leipsic
TAVR Access Alternatives and Closure
5:05 pm - Subclavian/Axillary Access
(And Results)
Jean-Claude Laborde
5:13 pm - Transaortic Options
Michael J. Reardon
5:21 pm - Percutaneous Closure Techniques
Susheel Kodali
The Emerging Minimalist TAVR Approach:
Who Needs. . . .
5:35 pm - General Anesthesia? (Monitored
Anesthesiology Control Is Better)
Augusto D. Pichard
5:40 pm - Transesophageal Echo?
(Transthoracic Echo Is Sufficient)
Alain G. Cribier
6:00 pm - Strokes May Be the Achilles’
Heel of TAVR!
D. Craig Miller
6:10 pm - The Stroke-TAVR Controversy
Has Been Exaggerated and Will Be Solved
in the Future!
John G. Webb
- N o v e m b e r 7 , 2 0 11
1:55 pm - The France Multicenter TAVR
Registry Experience
Helene Eltchaninoff
monday
1:45 pm - Canadian TAVR Experiences: Focus
on Procedural Complications, Late Clinical
Outcomes, and Echo Core Lab Findings
Josep Rodes-Cabau
Cardiovascular
Therapeutics
6:25 pm - Conduction Abnormalities
After TAVR: Frequency, Predictors,
and Clinical Relevance
Nicolo Piazza
6:35 pm - Vascular and Bleeding Events
Associated with TAVR: Insights from
PARTNER and Future Expectations
Philippe Genereux
6:45 pm - Paravalvular Regurgitation: Accurate
Diagnosis and Clinical Implications
Linda D. Gillam
7:00 pm - Adjourn
PFO and ASD Closure: Evolving
Indications, Patient Selection,
Devices, and Technique
1:00 pm-6:10
Room 130
pm
Session I. Update on PFO Stroke Trials
Moderators: Ziyad M. Hijazi, Bernhard Meier
Discussants: John D. Carroll, Ted Feldman,
Mark Reisman, Jeffrey Saver, David E. Thaler
1:00 pm - How to Evaluate Patients with
Cryptogenic Stroke
David E. Thaler
1:10 pm - PFO Closure for Stroke Prevention:
Meta-analysis Evidence from
Nonrandomized Trials
Jeffrey Saver
1:20 pm - In-depth Review and Failure
Analysis of CLOSURE I
Mark Reisman
Flash Debate: Should We Stop Closing
PFOs After CLOSURE I?
5:45 pm - Pretreatment with BAV?
(Better Results with “Direct” TAVR)
Eberhard Grube
1:30 pm - Pro: With Rare Exception—Primum
Non Nocere!
5:50 pm - On-site Surgical Backup?
(May Not Be Necessary?)
Mirko Doss
1:38 pm - Con: We Certainly Should Continue
Closing PFOs!
Ted Feldman
53
MOnday, November 7
1:46 pm - The RESPECT Trial: Baseline
Characteristics and Early Insights
John D. Carroll
4:31 pm - The Next Generation of PFO Closure
Devices: Problems Solved and Unsolved
Horst Sievert
Session II. PFO and Migraine
Moderators: Mark Reisman, Horst Sievert
Discussants: John D. Carroll,
Peter J. Goadsby, Jonathan M. Tobis
Session V. ASDs in Adult Patients
Moderators: Frank F. Ing,
Eustaquio Maria Onorato
Discussants: Ziyad M. Hijazi, Eric Horlick,
Thomas K. Jones, Horst Sievert
2:11 pm - How Could a PFO Possibly
Cause Headache?
Peter J. Goadsby
2:21 pm - A Tale of Two PFO Migraine
Patients: A Great Success and a
Complete Failure
Jonathan M. Tobis
2:31 pm - Status of PFO Migraine Clinical
Trials: Completed and Ongoing
Peter J. Goadsby
2:41 pm - When to Consider Closing PFOs
in Migraine Patients TODAY (If Ever)
John D. Carroll
Session III. PFO Closure Beyond Stroke
and Migraine
Moderators: Michael J. Mullen,
Robert J. Sommer
Discussants: Paul H. Kramer, Bernhard Meier,
John F. Rhodes, Kevin Walsh
3:01 pm - The Truth About PFO and Divers
Kevin Walsh
4:53 pm - Indications for ASD Closure and
Long-term Outcomes
Ziyad M. Hijazi
5:05 pm - REPERA: A Multicenter Registry
Examining the Acute and Late Outcomes
Following Percutaneous Repair of Large
Atrial Septal Defects
Felipe Hernandez
5:15 pm - Case 1: Closure of Multiple ASDs
Eric Horlick
5:25 pm - Case 2: Closure of a Large ASD
with Aneurysm
5:35 pm - Case 3: Closure of an ASD in an
Elderly Patient with a Stiff Ventricle
Thomas K. Jones
5:45 pm - Novel Emerging ASD Devices:
What Benefits Can We Expect?
Horst Sievert
6:10 pm - Adjourn
3:11 pm - PFO, Sleep Apnea, and Hypoxemia
John F. Rhodes
3:21 pm - PFO, DVT, and Thrombogenic
Disorders
Paul H. Kramer
3:31 pm - Long-term Outcomes of
PFO Closure
Bernhard Meier
Session IV. Difficult Cases, Troubleshooting
Moderators: John D. Carroll, John F. Rhodes
Discussants: Clifford J. Kavinsky,
Michael J. Mullen, Mark Reisman,
Horst Sievert, Robert J. Sommer
3:51 pm - Case 1: A Patient with
a Questionable Indication
Robert J. Sommer
4:01 pm - Case 2: Device Embolization
Michael J. Mullen
4:11 pm - Case 3: Thrombus on the Device
Clifford J. Kavinsky
4:21 pm - Case 4: Residual Shunt: Assessment
and Management
Mark Reisman
54
program ·
Special Twilight
Sessions
Featured Clinical Research I.
Transcatheter Valve and
STEMI/Heart Failure Therapies
6:00 pm-8:00 pm
Room 121
Moderators: Jeffrey J. Popma,
Martyn R. Thomas
Discussants: Maurice Buchbinder,
Daniel Burkhoff, Charles J. Davidson,
Larry S. Dean, Ted Feldman, Olaf Franzen,
Thierry Lefevre, Ganesh Manoharan
6:00 pm - UK TAVI: A Large-Scale National
Registry Comparing Transcatheter Aortic
Valve Type and Access Route
Daniel J. Blackman
6:15 pm - CoreValve Subclavian: A SingleCenter, Propensity-Case-Controlled Registry
of Transcatheter Aortic Valve Implantation
via Subclavian vs. Transfemoral Access
Anna Sonia Petronio
6:30 pm - ACURATE TA: A Prospective
Observational Study of a New SelfExpanding Transapical Bioprosthesis
in Elderly High-Risk Patients with
Aortic Stenosis
Joerg Kempfert
6:45 pm - SAT-TAVI: A Prospective,
Randomized Trial of Single vs. Dual
Antiplatelet Therapy After Transcatheter
Aortic Valve Replacement in High-Risk
Patients with Aortic Stenosis
Eugenio Stabile
7:00 pm - A Two-Center Registry Study
Comparing Bivalirudin and Unfractionated
Heparin in Patients Undergoing Balloon
Aortic Valvuloplasty
George D. Dangas
7:15 pm - C-PULSE. A Prospective,
First-in-Man Study with a Non-Blood
Contacting Extra-Aortic Counterpulsation
System in Patients with Moderate to
Severe Ambulatory Heart Failure
William T. Abraham
7:30 pm - A Prospective, Randomized Trial
of Thrombus Aspiration in Patients with
ST-Segment Elevation Myocardial Infarction
Assessed by Optical Coherence Tomography
Patrick W. Serruys
7:45 pm - A Prospective, Multicenter,
Randomized Trial of Zotarolimus-Eluting
Stents and Sirolimus-Eluting Stents in
Patients with ST-Segment Elevation
Myocardial Infarction
Lefeng Wang
8:00 pm - Adjourn
New Patients for New
Interventional Therapies
6:00 pm-7:15 pm
Room 122
Moderators: Saibal Kar, Horst Sievert
Discussants: Tony Das, Manish A. Parikh,
Robert J. Whitbourn
6:00 pm - Maintaining a Robust Coronary
Referral Practice in the Modern Era
Manish A. Parikh
TCT2011
6:15 pm - Growing a Thriving Endovascular
Referral Base: Outreach Programs and
Opportunities
Tony Das
8:00 pm - Adjourn
7:00
Evening Programs
- N o v e m b e r 7 , 2 0 11
Creating New Referral Sources for New
Interventional Programs: Structural, Valve,
Adult Congenital, and Hypertension
monday
Cardiovascular
Therapeutics
pm -10:00 pm
Please see page 146 for the Evening
Programs schedule
6:30 pm - A European Success Model
Horst Sievert
6:40 pm - US Approaches
Saibal Kar
6:50 pm - Strategies from “Down Under”
Robert J. Whitbourn
7:15 pm - Adjourn
Partnership Session:
Angioplasty Summit-TCTAP
6:00 pm-8:00
Room 120
pm
Optimization with FFR and IVUS
Moderators: Gary S. Mintz, Seung-Jung Park,
Gregg W. Stone
David J. Hildick-Smith, Soo-Jin Kang,
Young-Hak Kim, Akiko Maehara, Raj Makkar,
Jeffrey W. Moses, Patrick W. Serruys
6:00 pm - Welcome and Introductory Remarks
Seung-Jung Park
6:03 pm - Morphology and Distribution of
Left Main and Non-Left Main Bifurcation
Atherosclerosis: Why Is This Important?
Akiko Maehara
6:16 pm - IVUS and FFR to Guide Non-Left
Main Bifurcation PCI
Soo-Jin Kang
6:38 pm - Two Complex Non-Left Main
Bifurcation Cases: My Solutions
6:53 pm - IVUS and FFR to Guide Left Main
Bifurcation PCI
Seung-Jung Park
7:15 pm - Two Distal Left Main Bifurcation
Cases: My Solutions
Jeffrey W. Moses
7:30 pm - Two Distal Left Main Trifurcation
Cases: My Solutions
Antonio Colombo
55
TCTMD
The source for interventional cardiovascular news and education
Become a member
of TCTMD GOLD at
www.tctmd.com/GOLD
Get the most out of TCTMD with TCTMD Gold!
Get the most out
of TCTMD with
TCTMD Gold!
Subscribe to TCTMD Gold for access to:
• M
orethan8,000PowerPointandmultimedia
web cast presentations from:
- TCT 2011
- Transcatheter Valve Therapies 2011
- OptimizingPCIOutcomes2011
- InterventionalCardiologyFellowsCourse2011
- InternationalChronicTotalOcclusionSummit2011
- TCT 2010
- S
electpresentationsarealsoavailablefrom
ACC2011,PCR2011andESC2011
• Morethan300livecasevideosfrom:
- TCT 2011, TCT 2010, TCT 2009
- TVT 2011, TVT 2010
- CTO 2011
Additional premium content will be available throughout the year.
Visit www.tctmd.com/GOLD to register!
For more information, visit www.tctmd.com/GOLD or contact Josh Hartman, Managing Editor,
TCTMD, at 646-434-4604 or [email protected].
TCT2011
Cardiovascular
Therapeutics
Board Review Course with Self-Assessment
in Interventional Cardiology (Part 2)......................................... 58
TCT for Nurses and Technologists . . ..................................58, 59
TCT for Surgeons...................................................................59, 93
Scientific Symposia
Coronary Revascularization ....................................................................... 59
Peer-Reviewed Research
Poster Abstract Sessions .......................................................................... 60
Challenging Cases Video Abstracts........................................................... 79
Oral Abstract Sessions .............................................................................. 82
Scientific Symposia (Continued)
Device-Based Approaches for Heart Failure:
Recent Developments and New Directions................................................ 88
Endovascular Intervention (Part 2) ............................................................. 89
Hot Topics in Interventional Cardiology: ACC.11 Highlights
for the Interventional, Invasive, and General Cardiologist ......................... 89
Next Generation Drug-Eluting Stents and Bioabsorbable Scaffolds........... 92
The Valvular Heart Disease Summit (Part 2): Mitral Valve Therapies........... 93
Translational Research and First-in-Human Studies
for Emerging Cardiovascular Technologies................................................ 93
Transradial Angiography and Intervention: From Basic to Advanced ........ 94
Japan-US Synergies for Medical Device Innovation:
A Harmonization by Doing (HBD) Educational Symposium.........................95
Presentation Theater South.......................................................... 150
Drug-Eluting Stent vs. Stent Studies ......................................................... 96
san francisco, ca
SCAI ELM Program in Partnership with ACC and CRF............................... 95
·
Special Sessions
November 8, 2011
Left Atrial Appendage Closure: Indications, Devices, and Techniques....... 91
the Moscone Center
Identifying the High-Risk Patient and Lesion:
From Vulnerable Plaque to Ischemia and Viability...................................... 90
Tuesday
Breakfast Meetings............................................................................147
How to Treat Complex Lesions.................................................................. 96
Partnership Session: CIT in Partnership with TCT:
Challenging Cases in Clinical Practice....................................................... 97
Partnership Session: TCT Russia: Focused Session on
Endovascular and Structural Heart Disease............................................... 97
Evening Programs............................................................................. 150
57
Tuesday, November 8
Breakfast Meetings
7:00
am -8:00 am
Please see page 147 for the Breakfast
Meetings schedule.
Board Review Course
with Self-Assessment
In Interventional
Cardiology (Part 2)
8:00 am-6:00
Room 103
pm
Devices and Outcomes
George D. Dangas
1:00 pm - PCI for Left Main and
Multivessel CAD
David R. Holmes Jr
1:30 pm - Complex Lesions:
Bifurcations and CTO
David E. Kandzari
2:00 pm - Thrombectomy and Distal Protection
in Native Coronary Artery and Saphenous
Vein Graft Lesions
2:30 pm - Break
Cardiac Cath Lab Basics
Manish A. Parikh
8:00 am - Coronary Angiography and
Ventriculography: Anatomy and Anomalies
Michael J. Lim
8:30 am - Chronic Kidney Disease, Contrast
Agents, and Radiocontrast Nephropathy
Roxana Mehran
8:50 am - Selection of Angioplasty Guiding
Catheters, Wires, and Balloons
Aaron D. Kugelmass
9:10 am - Angioplasty, Atherotomy, and
Atherectomy: Mechanisms of Action,
Results, and Current Indications
Steven R. Bailey
Special Interventional Imaging
and Physiology Session
Moderators: Massoud A. Leesar,
Gary S. Mintz
3:00 pm - Physiologic Lesion Assessment
Guidelines, Key Clinical Results, and Case
Presentations (with Integrated Q&A)
Michael J. Lim
Stents
Moderators: George D. Dangas,
Ajay J. Kirtane
10:00 am - Bare Metal vs. Drug-Eluting Stents:
Mechanisms of Action, Results, and
Comparative Effectiveness
Ajay J. Kirtane
10:30 am - Drug-Eluting Stent Systems
and Results
Duane S. Pinto
11:00 am - In-Stent Restenosis: Mechanisms,
Predictors, and Treatment
Roxana Mehran
Breakout Symposium I.
The Great Debates
8:00 am-12:00
Room 102
pm
Topic I. The Status of PFO
Closure After CLOSURE 1
Moderator: Russell A. Brandwein
8:00 am - Understanding PFO
Russell A. Brandwein
8:12 am - PFO Closure Is No Longer Indicated!
Brad I. Munt
8:24 am - PFO Closure Still Has Its Place!
Jonathan M. Tobis
8:36 am - Rebuttals and Discussion
Topic II. Treatment of Carotid
Artery Disease
8:48 am - Carotid Artery Disease Essentials
Pilar Dolcimascolo
3:45 pm - Intravascular Ultrasound Guidelines,
Key Clinical Results, and Case Examples
(with Integrated Q&A)
Gary S. Mintz
9:00 am - CEA Is the Way!
Michael J. Reardon
Essentials of Vascular Disease
Moderators: Prakash Krishnan, Jeffrey W. Olin
Topic III: Vascular Access
4:30 pm - Endovascular Rescue During
Cardiac Interventions
Prakash Krishnan
9:30 am - Break
TCT for Nurses and
Technologists
5:00 pm - Essentials of Aortic and Peripheral
Arterial (Upper/Lower Extremity) Diseases:
Guidelines, Assessment, and Outcomes
Jeffrey W. Olin
5:30 pm - Essentials of Carotid Artery
Diseases: Guidelines, Assessment,
and Outcomes
Jose M. Wiley
5:45 pm - Essentials of Renal Artery Disease:
Guidelines, Assessment, and Outcomes
Jeffrey W. Olin
6:00 pm - Adjourn
11:30 am - Stent Thrombosis: Mechanisms,
Predictors, and Treatment
George D. Dangas
12:00 am - Lunch Break
9:12 am - PTA Is the Way!
Herbert D. Aronow
9:36 am - Vascular Anatomy 101
Sheehan L. Raab
9:48 am - Radial Access for All!
Martial Hamon
10:00 am - Femoral Is Still No. 1!
Jeffrey W. Moses
Topic IV. Lesion Assessment in
the Cath Lab
10:24 am - Lesion Assessment
Beyond Angiography
Caesar Alvero
10:36 am - IVUS Is All You Need!
Michael J. Rinaldi
10:48 am - FFR Wins by Far!
Pim A.L. Tonino
Topic V. Left Main Disease
11:12 am - Left Main Disease Review
Sarah Clarke
58
program ·
TCT2011
11:36 am - Left Main Disease Equals PCI!
Paul S. Teirstein
12:00 pm - Adjourn
Breakout Symposium II.
Working in Today’s Cath Lab
8:00 am-12:00
Room 134
pm
8:00 am - Introduction and Session Objectives
Trends in Professional Practice
Moderator: Janet F. Wyman
Discussants: Marian C. Hawkey,
8:05 am - Maintaining Staff Proficiency with
Professional Certification and Competencies
8:20 am - Role of Midlevel Practitioners
Janet F. Wyman
8:35 am - Integrating Clinical Research
into the Cath Lab
Marian C. Hawkey
Trends in Patient Management
Discussants: Jacqueline Kixmiller,
Michael Querijero
9:00 am - Adapting to the Needs of Our
Diverse Patient Population
Michael Querijero
9:15 am - Adapting to New Techniques
and Technology
Thomas H. Maloney
9:35 am - Adapting to the Challenges of
the 23-Hour Admission
Jacqueline Kixmiller
Spotlight Session: TAVR Program
Development and Clinical Management
Discussants: Sarah Clarke, Marian C. Hawkey,
Martina Kelly Speight, Sandra Lauck
10:00 am - Moving Parts: Who and What
Do You Need?
Marian C. Hawkey
10:15 am - Managing Referral Volume
Sarah Clarke
10:30 am - Matching Patients to
Treatment Options
10:45 am - Recommendations for
Clinical Management
Sandra Lauck
11:15 am - Austria
Lynne Hinterbuchner
11:20 am - New Zealand
Rhona MacDonald
11:25 am - Qatar
Elsayed Mahmoud
11:30 am - Spain
Siro Buendia
11:50 am - Final Comments and Wrap-up
12:00 pm - Adjourn
Breakout Symposium III.
Business Development
and Operations
8:00 am-12:00 pm
Room 135
Moderators: Michael Guiry, Hilary Nierenberg
8:00 am - Health Care Reform:
A Climate Overview
James M. Palazzo
8:25 am - What Is Happening with
Fee for Service?
James M. Palazzo
8:38 am - Cardiology Practice Acquisitions:
How Will This Impact Your Volume?
Robert R. Moss
8:50 am - Cardiovascular Practice Trends
Michael Guiry
9:12 am - The Cardiovascular Service Line
Physician Growth Strategies
Ellen Komar
9:24 am - Drivers of Patient Satisfaction
to Improve Market Share
Patricia M. Pye
9:36 am - Effectively Branding and Marketing
Your Cardiovascular Program
Dan Polcyn
10:24 am - RAC Protection Program:
Successful Documentation to
Maintain Revenue
Glenna Friedman
10:36 am - Cloud Technology and
Patient Education
Rob Dhoble
11:12 am - Staffing Competencies for Hybrid
Rooms: Nightmare or Nirvana?
Anthony Dawson
11:24 am - Is That a Cardiac Surgeon in
My Cath Lab?
Mathew Williams
- N o v e m b e r 8 , 2 0 11
International Perspectives on Working
in the Cath Lab
Moderator: Regina Deible
Discussants: Siro Buendia,
Lynne Hinterbuchner, Sumaira Macdonald,
Elsayed Mahmoud
Tuesday
11:24 am - Left Main Disease Equals CABG!
Mark W. Connolly
Cardiovascular
Therapeutics
11:36 am - Cardiovascular Programs of
the 21st Century
Charanjit S. Rihal
12:00 pm - Adjourn
SciEntific Symposia
Surgical, Interventional, and
Hybrid Procedures (Part 1):
Coronary Revascularization
Co-sponsored by the American Association
for Thoracic Surgery
8:00 am-12:00
Room 133
pm
Session I. Evolution of Coronary
Revascularization
Moderators: William E. Cohn, A. Marc Gillinov
Discussants: Johannes Bonatti,
Robert A. Guyton, Martin B. Leon,
Friedrich W. Mohr, Marie-Claude Morice,
Jeffrey W. Moses, Joseph F. Sabik,
Gregg W. Stone, Paul S. Teirstein
8:00 am - PCI Technique and Technology:
Evolution from the Past to the Present
with Prediction for the Future
Martin B. Leon
8:12 am - CABG Technique and Technology:
Evolution of a Subspecialty—And Are Most
Surgeons Adapting?
Johannes Bonatti
10:00 am - Cath Lab Quality Reporting:
Appropriate Use Criteria and What It Means
Judy Tingley
8:24 am - Chair’s Informal Comments: On the
Evolution of Coronary Revascularization
William E. Cohn, A. Marc Gillinov
10:12 am - Successful Practices Leave
Nothing Behind
Rona G. Kahn
59
Tuesday, November 8
Session II. Multivessel Disease
Moderators: Robert A. Guyton,
Paul S. Teirstein
Discussants: Johannes Bonatti,
William E. Cohn, A. Marc Gillinov,
Martin B. Leon, Friedrich W. Mohr,
Jeffrey W. Moses, Joseph F. Sabik,
Gregg W. Stone
8:29 am - PCI Today: Best Practices, Optimal
Outcomes, and Limitations: When Do I
Prefer CABG for MVD?
Gregg W. Stone
8:41 am - CABG Today: Best Practices,
Optimal Outcomes, and Limitations: When
Do I Prefer PCI for MVD?
Joseph F. Sabik
Should the Syntax Score Guide Therapy
in MVD?
8:53 am - Yes: The Data Are Clear!
Friedrich W. Mohr
9:03 am - No: The Syntax Score Is
Too Simplistic!
Jeffrey W. Moses
Moderators: Robert A. Guyton,
Marie-Claude Morice
Session III. Left Main Disease
Moderators: A. Pieter Kappetein,
Patrick W. Serruys
Discussants: Vladimir Dzavik,
Marie-Claude Morice, David Taggart
Is PCI Appropriate for Up to 50% of
Patients with Left Main Disease?
9:23 am - Yes: Today and Tomorrow!
Marie-Claude Morice
9:33 am - Based on Today’s Evidence,
Most Patients with Left Main Disease
Should Go to the OR!
David Taggart
9:43 am - Ventricular Support for Unprotected
Left Main (and Other High-Risk PCI
Scenarios): Options and Indications
(Routine vs. Provisional)
Vladimir Dzavik
Session IV. Hybrid Treatment of Coronary
Artery Disease
Moderators: Johannes Bonatti, David Zimrin
Joseph J. DeRose, John D. Puskas,
Corrado Tamburino, Vinod H. Thourani
10:03 am - Rationale for Hybrid
Revascularization: The Best of Both Worlds?
Johannes Bonatti
60
program ·
10:13 am - Hybrid Revascularization:
Who Goes First?
Joseph J. DeRose
10:23 am - Antiplatelet Therapy for
Hybrid Revascularization
David Zimrin
10:33 am - The NIH Trial on Hybrid
Revascularization: Rationale, Design,
and Status Update
John D. Puskas
10:43 am - Concurrent Coronary Artery and
Valvular Heart Disease 1: Hybrid PCI with
Surgical Valves
Vinod H. Thourani
10:53 am - Concurrent Coronary Artery and
Valvular Heart Disease 2: Hybrid PCI with
Transcatheter Valves
Corrado Tamburino
11:03 am - The Hybrid Room: What Is It,
and Is It Necessary?
Michael J. Davidson
Session V. CAD Case Presentations: CABG,
PCI, Hybrid, or Medical Therapy?
(Multidisciplinary Panel)
Moderators: Johannes Bonatti,
Mathew Williams
Discussants: William E. Boden,
Joseph J. DeRose, William F. Fearon,
Gregory P. Fontana, Isaac George,
Jeffrey W. Moses, Robert S. Poston,
John D. Puskas, Robaayah Zambahari,
David Zimrin
11:25 am - Three Cases of Increasing Patient
and Anatomic Complexity
Isaac George
12:00 pm - Adjourn
Adjunct Pharmacology
TCT-150. Genetic Variants Affecting
Clopidogrel Metabolism Have Minor
Influence on Platelet Reactivity After Elective
Percutaneous Coronary Intervention
Andras Komocsi et al
TCT-151. Paraoxonase-1 (PON1) Activity
and PON1 Polymorphisms Have No Effect
on Platelet Reactivity in Patients Treated
with Clopidogrel
Jean-Pierre P. Dery et al
TCT-152. Pharmacodynamic Effect of
Double-Dose Clopidogrel vs. Adding
Dipyridamole In Patients with High
On-Treatment Platelet Reactivity
(ACCEL-DIP) Study
Yongwhi Park et al
TCT-153. CYP3A4 Genetic Status May Be
Associated with Increased Vulnerability to
the Adverse Effect of Calcium Channel
Blockers on Clopidogrel Response Variability
Jin Joo Park et al
TCT-154. Stopping Clopidogrel One-Year
After Drug-Eluting Stent (DES) Implantation:
Is It Safe?
Nalyaka Sambu et al
TCT-155. Genetic Determinants of Clopidogrel
Responsiveness in Koreans
Jin Joo Park et al
TCT-156. Safety of Dual Antiplatelet Therapy
in Patients Treated with Coronary DrugEluting Stents
Andrzej Drewnicki et al
TCT-157. Methods of Measurement of
Aspirin-Mediated Antiplatelet: Degree of
Correlation and Agreement Between Two
Point of Care: VerifyNow Aspirin Assay
and PFA-100
Jose Maria Cubero Gomez et al
Poster Abstract
Sessions and
Challenging Cases
Video Abstracts
TCT-158. Inhibition of Platelet Aggregation by
Prostaglandin E1 (PGE1) May Be Attenuated
in Diabetic Patients During Therapy with
Clopidogrel
Rolf P. Kreutz et al
8:00 am-10:00 am
Hall D
See page 166 for the poster abstracts map.
TCT-159. Recovery of Platelet Function After a
Loading Dose of Prasugrel or Clopidogrel in
Patients with Coronary Artery Disease
Isabell Bernlochner et al
Poster Session Moderators:
Michael J. Cowley, Raimund A. Erbel,
James R. Margolis, E. Magnus Ohman
Poster Session Discussants: Andrea Abizaid,
Vinay K. Bahl, Daniel H. Berrocal,
Graham A. Cassel, Leslie Cho, Roberto Corti,
David Erlinge, Marc D. Feldman,
Ioannis Iakovou, Henning Kelbaek,
Carey D. Kimmelstiel, Gervasio A. Lamas,
Guy LeClerc, Pedro A. Lemos,
Norman E. Lepor, Massimo Napodano,
Pedro R. Moreno, Juan C. Parodi,
Frederic S. Rensic, Peter H. Stone
TCT-160. High On-Treatment Platelet
Reactivity Measured by Various Platelet
Function Tests: Is the Current VASP-PRI
Cutoff Too Low?
Young-Hoon Jeong et al
TCT-161. Anemia Is a Major Predictor of
Decreased Platelet Response to Clopidogrel
Following Coronary Stenting
Catalin Toma et al
TCT2011
TCT-164. Impact of Bleedings on Prasugrel
Adherence in Real-World Patients
Guido Parodi et al
TCT-165. Response to Prasugrel in
ST-Elevation Myocardial Infarction Patients:
Is It as Rapid as We Expected?
Frédéric Casassus et al
TCT-166. Clinical Outcomes of Intracoronary
Eptifibatide Bolus-Only vs. Intracoronary
Bolus and Intravenous Infusion of
Eptifibatide in Primary Percutaneous
Coronary Intervention
Dinna K. Soon et al
TCT-167. Protease Activated Receptor-1
(PAR-1) Mediated Platelet Aggregation Is
Dependant on Clopidogrel Response
Rolf P. Kreutz et al
TCT-168. Adherence to Evidence-Based
Medical Therapy According to Management
Strategy in Patients with Acute
Coronary Syndrome
Samer Mansour et al
TCT-169. Safety and Efficacy for the Use
of Prasugrel in Patients Undergoing
Percutaneous Coronary Intervention and
Anticoagulated with Bivalirudin
Ana Laynez et al
TCT-170. Additive Pharmacodynamic Effects
of Double-Dose Clopidogrel According to
CYP2C19*2 vs. *3 Variant
TCT-171. Cytochrome P450 2C19
Loss-of-Function Genetic Variants but
Not Paraoxonase-1 Activity Modulate
P2Y12 Blockade in Response to
Clopidogrel Therapy
Arun Karunakaran et al
TCT-172. Long-term Dual Antiplatelet Therapy
in Patients Treated with Bare Metal Stent
Implantation: Results from the NHLBI
Dynamic Registry
Gopi Manthripragada et al
TCT-174. Low-Molecular-Weight Heparins vs.
Unfractionated Heparin in the Setting of
Percutaneous Coronary Intervention for
ST-Elevation Myocardial Infarction: A
Meta-analysis
Eliano P. Navarese et al
TCT-175. Evaluation of Dose Requirements
for Prolonged Bivalirudin Administration
in Patients with Renal Insufficiency
and Suspected Heparin-Induced
Thrombocytopenia
James W. Wisler et al
TCT-176. Access and Non-Access Site
Bleeding in Acute Coronary Syndrome
Patients Treated with a Novel Actively
Reversible Factor IXa Inhibitor: Results from
the RADAR Trial
Mauricio G. Cohen et al
TCT-177. In-Hospital and 30-Day Outcomes in
All-Comer Percutaneous Coronary
Intervention with Bivalirudin: Initial Report of
the Prospective EUROVISION Registry
Martial Hamon et al
TCT-178. Use of the REG1 Anticoagulation
System During PCI May Improve Bleeding
and Ischemic Complications Compared with
Heparin: A PCI Substudy from the Phase 2B
RADAR Trial
Thomas J. Povsic et al
TCT-179. Efficacy and Safety of Bivalirudin
Compared to Unfractionated Heparin in
Relation to the Use of “Preclose” Technique
Using the Perclose Vascular Closure Device
Among Patients Undergoing Balloon Aortic
Valvuloplasty
Shyam Poludasu et al
TCT-180. Patients with Acute Coronary
Syndrome Have Higher Levels of OnTreatment Platelet Reactivity
Michael A. Gaglia et al
TCT-181. Benefits of CD34 Antibody-Coated
Stent in Patients with High Risk for Bleeding
During Dual Antiplatelet Therapy
Miltiadis Papalexandris et al
TCT-182. On-Treatment Platelet Reactivity
Before Coronary Artery Bypass Surgery Is
Associated with In-Hospital Major Bleeding:
Results of a Prospective Evaluation
Gabriel L. Sardi et al
TCT-183. The Impact of Paraoxonase-1
Activity on the Incidence of Intrastent
Thrombus After Drug-Eluting Stent
Implantation in the Japanese CYP2C19*2
Carriers Receiving Clopidogrel
Ryo Nishio et al
TCT-184. Immobilized Recombinant Human
Tropoelastin on a Plasma-Activated
Coating Dramatically Enhances
Biocompatibility of Metal Alloys:
Implications for Coronary Stents
Martin Ng et al
TCT-185. Comparison of Bivalirudin vs.
Heparin During PCI in Patients
Receiving Prasugrel
Martial Hamon et al
- N o v e m b e r 8 , 2 0 11
TCT-163. Accelerated Platelet Inhibition After
Switching with Hydrophilic Statin in Patients
with Increased Platelet Reactivity During
Atorvastatin and Clopidogrel
Coadministration (ACCEL-STATIN) Study:
A Randomized, Parallel-Group Trial
TCT-173. The Association Between Duration
of Clopidogrel Therapy After Saphenous Vein
Graft Intervention and Long-term Death and
Amit Sachdeva et al
Tuesday
TCT-162. Ticagrelor Enhances Adenosineinduced Coronary Vasodilatory Responses in
Humans: Randomized, Double-Blind,
Placebo-Controlled, Crossover, SingleCenter Study Using Transthoracic Color
Doppler Echocardiography
Li-Ming Gan et al
Cardiovascular
Therapeutics
TCT-186. Combination Abciximab and tPA
Use with the Trellis-6 Peripheral Infusion
System for Thrombotic Occlusion of the
Superficial Femoral and Popliteal Arteries
Eric J. Dippel et al
TCT-187. The Utility and Safety of Bilivalirudin
in Out-Patient Peripheral Procedures
R. Stefan Kiesz et al
TCT-188. Long-term Outcomes in Patients
with Acetylsalicylic Acid Sensitivity
Undergoing a Novel Desensitization Protocol
Roberta Rossini et al
Bioabsorbable, Drug-Eluting,
and Bare Metal Stent Studies
TCT-192. Two-Year Patient Outcomes with the
Resolute Zotarolimus-Eluting Stent: Results
of the RESOLUTE International Registry
Jorge Belardi et al
TCT-193. Outcomes After Revascularization
with Everolimus- and Sirolimus-Eluting
Stents In Patients with Acute Coronary
Syndromes: A Substudy of the
SORT OUT IV Trial
Lisbeth Antonsen et al
TCT-194. Off-Label Use of Drug-Eluting Stent
with Biodegradable Polymer at Two Years
Gian Battista Danzi et al
TCT-195. Current Treatment and Outcome of
Coronary In-Stent Restenosis: Report from
the Swedish Angiography and Angioplasty
Registry (SCAAR)
Torsten Schwalm et al
TCT-196. Restenosis Pattern of Drug-Eluting
Stent: Impact of Stent Type and Timing
Noriyuki Ohashi et al
61
Tuesday, November 8
TCT-197. Multicenter, Prospective,
Randomized, Single-Blind, Consecutive
Enrollment Evaluation of the Elixir DESyne
BD Novolimus-Eluting Coronary Stent
System with Bioabsorbable Polymer
Compared to the Endeavor ZotarolimusEluting Coronary Stent System: Six Months
Alexandre Abizaid et al
TCT-198. The Impact of XIENCE V:
Everolimus-Eluting Coronary Stents on
Health Status in COURAGE-Like Patients
David R. Rutledge et al
TCT-199. ENERGY 1,000-Patient Registry
with a Thin Strut Bare Metal Stent with
Passive Coating Presenting Six Month
Follow-up MACE
Raimund Erbel et al
TCT-200. DES vs. MIDCAB for Proximal
LAD Disease: Long-term Registry Results
Piotr P. Buszman et al
TCT-201. Incidence of Periprocedural
Myocardial Infarction Following Stent
Implantation: Comparison Between First
and Second Generation Drug-Eluting Stents
Kenneth Tandjung et al
TCT-202. The Difference of Predictors for
Occurrence of Instent Restenosis in the
Underexpanded or Non-Underexpanded
Post-DES Implantation: An Intravascular
Ultrasound Analysis from Multicenter,
Randomized Trials
Ki-Woon Kang et al
TCT-203. No Difference In Long-term
Major Adverse Cardiac Event Rates
Between Paclitaxel-Eluting and SirolimusEluting Stents
James P. Howard et al
TCT-204. A Comparative Analysis of Major
Clinical Outcomes with Drug-Eluting
Stents vs. Bare Metal Stents in Male vs.
Female Patients
Ran Kornowski et al
TCT-205. The Nine-Month Outcomes of a
Polymer-Free Drug-Eluting Stent (YUKON)
Compared with Different Polymer Based
Drug-Eluting Stents in Real-World Coronary
Artery Lesions
Ted S. Trajceski et al
TCT-206. Real-World Comparison of Clinical
Outcomes of Patients Who Received New
Generation Platinum Chromium EverolimusEluting Stent vs. Cobalt Chromium
Everolimus-Eluting Stent
Ruogu Li et al
TCT-207. Interim Analysis of the IMOS
MGUARD International Registry
Chaim Lotan et al
62
program ·
TCT-208. Late Clinical Impact of
Postprocedural Incomplete Stent Apposition
and Late Acquired Incomplete Stent
Apposition After Deployment of ZotarolimusEluting Stent or Everolimus-Eluting Stent
Sang-Rok Lee et al
TCT-209. Drug-Eluting Stents in the Treatment
of Isolated Proximal LAD Disease Are
Associated with Similar Outcomes
Compared to Minimally Invasive LIMA Grafts
Daniel A. Jones et al
TCT-210. Low Incidence of Stent Thrombosis
in Asian Races: Multicenter Registry in Asia
Six-Year Follow-up Results
Sunao Nakamura et al
TCT-211. The SYNTAX Trial at Three Years: A
Global Risk Approach to Identify Patients
with Three-Vessel and/or Left Main Stem
Disease Who Could Safely and Efficaciously
Be Treated with Percutaneous Coronary
Intervention (Part 2): The All-Comers
SYNTAX Population
Vasim Farooq et al
TCT-212. Are Results from an All-Comers
Registry Comparable with the Results from
an All-Comers Randomized Clinical Trial?
Insights from 12-Month Results of the
e-BioMatrix PMS Registry
Philip Urban et al
TCT-213. Increased Tissue Stress Leads to
Increased Neointima Evaluated by Histology
and Computational Modeling
Chad Abunassar et al
TCT-214. Safety and Effectiveness of
Everolimus-Eluting Stents in 5,054 Patients
from a Large, Prospective, Real-World
Study: Two-Year Clinical Outcomes from the
XIENCE VÆ USA Study
Mitchell W. Krucoff et al
TCT-215. STEALTH I: Five-Year Follow-up
from a Prospective, Randomized Study of
Biolimus A9-Eluting Stent with a
Biodegradable Polymer Coating vs.
a Bare Metal Stent
Ricardo Costa et al
TCT-216. In-Hospital Experience of
“Real-World” Patients Enrolled in the
TAXUS Liberte Post-Approval Study:
The TAXUS Liberte Stent with Concomitant
Prasugrel Therapy
David P. Lee et al
TCT-217. Impact of Total Stent Length
per Patient and per Lesion on Five-Year
Clinical Outcomes
Shirai Shinichi et al
TCT-218. New Application of a LongExisting Index Score
Philip Urban et al
TCT-219. Prospective Evaluation of the Xience
V Everolimus-Eluting Stent In Saphenous
Vein Graft Atherosclerosis:
The Xience V-SVG Angiographic Study
Emmanouil S. Brilakis et al
TCT-220. Efficacy and Saftey of 38-mm-Long
Stent Treatment for Diffuse Coronary
Disease: A Multicenter Evaluation by
Angiography and OCT Analysis at One
Year After Implantation
Giuseppe Sangiorgi et al
TCT-221. Long-term Safety and Effectiveness
of Drug-Eluting Stents Compared to Bare
Metal Stents in Non-ST-Elevation Myocardial
Infarction: Findings from the Guthrie Health
Off-Label STent (GHOST) Registry
Sudhakar Sattur et al
TCT-222. Everolimus-Eluting Stents Show No
Stent Thrombosis with Similar One-Year
Outcomes Compared with First and Second
Generation Drug-Eluting Stents for the
Treatment of ST-Segment Elevation
Kyounghoon Lee et al
TCT-223. Complete Revascularization
and Clinical Outcomes of Patients with
Multivessel Disease
Jozef Bartunek et al
TCT-224. Coating Irreguralities of Drug-Eluting
Stents as Assessed by Scanning Electron
Microscopy
Takeshi Ijichi et al
TCT-225. Safety and Efficacy of the Xience
Everolimus-Eluting Stent Compared to
First-Generation Drug-Eluting Stents in
Contemporary Clinical Practice
Israel M. Barbash et al
TCT-226. Five-Year Survival After
Percutaneous Coronary Intervention with
Drug-Eluting Stents and Bare Metal Stents
in All-Comers: A New Jersey Statewide
Database Study
Tudor Vagaonescu et al
TCT-227. Validation of Age, Creatinine,
and Ejection Fraction Score as a Risk
Assessment Tool in Patients Undergoing
Stent Implantation During Percutaneous
Coronary Intervention: A Report from the
Dynamic Registry of the National Heart,
Lung, and Blood Institute
Hiroya Nambu et al
TCT-228. Four-Year Follow-up of the SYNTAX
Trial: Optimal Revascularization Strategy in
Patients with Three-Vessel Disease and/or
Left Main Disease
David R. Holmes et al
TCT2011
TCT-231. One-Year Results of the
Multicenter, Double-Blinded, Randomized,
VESTAsync II Trial
Jose De Ribamar Costa et al
TCT-232. Impact of Stent Size and Length
on Neointimal Hyperplasia After Resolute
Zotarolimus-Eluting Stent Implantation:
Insights from the RESOLUTE Trials
Ryotaro Yamada et al
TCT-233. First-in-Man IVUS Findings of the
Prohealing PROTEX Coronary Stent System
for the Treatment of Coronary
Artery Disease
Kenji Sakata et al
TCT-234. Vascular Healing After Endothelial
Progenitor Cell Capturing Stent Implantation
at 30 Days
Tuomas Lehtinen et al
TCT-235. Evaluation of Neointimal Healing
of EPC-Capturing Sirolimus-Eluting COMBO
Stent by Optical Coherence Tomography:
The EGO-COMBO Pilot Study
(Interim Results)
Stephen W. Lee et al
TCT-236. Twelve-Month Clinical Efficacy
and Safety of Zotarolimus- vs.
Everolimus-Eluting Stents in a Series
of Asian Population
SunWon Kim et al
TCT-237. Two-Year Outcomes of a PropensityMatched Comparison of the ION and TAXUS
Liberte Paclitaxel-Eluting Stents
Dean J. Kereiakes et al
TCT-238. Proximal and Distal Maximal Luminal
Diameters (Dmax) as a Guide to Appropriate
Deployment of the Everolimus-Eluting
Bioresorbable Vascular Scaffold: A Substudy
of the ABSORB Cohort B and Ongoing
ABSORB EXTEND Single-Arm Study
Vasim Farooq et al
TCT-239. Final Results of the SVELTE Trial
with the Novel Acrobat Balloon-Expandable
SOAW Coronary System
TCT-240. Platinum Chromium EverolimusEluting Stent in Long Coronary Lesions
Paul S. Teirstein et al
TCT-242. First Report of a Novel Abluminal
Groove-Filled Biodegradable Polymer
Rapamycin-Eluting Stent in De Novo
Coronary Artery Disease: Results of the
First-in-Man FIREHAWK Trial
Bo Xu et al
TCT-243. Six-Month Clinical and Angiographic
Results of the BIOSOLVE-I with the
Drug-Eluting Absorbable Metal Scaffold
Michael Haude et al
TCT-244. Bioadhesive, Drug-Impregnated Thin
Films for Vascular Restenosis Treatment
Terry W. Steele et al
TCT-245. ABSORB Cohort B Trial: Two-Year
Clinical and Angiographic Results of the
ABSORB Bioresorbable Everolimus-Eluting
Vascular Scaffold
John Ormiston et al
TCT-246. Differences in Cardiovascular
Risk Factors and Clinical Outcomes
Between Western European and Southeast
Asian Patients Treated with the EPC
Capturing Stent: A Substudy of the
e-HEALING Registry
Margo Klomp et al
TCT-247. Preliminary Data from ABSORB
EXTEND: A Report of the Six-Month
Clinical Outcomes from the First 200
Patients Enrolled
Alexandre Abizaid et al
TCT-248. Predictors of Adverse Cardiac
Events After PCI with GENOUS EPC-Coated
Stents Compared to Drug-Eluting Stents
Boris Rudenko et al
TCT-249. DESSOLVE I FIH Trial of the MiStent
DES: Sirolimus-Eluted from an
Absorbable Polymer on a Thin Strut
Stent Is Highly Efficacious
John Ormiston et al
TCT-250. An All-Comers Randomized Trial
Comparing Xience Prime and Promus
Element Stents: Preliminary Results
Jose M. De la Torre Hernandez et al
TCT-251. Comparison of Polymer-Free
BioFreedom Stents with Durable Polymer
Taxus Liberte Stents: Two-Year Results from
the BioFreedom First-in-Man Trial
Eberhard Grube et al
TCT-252. Proof-of-Concept Experience with
the Acrobat Svelte Stent-on-a-Wire System
in Complex Coronary Interventions:
A Multicenter European Pilot Study, the
“PEACE” Study
Ahmed Rezq et al
TCT-253. Long-term Luminal Change After
Drug-Eluting Stent Implantation: Serial
Angiographic Follow-up Study of the
ZEST Randomized Trial
Gyung-Min Park et al
TCT-254. Lipoprotein(a) Level and Two-Year
Clinical Outcomes in Patients Undergoing
Drug-Eluting Stents
Sang-Ho Park et al
- N o v e m b e r 8 , 2 0 11
TCT-230. BIOSOLVE-I Optical Coherence
Tomography (OCT) Results of Cohort 1 with
the First Drug-Eluting Absorbable Metal
Scaffold (DREAMS)
Jacques Koolen et al
TCT-241. NOYA I: A Prospective, Randomized
Trial of NOYA Sirolimus-Eluting Stent with
Biodegradable Coating Compared to
FIREBIRD 2 Sirolimus-Eluting Stent with
Durable Coating in Patients with Coronary
Artery Disease
Kefei Dou et al
Tuesday
TCT-229. First Report of a Novel Polymer-Free
Dual-Drug-Eluting Stent in De Novo
Coronary Artery Disease: Results of the
First-in-Man BICARE Trial
Mengyue Yu et al
Cardiovascular
Therapeutics
TCT-255. Impact of ApoB/ApoA-I Ratio on
Two-Year Clinical Outcomes in Patients
Undergoing Percutaneous Coronary
Intervention with Drug-Eluting Stents
Sang-Ho Park et al
TCT-256. Use of the HearTrial Catheter as a
Distal Stent Delivery Device
Darragh P. Moran et al
TCT-257. Long-term Follow-up of the Platinum
Chromium TAXUS Element (ION) Stent:
PERSEUS Two-Year Results
Louis A. Cannon et al
TCT-258. Applying the National Institute for
Clinical Excellence Criteria to Patients
Treated with the Genous EPC-Capturing
Stent: A Substudy of the e-HEALING
Worldwide Registry
Margo Klomp et al
TCT-259. Response of Endothelial Progenitor
Cells to Antiproliferative Drugs Currently
Used in Drug-Eluting Stents
Hao Xu et al
TCT-260. Drug-Eluting Stent Failure: Report
from the Swedish Angiography and
Angioplasty Registry (SCAAR)
Torsten Schwalm et al
TCT-261. Long-term Clinical Outcomes
from the Zotarolimus-Eluting Stent Program:
Final Five-Year Pooled Results from the
ENDEAVOR Program
David E. Kandzari et al
TCT-262. Serial Angiographic Follow-up After
Successful Implantation of Sirolimus-,
Paclitaxel-, Everolimus-, and ZotarolimusEluting Stents for Chronic Total Occlusions:
Multicenter Registry in Asia
TCT-263. Elevated Preprocedural HighSensitive CRP Levels Are Associated with
Uneven Vessel Healing After PaclitaxelEluting Stents Implantation in Patients with
Stable Angina
Hiromasa Otake et al
63
Tuesday, November 8
TCT-264. Twelve-Month Clinical
Outcomes After Coronary Stenting with
the Genous Bioengineered R Stent in
Patients with a Bifurcation Lesion from
the e-HEALING Registry
Pier Woudstra et al
TCT-275. Three-Year Outcomes of Chronic
Total Occlusion Treatment with BiolimusEluting Biodegradable Polymer Stent vs.
Sirolimus-Eluting Permanent Polymer Stent
In the LEADERS All-Comers Trial
Joanna J. Wykrzykowska et al
TCT-287. Multicenter Clinical Trial with
Everolimus-Eluting Stent for the Treatment
of Bare Metal In-Stent Restenosis:
Immediate and Long-term Clinical
and Angiographic Outcomes
Didier Carriè et al
TCT-265. Impact of Stent Fracture on Stent
Thrombosis After Drug-Eluting Stent and
Bare Metal Stent Implantations
Shunsuke Kubo et al
TCT-276. New Generation Drug-Eluting Stent
Nobori: Two-Year Clinical Outcome of
Patients with Chronic Total Occlusion
Bernard Chevalier et al
TCT-288. Serial Morphological and Functional
Assessment of In-Stent Restenosis Treated
with Drug-Eluting Balloon
Anouar Belkacemi et al
TCT-266. Impact of Stent Length in Diffuse
Coronary Disease on Clinical Outcome
After Zotarolimus-Resolute-Eluting Stent
Implantation: An Italian Multicenter
Observational Evaluation
Claudio Larosa et al
TCT-277. Effect of Coronary Revascularization
for Chronic Total Occlusions on Long-term
Prognosis: Analysis of 585 Patients
Mikhail A. Maslennikov et al
TCT-289. The Pacifier Trial: A Randomized,
Multicenter Trial Evaluating Prevention of
Restenosis with Paclitaxel-Coated PTA
Balloon Catheters in Stenosis or Occlusion
of Femoropopliteal Arteries: First Report
Michael Werk et al
TCT-267. No Recovery of Drug-Eluting Stent
Use in Clinical Practice in Europe After the
Collapse Following Initial Reports of
Impaired Outcomes in September 2006:
Results of The Euro Heart Survey
PCI-Registry
Anselm K. Gitt et al
TCT-268. Eight-Year Clinical Outcomes
After Unrestricted Sirolimus-Eluting
Stent Implantation for Severe Coronary
Artery Disease
Alfonso Ielasi et al
Chronic Total Occlusions
TCT-270. Multicenter Chronic Total Occlusion
Intervention Experience in Korean
Population: Korean Perspectives
from Korean e-CTO Club
Seung Woon Rha et al
TCT-271. Impact of Multislice Computed
Tomography in Evaluating Micro-Channels in
Coronary Chronic Total Occlusion Lesions
Prior to Percutaneous Coronary Intervention
Masashi Kimura et al
TCT-272. Impact of Stent Length on
Long-term Clinical Outcomes of SirolimusEluting Stent Implantation for Chronic Total
Occlusion
Hiroyuki Tanaka et al
TCT-273. Elective Stenting After Subintimal
Tracking and Reentry (Star) Technique in
Coronary Chronic Total Occlusions
Gabriella Visconti et al
TCT-274. Prognostic Impact of a Chronic Total
Occlusion in a Non-Infarct-Related Artery in
Patients with ST-Elevation Myocardial
Infarction: Three-Year Results from the
HORIZONS-AMI Trial
Bimmer E. Claessen et al
64
program ·
TCT-278. Short- and Long-term Clinical
Outcomes After Percutaneous Coronary
Intervention in Patients with Chronic Total
Occlusions: Results from a Multicenter,
Prospective Study
Shao-Liang Chen et al
TCT-279. Impact of Lesion Length on Chronic
Total Occlusion Intervention Outcomes
Amro Elnagar et al
In-Stent Restenosis and
Drug-Eluting Balloons
TCT-281. Three Different Strategies for
Restenosis with Stent Fracture After
Sirolimus-Eluting Stent Implantation:
POBA vs. DES vs. DEB
Suguru Otsuru et al
TCT-282. Practice of Treatment of In-StentStenosis in PCI for ACS in Clinical Practice
in Europe: Results of the EHS PCI Registry
TCT-283. Impact of Initial Procedure and
Revascularization Strategy on the Treatment
of Drug-Eluting Stent Restenosis Following
Unprotected Distal Left Main PCI: The Milan
and New-Tokyo Registry
Kensuke Takagi et al
TCT-284. Paclitaxel-Eluting Balloon
Catheter vs. Repeat Sirolimus-Eluting Stent
for the Treatment of Sirolimus-Eluting Stent
Restenosis
Seiji Habara et al
Left Main and
Bifurcation Stenting
TCT-290. Challenging Bifurcation Stenting:
Clinical Outcomes at Two Years
Bernard Chevalier et al
TCT-291. Coronary Artery Bifurcation Stenting
Using a Dedicated Sidebranch Stent
Combined with DES (Facilitated Culottes):
Two-Years Clinical Outcomes
Solomon D. Asgedom et al
TCT-292. Use of a Dedicated Sidebranch
Device for Bifurcation Disease: A SingleCenter Experience of the TRYTON Stent
Michael Norell et al
TCT-293. Advanced Bifurcation Systems
Mother-Daughter Platform in Complex
Coronary Bifurcations: Prospective,
Multicenter First-in-Man Experience
Mehran J. Khorsandi et al
TCT-294. Acute Procedural Outcome in
Patients Treated with a Dedicated
Bifurcation Stent for Left Main Stem
Disease: The TRYTON LM
Multicenter Registry
Michael Magro et al
TCT-295. Crush vs. Culotte for the Treatment
of Coronary Bifurcations: Insights from a
Long-term Follow-up
Xavier Freixa et al
TCT-285. Incidence of Acute Thrombosis After
Paclitaxel-Eluting Balloons in a Clinical
Setting and in Clinical Trials
Klaus Bonaventura et al
TCT-296. Comparison of Ostial and
Crossover Drug-Eluting Stent Implantation
Technique for Medina (0,1,0) and (0,0,1)
Bifurcated Lesion
Yasunari Sakamoto et al
TCT-286. Paclitaxel-Eluting Balloon for High
Risk Coronary Lesions: One-Year Clinical
Results with Angiographic Follow-up of
a Multicenter Registry
Beatriz Vaquerizo et al
TCT-297. Periprocedural Myocardial Infarction
Is Not Associated with Increased Risk of
Long-term Cardiac Mortality After Coronary
Bifurcation Stenting: Result from the COBIS
Registry
Pil Sang Song et al
TCT2011
TCT-300. Procedural Outcomes from
the European Sideguard Registry
Azeem Latib et al
TCT-301. Sequential Sidebranch and
Main Vessel Dilatation Instead of Kissing
Balloon After Provisional Bifurcation
Stenting: Lessons from Micro-CT and
Computational Simulations
Nicolas Foin et al
TCT-302. Long-term Follow-up of SirolimusEluting Stent (SES) Implanted in Coronary
Bifurcation Lesion: Insight from
OCT Observations
Hirotoshi Hariki et al
TCT-303. Favorable Long-term Clinical
Outcomes of Intravascular UltrasoundGuided Provisional Single-Stent Strategy for
Feasible Unprotected Left Main Trunk
Distal Bifurcation Lesions
Takayoshi Toba et al
TCT-304. True Bifurcation: A Special Subeset?
Mario Bollati et al
TCT-305. Left Main Percutaneous Coronary
Intervention in Spain: The National
Registry RENACIMIENTO
Augustin Albarran G. Trevilla et al
TCT-306. Use of the Novel Sideguard
Dedicated Bifurcation Stent:
A Real-World Experience
Mamas Mamas et al
TCT-307. Impact of Acute Coronary Syndrome
on Clinical Outcomes in Patients with
Coronary Bifurcation Lesions Treated with
Drug-Eluting Stents.
Pil Sang Song et al
TCT-308. Left Main Bifurcation Stenting:
Long-term Follow-up of Simultaneous
Kissing Stents in 140 Consecutive,
Unselected Patients
Julian Gunn et al
TCT-309. Outcomes Following Unprotected
Left Main Stenting with Everolimus-Eluting
Stents: The Milan Experience
Gill L. Buchanan et al
TCT-310. Treatment of Bifurcations with the
Dedicated Sideguard Nitinol Stent
Compared with Conventional
Two-Stent Strategies
Nicolas Foin et al
TCT-312. Effect and Mechanisms of Coronary
Bifurcation Angle from 3-D on Clinical
Outcomes After Percutaneous Treatment
with Stents: Results from DKCRUSH-II Trial
TCT-313. Clinical Outcomes of Left Main
Crossover Stenting Without Opening of
Left Circumflex Coronary Artery
Homyung Lee et al
TCT-314. Predictive Factors of Long-term
Outcomes After Crush Technique for
Bifurcation Coronary Lesions
Hae-Geun Song et al
TCT-315. Acute Myocardial Infarction Due to
Unprotected Left Main Coronary Artery
Occlusion Treated with Primary Angioplasty
Ivan Gomez et al
TCT-316. First Generation vs. Newer
Generation Drug-Eluting Stents in
Unprotected Left Main Coronary
Artery Intervention
Amro Elnagar et al
TCT-317. The SYNTAX Trial at Three Years:
A Global Risk Approach to Identify Patients
with Three-Vessel and/or Left Main Stem
Disease Who Could Safely and
Efficaciously Be Treated with
Percutaneous Coronary Intervention (Part 1):
The Randomized Population
Patrick W. Serruys et al
TCT-318. Bench Micro-CT Study and
OCT Experience of a Final Proximal
Postdilatation to Optimize Results in
Nicolas Foin et al
TCT-319. Left Main to Left Anterior
Descending Artery or Left Main to Circumflex
Stenting? This Is the Question
Marco Di Cuia et al
TCT-320. Natural History of Unprotected
Sidebranch Jailed by Drug-Eluting Stent
Masahiro Yamawaki et al
TCT-321. Computational Analysis of Wall
Shear Stress at the Distal Left Main
Coronary Artery Bifurcation
Wang Soo Lee et al
TCT-322. Inmediate and Midterm Results
of the E-Tryton Spanish Registry for the
Treatment of Bifurcations Lesions
Eulogio Garcia et al
TCT-323. Five-Year Outcomes of SirolimusEluting Stent in Patients with Unprotected
Left Main Coronary Arteries: The Milan and
New-Tokyo Registry
Kensuke Takagi et al
TCT-324. Five-Year Results of Treatment of
Unprotected Left Main Stenosis by CABG
or PCI with Sirolimus-Eluting Stent:
A Multicenter, Randomized Trial
Enno Boudriot et al
- N o v e m b e r 8 , 2 0 11
TCT-299. Clinical Outcomes of Periprocedural
Myocardial Infarction After Intracoronary
Stent Implantation for Bifurcation Lesion:
Results from Coronary Bifurcation Stenting
Registry (COBIS)
Keun-Ho Park et al
TCT-311. Healing Responses After Bifurcation
Stenting with the Dedicated TRYTON
Sidebranch Stent in Combination with
XIENCE V Stents: An Angiography and
Optical Coherence Tomography Study
Christophe L. Dubois et al
Tuesday
TCT-298. Ischemia Detection by Intracoronary
ECG After Stent Implantation in Coronary
Bifurcation Lesions
Dobrin Vassilev et al
Cardiovascular
Therapeutics
STEMI Intervention
TCT-328. Long-term Outcome After
Titanium-Nitride-Oxide-Coated Stents vs.
Paclitaxel-Eluting Stents in Acute Myocardial
infarction: A Five-Year Follow-up of the
TITAX-AMI Trial
Petri O. Tuomainen et al
TCT-329. Prolonged Bivalirudin Infusion Is
Associated with Enhanced ST-Segment
Resolution Following Primary Percutaneous
Bernardo Cortese et al
TCT-330. DES vs. BMS in Large
Coronary Arteries During Primary PCI
Eva C. Sammut et al
TCT-331. Predictors and Prognostic
Consequence of Gastrointestinal
Bleeding in Patients with ST-Elevation
Wouter J. Kikkert et al
TCT-332. Four-Year Cardiovascular Event
Rates Were Lower in Myocardial Infarction
Patients with Early Increases in Mobilization
of Oct-4-High Nanog-High Stem Cells
Soon Jun Hong et al
TCT-333. Impact of Positive Thrombus
Retrieval During Primary Percutaneous
Coronary Intervention with
Thrombectomy on Infarct Size and
Microvascular Obstruction
Romain Chopard et al
TCT-334. Equivalent Improvement of
Cardiac Function After Delayed Reperfusion
By Primary Percutaneous Coronary
Intervention for ST-Segment Elevation
Shinichiro Yamada et al
TCT-335. Clinical Outcomes of Primary
Percutaneous Coronary Intervention In
Elderly vs. Younger Patients Presenting with
Acute Myocardial Infarction
(From the KAMIR)
Jin Hee Choi et al
TCT-336. Patient Differences by Mode of
Hospital Arrival for ST-Elevation Myocardial
Infarction Treated with Primary PCI
Robert S. Lee et al
65
Tuesday, November 8
TCT-337. Does the Increase in Mortality in
Patients with Acute Myocardial Infarction
Admitted on Weekends Still Exist?
Abhishek Deshmukh et al
TCT-338. Associations Between Symptom-toDoor Time and Biomarkers on 12-Month
Mortality in Patients with Acute
Myocardial infarction
Jang Hoon Lee et al
TCT-339. Transradial Intervention Procedure
for Unshock, ST-Segment Elevation
Myocardial Infarction Patients with
Palpable Radial Artery
Hung M. Ngo et al
TCT-340. Efficacy and Safety of
The MGuard Stent in Primary Percutaneous
Coronary Intervention for ST-Elevation
Prodromos Anthopoulos et al
TCT-341. Prognostic Consequence of
Periprocedural Hemoglobin Decrease
With and Without Observed Blood Loss in
Patients with ST-Elevation Myocardial
Infarction Undergoing Primary Percutaneous
Wouter J. Kikkert et al
TCT-342. Accuracy of Acef, EuroScore
and Syntax Score in Risk Stratification of
Elderly (≥70 Years) Patients Undergoing
Primary Angioplasty
Flavia Ballocca et al
TCT-343. In-Hospital Mortality of Patients
Undergoing Primary Percutaneous Coronary
Intervention: Validation of the EuroHeart
STEMI PCI Score
Ana Belen Cid Alvarez et al
TCT-344. Postdischarge Bleeding and
Thienopyridine Discontinuation Among AMI
Patients Treated with PCI: Insights from the
TRANSLATE-ACS Study
Tracy Y. Wang et al
TCT-345. Impact of the Novel Mobile
Telemedicine System in Realtime
Transmission of Prehospital 12-Lead
ECG for ST-Segment Elevation Acute
Nobuhtio Yagi et al
TCT-346. Routing Angioplasty After
Fibrinolytic Therapy for ST-Segment
Elevation Myocardial Infarction: An Updated
Meta-analysis (RAFT-STEMI)
Jose Donato A. Magno et al
TCT-347. The Impact of Symptom-to-Door
Time and Door-to-Balloon Time on 12-Month
Mortality in Patients Undergoing Primary
Percutaneous Coronary Interventions for
Jang Hoon Lee et al
66
program ·
TCT-348. Temporal Trends in Treatment
and Outcomes of Patients with ST-Segment
Elevation Myocardial Infarction in
Clinical Practice: Analysis from the
PL-ACS Registry
Lech Polonski et al
TCT-349. Monocyte Platelet Aggregate Act
as Platelet Function Assay and Prognostic
Marker for Acute Myocardial Infarction
Ho Lam et al
TCT-350. Very Late Hazard with Primary
Stenting vs. Primary PTCA for STEMI:
A 16-Year Single-Center Experience
Bruce R. Brodie et al
TCT-351. Impact of Bleeding on Mortality
in Patients Referred for Primary PCI
Michel Le May et al
TCT-352. Prior Coronary Artery Bypass Graft
(CABG) Patients Treated with Primary
Percutaneous Coronary Intervention (PPCI)
Have Higher Long-term Major Adverse
Cardiovascular Event (MACE) Rates
Mohammed M. Akhtar et al
TCT-353. Time-to-Treatment and Infarct
Size in STEMI Patients Undergoing
Primary Angioplasty
Guido Parodi et al
TCT-354. Impact of Prehospital Activation
Strategy on Revascularization Time, Left
Ventricular Ejection Fraction, and Mortality
in Patients with ST-Elevation
Sofia A. Horvath et al
TCT-355. Does Thrombus Extraction from
IRA During Rescue PCI After Prehospital
Thrombolysis Improve Early and Midterm
Follow-up in STEMI Patients?
Anton Koledinsky et al
TCT-356. Reperfusion Delay in Patients with
ST-Elevation Myocardial Infarction
Presenting to Hospitals Without Angioplasty
Capability: Should “Door-to-Ambulance”
Time Be The New Quality Parameter?
Kishore Harjai et al
TCT-357. Incidence and Predictors of Definite
Stent Thrombosis After Primary
for Acute Myocardial Infarction in
“Real-World” Patients
Ivan Gomez et al
TCT-358. Infarct Size Evaluation in Multidevice
Thrombus Aspiration Study
Elena Guerra et al
TCT-359. Prognostic Value of the Syntax
Score in Patients Undergoing Primary
Ana Belen Cid Alvarez et al
TCT-360. Use of Thrombectomy Devices in
Primary Percutaneous Coronary Intervention
Neville Kukreja et al
TCT-361. Safety and Efficacy of
Biodegradable vs. Durable Polymer
Drug-Eluting Stents: Evidence from a
Meta-analysis of Randomized Trials
Eliano P. Navarese et al
TCT-362. The Impact of LV Function on
the Mortality of Patients Undergoing
Transcatheter Aortic Valve Implantation
Yacine Elhmidi et al
TCT-363. Cerebrovascular Events in Patients
with ST-Segment Elevation Myocardial
Infarction Undergoing a Primary PCI
Management Strategy: Analysis from the
HORIZONS-AMI Trial
Eugenia Nikolsky et al
TCT-364. The Association of Preinfarction
Angina, Preprocedural Thrombolysis in
Myocardial Infarction Flow, and Collateral
Flow with Myocardial Salvage in Patients
with ST-Segment Elevation Myocardial
Infarction
Jacob T. Lønborg et al
TCT-365. Primary Percutaneous Coronary
Intervention with Off-Site Cardiac Surgery
Backup in Unselected Patients with
ST-Segment-Elevation Myocardial Infarction:
The RIvoli ST-Segment Elevation Myocardial
Infarction (RISTEMI) Registry
Francesco Tomassini et al
TCT-366. Prognostic Role of Thrombus
Aspiration and GP IIb/IIIa Inhibitors During
Stylianos A. Pyxaras et al
TCT-367. Quantitative Proteomic Approach
for Identification of Differentially Expressed
Proteins After Primary Percutaneous
Coronary Intervention in ST-Segment
Elevation Myocardial Infarction
Sergio Alonso-Orgaz et al
TCT-368. Copeptin: An Ultra Early Prognostic
Marker for Acute Myocardial Infarction
Ho Lam et al
TCT-369. Prognosis After Primary
ST-Elevation Myocardial Infarction Is
Predicted by Extent and Complexity of
Coronary Artery Disease as Assessed by
the Syntax Score
Adam J. Brown et al
TCT-370. Door-to-Balloon Time and
Long-term Clinical Outcome in Patients with
STEMI Undergoing Primary PCI in Japan
Hiroki Shiomi et al
TCT2011
TCT-373. Influence of Acute Myocardial
Infarction on the Incidence and Outcome of
Early Surgical Procedure After Coronary
Stent Implantation: A Report from the
CREDO-Kyoto Registry Cohort 2
Akihiro Tokushige et al
TCT-374. Twelve-Month Mortality of NSTEMI
Patients Treated by PCI with Multivessel
Disease and Chronic Total Occlusions:
Analysis from the PL-ACS Registry
Mateusz Tajstra et al
TCT-375. Select EKG Characteristics
Predict Door to Balloon Time In Primary
PCI for STEMI
Rajinder S. Marok et al
TCT-376. Relationship Between Elevated
BNP Levels in STEMI and Clinical Outcomes:
The HORIZONS-AMI Trial
Rudolf Jarai et al
TCT-377. The Impact of the Location of a
Chronic Total Occlusion in Conjunction with
the Location of the Infarct Related Artery on
Long-term Mortality in ST-Elevation
Myocardial Infarction Patients
Loes P. Hoebers et al
TCT-379. Routine Thrombus Aspiration and
Glycoprotein Inhibitor Use During Primary
ST-Elevation Myocardial Infarction: Do All
Patients Benefit?
Liam M. McCormick et al
TCT-380. No Difference in Periprocedural
Myocardial Infarction Between Direct
Stenting and Balloon Predilatation
During Elective Percutaneous
Gabriel L. Sardi et al
TCT-381. Improvement of Early Invasive
Treatment for NSTE-ACS Over Time in
Clinical Practice in Europe: Results of
the EHS ACS Registry
Unstable Angina and
NSTEMI Intervention
TCT-382. Influence of Chronic Pulmonary
Disease on In-Hospital Outcome in 21,576
Patients with Acute Coronary Syndromes:
Data from Euro Heart Survey ACS III
Registry (2006-2008)
Wojciech Wojakowski et al
TCT-384. Incidents and Types of Ischemic
Events Detected Using Permanent
Intracardiac ST-Segment Monitoring:
First-in-Human Experience
TCT-385. Thrombus Aspiration vs. Local
Intracoronary Delivery of Abciximab In
Acute Coronary Syndromes: An OCT Study
Fabrizio Imola et al
TCT-386. Admission Electrocardiogram
Analysis for the Prediction of Long-term
Outcomes After Non-ST-Elevation Acute
Coronary Syndrome
Peter Damman et al
TCT-387. Prognosis of Patients Presenting
with Acute Coronary Syndromes with
Elevated Serum Troponins and
Nonobstructive Coronary Artery
Disease: The ACUITY Trial
David Planer et al
TCT-388. A “Direct” Transfer Protocol for
Patients with Non-ST-Elevation
Myocardial Infarction Reduces Time
to Coronary Angiography
Sean Gallagher et al
TCT-389. Are Adverse Events Following an
Invasive Strategy in Patients with Non-STSegment Elevation Acute Coronary
Syndromes (NSTEACS) More Frequent
at US Sites vs. Non-US Sites (OUS)?
Analysis from the ACUITY Trial
Patrick Tobbia et al
PCI Outcomes
TCT-390. A Prospective Appropriate Use
Criteria Tool Aids Revascularization
Decision-Making in the Catheterization
Laboratory
Michael A. Wilson et al
TCT-391. Red Blood Cell Transfusion and
Long-term Major Adverse Events in Patients
Interventions: Results from a Large
Prospective Multicenter Registry—the
STENT Group
Hiroki Ito et al
TCT-392. The Frequency and Etiology of
Readmission in the 30 Days After
Gregory W. Yost et al
TCT-393. Incidence, Predictors, and
Long-term Clinical Outcomes of Coronary
Perforation in the Modern Era
Samer Mansour et al
TCT-394. Early and Long-term Results After
Five-Hour Discharge Percutaneous
Coronary Interventions
TCT-395. Study Modifications and
Primary Endpoint Reinterpretations
Prior to FDA Approval of High-Risk
Cardiovascular Devices
Sanket S. Dhruva et al
TCT-396. Percutaneous Coronary Intervention
in Patients with Severe Left Ventricular
Dysfunction: A Meta-analysis of 19 Studies
Vijay Kunadian et al
- N o v e m b e r 8 , 2 0 11
TCT-372. Prehospital ECG Triage Strategy vs.
Interhospital Transfer for STEMI
Albert Chan et al
TCT-383. Effect of Chronic Use of Vitamin K
Antagonists on In-Hospital Outcomes of
Patients Presenting with Acute Coronary
Syndromes: Data from 19,000 Patients
from EuroHeart Survey ACS III
Registry (2006-2008)
Wojciech Wojakowski et al
Tuesday
TCT-371. Frequency and Predictors of
Drug-Eluting Stents Implantation in Patients
with Acute Myocardial Infarction: Analysis
from the PL-ACS Registry
Marek Gierlotka et al
Cardiovascular
Therapeutics
TCT-397. Statin Therapy Reduces Late Target
Lesion Revascularization After SirolimusEluting Stent Implantation
Masahiro Natsuaki et al
TCT-398. Married Patients Suffer Less Death
and Myocardial Infarction After
Michael A. Gaglia et al
TCT-399. Pressure-Controlled Intermittent
Coronary Sinus Occlusion (PICSO): Results
From the First-in-Man Prepare PICSO
Pilot Study
Tim P. van de Hoef et al
TCT-400. Correction of Anemia During
Follow-up Periods Improves Clinical
Outcomes in Patients Who Underwent
Drug-Eluting Stents
Pum-Joon Kim et al
TCT-401. Determining a Troponin I
Threshold for Predicting 30-Day Mortality:
Results from the Troponin I In the
Emergency Room (TiER) Study
Saman Fakheri et al
TCT-402. Regular Exercise Improve FMD,
Carotid IMT, and EPC in PCI Patients
Je Sang Kim et al
TCT-403. Could Mean Platelet Volume Be a
Predictive Marker for One-Year Clinical
Outcomes in Patients Who Underwent
Percutaneous Coronary Intervention?
Cheol Ung Choi et al
TCT-404. Age and Five-Year Outcomes After
a Routine or Selective Invasive Strategy
for Non-ST-Segment Elevation Acute
Coronary Syndromes
Peter Damman et al
TCT-405. Rotational Atherectomy Following
by Second Generation Drug-Eluting Stents
Implantation Against Heavily Calcified
Coronary Lesions
Munetaka Yamaguchi et al
67
Tuesday, November 8
TCT-406. Syntax Score Does Not Add
to Clinical Risk Score in a Typical
PCI Population
Julian Gunn et al
Heart Disease in Women
TCT-416. Female Patients with
Acute Coronary Syndrome: Two-Year
Clinical Outcomes
Philip Urban et al
TCT-417. Gender-Specific Outcomes After
Paclitaxel-Eluting Stent Implantation in
Japanese Patients with Coronary Artery
Disease: A Subanalysis of Japan TAXUS
Express2 Postmarketing Survey
Hiroyuki Okura et al
TCT-418. Bivalirudin Use During Percutaneous
Coronary Intervention Improves Clinical and
Economic Outcomes in Diabetic Women
Erin M. Galbraith et al
TCT-419. Outcomes of Women After Acute
Myocardial Infarction: Results from the
HORIZONS-AMI Study
Jennifer Yu et al
TCT-420. Predictors of Major Adverse Events
in Female Patients with Acute Myocardial
Infarction Undergoing Primary PCI:
Three-Year Results from the
HORIZONS-AMI Study
Jennifer Yu et al
TCT-421. The SPIRIT WOMEN Single
Arm Study: Two-Year Follow-up Results
Marie-Claude Morice et al
TCT-422. Nonatherosclerotic Coronary
Artery Disease in Young Women
Jacqueline Saw et al
TCT-423. Higher Rates of Repeat
Revascularization in Young Women
Intervention: Results from the NHLBI
Dynamic Registry
Kelly C. Epps et al
TCT-424. Do Women Continue to Have
Longer Door-to-Balloon Times in the Era
of STEMI Systems?
Melissa Blondeau et al
Heart Disease in Diabetics
TCT-426. Diabetes Mellitus Requiring Insulin
and High Residual Platelet Reactivity After
Clopidogrel Loading Dose Are Predictors of
Long-term Clinical Outcome in Patients with
Acute Coronary Syndrome: The RECLOSE2ACS Diabetes Mellitus Substudy
Renato Valenti et al
68
program ·
TCT-427. Clopidogrel Hyporesponsiveness,
Interacting with Diabetes Mellitus, Predicts
Two-Year Cardiovascular Outcome Among
Taiwanese Population Underging
Ping-Yen Liu et al
TCT-428. Effects of Low Dose Pioglitazone on
Restenosis and Atheroma Plaques in
Patients with Diabetes Mellitus Undergoing
Sung Gyu An et al
TCT-429. Clinical and Angiographic Results of
the Titanium vs. Everolimus Stent in Diabetic
Patients Randomized Trial (TITANIC-XV)
Jose Ramon Lopez-Minguez et al
TCT-430. Two-Year Clinical Outcomes of
Diabetic Patients Treated with a New
Generation Drug-Eluting Stent
Francesco Saia et al
TCT-431. Coronary Plaque Characteristics in
Diabetic and Nondiabetic Patients
Evaluated by Integrated Backscatter
Intravascular Ultrasound
Yoshinori Miyamoto et al
TCT-432. Impaired Lung Function is an
Independent Predictor of Type 2 Diabetes in
Korean Men: Five-Year Follow-up Study
Ki-Chul Sung et al
TCT-433. Does Diabetes Mellitus Impact
Clinical Outcomes Following Chronic
Total Occlusion Intervention with DrugEluting Stents?
Amro Elnagar et al
TCT-434. Impact of Chronic Dialysis on
Below-the-Knee Intervention Outcomes in
Patients with Critical Limb Ischemia
Amro Elnagar et al
TCT-435. Long-term (Five-Year) Outcomes of
Drug-Eluting Stents and Coronary Artery
Bypass Grafting for Multivessel Coronary
Revascularization in Diabetic and
Nondiabetic Patients
Yong-Giun Kim et al
TCT-436. Clinical Outcome in Diabetic
Patients Treated for Coronary Bifurcation
Lesions by Drug-Eluting Stents: Pooled
Analysis of the BBC ONE Study and the
Nordic Bifurcation Studies
Michael Maeng et al
Heart Disease in the Elderly
TCT-407. Population-Based Analysis of the
Epidemiology and Reintervention Rates of
Cardiovascular Stenting Procedures:
A Medicare Study
Jasmine D. Patel et al
TCT-408. Effect of Invasive Strategy
on Long-term Outcome in Elderly
Chinese Patients with Non-ST-Elevation
Shao-Sung Huang et al
TCT-409. Long-term Clinical Follow-up
of Percutaneous Coronary Intervention in
Nonagenarians
Paolo Angioli et al
TCT-410. Impact of Age for Treatment
of Acute Coronary Syndromes in
Elderly Patients
Harald Rittger et al
TCT-411. Survival and Discharge Rates for
Octogenarians Undergoing Coronary
Revascularization Procedures After Acute
Abhishek Deshmukh et al
TCT-412. Impact of Age on Coronary
Endothelial Dysfunction in Patients
with Myocardial Bridge
Amro Elnagar et al
TCT-413. Safety and Efficacy of the Resolute
Zotarolimus-Eluting Stent in Patients ≥70
Years of Age
Ganesh Manoharan et al
TCT-414. Predictors of In-Hospital Mortality
in Acute Myocardial Infarction in
Elderly Patients
TCT-415. Impact of Old Age on Clinical and
Angiographic Characteristics of Coronary
Artery Spasm as Assessed by Acetylcholine
Provocation Test
Woong Gil Choi et al
Basic Science, Animal Models,
and Preclinical Studies
TCT-437. The Mitochondrial Permeability
Transition Pore is a Target for
Pharmacological Cardioprotection in
Human Hypertrophic Cardiomyopathy
Paul S. Rees et al
TCT-438. Atorvastatin, Administered at the
Onset of Reperfusion, Protects Human
Myocardium Against Lethal Reperfusion
Injury by Activation of the RISK Pathway
Paul S. Rees et al
TCT-439. Periadventitial Delivery of a
Nanoparticle Albumin-Bound (Nab)
Rapamycin Solution Reduces Luminal
Stenosis in a Porcine Femoral Artery
Balloon Injury Model
Warren J. Gasper et al
TCT2011
TCT-442. The Controlled Reperfusion with
Bivalirudin and Intracoronary Abciximab
in the Porcine Mycoardial Infarction/
Reperfusion Model
Piotr P. Buszman et al
TCT-443. Systemic and Local Tissue
Pharmacokinetics of Single and Overlapping
NEVO Sirolimus-Eluting Stents in the Porcine
Coronary Artery Model
Rami Tzafriri et al
TCT-444. Antiinflammatory Effect of Arsenic
Trioxide-Eluting Stents in a Porcine
Coronary Model
Li Shen et al
TCT-445. Optical Characteristics of Neointimal
Formation Correlate with Histological
Markers of Stent Healing in a Porcine
Model of Restenosis
Jung-Sun Kim et al
TCT-446. Short-term Effects of SirolimusEluting Fully Bioabsorbable Polymeric
Coronary Stents in a Porcine Model
Li Shen et al
TCT-447. Angiographic and Histological
Response Following Implantation of a Novel
Stent-on-a-Wire in the Animal Model
Roberto Diletti et al
TCT-448. Scanning Electron Microscopic
Observation of Coating Irregularities and
Their Precursors in Unexpanded Durable
Polymer-Based Drug-Eluting Stents
Mounir W. Basalus et al
TCT-449. Preclinical Evaluation of a
Myolimus-Eluting Bioresorbable
Polymeric Scaffold in the Porcine
Coronary Artery Model
Guy Leclerc, MD et al
TCT-450. Insights from Network Analysis:
Deficiency of Glutathione Peroxidase-1
Increases In-Stent Stenosis
Ziad A. Ali et al
TCT-451. Right Through the Heart: Transseptal
Access for Stent-Graft placement in the
Ascending Aorta
Sabine H. Wipper et al
TCT-453. Early Enzymatic Infarct Size
Assessment Using Heart Specific Fatty
Acid Binding Protein
Andre Uitterdijk et al
TCT-454. A Highly Reproducible and Clinically
Relevant Large Animal Model of Myocardial
Ischemia and Heart Failure as Determined
by MRI Imaging
Michael B. Sweet et al
TCT-455. Evaluation of Second
Generation DES in an Ex Vivo Model of
Stent Thrombosis
Alexander Sheehy et al
TCT-456. Microarray Analysis for Nobori
Biolimus A9-Eluting Stent and Xience V
Everolimus-Eluting Stent in Porcine
Coronary Artery
Arihiro Sumida et al
TCT-457. Evaluation of Drug Tissue
Concentration Following Stenting in a
Healthy Rabbit Iliac Model
TCT-458. Which Genes of the Nitric Oxide
Pathway Contribute to Vascular Dysfunction
Following DES Implantation in Swine
Coronary Arteries?
Selvamuthu K. Natarajan et al
TCT-459. Pharmacokinetic Evaluation of
Drug-Eluting Stents in a Healthy and
Atherosclerotic Rabbit Iliac Model
TCT-460. Anatomic Substrate for Renal
Sympathetic Denervation: A Human
Post-Mortem Histological Study
Farrell O. Mendelsohn et al
TCT-461. Animal Studies on the Mechanisms
and Radiofrequency Catheter Ablation of the
Syncope with Vasovaga1 Syncope:
Radiofrequency Ablation of Cardiac Nerve
Attenuates Bezold-Jarisch Reflex in Canine
Chunshan Lu et al
TCT-462. Percutaneous Renal Sympathetic
Denervation Exerts a Chronic Effect on
Renal Hemodynamics and Plasma
Norepinephrine Levels Using a Novel
Catheter for Radiofrequency Ablation: Data
from an Animal Study
Konstantinos Tsioufis et al
TCT-463. Characterization of Cellular
Responses to Stent Materials
Jeffrey S. Garanich et al
TCT-464. Acute Effect of Percutaneous
Renal Sympathetic Denervation on
Renal Hemodynamics Using a Novel
Radiofrequency Ablation Catheter in a
Swine Model
Vasilios Papademetriou et al
TCT-465. Impact of the Different Route of
Cell Delivery in Chronic Ischemic
Cardiomyopathy Ovine Model
Yanping Cheng et al
TCT-466. Circadian Body Temperature
Variability Corresponds to Significant
Decline in Left Ventricular Function in
Cardiomyopathic Hamsters
Amany Ahmed et al
- N o v e m b e r 8 , 2 0 11
TCT-441. Periadventitial Renal Artery Delivery
of Guanethidine Monosulfate Attenuates
Renal Nerve Function: Preclinical Experience
and Implication for Resistant Hypertension
Christopher D. Owens et al
TCT-452. Increased Endothelial
Tetrahydrobiopterin Reduces In Stent
Stenosis in Apolipoprotein E-Knockout Mice
Ziad A. Ali et al
Tuesday
TCT-440. Allogeneic Mesenchymal Precursor
Cells Reduce Infarct Size and Preserve
Cardiac Function Following Intracoronary
Infusion in a Sheep Model of Acute
Jaco Houtgraaf et al
Cardiovascular
Therapeutics
TCT-467. Quantitative OCT Analysis of
In-Stent Neointimal Growth After
Implantation of ABSORB BVS in a
Diabetic Animal Model
Nienke van Ditzhuijzen et al
Cardiogenic Shock,
Heart Failure, and
Hemodynamic Support
TCT-468. The Impact of Revascularization
and Optimal Medical Therapy on Six-Month
Clinical Outcome in Patients With and
Without Congestive Heart Failure After Acute
Jang Hoon Lee et al
TCT-469. Comparison of Clinical Outcomes
Between Infarct-Related Artery
Revascularization Only and Multivessel
Revascularization in Patients with Acute
Myocardial Infarction and Cardiogenic Shock
Ju Yeol Baek et al
TCT-470. Early Hemodynamic Support with
Impella 2.5 Improves Survival in Refractory
Cardiogenic Shock After Acute Myocardial
Infarction
Brijeshwar Maini et al
TCT-471. Radial vs. Femoral Approach
in Primary PCI for STEMI with Cardiogenic
Shock: Prospective Comparison
Ivo Bernat et al
TCT-472. Gradual Decline in the Age-Adjusted
Mortality Rate from Cardiogenic Shock of
Any Cause or in the Setting of ST-Elevation
Myocardial Infarction in the United States
Mohammad Reza Movahed et al
TCT-473. Suppression of Oxidative Stress
in Endovascular Hypothermia-Treated
and Cardiac Arrest
Petr Ostadal et al
TCT-474. Improvements in LV Function
and Afterload with TandemHeart for the
Treatment of Refractory Cardiogenic Shock
Michael Tempelhof et al
69
Tuesday, November 8
TCT-475. Gradual Reduction in the AgeAdjusted Nationwide Trends in the Incidence
of Cardiogenic Shock Occurring in the
Setting of ST-Elevation Myocardial Infarction
Across Different Ethnicities and Gender
in the United States
TCT-476. New Definition for Stress-Induced
Cardiomyopathy: The Gothenburg Criteria
Elmir Omerovic
TCT-477. No Reduction in the Age-Adjusted
Nationwide Trends in the Incidence of
Cardiogenic Shock in the United States
Irrespective of Gender or Ethnicities
TCT-478. Epicardial Catheter-Based
Ventricular Reconstruction Restores Left
Ventricular Rotation and Reverses
Myocardial Remodeling in an Ovine Model
of Left Ventricular Aneurysm
Yanping Cheng et al
TCT-479. The Utility of Remote Wireless
Pulmonary Artery Pressure Monitoring in
Patients With or Without a History of
Myocardial Infarction: Experience from
the CHAMPION Trial
Warren L. Strickland et al
TCT-480. Safety and Feasibility of
Percutaneous Delivery of a Partial Left
Ventricular Support Device (CircuLite
Synergy Micro-Pump) in a Porcine Model
Geng-Hua Yi et al
TCT-481. Diastolic Heart Failure: Innovative
Extra- and Intraventricular Solutions
TCT-482. A Prospective Multicenter
Randomized Clinical Trial of Intraaortic
Balloon Pump vs. Impella for Hemodynamic
Support During High-Risk PCI: Final Clinical
and Angiographic Results of PROTECT II
William O’Neill et al
TCT-483. Is It Appropriate to Take All
Postresuscitation Patients Suspected
of Having an Acute MI for
Urgent Angiography?
Vivek K. Reddy et al
TCT-484. Cost-Effectiveness and Clinical
Outcomes of Impella Hemodynamic Support
Compared with Intraaortic Balloon Pump in
High-Risk Patients Receiving PCI: Results
from the PROTECT II Trial
TCT-485. Aspiration of the Blood from the Left
Ventricular Cavity to Treat Refractory
Ventricular Arrhythmias During Complex
Waleed Y. Kadro et al
70
program ·
TCT-486. Medical Treatment and Coronary
Angioplasty in Patients with Severe Left
Ventricular Dysfunction and Coronary
Artery Disease
Diego D. Grinfeld et al
TCT-487. Coronary Sinus Technique in
End Stage Heart Failure
Jorge Tuma et al
TCT-488. Percutaneous Retrograde Left
Ventricular Assist Support for Patients
with Aortic Stenosis and Left
Ventricular Dysfunction
Claudia A. Martinez et al
TCT-489. Predictive Value of EuroScoreDerived Parameters for the Development
of Right Ventricular Failure After
Cardiac Surgery
Annemarie Engstrom et al
TCT-490. Complete Revascularization
Improves Survival in Patients with STEMI
Complicated by Cardiac Arrest and
Cardiogenic Shock
Darren Mylotte et al
TCT-491. Percutaneous Left Ventricular
Support with the Impella 2.5 Assist Device in
Severe Cardiogenic Shock
Markus Ferrari et al
TCT-492. Interim Analysis of the Reitan
Catheter Pump (RCP) Heart Failure
Efficacy Study: RCP Improves
Cardiovascular and Renal Function in Acute
Decompensated Heart Failure (ADHF)
Thomas R. Keeble et al
Contrast-Induced Nephropathy
and Chronic Kidney Disease
TCT-493. Biomarkers to Predict ContrastInduced Nephropathy After Primary
ST-Segment Elevation Myocardial Infarction:
A HORIZONS-AMI Substudy
Bimmer E. Claessen et al
TCT-494. Impact of Renal Impairment on
Clinical and Angiographic Outcomes After
Drug-Eluting Stents: A Pooled Analysis of
SIRTAX, LEADERS, and RESOLUTE
All-Comers Trials
Giulio G. Stefanini et al
TCT-495. The Effect Of Cilostazol on the
Antiplatelet Efficacy of Patients with
Moderate Renal Dysfunction: Post-hoc
Analysis of CILON-T (Influence of CILostazol
based triple antiplatelet therapy ON
ischemic complication after drug-Eluting
Stent implantation) Trial
Min-Ho Lee et al
TCT-496. Objectives: The Purpose of
This Study Was to Determine the Functional
Impact of Cilostazol in Patients with
Chronic Kidney Disease (CKD)
Undergoing Hemodialysis
Weon Kim et al
TCT-497. Duration of Dual Antiplatelet
Therapy After Drug-Eluting Stent
Implantation in Patients with Chronic Kidney
Disease: A Report from the National Heart,
Lung, and Blood Institute Dynamic Registry
Joseph Kim et al
TCT-498. The Prognostic Value of Admission
Serum Creatinine for Contrast-Induced
Nephropathy and 12-Month Mortality In
Patients with Acute ST-Elevation Myocardial
Infarction Underwent Primary Percutaneous
Han-Young Jin et al
TCT-499. Comparison of Four-Year Clinical
Outcomes of Stent Implantation in Renal
Failure Patients with Dialysis: Comparison
with Bare Metal Stents and First and Second
Generation Drug-Eluting Stents
TCT-500. Effectiveness of Theophylline in
Prevention of Contrast-Induced Nephropathy
in Risky Egyptian Patients Undergoing
Elective Coronary Angiography or
Percutaneous Intervention:
A Randomized, Controlled Trial
Mohammed Elshawadfy et al
TCT-501. Baseline Renal Dysfunction
is Associated with Worse Outcomes in
Patients Undergoing Primary Percutaneous
Coronary Intervention for ST-Elevation
Sean Gallagher et al
TCT-502. Cystatin C Is Superior Diagnostic
Tool Compared with Conventional Serum
Creatinine or Estimated Glomerular
Filtration Rate in Prediction of ContrastInduced Nephropathy
Hyuck Jun Yoon et al
TCT-503. Relationship Between Syntax Score
and Contrast-Induced Acute Kidney Injury in
Patients with CKD Undergoing Coronary
Angiography or PCI
Ayesha C. Qureshi et al
TCT-504. Clinical Impact of Renal Function
Recovery After Contrast-Induced
Nephropathy on Long-term Adverse Events
Hyuck Jun Yoon et al
TCT-505. Contrast-Induced Acute Kidney
Injury In Patients Undergoing Primary
Angioplasty for Acute Myocardial Infarction:
A Randomized Trial on Hydration with Saline
or Bicarbonate
Mila Menozzi et al
TCT2011
TCT-508. The Dynamic Hemodialysis to
Prevent Contrast-Induced Nephropathy
in Catheterization Laboratory
Osamu Matsuda et al
TCT-509. High Concentration Sodium
Bicarbonate for the Prevention of ContrastInduced Nephropathy
Nozomu Tamai et al
TCT-510. Use of Paclitaxel-Eluting Stents
Reduces Target Lesion Revascularization
for Dialysis Patients
Hirotoshi Watanabe et al
TCT-511. Tridimensional Rotational
Angiography and Transplant Renal Artery
Stenosis: 40-Case Analysis
Erlon O. Silva et al
Vascular Access and Closure
TCT-513. Transradial Approach for Coronary
Procedures: Confronting the Myth of
Prolonged Preparation Time
Sara V. Sloan et al
TCT-514. Radiation Exposure During
Percutaneous Coronary Interventions
and Coronary Angiograms Performed by
the Femoral Route as Compared to the
Radial Route
Ronak Delewi et al
TCT-515. Outcome and Safety of Same-Day
Discharge Percutaneous Coronary
Interventions with Femoral Access:
A Single-Center Experience
Lisbeth Antonsen et al
TCT-516. Impact of Increased Distance on
Operator Radiation Exposure During
Transradial Catheterization
Ranya N. Sweis et al
TCT-517. Safety and Efficacy of Ulnar
Approach: A New Route for Cardiac
Catheterization and Intervention
Luis Jhonathan Uribe Gonz·lez et al
TCT-518. Radial vs. Femoral Access
Approaches in Percutaneous Coronary
Intervention of Patients Receiving Bivalirudin
Martial Hamon
TCT-520. Transradial Approach to Coronary
Interventions: How Steep Is the
Learning Curve for Trained
Interventional Cardiologists?
Bharat Gummadi et al
TCT-521. Safety and Efficacy of Radial Arterial
Injection of Nicorandil Compared to the
Usual Cocktail of Nitroglycerine (NTG) and
Diltiazem Given During Radial Angiography
Jamshed J. Dalal et al
TCT-522. Comparison of Clinical Outcomes
Between Transradial and Transfemoral
Access in Patients with Acute Myocardial
Infarction: Results from the Korea Acute
Myocardial Infarction Registry
Kwang S. Cha et al
TCT-523. Influence of Access Site Selection
on PCI-Related Adverse Events in STEMI
Patients; Meta-analysis of Randomized
Controlled Trials
Karim Ratib et al
TCT-524. Transradial vs. Transfemoral
Approach in Elderly Patients with
ST-Segment Elevation Acute Myocardial
Infarction Treated with Primary Angioplasty:
Feasibility, Predictors of Success,
and Outcome
Victor A. Jimenez Diaz et al
TCT-525. Impact of Low-Molecular-Weight
Heparin on Reperfusion Rates in Patients
with Radial Artery Occlusion after Cardiac
Catheterization. Results and Follow-up
in 113 Patients
Madlen Uhlemann et al
TCT-526. Radial vs. Femoral Approach for
in Patients with Acute Myocardial Infarction:
An Update Meta-analysis
Jae-Sik Jang et al
TCT-527. Transulnar and Transradial Approach
for Coronary Intervention: A Comparative
Study
Adolfo G. Lopez Campanher et al
TCT-528. Feasibility of Transradial Coronary
Intervention for Chronic Total Occlusions
Yutaka Tanaka et al
TCT-529. Single-Center Registry of
Percutaneous Ulnar Artery Approach for
Coronary Intervention as an Alternative
to Transradial Access
Sashko Kedev et al
TCT-530. Transradial and Transulnar Coronary
Diagnostic and Interventional Procedures
Performed Using Color: Doppler Guidance
Sanjay K. Chugh et al
TCT-531. Transradial vs. Transfemoral
Approach for Chronic Total Occlusion of
Coronary Arteries: Feasibility and
Predictors of Success
Victor A. Jimenez Diaz et al
TCT-532. Is Verapamil in Transradial
Interventions Omittable? The VITRIOL Trial
Istvan Hizoh et al
TCT-533. Effect of Adopting a Transradial
Access Program on Resource Utilization
and Efficiency of an Academic Cardiac
Catheterization Laboratory
Joshua Stolker et al
- N o v e m b e r 8 , 2 0 11
TCT-507. Contrast-Induced Nephropathy
in Patients with Normal Renal Function
Undergoing Complex PCI with High Dose
of Contrast Media: Predictive Value of
Cystatin C
Norbert Mayaud et al
TCT-519. Radial vs. Femoral Access in
Patients Referred for Primary Percutaneous
Coronary Intervention: Characteristics and
Clinical Outcomes
Samer Mansour et al
Tuesday
TCT-506. Invasive Treatment of Patients with
Non-ST-Segment Elevation Myocardial
Infarction and Severe Renal Dysfunction:
Early and 12-Month Outcomes from the
PL-ACS Registry
Marek Gierlotka et al
Cardiovascular
Therapeutics
TCT-534. Transradial Coronary Angiography
via Right or Left Radial Artery Approaches
in Real-World Practice: A PREVAIL Study
Data Subanalysis
Francesco Pelliccia et al
TCT-535. Shortened Time to Hemostasis,
Sitting up, and Ambulation with a Novel
Access Technology for Femoral Artery
Catheterization: Results of the RECITAL Trial
Dale C. Wortham et al
TCT-536. Femoral Artery Complications
Associated with Mynx vs. Suture-Mediated
Closure Device vs. Collagen-Based
Closure Device
Itsik Ben-Dor et al
TCT-537. Influence of Vascular Closure
Devices on Femoral Access Site
Related Bleeding in ST-Elevation
Sophie H. van Nes et al
TCT-538. Routine Use of the Transradial
Approach in Primary Percutaneous Coronary
Intervention: Procedural Aspects and
Outcomes in 2,209 Patients Treated in
a Single, High-Volume Center
Maarten Vink et al
TCT-539. Same Wrist Intervention via the
Cubital (Ulnar) Artery in Case of Radial
Puncture Failure for Percutaneous Cardiac
Catheterization or Intervention: The
Multicenter Prospective SWITCH Registry
Pierfrancesco Agostoni et al
TCT-540. Resource Utilization for Propensity
Matched Radial and Femoral Catheterization
and Intervention
Pascha E. Schafer et al
TCT-541. Comparison of Transradial and
Transfemoral Approach for Carotid Artery
Stenting: Radcar Study
Zoltan Ruzsa et al
71
Tuesday, November 8
TCT-542. Procedural Trends Associated with
Successful Initiation of a Transradial
Program at an Academic Training Institution
Usman Javed et al
Peripheral Vascular
Intervention (Noncarotid
and Nonneurovascular)
Carotid and Neurovascular
Intervention
TCT-554. The Iliac Sidebranch: For All or Only
the Few? A Morphological Suitability Study
Daphne Pavlidis et al
TCT-543. Safety of Carotid Stenting (CAS)
Is Based on the Center Experience More
Than on the Individual Performance
Paola De Rango et al
TCT-544. The Safety and Feasibility of
Sheathless Transradial Carotid Artery
Stenting (Comparing with Transbrachial
Carotid Artery Stenting)
Hsiu-Yu Fang et al
TCT-545. Carotid Artery Stenting in
Patients With and Without Contralateral
Stenosis (≥50%)
Alexander Kypta et al
TCT-546. Novel Predictors for In-Stent
Restenosis (ISR) After Carotid Artery
Stenting (CAS)
Roland R. Macharzina et al
TCT-547. Transcatheter Laser
Revascularization of Brain Vessels in the
Treatment of Vascular Dementia
Ivan V. Maksimovich
TCT-548. Outcomes of Modern Endovascular
Treatment of Vein of Galen Malformations in
the Neonatal Period
Alejandro Berenstein
TCT-549. Selective Basilar Artery
Thrombolysis for Posterior Territory Stroke:
Acute Stroke Registry from Western India
Kamaldeep Chawla et al
TCT-550. Carotid Stent Placement (CAS) With
or Without Debris Aspiration Prior to Embolic
Protection (EDP) Retrieval: A CHOICE
Registry Subset Study
Thomas K. Pow et al
TCT-551. Inflammatory Markers Predict
Future Cardiovascular Events in Patients
Undergoing Carotid Stenting
Francesco Versaci et al
TCT-552. Fasttrack Carotid Surgery Is the
Gold Standard for High-Risk (HRP) Carotid
Artery Intervention: Five-Year CostEffectiveness and Quality Stroke-Free
Survival Comparison
Sherif Sultan et al
TCT-553. The Impact of Periprocedural
Myocardial Infarction on Long-term
Outcomes After Carotid Artery Stenting
Christopher Metzger et al
72
program ·
TCT-555. Higher CD34+ Cells Concentration
and Lower Degree of Inflammation Are
Associated with Better Therapeutic
Response to Autologous Bone Marrow
Cells Application in Patients with Critical
Limb Ischemia
Juraj Madaric et al
TCT-556. Percutaneous Transluminal
Angioplasty of the Subclavian Arteries:
Long-term Follow-up
Michel Henry et al
TCT-557. Thoracic Abdominal Endovascular
Aneurysm Repair (TEVAR) in the
Management of Acute Aortic Syndrome
(AAS). An Early Experience with
Debranching, Chimney Techniques, and
Multilayer Stenting
Sherif Sultan et al
TCT-558. Five-Year THUNDER Follow-up:
Patients with PAD Treated with
Uncoated vs. Paccocath PaclitaxelCoated Balloons
Gunnar Tepe
TCT-559. Impact of Angiosome Approach on
Clinical Outcomes of Endovascular
Therapy in Patients with Critical Limb
Ischemia Presenting with Isolated
Below-the-Knee Lesions
Kiyonori Nanto et al
TCT-560. Results of the CONFIRM II Study
Demonstrate the Value of Orbital Technology
in Effectively Restoring Flow in Patients with
Calcified Infrainguinal Disease
Gaurav Aggarwala et al
TCT-561. New Conformable Thoracic
Stentgraft (SG): Apposition Scoring in
the Thoracic Aorta Near the Arch
Michael Gawenda et al
TCT-562. Retrograde Transpedal Access for
Below-the-Knee Chronic Total Occlusions
After Failed Anterograde Recanalisation
Zolt·n Ruzsa et al
TCT-563. Five-Year Trial of TASC II Type C/D
Lesions Undergoing Subintimal
Angioplasty or Bypass Surgery Based
on Plaque Echolucency
Niamh Hynes et al
TCT-564. Vertebral Angioplasty Stenting.
Are Protection Devices Useful?
Michel Henry et al
TCT-565. The Role of Pull-Back Pressure
Gradient in Percutaneous Transluminal
Angioplasty for Central Vein Stenosis in
Dialysis Patients
Yu Sheng Lin et al
TCT-566. Nitinol Stent Implantation for
TASC C and D Lesions in the Superficial
Femoral Artery (STELLA Trial)
Yann GouÎffic et al
TCT-567. The Multilayer Stent for the
Treatment of Popliteal Aneurysm
Michel Henry et al
TCT-568. Ten-Year Outcomes After
Revascularization of Peripheral Arterial
Disease with Adjunctive Atherectomy
Alix J. Tercius et al
TCT-569. Prognosis of Chronic Hemodialysis
Patients with Critical Limb Ischemia After
Isolated Infrapopliteal Balloon Angioplasty
from the J-BEAT Registry
Masatsugu Nakano et al
TCT-570. Six-Month Outcomes of Prospective,
Randomized CALCIUM 360 Study
Demonstrate the Advantages of Plaque
Modification with the Orbital Technology vs.
Treatment with Balloon Angioplasty
in Patients with Critical Limb Ischemia
Nicolas W. Shammas et al
TCT-571. Transvenous Intravascular
Ultrasound-Guided Endovascular Treatment
of Chronic Total Occlusion of a Lower
Extremity Artery: A Novel Strategy
Yasuhiro Takahashi et al
TCT-572. Percutaneous Abdominal Aortic
Aneurysm Repair: Methods and Initial
Outcomes from the First Prospective,
Multicenter Trial
Zvonimir Krajcer et al
TCT-573. Long-term Mortality After Aortic
Dissection in the Community: Results from
the Kaiser Permanente Registry of Aortic
Dissections (KP-RAD)
Cuong Lam et al
TCT-574. Dexamethasone Infusion to the
Adventitia to Enhance Clinical Efficacy After
Femoropopliteal Revascularization: A Firstin-Man Study
Christopher D. Owens et al
TCT-575. Thoracic Endovascular Aortic
Repair for Acute Type A Dissection:
A Computational and Anatomic Analysis of
Technical Limitations for Available Devices
Sam Chitsaz et al
TCT-576. Use of Orbital Treatment in a
High-Volume Clinical Practice Modifies
Noncompliant Plaque to Deliver Durable
Long-term Results
Prakash Makam et al
TCT2011
TCT-579. A New Concept of Stent: The
Multilayer Stent First-in-Human Study in
Peripheral Aneurysms
Michel Henry et al
TCT-580. Clinical Evaluation of the IN.PACT
Drug-Eluting Balloon for Treatment of
Femoropopliteal Arterial Disease:
Twelve-Month Results from a Multicenter
Italian Registry
Antonio Micari et al
TCT-581. Drug-Eluting Balloon for
Below-the-Knee Angioplasty Evaluation:
The DEBATE-BTK Study
Francesco Liistro et al
TCT-582. Endovascular Therapy of
Common Femoral Arterial Disease
Philip B. Dattilo et al
TCT-583. Pathologic Features of
Atherosclerotic Plaques Retrieved by
Excision and Relevant Biomarkers for
the Risk Stratification of Peripheral
Artery Disease
Fumiyuki Otsuka et al
TCT-584. Para-Millennium High-Risk AAA
Saga: A Clinical Dilemma But Is Not a Major
Concern for the Endovascular Specialist
Niamh Hynes et al
TCT-585. Usefulness of the Novel
Ultrasonography “Vascular Elastography”
for Endovascular Therapy
Hideyuki Takimura et al
TCT-586. Catheter-Based Renal Sympathetic
Denervation: Chronic Preclinical Evidence
for Renal Artery Safety
Marian K. Rippy et al
TCT-591. A New Concept of Stent: The
Multilayer Stent: First-in-Human Study
in TAA and AAA
Michel Henry et al
TCT-592. Antibiotic-Bonded Aortic Graft for
Prevention of Vascular Graft Infection
Ibrahim Aboshady et al
TCT-593. Relationship Between Novel
Angiographic Endpoint of Endovascular
Therapy and Clinical Result of Patients with
Critical Limb Ischemia
Makoto Utsunomiya et al
TCT-594. Clinical Outcomes Using the
Viabahn Stent Graft in Complex
Femoropopliteal Lesions
Peter Mohr et al
TCT-595. One-Year Clinical Outcomes of
MISAGO2 the Large Multicenter Study with
Misago the New Self-Expanding Nitinol
Peripheral Stent: Final Results
Karl-Ludwig Schulte et al
TCT-596. Factors Related to the Failure of
Limb Salvage Following Endovascular
Therapy in Patients with Critical
Limb Ischemia
Shin Okamoto et al
TCT-597. Utilization of Imaging Modalities
Prior to Amputation Among Patients with
Peripheral Arterial Disease or Diabetes:
A Nationwide Study
Sumeet Subherwal et al
TCT-598. Paradigm Shift in Ruptured AAA
(RAAA) Management: Twelve-Year
Experience in a Tertiary Referral Center of
Endovascular Repair of RAAA (REVAR) vs.
Open Repair (OR)
Sherif Sultan et al
TCT-599. Results of the US IDE Study of
the Wildcat Catheter (CONNECT)
John P. Pigott et al
TCT-587. Acute Limb Ischemia in an
Interventional Cardiology Practice
Jeremy R. Warner et al
TCT-600. The OCELOT Catheter for Long SFA
Occlusions: Six-Month Follow-up
TCT-588. Risk Stratification in Abdominal
Hybrid-Procedures (AHP) of TAAA: Which
Scoring System Fits Best?
Michael Gawenda et al
TCT-601. Midterm Outcomes of SMART
Self-Expanding Nitinol Stent Implantation
for Chronic Total Occlusion of Superficial
Femoral Artery
Yasunari Sakamoto et al
TCT-589. New Concept for Percutaneous
Peripheral Intervention to Calcified Lesion:
Aggressive Wire Recanalization in
Calcified Atheroma and Dilatation
(ARCADIA) Technique
Daisuke Yokota et al
Coronary Angiography and CTA
TCT-602. Matrix Metalloproteinases Can
Predict the Progression of Nonculprit Lesions
Konstantinos Toutouzas et al
TCT-603. Incidence, Morphological
Pattern, and Time Course of Peristent
Contrast Staining
Haruki Eguchi et al
TCT-604. Reduced Coronary Angioplasty
Screening Frame Rate Significantly Lowers
Radiation Exposure Without Affecting Image
Quality or Patient Outcome
Sam J. Wilson et al
TCT-605. Angiographic Progression of
Coronary Atherosclerosis in Culprit and
Nonculprit Lesion
Seung pyo Hong et al
TCT-606. Radiation Dose Reduction During
Radial Cardiac Catheterization: Evaluation
of a New Absorption Shielding Drape
Jeffrey Nadelson et al
- N o v e m b e r 8 , 2 0 11
TCT-578. Mechanical Thrombectomy in
Treatment of Limb Ischemia: Interim Results
of a Prospective Multicenter Registry
Peter Soukas et al
TCT-590. Endovascular Peripheral and
Visceral Aneurysms Repair with Cardiatis
Multilayer Flow Modulator: Results
at 6- and 12-Month Follow-up
Maria Antonella Ruffino et al
Tuesday
TCT-577. TEVAR in 2011: Worldwide
Experience with a Conformable Graft: Does
the Combination of Flexibility and Radial
Strength Lead to Positive Outcomes in
Thoracic Pathologies?
Zvonimir Krajcer
Cardiovascular
Therapeutics
TCT-607. Patients Radiation Doses
in a Contemporary Cohort of
Patients Undergoing Interventional
Cardiology Procedures
Juan Manuel Nogales-Asensio et al
TCT-608. Plasma Levels of Haptoglobin
Is Elevated in Patients with Coronary
Artery Disease
Ching-Wei Lee et al
TCT-609. Safety and Feasibility of the
Magnetic Positioning System (MPS)
for Percutaneous Coronary Intervention
Carl J. Schultz et al
TCT-610. What Is the Likelihood That an
Individual Who Has a Normal Coronary
Angiogram After the Age of 40 Will Develop
Significant Coronary Artery Disease?
Siddhartha Rao et al
TCT-611. Radiation Exposure and
Diagnostic Efficacy in Dual-Axis Rotational
Coronary Angiography vs. Standard
Coronary Angiography
Gerardo Nau et al
TCT-612. Feasibility of Myocardial
Perfusion Assessment by the Novel
C-Arm CT Angiography
TCT-613. Histologic Features of Advanced
Coronary Plaques Predict the Delineation
of the of Napkin Ring Sign in Coronary
CT Angiography
Harald Seifarth et al
TCT-614. Prognostic Role of Coronary Artery
Plaque in Patients with Suspected Coronary
Artery Disease Using Multislice Computed
Tomography (PREDICT)
Sung Uk Kwon
TCT-615. The New 320-Row Computed
Tomography with Lower Radiation Exposure
to Rule Out Coronary Artery Disease in
Patients with Atrial Fibrillation
Francesco Pelliccia et al
73
Tuesday, November 8
TCT-616. Relationship Between Angiographic
Dynamic and Densitometric Assessment of
Myocardial Reperfusion and Survival in
Treated with Primary Percutaneous Coronary
Intervention: The HORIZONS-AMI Trial
Sorin J. Brener et al
TCT-617. Noninvasive Assessment of In-Stent
Restenosis by High-Definition Computed
Tomography Coronary Angiography with
New Gemstone Detector
Hirotsugu Mihara et al
TCT-618. Quantitative Monitoring of
Atherosclerotic Plaque Development
and Characterization by Flat-Panel
Computed Tomography
Ibrahim Aboshady et al
TCT-627. Risk Evaluation of Distal
Embolization During Percutaneous Coronary
Intervention by Angioscopy and Virtual
Histology Intravascular Ultrasound Imaging
Koshi Matsuo et al
TCT-628. Relative Dose and Vascular
Response After Resolute Zotarolimus-Eluting
Stent Implantation: A Dosimetric
3-D-Intravascular Ultrasound Study
Hideki Kitahara et al
TCT-629. Comparison of Optical Coherence
Tomography and Histopathology Findings
Following Paclitaxel-Coating Balloon in
Porcine In-Stent Stenosis Model
Arihiro Sumida et al
TCT-639. Plaque Morphology with Optical
Coherence Tomography and Biomarkers
Kohei Koyama et al
TCT-640. Totally Occluded Infarct-Related
Arteries in STEMI Patients Are Associated
with More Calcification and Myonecrosis
Sang-Wook Kim et al
TCT-630. Does Measurement of Serum
1.5-Anhydroglucitol (1.5-AG) Level Be Able
to Predict the Presence of Coronary Plaque?
Suguru Murase et al
TCT-641. What Is the Optimal Blood Pressure
for Coronary Plaque regression in
Hypertensive Patients? ALPS-J Subanalysis
Akihisa Nishino et al
Intravascular Imaging: IVUS,
OCT, Spectroscopy, and Other
TCT-631. Correlation Between Modification in
Plaque Composition and Changes in
Vascular Geometry at the Edges of Bare
Metal and Drug-Eluting Stents
TCT-642. The Impact of Endothelial Wall
Shear Stress on Vulnerable Plaque Growth
Wang-Soo Lee et al
TCT-621. Long-term (Five Years) Serial In
Vivo Evaluation of Chronic Stent Recoil
after Drug-Eluting Stent Implantation:
Does It Exist?
Carlos A. Collet et al
TCT-632. Impact of Stent Platform of
Paclitaxel-Eluting Stents: Detailed
Assessment of Neointimal Distribution
by Optical Coherence Tomography
Hiromasa Otake et al
TCT-622. The Clinical Impact of Intravascular
Ultrasound in Patients Undergoing
Implantation of Drug-Eluting Stents in
the Left Main
Abdi Jama et al
TCT-633. Stent Recoil and Angiographic
Outcome in Drug-Eluting Stents. Results
of the STEREO-DES Pilot Study
Javier Escaned et al
TCT-619. Direct Mapping and Digital
Reconstructions of the Human
Cardiac Venous Anatomy
Julianne Eggum et al
TCT-623. Intravascular Ultrasound and Optical
Coherence Tomography Comparison of the
Self-Expanding Sideguard Stent in the
Sidebranch vs. a Balloon-Expandable
Drug-Eluting Stent in the Main Vessel:
Follow-up Results of Bifurcation Lesions
Treated with this Novel Device
Shixin Ma et al
TCT-624. Comparison by Optical FrequencyDomain Imaging of Paclitaxel-Eluting Stents
and Everolimus-Eluting Stents Implanted in
One Coronary Artery in One Procedure:
12-Month Follow-up Evaluation
TCT-625. Tissue Coverage and Neointimal
Hyperplasia of Overlap vs. Nonoverlap
Segments in Drug-Eluting Stents 9 to 13
Months After Implantation: In Vivo
Assessment with Optical
Coherence Tomography
Juan Luis Gutiérrez-Chico et al
TCT-634. Impact of Peristent Plaque Change
After Drug-Eluting Stents Implantation:
Comparison Between Zotarolimus-Eluting
Stents and Paclitaxel-Eluting Stents
Yoshitaka Muraoka et al
TCT-635. Distorted Balloon Shape During
Predilatation Before Stenting Predicts
Stent Underexpansion
Shinichiro Yamada et al
TCT-636. Frequency and Distribution of
Thin-Capped Fibroatheroma in the Left
Main Coronary Artery: A Virtual Histology
Intravascular Ultrasound Analysis
Sang-Wook Kim et al
TCT-637. In Vivo Characterization of
Bioresorbable Vascular Scaffold Strut
Interfaces Using Optical Coherence
Tomography with Gaussian Line Spread
Function Analysis
TCT-626. Relation Inflammatory Status
and Cholesterol Metabolism to Coronary
Plaque Vulnerability
Kenya Nasu et al
74
TCT-638. Changes In Quantitative IVUSDerived Hyperechogenicity of EverolimusEluting Bioresorbable Vascular Scaffold In
Relationship to Coronary Arterial
Remodeling and Baseline Morphology
of the Scaffolded Plaque: Insight from
ABSORB Trial
Salvatore Brugaletta et al
program ·
TCT-643. Six-Month Follow-up Data of Orbital
Atherectomy System for the Treatment of
De Novo Calcified Coronary Lesions
(ORBIT I Trial)
Keyur Parikh et al
TCT-644. Detection of Lipid Core Coronary
Plaques by Serial Intracoronary Imaging
with a NIRS Catheter in Coronary Arteries
of Atherogenic Swine
Oana Sorop et al
TCT-645. Debulking by Rotational
Atherectomy with a Modified Protocol
Increases Long-term Survival
Georg Gaul et al
TCT-646. Excimer Laser Lesion Modification
to Expand Nondilatable Stents
(The ELEMENT Registry)
Azeem Latib et al
TCT-647. Two-Year Follow-up Data of Orbital
Atherectomy System for the Treatment of
De Novo Calcified Coronary Lesions:
A Single-Center Experience
Keyur Parikh et al
TCT-648. Evidence of Late Neointimal
Hyperplasia Formation After Five Years of
Different Generations Drug-Eluting Stents
Carlos A. Collet et al
TCT-649. Classification of Atherosclerotic
Plaques Using Depth Resolved Spectral
Analysis of Optical Frequency Domain
Imaging Datasets
Christine P. Fleming et al
TCT-650. In Vivo Tissue Characterization of
Coronary Lipid Plaques: Comparison of
Optical Coherence Tomography and
Near-Infrared Spectroscopy
TCT2011
TCT-672. Relation Between Microalbuminuria
and Vulnerable Plaque Components in
Patients with Acute Coronary Syndrome and
with Diabetes Mellitus: Virtual HistologyIntravascular Ultrasound Analysis
Young Joon Hong et al
TCT-662. Impact of Post-interventional
Minimal Stent Area on Angiographic
Restenosis After Zotarolimus and
Everolimus-Eluting
Stent implantation
Hae-Geun Song et al
TCT-673. Optical Coherence Tomography
Characteristics of Coronary Plaques with
Ultrasonic Attenuation
Takashi Kubo et al
TCT-653. Quantitative and Qualitative
Changes of Neointimal Tissue in DrugEluting Stents: Serial (Nine Months and Two
Years) Observation Using Intracoronary
Optical Coherence Tomography
Jung-Sun Kim et al
TCT-663. Relationship Between Plaque
Composition Assessed with Radiofrequency
IVUS and Clinical Outcomes in Patients with
Acute Coronary Syndromes and Diabetes
Mellitus or Metabolic Syndrome:
The PROSPECT Trial
Steven P. Marso et al
TCT-654. Quantitative Multimodality Imaging
Analysis of a Fully Bioresorbable Scaffold: A
Head-to-Head Comparison Between QCA,
IVUS, and OCT
Juan Luis Gutiérrez-Chico et al
TCT-664. Syntax Score Reflects Coronary
Plaque Characteristics Assessed by
Integrated Backscatter Intravascular
Ultrasound
Hideaki Ota et al
TCT-655. Effectiveness of Thromboaspiration
Therapy in Patients with Acute Myocardial
Infarction: An Optical Coherence
Tomography Study
Takashi Kubo et al
TCT-665. Association Between Novel 3-D
Geometrical Lesion Analysis and Indicators
of Plaque Vulnerability
Danny Dvir et al
TCT-656. Relation Between the Multivessel
Disease and Culprit Lesion Morphology in
Acute Coronary Syndrome: An Optical
Coherence Tomography Study
Kenichiro Saka et al
TCT-657. Assessment of Atherosclerosis at
Coronary Bifurcations with Multislice
Computed Tomography and Intravascular
Ultrasound-Virtual Histology
Stella-Lida Papadopoulou et al
TCT-658. Differential Healing Response in
Acute Coronary Syndrome vs. Stable
Coronary Artery Disease Patients Five
Years Following Early Generation DES
Implantation: An Optical Coherence
Tomography Study
Lorenz Raber et al
TCT-659. Natural History of Optical Coherence
Tomography-Detected Edge Dissections 12
Months Following Drug-Eluting Stent
Implantation
Maria D. Radu et al
TCT-660. In Vivo Findings of Tissue
Characteristics in High-Risk Coronary
Artery Plaques Using iMap IVUS
Karlis Trusinskis et al
TCT-666. Near-Infrared Spectroscopic
Assessment of Lipid Core Plaque Changes
After Coronary Artery Stenting
Diaa A. Hakim et al
TCT-667. Acute Effects of Nicardipine and
Esmolol on the Cardiac Cycle,
Hemodynamic and Endothelial Shear Stress
in Patients with Unstable Angina Pectoris
and Moderate Coronary Stenosis: Results
from a Single-Center, Randomized Study
TCT-674. Automated 3-D Detection of
Intracoronary Stent Struts in Optical
Coherence Tomography Images
Nico Bruining et al
TCT-675. In Vivo Assessment of
Neoatherosclerosis After Sirolimus-Eluting
Stent Implantation: Comparisons of Serial
Optical Coherence Tomography Findings
Between Early and Late Follow-up
Amane Kozuki et al
TCT-676. Comparison of Virtual Histology
and OCT in the Tissue Characterization
of In-Stent Restenosis
Koichi Hanada et al
Analysis for Restenosis of EverolimusEluting Stents in Comparison with Bare
Metal Stents and Paclitaxel-Eluting Stents
Shoichi Kuramitsu et al
TCT-678. Comparative Study in Two
Institutions Between IVUS and Pressure Wire
in the Assessment of Intermediate Lesions
TCT-679. The Relationship Between
Long-term Clinical Outcomes and Serial
Atheroma Changes by Volumetric
Atsushi Hirohata et al
TCT-668. New Insights into the Coronary
Artery Bifurcation: Hypothesis Generating
Concepts Utilizing 3-D Optical Frequency
Domain Imaging
Vasim Farooq et al
TCT-680. Extent, Characterization, and
Clinical Implications of Untreated Lesions
with High Plaque Burden After Successful
Percutaneous Coronary Intervention: A
PROSPECT Substudy
John A. McPherson et al
TCT-669. Long-term Follow-up of a Large
Cohort of Patients with Intermediate
Lesions Assessed with IVUS
TCT-681. Volumetric Intravascular Ultrasound
Assessment of Mechanisms and Results of
Stent Expansion in Heart Transplant Patients
Elias Sanidas et al
TCT-670. Uniform Vessel Healing After
Everolimus-Eluting Stent Implantation:
Detailed Comparison with Paclitaxel-Eluting
Stent by Optical Coherence Tomography
Tsuyoshi Osue et al
TCT-682. Impact of Plaque Composition on
Postprocedural Myocardial Injury During
Stent Implantation: A Meta-analysis
Jae-Sik Jang et al
TCT-671. Can Metabolic Syndrome Predict
the Vulnerable Plaque in Patients with Stable
Angina Pectoris? Virtual HistologyIntravascular Ultrasound Analysis
Min Goo Lee et al
- N o v e m b e r 8 , 2 0 11
TCT-652. In Vivo Distribution of Lipid
Core Containing Plaque According
to Distance from the Ostium by Near-Infrared
Spectroscopy in Noncuprit Coronary Arteries
Salvatore Brugaletta et al
TCT-661. Relation Between Poststenting
Peristent Plaque Components and Late
Acquired Drug-Eluting Stent Malapposition:
Virtual Histology-Intravascular
Ultrasound Analysis
Young Joon Hong et al
Tuesday
TCT-651. Assessment of the Bioresorption
Process Utilizing Intravascular UltrasoundDerived Echogenicity Analyses and
Vasomotion Testing of the ABSORB
Bioresorbable Everolimus-Eluting Vascular
Scaffold: A Substudy of the ABSORB
Cohort B Trial
Jung Ho Heo et al
Cardiovascular
Therapeutics
TCT-683. Prediction of Distal Embolization
During Percutaneous Coronary Intervention
for Unstable Plaques with Grayscale
and Integrated Backscatter
Daisuke Morisawa et al
75
Tuesday, November 8
TCT-684. Detection of >0.4 mm of Minimal
Intimal Thickness During Routine
Intracoronary Ultrasound Studies Without a
Baseline Study Correlates Strongly with Total
Death and Adverse Outcomes in Cardiac
Transplant Patients
Reza Arsanjani et al
TCT-685. Neointimal Hyperplasia and
Peristent Vascular Remodeling After
Implantation of Everolimus-Eluting Stent vs.
Sirolimus-Eluting Stent: Intravascular
Ultrasound Results from EXCELLENT Study
Young-Guk Ko et al
Assessment of Neointimal Coverage
According to the Presence or Absence
of Malapposed Struts After Drug-Eluting
Stent Implantation
Byeong-Keuk Kim et al
TCT-687. Neointimal Coverage of EverolimusEluting Stent at One, Two, and Three Months
Follow-up: Evaluation by Optical
Takao Shimohama et al
TCT-688. Two-Year Long-term Follow-up
Optical Coherence Tomographic Findings
Compared with Nine Months After
Implantation of Everolimus-Eluting Stents
Jun-Won Lee et al
TCT-689. The Utility of Three Primary
Prevention Scoring Systems (Framingham,
PROCAM, and SCORE) in Predicting Future
Events in Patients with Acute Coronary
Syndromes: The PROSPECT Trial
Jung-Won Suh et al
TCT-690. Age- and Sex-Related Plaque
Composition of Nonculprit Lesions in
Patients with Acute Coronary Syndromes:
The PROSPECT Study
Juan Ruiz GarcÌa et al
TCT-691. Contributions of Mechanical Factors
and Biologic Response to Sirolimus-Eluting
Stent Thrombosis: Final IVUS Results from
the RESTART Registry
Teruyoshi Kume et al
Physiologic Lesion Assessment
TCT-697. Percent Stenosis Is a Weak
Predictor of Fractional Flow Reserve:
Insights from a French Multicenter
Registry (R3F)
Eric Van Belle et al
TCT-698. Optimal Cutoff Value of Coronary
Flow Velocity to Predict Functional Recovery
in TIMI-3 Reperfused Acute Myocardial
Infarction
Hiroyuki Hikita et al
76
program ·
TCT-699. Can Potentially Significant
Competitive Flow Be Identified at the Time
of CABG?
T. Bruce Ferguson et al
TCT-700. Influence of Cardiac Contractility on
Functional and Anatomical Diagnostic
Endpoints Under Concomitant Microvascular
Dysfunction in a Porcine Model
Srikara Viswanath Peelukhana et al
TCT-701. Assessment of Lesion Length
on Fractional Flow Reserve in Intermediate
Coronary Lesions
Hiroaki Takashima et al
TCT-702. A Comparative Study Between
Intravenous and Intracoronary Administration
of High Doses Adenosine for Fractional Flow
Reserve Measurements in the “FAME” Era
Jose M. Cubero et al
TCT-703. Functional Assessment of Jailed
Sidebranches in Coronary Bifurcation
Lesions Using Fractional Flow Reserve
Jung-Min Ahn et al
TCT-704. Improving Syntax Score with
Fractional Flow Reserve
Marco Novara et al
TCT-705. Intravascular Ultrasound
Characteristics in Patients with Intermediate
Coronary Lesions and Borderline Fractional
Flow Reserve Measurements
Hyoung-Mo Yang et al
TCT-706. New Perspective on the Fractional
Flow Reserve: High Predictive Value of
Baseline Pd/Pa During Intracoronary
Pressure Wire Study
June-Hong Kim et al
TCT-707. The Difference of Lesion Location
Affects Physiological Severity in Intermediate
Coronary Lesions
Hiroaki Takashima et al
TCT-708. Virtual Coronary Physiology and
Anatomy Derived from Rotational
Angiography: The First Step
Paul D. Morris et al
TCT-709. Contemporary Patterns of FFR and
IVUS Use Among Patients Undergoing PCI in
the United States: Insights from the NCDRÆ
Philip B. Dattilo et al
TCT-710. Impact of FFR on Global and
Individual Decision of Coronary
Revascularization: Insights from a
Large Multicenter Registry
Eric Van Belle et al
Congenital Heart Disease and
Acquired Structural Defects
TCT-711. Large Devices for Transcatheter
Closure of Atrial Septal Defects in Adult
Patients: the REPERA Multicenter Registry
Felipe Hernandez et al
TCT-712. Percutaneous Paravalvular Leak
Closure Abates Heart Failure Symptoms,
Reduces NT-proBNP Plasma Concentration
and Left Ventricle Size
Grzegorz Smolka et al
TCT-713. Safety and Performance of a
New Ceramic-Coated Double-Disc Patent
Foramen Occluder: One- and Six-Month
Follow-up
Tina Edwards-Lehr et al
TCT-714. Percutaneous Transcatheter
Pulmonary Valve Implantation Induces a
Reduction of B-Type Natriuretic
Peptide at 30 Days
Joelle Kefer et al
TCT-715. Transcatheter Occlusion of the
Patent Ductus Arteriosus with the New
ADO II Amplatzer Device
Norberto Herrera Guemez et al
TCT-716. Complications Leading to
Explantation of PFO Closure Devices:
A Multicenter Review
Swarnendra Verma et al
TCT-717. Comparison of Long-term Follow-up
After Endovascular Stent Placement
Between Patients with Native Coarctation
or Postsurgical Recoarctation
Maria Giulia Gagliardi et al
TCT-718. Preclosure of Large-Sized
Venous and Arterial Sheath Access Sites
in Adults Undergoing Transcatheter
Structural Interventions
Tahir Hamid et al
TCT-719. A New Anatomical Classification of
the Left Atrial Appendage Based on Carto/
CT/MR: Implications for the Implantation
of Left Atrial Apppendage Closure Device
Jose R. Lupez-Minguez et al
TCT-720. Percutaneous Closure of the Left
Atrial Appendage with the Amplatzer Cardiac
Plug: Initial Latin American Experience
AnÌbal A. Damonte et al
TCT-721. Thrombi on the Amplatzer Cardiac
Plug After LAA Occlusion: Evaluation of
Potential Echo Risk Factors
Börn Plicht et al
TCT-722. Single-Center Experience of Left
Atrial Appendage Closure. Role of Carto/CT/
MR in the Selection of Device Size
Jose R. Lupez-Minguez et al
TCT2011
TCT-725. Interventional Perspective of
Tricuspid Regurgitation: Heterotopic
Percutaneous Valve Implantation from
Preclinical Trials to First-in-Man Application
Alexander Lauten et al
TCT-726. Transcatheter Laser Irradiation in
the Treatment of Migraine
Ivan V. Maksimovich
Valvular Heart Disease: Aortic
TCT-727. Most Patients Fulfill the Access
Way Criteria in Transcatheter Aortic
Valve Implantation
Daniel John et al
TCT-728. Sutureless Implantation of a
Expandable Mitral Stent-Valve Prosthesis
in Acute Animal Model
Jose L. Navia et al
TCT-729. Reduced Incidence of Bleedings,
Vascular Complications, and 30-Day
Mortality with the Sapien Novaflex System:
Results from a Single-Center Transfemoral
TAVI Registry
Giovanni Sorropago et al
TCT-730. Transcranial Doppler Analysis of
Embolic Events During Transcatheter Aortic
Valve Implantation
William T. Brinkman et al
TCT-731. Clinical and Functional Outcome
After Transapical Aortic Valve Implantation
Using the JenaValve AVR System: One-Year
Results of the First-in-Man Study
Ardawan J. Rastan et al
TCT-732. Transcatheter Aortic Valve
Replacement with a Self-Expandable
Bioprosthesis Performed Without Balloon
Valvuloplasty: Comparative Results in a
Consecutive Series of Patients
Dimytri A. Siqueira et al
TCT-733. The Ratio Between Bioprosthesis
and CT-Measured Mean Annulus Diameter
Predicts Significant Postprocedural Aortic
Regurgitation in Transcatheter Aortic
Valve Implantation
Kentaro Hayashida et al
TCT-734. Predictors and Clinical Outcome of
Patients with Acute Kidney Injury Following
Transcutaneous Aortic Valve Replacement
Israel M. Barbash et al
TCT-736. Impact of CT-Guided Bioprosthesis
Sizing on Postprocedural Aortic
Regurgitation in Transcatheter Aortic
Valve Implantation
TCT-737. Does the STS-PROM Score or
the Logistic EuroScore Predict
Outcomes Following Transcatheter Aortic
Valve Replacement at 30 Days:
The Milan Experience
Gill L. Buchanan et al
TCT-738. Geometry of the Edwards SAPIEN
XT Valve as Assessed by Multidetector
Computed Tomography
Alex B. Willson et al
TCT-739. Midterm Stability and Hemodynamic
Performance of a Transfemorally Implantable
Nonmetallic, Retrievable, and Repositionable
Aortic Valve in Patients with Severe Aortic
Stenosis: Two-Year Results of the Direct
Flow Medical Valve
Klaudija Bijuklic et al
TCT-740. Does Left Atrial Diameter in Patients
with Severe Aortic Stenosis Have a Clinical
Impact on Outcome?
Camille Hauville et al
TCT-747. Balloon Aortic Valvuloplasty as a
Bridging Thearpy to Aortic Valve
Replacement or Transcatheter Aortic
Valve Implantation
Michael Tempelhof et al
TCT-748. Optimal Projection for Transcatheter
Aortic Valve Implantation Determined from
the Reference Projection Angles
James A. Cockburn et al
- N o v e m b e r 8 , 2 0 11
TCT-724. Percutaneous Closure of Multiple
Paravalvular Leaks with Amplatzer Vascular
Plug III Device: Single-Center Experience
Jaime R. Dutary et al
TCT-735. New Onset Atrioventricular Block
After Corevalve Implantation Is Due to Direct
Damage on the His-Bundle System
Raquel del Valle et al
Tuesday
TCT-723. Percutaneous Pericardiocentesis vs.
Surgical Pericardial Drainage
in the Treatment of Symptomatic
Pericardial Effusions: Recurrence and
Complication Rates
A. Garvey Rene et al
Cardiovascular
Therapeutics
TCT-749. Efficacy and Safety of
Transcatheter Aortic Valve Replacement:
Northern Ireland Experience
Ganesh Manoharan et al
TCT-750. The STS-Score Outperforms the
EuroSCORE in Predicting Short-term
Outcome Following Transcatheter Valve
Implantation but Does Not Predict
Long-term Outcome
Ralf Lehmann et al
TCT-751. Outcome Comparison of
Nontransfemoral Approaches for
Utilizing CoreValve
Pak Hei Chan et al
TCT-752. Comparison of Transcatheter Aortic
Valve Implantation vs. Surgical Aortic Valve
Replacement in a High-Risk Patient
Population: A Propensity Score Analysis
Lenard Conradi et al
TCT-741. Candidates for Transcatheter
Aortic Valve Replacement (TAVR):
Fitting the Current PARTNERS Criteria?
Michael J. Babcock et al
TCT-753. In-Hospital Complications After
Revisited According to the Valve Academic
Research Consortium Definitions
Rutger-Jan Nuis et al
TCT-742. Finite Element Analysis of
Transcatheter Aortic Valve Implantation:
Impact of Oversizing on Stent and
Leaflet Stresses
Ali Azadani et al
TCT-754. B-Type Natriuretic Peptide Predicts
Improvement of Left Ventricular Function
and Clinical Outcome After Balloon
Aortic Valvuloplasty
Joelle Kefer et al
TCT-743. Incidence, Timing, and Predictors
of Valve Dislodgment During TAVI with
the Medtronic Corevalve System
Nicolas M. Van Mieghem et al
TCT-755. Surgical vs. Transcatheter Aortic
Valve Replacement with the Sapien XT Valve
and NovoFlex Delivery System in High-Risk
Patients with Severe Aortic Stenosis
Azeem Latib et al
TCT-744. Edwards-SAPIEN Valve Positioning
During Transcatheter Aortic Valve
Implantation: Multicenter Evaluation
with Clinical and Anatomical Correlates
Danny Dvir et al
TCT-745. Reconsidering Outcomes After
Following the Valve Academic Research
Consortium Definitions
Moritz Seiffert et al
TCT-746. Mortality Outcomes in 501 TAVI
Patients Stratified According to Age Tertiles
Matthias Kornek et al
TCT-756. The Effects of Preexisting Significant
Coronary Artery Disease Defined by QCA
Analysis Upon Outcome After Transcatheter
Aortic Valve Implantation Using the
Edwards Bioprosthesis
Muhammed Z. Khawaja et al
TCT-757. Impact on the Need for Permanent
Pacemaker Requirement After CoreValve
Prosthesis Implantation with the New
Accutrak Delivery Catheter System
Antonio J. Munoz-Garcia et al
77
Tuesday, November 8
TCT-758. True Percutaneous Approach for
Transfemoral Aortic Valve Implantation Using
Prostar XL Device: Impact of the Learning
Curve on Vascular Complications
TCT-759. Geographic Variations In
Rates Across 14 European Countries
Stuart Mealing et al
TCT-760. Numerous Patients Fail the Aortic
Annulus Criteria In Transcatheter Aortic
Valve Implantation
Daniel John et al
TCT-761. Prognostic Impact of Permanent
Pacemaker Implantation Among Patients
with Severe Aortic Stenosis Undergoing
Lutz Buellesfeld et al
TCT-762. Predictive Factors and Prognostic
Value of Periprocedural Myocardial Injury
Implantation
Ze Yie Yong et al
TCT-763. Aortic Valve Calcium Scoring (AVCS)
Is a Predictor of Significant Paravalvular
Aortic Insufficiency in Transapical Aortic
Valve Implantation
Martin Haensig et al
Replacement: Outcome of Patients with
Moderate or Severe Mitral Regurgitation
Stefan Toggweiler et al
Implantation: Multicenter Study Evaluating
the Clinical Outcomes of Patients with
PARTNER Trial Exclusions
Ronen Gurvitch et al
TCT-766. Predictors of AVB After TAVR with
Both Edwards and CoreValve THV System
Marco Mussardo et al
TCT-767. Gender Differences in Patients
Undergoing Transcatheter Aortic Valve
Implantation with the Medtronic
CoreValve System
Yacine Elhmidi et al
TCT-768. Transcatheter Aortic Bioprosthesis
Embolization: Technical Aspects and
Midterm Follow-up
Marco Barbanti et al
TCT-769. Requirement of Small Size of
Prosthetic Aortic Valve in Asian Population:
Implication to Select Valve Size for
Transcatheter Aortic Valve
Implantation in Elderly
Mike Saji et al
TCT-770. FRANCE II: French Registry Aortic
National CoreValve and Edwards Registry II
Martine Gilard et al
78
program ·
TCT-771. Expanded Anatomic Suitability of
Current Generation Transcatheter Aortic
Balloon-Expandable Prostheses
Massimo Napodano et al
TCT-783. Transaortic Access for
Transcatheter Aortic Valves Implantation:
Single-Center Experience
Giuseppe Bruschi et al
TCT-772. Clinical Outcome Following
Transcatheter Aortic Valve Implantation in
Patients with Impaired Left Ventricular
Systolic Function
Robert M. van der Boon et al
TCT-784. Multislice Computed Tomography:
New Gold Standard for Valve Sizing and
Prevention of Aortic Regurgitation in Patients
Referred for Transcatheter Aortic Valve
Implantation?
Mariam Samim et al
TCT-773. Prediction of Optimal Deployment
Projections in Transcatheter Aortic Valve
Replacement: Angiographic 3-D
Reconstruction of the Aortic Root vs.
Multidetector Computed Tomography
Ronald K. Binder et al
TCT-774. Feasibility and Safety of Transaortic
Transcatheter Aortic Valve Implantation In
Patients with Previous Cardiac Surgery
Using the Edwards SAPIEN Bioprosthesis
Muhammed Z. Khawaja et al
TCT-785. Is “Porcelain Aorta” a Real
Contraindication for Transaortic
Transcatheter Aortic Valve Replacement?
Vinnie Bapat et al
TCT-786. Beyond the Short-term: Clinical
Outcome and Valve Performance Two Years
After Transcatheter Aortic Valve Implantation
in 227 Patients
Sabine Bleiziffer et al
TCT-775. Improved Procedural Results After
CoreValve Implantation with the New
AccuTrak Delivery System
Emmanuel Chorianopoulos et al
TCT-787. Australian and New Zealand
Source Registry: Edwards Sapien
Replacement: 30-Day Outcomes
Darren Walters et al
TCT-776. Outcome of Residual Paravalvular
Aortic Regurgitation (PAR) After Transfemoral
Aortic Valve Implantation (TAVI) and
Importance of Hemodynamic Assessment
P. C. Patsalis et al
TCT-788. Three-Month Results of the
JenaValve Multicenter Study Evaluating a
Second Generation Transcatheter Aortic
Valve Implantation System
Hendrik Treede et al
TCT-777. Preprocedural Predictors of Early
and Midterm Mortality in Patients Treated
with Transcatheter Aortic Valve Implantation:
A Single-Center Experience.
Kirsten Boerlage-van Dijk et al
TCT-789. Clinical Profile and Outcome
Correlates in Patients with Severe
Aortic Stenosis at High-Surgical Risk:
Prospective Evaluation According to
Treatment Assignment
Danny Dvir et al
TCT-778. Myocardial Injury and
Electrocardiographic Changes Following
Manolis Vavuranakis et al
TCT-779. Predictive Factors of Major VARC
Vascular Complications Following
Transfemoral Transcatheter Aortic Valve
Implantation
Ilyes Kharrat et al
TCT-780. Accuracy of Intracardiac
Echocardiography for Aortic Root
Assessment in Patients Candidated to
Marco Barbanti et al
TCT-790. Late Occurrence of
Bradyarrhythmias After TAVI with the
CoreValve Aortic Bioprosthesis
Emmanuel Chorianopoulos et al
TCT-791. Transient Increase in Pressure
Gradient After TAVI: A Question of Dual
Antiplatelet Therapy?
Fadi Al-Rashid et al
TCT-792. A Low-profile Highly Conformable
Sealing Technology for Transcatheter
Heart Valves
Martin Ng et al
TCT-793. The Importance of Aortic
Annular Area and Eccentricity on Balloon
Expandable Aortic Valve Sizing, Geometry,
and Paravalvular Regurgitation
Alex B. Willson et al
TCT-781. 3-D Multislice Computed
Tomography to Predict Annulus Plane
Angulation and C-Arm Positioning in
Patients Referred for TAVI: Benefit on
Safety Procedural Outcome
Mariam Samim et al
Valvular Heart Disease: Mitral
TCT-782. Timing and Potential Mechanisms
of New Conduction Abnormalities During
the Implantation of the Medtronic CoreValve
System in Patients with Aortic Stenosis
Rutger-Jan Nuis et al
TCT-795. MitraClip for Patients with Mitral
Regurgitation Who Are Ineligible for Surgical
Repair or Replacement: A UK-Based
Cost-Utility Analysis
Stuart Mealing et al
TCT2011
TCT-798. Long-term Follow-up of Mitral
Valvuloplasty with Single Balloon:
Independent Predictors of Survival and
Event-Free Survival
Edison S. Peixoto et al
TCT-799. Functional vs. Degenerative Mitral
Regurgitation in Patients Not Amenable to
Surgery Undergoing MitraClip Treatment
Stephan Baldus et al
TCT-1001. The Use of Multimodality
Imaging Optimizes Primary PCI Strategy
in Stent Thrombosis
Paul Rees et al
TCT-1002. Bailout Application of Five-in-Six
Double-Catheter in Transradial Coronary
Intervention
Qi Zhang et al
TCT-1003. A Self-Expandable Coronary Stent
System to Treat Complex Coronary Stenosis
Complicated by Post-Stenotic Aneurysm: An
Optical Coherence Tomographic EvidenceBased Case Report
Salvatore Geraci et al
TCT-800. Quality-of-Life Changes in High-Risk
Patients After Percutaneous Mitral Valve
Repair with MitraClip
Maurizio Taramasso et al
TCT-1004. Percutaneous Closure of
Secundum Atrial Septal Defect in Left
Ventricular Assist Device Recipient with
Hypoxia and Right-to-Left Intraatrial Shunt
Ethan Korngold et al
TCT-801. The Impact of Commissural
Morphology on Clinical Outcome in
Patients Undergoing Percutaneous
Balloon Mitral Valvuloplasty
Mohamed A. Sadaka et al
TCT-1005. Use of a Novel Stent Delivery
Device for Severe Multivessel Diffuse and
Chronic Disease
Bruno del Blanco et al
TCT-802. MitraClip Treatment of Functional
Mitral Regurgitation in Patients Not
Amenable to Surgery
Volker Rudolph et al
TCT-803. Changes in Platelet, Coagulation,
Fibrinolytic Activities in Mitral Stenosis
After Percutaneous Mitral Valvotomy:
Role of Hemodymamic Changes and
Systemic Inflammation
Hosam Hasan-Ali et al
TCT-804. Effectiveness of Percutaneous
Reduction of Significant Mitral Regurgitation
of Functional Etiology in High Surgical
Risk Patients
Michael Argenziano et al
TCT-805. Tissue-Doppler Assessment of
the Changes in Longitudinal Left and Right
Ventricular Functions After Percutaneous
Mitral Valvotomy
Hosam Hasan-Ali et al
TCT-806. Acute Hemodynamic Changes
After Percutaneous Mitral Valve Repair
Oliver Gaemperli et al
TCT-1006. Only One Radial Artery Access for
Retrograde PCI
Bin Zhang et al
TCT-1007. One Stage Unprotected Left Main
and Multiple Vessel Angioplasty
Alejandro Fernandez et al
TCT-1008. A Case of Treatment for Proximal
Left Anterior Descending Artery Chronic
Total Occlusions Because of Unsuccessful
Intervention via Left Internal Thoracic
Artery to Left Anterior Descending
Bypass Graft Interfered by Severe Stenosis
of Nearby Graft Anastomosis
Ryo Gotoh et al
TCT-1009. Unusual Case of Coronary-Cameral
Fistula with Failure of Surgical Ligation and
Successful Outcome with Transradial
Coil Embolization
Abdul Basit et al
TCT-1010. Rewiring and Fixation of a Lost
Stent in Proximal LCx
Enno Boudriot et al
TCT-1011. Left Main Bifurcation Reverse
T Stenting with Rotablation of Diffuse
LAD Lesion
Ananthakrishna Ajith Pillai et al
TCT-1012. Which Is the Culprit? Complex
Revascularization in a 63-Year-Old Male with
Previous Coronary Artery Bypass Grafting
Presenting with Non-ST-Segment Elevation
Crochan O’Sullivan et al
TCT-1013. Percutaneous Retrieval of
Entrapped Partially Inflated Broken Coronary
Angioplasty Balloon by Modified Fogarty
Technique
Girish Palleda et al
TCT-1014. Stenting: Treatment of Dual
Bifurcation Lesions in a Patient with
Non-ST-Elevation Myocardial Infarction
Kimberly Brayton et al
- N o v e m b e r 8 , 2 0 11
TCT-797. Immediate Mitral Valve Area After
Successful Percutaneous Mitral
Valvuloplasty: A Simple Predictor of
Restenosis at Long-term Follow-up
Rodrigo Blanco et al
Challenging Cases
Video Abstracts
Tuesday
TCT-796. EVEREST II High Surgical Risk
Cohort: Clinical Benefit by MR Grade in High
Surgical Risk Patients One Year Following
MitraClip Therapy
Paul Grayburn et al
Cardiovascular
Therapeutics
TCT-1015. Unpreventive Distal Embolism Even
with Distal Protection Device Due to Massive
Vulnerable Plaque in RCA Observed by
MDCT, IVUS, OCT
Taku Asano et al
TCT-1016. Stent Catheter Break During
Percutaneous Coronary Angioplasty:
Managing an Iatrogenic Emergency
Praveen Sreekumar et al
TCT-1017. No Reflow in Case of PAMI of
Anterior Wall MI with Distal LAD Total
Occlusion After All Measures, Left with
Pharmacotherapy with Established Flow
After 2 Days
Jayesh Prajapati et al
TCT-1018. Stage Complete Revascularization
of a Cardiogenic Shock Patient Under ECMO
Support
Hsiu-Yu Fang et al
TCT-1019. Successful Retrieval of Entangled
Stents Using Basket Device During LM PCI
Hsiu-Yu Fang et al
TCT-1020. Two Cases with Significant
Coronary Stenosis Accompanied by De
Novo Coronary Artery Aneurysm; Successful
PCI with Stent In Stent Technique - Case 2
Cheol-Yoong Yu et al
TCT-1021. Graft Stent Deployment and an
Iatrogenic Coronary Arteriovenous Fistula
Occurring in Percutaneous Coronary
Intervention of Chronic Total Occlusion
Lesion
Sang-Ho Park et al
TCT-1022. Left Anterior Descending Artery
Rupture Resolution
Diego Grinfeld et al
TCT-1023. A Case of Septal Channel
Perforation During Retrograde Approach
for LAD CTO
Rei Fukuhara et al
79
Tuesday, November 8
TCT-1024. Hybrid Single Stage Antegrade and
Retrograde Procedure for Long Segment
Chronic Total Occlusion In Dominant
Circumflex
Pravin Goel et al
TCT-1025. A Thromboid Severe Calcification
on Left Main Coronary Artery
Yoshihide Fujimoto et al
TCT-1026. Left Main PCI in an Elderly Male
with 3-Vessel Coronary Disease and Severe
LV Dysfunction
H. Prabhakar Shetty et al
TCT-1027. Multivessel PCI of a Right Coronary
Artery Chronic Total Occlusion and an
Unprotected Left Main
Rajan Patel et al
TCT-1028. Stent Treatment of an
Aortocoronary Dissection During
Juan Manuel Nogales-Asensio et al
TCT-1029. Rescue of the Coronary Dissection,
Identify the True Lumen via IVUS Guidance
Chun-Yuan Chu et al
TCT-1030. PCI of Left Main Coronary Artery
After Successful TAVI (CoreValve)
Matjaz Bunc et al
TCT-1031. Retrograde RCA CTO Intervention
via Ipsilateral Radial and Brachial Artery
Approach
Hsiu-Yu Fang et al
TCT-1032. First Report of Successful
Occlusion of Complex Coronary
Arteriovenous Malformation by Using
Cyanoacrylate-Based Synthetic Glue
(Glubran 2)
Emanuela de Cillis et al
TCT-1033. Impella Support for Unprotected
Left Main PCI in a Patient with a Large Aortic
Aneurysm
Philip Dattilo et al
TCT-1034. Multiple Steps Revascularization
with Twice Perforation and LM Dissection
Hsiu-Yu Fang et al
TCT-1035. Repeated Percutaneous Coronary
Intervention for Recurrent Spontaneous
Coronary Dissection in a Patient with Acute
Myocardial Infarction During Postpartum
Period
Takashi Nakayama et al
TCT-1036. A Case with Coronary Perforation
which was Treated with Embolic Coils and
Fibrin Glue
Motoo Date et al
TCT-1037. Wiring Trapping in Torturous and
Calcified Lesion
Feng-Yu Kuo et al
80
program ·
TCT-1038. Successful Treatment of Radial
Artery Occlusion Using a Clearway Catheter
and Balloon Angioplasty
George Revtyak et al
TCT-1039. Excimer Coronary Laser
Atherectomy Applied with Guideliner
Catheter Support: A Novel Strategy to Treat
a Distal Balloon Uncrossable Coronary
Stenosis
Wissam Al Sahli et al
TCT-1040. Getting There is Half the Fun:
Recanalizing a Chronically Occluded
Brachial Artery Prior to Treatment of an
Acute Distal Left Main Bifurcation Lesion
from the Right Radial Approach
Ronald Caputo et al
TCT-1041. Successfully Rescue of Guidewire
Fracture in Coronary Collaterals During LAD
CTO Intervention
Hsiu-Yu Fang et al
TCT-1042. Immediately Bilateral Approach for
Saving LAD CTO Antegrade Wiring
Perforation
Hsiu-Yu Fang et al
TCT-1043. The Iron Man: Multiple
Interventions in an Elderly Patient
TCT-1044. Challenging Anterior Myocardial
Infarction in a Young Woman
Stuart Watkins et al
TCT-1045. Two Cases with Significant
Coronary Stenosis Accompanied by De
Novo Coronary Artery Aneurysm: Successful
PCI with Stent in Stent Technique - Case 1
Hyunjong Lee et al
TCT-1046. Retrograde LM Bifurcation
Dissection During CTO Intervention
Feng-Yu Kuo et al
TCT-1047. Wire Fishing for an Unexpectedly
Deployed Stent
Zu-Yin Chen et al
TCT-1048. Two-Step Parallel Wiring for
Chronic Total Occlusion
Shinichi Furuichi et al
TCT-1049. Guideliner for a Difficult
Coronary Fistula
Elchanan Bruckheimer et al
TCT-1050. Detection of Plaque Shifting by
Intracoronary Pressure Measurement During
Left Main Intervention
Zsolt Koszegi et al
TCT-1051. Plaque Hunting: Multimodality
Imaging Is Mandatory to Allow Target Lesion
Identification in ACS
Paul Rees et al
TCT-1052. Rotational Atherectomy Is Useful to
Treat the Restenosis Lesion Due to
Under-Expansion of Drug-Eluting Stent
Implanted on Severe Calcified Lesion
Daisuke Morisawa et al
TCT-1053. Impacted Thrombus Within the
Introducer Sheath During Thrombus
Aspiration
Young-Jin Youn et al
TCT-1054. Coronary Embolization Following
Inadequate Anticoagulation in a Patient with
Prosthetic Mitral Valve
Vineet Bhatia et al
TCT-1055. Unusual Case of Left Main
Embolization Following Surgery for Post PCI
Mycotic Aneurysm
Narenda Khanna et al
TCT-1056. A Case of Transradial PCI Using
Four-in-Six System for Tortuous RCA Lesion
Setsuo Kumazaki et al
TCT-1057. PCI to Chronic Total Occlusion of
RCA, LAD, and Large LM Disease
Bin Zhang et al
TCT-1058. Rotational Atherectomy of Native
LAD via LIMA Graft
Aaron Wong et al
Endovascular Interventions
TCT-1059. Reuse of Occluded Ulnar Artery for
Repeat Coronary Intervention
David Dundua et al
TCT-1060. A Modified Chimney Technique for
the Treatment of Abdominal Aortic Graft
Detachment
Bernardo Cortese et al
TCT-1061. Acute Limb Ischemia Caused by
Recurrent Stent Thrombosis in
Femoropopliteal Arteries
Pil-Ki Min et al
TCT-1062. Bilateral Occluded Renal Arteries:
An Endovascular Approach
Ashraf Manzil et al
TCT-1063. A Case of May-Thurner Syndrome
Treated with Intralesional UK Infusion
Followed by Stent Implantation
Jae-Hwan Lee et al
TCT-1064. Renal Artery Stenting in Renal
Failure Patients: Without Contrast Media,
with Intravascular Ultrasound
Masayoshi Kimura et al
TCT-1065. Successful Recanalization of Both
Common Iliac Arteries with Kissing Stent
Techniques to the Patient with AxillaryFemoral and Femoral-Femoral Bypass
Surgery
Jiwon Jang et al
TCT2011
TCT-1068. The Ruptured Penetrating Aortic
Ulcer in the Ascending Aorta Corrected with
Stent Graft
Sung-Gyu An et al
TCT-1069. Complex [Iatrogenic] Vertebral
Artery Stenting
Harpreet Gilhotra et al
TCT-1070. Percutaneous Recanalization of
Occluded Aortic- and Bi-Iliac System
Massoud Arbabzadeh et al
TCT-1071. Severe Angina from Chronic
Subclavian Coronary Steal Syndrome
Jeffrey Cavendish et al
TCT-1072. Flip-it and Stick-it: A Creative
Approach to Peripheral Angioplasty
Mitul Patel et al
TCT-1073. Complex Endovascular Repair of
Chronic Type B Dissection
Turki Albacker et al
TCT-1074. A Case of Transcollateral
Retrograde Approach for Totally Obstructed
Peroneal Artery
Jong-Pil Park et al
TCT-1075. Endovascular Repair of a Chronic
Aortic and Biiliac Occlusion
Immad Sadiq et al
TCT-1076. Successful Retrograde Approach of
Superficial Femoral Artery Chronic Total
Occlusion Without a Stump
Shu-kai Hsueh et al
TCT-1077. How Do We Handle Mud Pie?
Endovascular Recanalization in a Patient
with Carotid Occlusion and Repeated TIA
Jen-Kuang Lee et al
TCT-1078. Carotid Angioplasty While Using an
Anchoring Technique of the External
Carotid Artery
Ramesh Gadepalli et al
TCT-1079. A Novel Compression Method for
Retrograde Tibial Artery Puncture
Toshio Makita et al
TCT-1082. Non-surgical Removal of an
Entrapped Rotablation Burr by Extracting
Drive Shaft Sheath Followed by Balloon
Dilatation
Kenichi Sakakura et al
TCT-1083. Widowmaker Saved by Mobile
ECMO Team in PCI Center Without Cardiac
Surgery Backup
Ulf Jensen et al
TCT-1084. Nightmare in the Cath Lab?
Bashir Hanif et al
TCT-1085. A Second Chance
Gopi Manthripragada et al
TCT-1086. Acute Cardiogenic Pulmonary
Edema Due to Microvascular Spasm
Hyun-Woong Park et al
TCT-1087. Substrate for Complications
Ajay Mhatre et al
TCT-1099. Sixteen-Year-Old Male with TAPVC
and Recurrent PV Stenosis
Daniel Mauriello et al
TCT-1100. Transjugular Approach as an
Alternative Access for Balloon Mitral
Commissurotomy in a Patient with
Venous Anomaly
Praveen Sreekumar et al
TCT-1101. Coiling of a Hemodynamically
Significant Coronary Fistula to the
Bronchial/Pulmonary Artery
Keshav Nayak et al
TCT-1102. Placement of a Second Gore Helex
Device to Treat Residual Shunting in an Elite
Navy Seal Diver
Keshav Nayak et al
TCT-1103. What and Where Is the Problem?
Li-wah Tam et al
TCT-1104. Recanalization of Right-Sided
Y-Prosthesis Occlusion
Thomas Konorza et al
TCT-1088. Retrieval of a Perforated Shaldon
Catheter
Bjoern Plicht et al
TAVR
TCT-1089. A Healthy Heart Needs More than a
Single LIMA
Florim Cuculi et al
TCT-1105. Subacute Dislocation of a
CoreValve Prosthesis
Dan Ioanes et al
TCT-1090. Stent Avulsion
Rajeev Menon et al
TCT-1106. PCI After TAVR: Technical
Challenges and Solutions
Didier Carrié et al
Structural Interventions
TCT-1091. Transcatheter Closure of Atrial
Septal Aneurysm (ASA) of the Fossa Ovalis
with Multiple Perforations
Do-Hoi Kim et al
TCT-1092. Percutaneous Closure of
Paravalvular Leaks of a Mechanical Mitral
Valve with an Unusual Atrial Position
Joachim Schofer et al
TCT-1093. Para-Bioprosthetic Mitral Valvular
Left Ventricular Pseudoaneurysm
Jonathan Roberts et al
TCT-1094. Transcatheter Therapy of
Lutembacher Syndrome: Easier Said
Than Done
Shiv Bagga et al
TCT-1095. A Rare Case of Left Main
Thrombotic Occlusion Following Balloon
Aortic Valvuloplasty: Did Protamine
Play a Role?
Gill Buchanan et al
TCT-1080. Use of a Drug-Eluting Stent with
Provisional T-stenting Technique in the
Treatment of Renal Artery Bifurcation
Stenosis
Sang-Ho Park et al
TCT-1096. Cyanotic Heart Disease
Bharat Chanana et al
TCT-1081. Vascular Closure Devices
Complications
Anish George et al
TCT-1098. Transcatheter Treatment of
Lutembacher Syndrome
Garikapati Mahesh et al
TCT-1097. Treatment of a 91-Year-Old Patient
with Symptomatic Aortic Stenosis
- N o v e m b e r 8 , 2 0 11
TCT-1067. Left Common Iliac Artery
Pseudo-Aneurysm Caused by a Gunshot
Bullet: A Challenging Transcatheter
Treatment
Gustavo Carvalho et al
Miscellaneous Interventions
Tuesday
TCT-1066. Percutaneous Revascularization of
a Renal Chronic Total Occlusion
Salman Arain et al
Cardiovascular
Therapeutics
TCT-1107. Transcatheter Aortic Valve-in-Valve
Implantation: Degenerate Surgical Freestyle
Aortic Root with False Aneurysm
Tiffany Patterson et al
TCT-1108. Successful Treatment for Aortic
Para Valvular Leak Post Core Valve
Carlos Balestrini et al
TCT-1109. Combined TEVAR plus
Transfemoral TAVI for the Treatment of
Thoracic Aortic Disease and Severe Aortic
Regurgitation in a Patient with Prior Valve
Sparing Root Replacement
Philipp Kahlert et al
TCT-1110. Successful Transfemoral Aortic
CoreValve Implantation During
Cardiopulmonary Resuscitation with the
LUCAS Device
Lionel Leroux et al
TCT-1111. Severe Retroperitoneal Bleeding
Due to Prostar Dislocation Following
Successful Medtronic CoreValve
Implantation
Vassilis Voudris et al
TCT-1112. Retrieval of the Sapien XT Valve
from Patient Who Underwent Transcatheter
Aortic Valve Implantation
Mike Saji et al
81
Tuesday, November 8
TCT-1113. A Case of Rotational Atherectomy
After Transcatheter Aortic Valve Implantation
with the Medtronic CoreValve Prosthesis
Mohamed Abdel-Wahab et al
TCT-1114. Dual Transcatheter Valvular
Intervention for Concomitant Severe Aortic
Stenosis and Mitral Regurgitation
Pak-Hei Chan et al
TCT-1115. Left-to-Right Interventricular Shunt
as a Late Complication of Transapical Aortic
Valve Implantation
Didier Carrié et al
TCT-1116. Retroperitoneal Hematoma
Post-TAVI Caused by Medial Circumflex
Artery Rupture
Azeem Latib et al
TCT-1117. An Unexpected Complication
Immediately Following Transapical
Aortic-Valve Implantation
Danny Dvir et al
TCT-1118. Cardiac Resynchronization Therapy
to Improve Cardiac Reserve as a Bridge to
Martin Sluka et al
TCT-1119. Implantation of a Sapien XT Aortic
Bioprosthesis Using the Novaflex Catheter
(Edwards LifeScience, Irvine, California,
USA) Through a Subclavian Access
Didier Carrie et al
TCT-1120. Migration of the Aortic CoreValve
Prosthesis Treated with Rescue “Valve-inValve” Implantation
Maciej Dabrowski et al
10:41 am - TCT-3. Percutaneous Coronary
Intervention for Chronic Total Occlusions:
Feasibility, Safety, and Clinical Outcomes
at One Year: An Analysis of 307 Patients
Virginie Brandao Carreira
10:54 am - TCT-4. The Impact of the Location
of a Chronic Total Occlusion in a Non Infarct
Related Artery on Long-term Mortality in
ST-Elevation Myocardial Infarction Patients
Loes Hoebers
Chronic Total Occlusions
11:07 am - TCT-5. Drug-Eluting Stents for the
Treatment of Chronic Total Occlusion: A
Comparison with Sirolimus, Paclitaxel,
Zotarolimus (Endeavor Resolute),
BiolimusA9, EPC Capture, and EverolimusEluting Stent: Multicenter Registry in Asia
Sunao Nakamura
10:28 am - TCT-12. Feasibility, Safety, and
Clinical Results of In-stent Restenosis
Treatment with a Novel Drug-Eluting Balloon:
A Single-Center Registry
Stefano Galli
11:20 am - TCT-6. Long-term Clinical Outcomes
After Percutaneous Coronary Intervention for
Chronic Total Occlusions in Insulin and
Non-Insulin Dependent Diabetes Mellitus:
Five-Year Outcomes from a 1,791 Patient
Multi-National Registry
Bimmer E. Claessen
11:33 am - TCT-7. MSCT Guided Coregistration
for CTO Procedures: A Pilot Feasibility Study
Ravit Barkama
82
11:46 am - TCT-8. Increased Radiation
Exposure in Percutaneous Coronary
Interventions for Chronic Total Occlusions
Sunil Kanwal
10:15 am - TCT-1. Successful Recanalization of
Chronic Total Occlusions Is Associated
with Improved Long-Term Survival
Daniel Jones
10:28 am - TCT-2. Prognostic Impact of
Complete Coronary Revascularization in
Patients with Diabetes Mellitus and Chronic
Total Occlusions
Renato Valenti
program ·
10:15 am - TCT-11. In-Stent Restenosis Is Not a
Benign Clinical Entity, Presenting as Acute
Coronary Syndrome in 40% of Cases
Jonathan Behar
10:15 am-12:30 pm
Room 113
Moderators: Alfredo R. Galassi,
Jacques J. Koolen
Discussants: Emmanouil S. Brilakis,
Mauro Carlino, Thierry Corcos,
Goran K. Olivecrona
10:15 am-12:30 pm
Room 130
Joseph P. Carrozza Jr
Aloke V. Finn, Semih Oktay, Pieter R. Stella
Oral Abstract Sessions
Drug-Eluting Balloons
and In-Stent Restenosis
11:59 am - TCT-9. Management of Procedural
Complications Related to Percutaneous
Coronary Intervention of Chronic Total
Occlusions via the Retrograde Approach.
A Toyohashi Experience
Masashi Kimura
12:12 pm - TCT-10. Development of a
High-Volume, Multiple-Operator Program for
Percutaneous Chronic Total Coronary
Occlusion Revascularization: Procedural,
Clinical, and Cost-Utilization Outcomes
Dimitri Karmpaliotis
12:30 pm - Adjourn
10:41 am - TCT-13. Findings Supporting Drug
Resistance in the Treatment of In-Stent
Restenosis Within Drug-Eluting Stents
Robert A. Byrne
10:54 am - TCT-14. A Single Center, Real World
Experience of Drug-Eluting Balloon Use
in the Treatment of In-Stent Restenosis
and Diffuse Coronary Artery Disease
Joann Shannon
11:07 am - TCT-15. Paclitaxel-Eluting Balloon in
in Amsterdam (PAPPA): Short Term Outcome
of a Pilot Study
Rene van der Schaaf
11:20 am - TCT-16. Drug Releasing Balloon with
a BTHC Excipient: Six-Month Results on 600
Patients of the International DELUX Registry
Ralph Töelg
11:33 am - TCT-17. Predilatation with DrugEluting Balloon Followed by Bare Metal
Stent Implantation vs. Drug-Eluting Stent in
the Treatment of Simple De Novo Native
Coronary Stenosis
Francesco Liistro
11:46 am - TCT-18. Six-Month Angiographic
and 18-Month Clinical Results of the
Multicenter Randomized DEBIUT (DrugEluting Balloon in Bifurcations Trial)
Anouar Belkacemi
TCT2011
Cardiovascular
Therapeutics
11:33 am - TCT-27. Four-Year Follow-up of the
SYNTAX Trial: Optimal Revascularization
Strategy in Patients with Three-Vessel
Disease
Friedrich W. Mohr
11:07 am - TCT-35. Initial Findings from
ABSORB EXTEND on the Use of Overlapping
Bioresorbable Scaffolds
Alexandre Abizaid
11:20 am - TCT-36. One-Year Clinical Outcomes
and Multivariate Predictors Following
XIENCE V�Everolimus-Eluting Coronary Stent
System Implantation in Real-World Clinical
Settings
Srihari S. Naidu
12:12 pm - TCT-20. Pathologic Features of
Everolimus vs. Sirolimus- and PaclitaxelEluting Stents in Human Coronary Arteries
Fumiyuki Otsuka
11:46 am - TCT-28. Risk Profile and Three-Year
Outcomes from the SYNTAX PCI and
CABG Registries
Stuart Head
12:30 pm - Adjourn
Drug-Eluting Stents I and
Bioabsorbable Scaffolds
11:59 am - TCT-21. Biodegradable PolymerCoated Sirolimus-Eluting Stent Implantation
in Acute Myocardial Infarction
Yang Shengli
10:15 am-12:30 pm
Room 125
Robert J. Whitbourn
Discussants: Bernard R. Chevalier,
Marc D. Feldman, Jonathan M. Hill,
Pedro R. Moreno
10:15 am - TCT-29. Comparison of EverolimusEluting and Paclitaxel-Eluting Stents: First
Report of the Five-Year Clinical Outcomes
from the SPIRIT III Trial
Gregg W. Stone
10:28 am - TCT-22. ABSORB Cohort B Trial:
18 Month Clinical and MSCT Results of the
ABSORB Bioresorbable Everolimus Eluting
Vascular Scaffold
Patrick W. Serruys
10:41 am - TCT-23. Drug-Eluting Stents with
Biodegradable Polymer: Do They Offer
Benefit in the Treatment of Very Small
Vessels (< 2.5 mm)?
Didier Carrie
10:54 am - TCT-24. The “Final” Five-Year
Follow-up from the ENDEAVOR IV Trial
Comparing a Zotarolimus-Eluting Stent with
a Paclitaxel-Eluting Stent
Martin B. Leon
11:07 am - TCT-30. A Large-Scale, Randomized
Comparison of Everolimus-Eluting and
Paclitaxel-Eluting Stents: Three-Year
Clinical Outcomes from the SPIRIT IV Trial
Gregg W. Stone
11:20 am - TCT-26. Appropriate Use Criteria for
Coronary Revascularization:
Results of Retrospective Analysis in a
Large Health System
Michael Wilson
12:12 pm - TCT-25. Bioresorbable Everolimus
Eluting Vascular Scaffold in Small Vessels:
One Year Results
Roberto Diletti
12:30 pm - Adjourn
Drug-Eluting Stents II
10:15 am-12:30 pm
Room 111
Moderators: Michael J. Cowley,
Peter Wenaweser
Discussants: Ronald Caputo, Shu-Kin Li,
Marco A. Perin, Richard A. Schatz
10:15 am - TCT-31. Final Five-Year Follow-up
from the RESOLUTE First-in-Man Trial
Ian T. Meredith
10:28 am - TCT-32. Intraprocedural Thrombotic
Events During Percutaneous Coronary
Intervention in Patients with Non-STElevation Acute Coronary Syndromes are
Associated with Adverse Outcomes:
Analysis From the ACUITY Trial
Margaret B. McEntegart
11:33 am - TCT-37. Are Adverse Events
Following Primary PCI for STEMI More
Frequent at US Sites than Sites Outside the
US (OUS)? Three-Year Analysis from the
HORIZONS-AMI Trial
Bruce R. Brodie
11:46 am - TCT-38. One-Year Outcomes After
Implantation of XIENCE PRIME and XIENCE
PRIME Long Lesion Stents in Patients with
Coronary Artery Disease: Primary Endpoint
Results of the SPIRIT PRIME Multicenter
Clinical Trial
Marco A. Costa
11:59 am - TCT-39. Comprehensive
Intravascular Ultrasound Assessment of
Stent Area and Its Impact on Restenosis and
Adverse Cardiac Events in 403 Patients with
Unprotected Left Main Disease
Soo-Jin Kang
12:12 pm - TCT-40. Strut Thickness and Type of
Metal Alloy of Bare Metal Stents and
Frequency of In-Stent-Restenosis: Data
from the Swedish Angiography and
Angioplasty Registry (SCAAR)
Jörg Carlsson et al
12:30 pm - Adjourn
10:41 am - TCT-33. Culprit Only or Multivessel
Percutaneous Coronary Intervention in
Myocardial Infarction and
Multivessel Disease
Mikkel Hougaard
Left Main and Bifurcation PCI
10:54 am - TCT-34. Everolimus-Eluting Stent vs.
Sirolimus- and Paclitaxel-Eluting Stents in
Real-Life Practice: Pooled Analysis From the
XAMI, COMPARE, and APPENDIX-AMI Trials
Matthijs Velders
- N o v e m b e r 8 , 2 0 11
11:59 am - TCT-19. A Temporal Assessment of
Drug Distribution Following Local Balloon
Delivery of Nanoparticle Sirolimus
Saami Yazdani
Tuesday
10:15 am-12:30 pm
Room 121
Moderators: Theodore A. Bass,
Davide Capodanno
Discussants: David Antoniucci, Nicola Corvaja,
Dietmar H. Glogar, Tak W. Kwan
10:15 am - TCT-41. Impact of Final Kissing
Balloon on Outcome After Unprotected
Left Main Stenting
Klaus Tiroch
83
Tuesday, November 8
10:28 am - TCT-42. Impact of Bifurcation Type
and Stenting Technique on Outcome After
Unprotected Left Main Stenting
Klaus Tiroch
12:12 pm - TCT-50. Complex Coronary
Bifurcation Lesions Treated with the Novel
Polymer-Free Dedicated Bifurcation
Paclitaxel-Eluting Stent (Nile Pax):
Nine-Month Clinical and Angiographic
Results of the Prospective, Multicenter
BIPAX Clinical Trial
Ricardo A. Costa
11:33 am - TCT-57. High On-Treatment Platelet
Reactivity After Prasugrel Loading Dose
and Cardiovascular Events After
Percutaneous Coronary Interventions
in Acute Coronary Syndromes
Laurent Bonello
10:41 am - TCT-43. Angiographic Outcome and
Predictors of Restenosis in Patients with
Unprotect Left Main Disease Treated with
Everolimus or Paclitaxel-Eluting Stent:
Florence Registry
Angela Migliorini
12:30 pm - Adjourn
Interventional Pharmacology
10:54 am - TCT-44. Unprotected Left Main
Stenting in the Real World: Five-Year
Outcomes of the French Left Main Taxus
Registry
Darren Mylotte
10:15 am-12:30 pm
Room 122
Moderators: David F. Kong,
Steven V. Manoukian
Discussants: Patricia J. Best, Kurt Huber,
Neal S. Kleiman, Tabassome Simon
11:07 am - TCT-45. The ESTROFA-LM Registry:
Comparison of Taxus and Xience Stents
in Left Main Coronary Artery Disease.
Preliminary Results at Three-Year Follow-up
11:20 am - TCT-46. Long-term Survival in
Patients Undergoing Sirolimus-Eluting Stent
PCI of the Unprotected Left Main Coronary
Artery According to EuroSCORE, Syntax
Score, and GRC: The Milan and
New-Tokyo Registry
Kensuke Takagi
11:33 am - TCT-47. Assessment of the Left
Main (LM) with Fractional Flow Reserve
(FFR): The Influence of Concomitant
Proximal Epicardial Coronary Disease
David Daniels
11:46 am - TCT-49. Four-Year Follow-up of the
SYNTAX Trial: Optimal Revascularization
Strategy in Patients with Left Main Disease
Patrick W. Serruys
11:59 am - TCT-48. Very Long-term Clinical
Outcomes of Patients with Coronary
Bifurcation Lesions Treated with the Biolimus
A9 Coated Dedicated Axxess Stent: Results
from the Prospective, Multicenter AXXESS
Plus Trial (Final Report of the Study)
Eberhard Grube
84
program ·
10:15 am - TCT-51. Concomitant Clopidogrel
and Statin Use and Risk of Major Adverse
Cardiovascular Events Following Coronary
Stent Implantation
Michael Maeng
10:28 am - TCT-52. Short-Acting, Reversible
Antiplatelet Therapy for Urgent Surgery
Early After Coronary DES Implantation
Nuccia Morici
10:41 am - TCT-53. Death and Acute Myocardial
Infarction Associated with Stopping
Clopidogrel After Saphenous Vein Graft
Amit Sachdeva
10:54 am - TCT-54. The Impact of HighResidual Platelet Reactivity After
Clopidogrel Loading on Long-Term
Clinical Outcome of Patients with Acute
Coronary Syndromes Receiving an Invasive
Treatment: The RECLOSE 2-ACS Trial
Renato Valenti
11:46 am - TCT-58. Use of Prasugrel in Primary
Percutaneous Intervention in Daily Clinical
Practice. Results of the Prospective
ATACS Registry
Uwe Zeymer
11:59 am - TCT-59. Concomitant Use of
Clopidogrel and Proton Pump Inhibitors and
Major Adverse Cardiovascular Events
Following Coronary Stent Implantation
Michael Maeng
12:12 pm - TCT-60. Protective Effects of
Ranolazine Before Elective
Percutaneous Coronary Intervention:
A Randomized, Double-Blind,
Placebo-Controlled Pilot Study
Francesco Pelliccia
12:30 pm - Adjourn
STEMI Intervention
10:15 am-12:30 pm
Room 123
Moderators: Cindy L. Grines, Holger Thiele
Discussants: Michael J. Lim, Keith G. Oldroyd,
Matthew T. Roe, Gary L. Schaer
10:15 am - TCT-61. Long-term Follow-up of
Four Treatment Strategies in Multivessel
Disease Following Primary Percutaneous
Intervention for Acute Myocardial Infarction
Pranobe V. Oemrawsingh
11:07 am - TCT-55. Is Clopidogrel Enough for
STEMI Patients with Cardiogenic Shock?
Klaus Tiroch
10:28 am - TCT-62. Culprit-Lesion-Only vs.
Multivessel Revascularization Using
Drug-Eluting Stents in ST-Segment
Elevation Myocardial Infarction:
A KAMIR-Based Analysis
Sangwook Kang
11:20 am - TCT-56. Impact of Major Bleeding on
Long-term Mortality in Patients With and
Without Anemia Undergoing Percutaneous
Coronary Intervention with Bivalirudin
Shyam Poludasu
10:41 am - TCT-63. Treatment of Multivessel
Coronary Artery Disease in Primary PCI for
STEMI: Culprit Only Revascularisation Is
Associated with Higher MACE Rates
Oliver Guttmann
TCT2011
Predictors and Prevention of
Stent Thrombosis
10:15 am-12:15 pm
Room 124
Moderators: Joost Daemen, Marco Valgimigli
Discussants: Anthony A. Bavry,
Giuseppe De Luca, Jurrien M. Ten Berg,
Bonnie H. Weiner
11:07 am - TCT-65. Does Cytoprotector Mexicor
Used Intracoronary During Rescue PCI
Limit Reperfusion Myocardial Injury in
STEMI Patients?
Anton Koledinsky
10:15 am - TCT-71. Incidence and Predictors of
Early or Late and Very Late Stent
Thrombosis Following Primary PCI with
BMS and DES for STEMI: A 16 Year
Single-Center Experience
Bruce R. Brodie
11:20 am - TCT-66. Postprocedural ST-Segment
Deviation Is an Independent Predictor
of Long-term Mortality in Patients
Undergoing Primary Percutaneous Coronary
Intervention for ST-Segment Elevation
Wichert Kuijt
10:28 am - TCT-72. Stent Thrombosis up to
Nine Years Follow-up in Real-World Patients
Undergoing Drug-Eluting Stent Implantation
Ricardo A. Costa
11:33 am - TCT-67. Incremental Value of
Thrombus Age to Multiple Biomarkers for the
Prediction of One-Year Mortality After
Maik Grundeken
11:46 am - TCT-68. Increased Mortality with
Post-infarct Ventricular Septal Ruptures at a
Tertiary Care Center
Lawrence Lazar
11:59 am - TCT-69. Factors Associated with
Delays in Primary PCI and Cardiac
Catheterization Laboratory Activation for
ST-Segment Elevation Myocardial
Infarctions: A Report from the
Activate-SF Registry
James McCabe
12:12 pm - TCT-70. Association Between
Intraprocedural Thrombotic Events and
Adverse Outcomes Following Percutaneous
Coronary Intervention for STEMI:
Ajay J. Kirtane
12:30 pm - Adjourn
10:41 am - TCT-73. Impact of Positive Peristent
Vascular Remodeling After Sirolimus-Eluting
and Paclitaxel-Eluting Stent Implantation on
Five-Year Clinical Outcomes: Intravascular
Ultrasound Analysis from POET, a
Multicenter, Randomized Trial
Ki-Woon Kang
10:54 am - TCT-74. ST-Elevation Myocardial
Infarction (STEMI) Due to Stent Thrombosis:
An Enlarging Subgroup of High Risk Patients
Bruce R. Brodie
11:07 am - TCT-75. Pooled Analysis of
RESOLUTE Clinical Trial Long-term
Safety Data
Martin B. Leon
11:20 am - TCT-76. The Clopidogrel Resistance
in Stent Thrombosis (CREST) Registry: The
Case for Personalized Antiplatelet Therapy?
Nalyaka Sambu
11:33 am - TCT-77. Stent Thrombosis After
Implantation of XIENCE V Everolimus-Eluting
Coronary Stent Systems in On-Label and
Off-Label Populations: Pooled Two-Year
Results from Seven XIENCE V Coronary
Stent Trials
11:46 am - TCT-78. Stent Thrombosis and Dual
Antiplatelet Interruption: Insights from the
XIENCE V Everolimus-Eluting Coronary
Stent System Trials
Gregg W. Stone
11:59 am - TCT-79. Clinical Outcomes After
Acute, Subacute, Late, and Very Late Stent
Thrombosis After Primary PCI for STEMI:
An Analysis from HORIZONS-AMI
Bimmer E. Claessen
12:15 pm - Adjourn
Intersection of Diabetes
and PCI
10:15 am-12:30 pm
Room 110
Moderators: Norman E. Lepor,
Robert L. Wilensky
Discussants: Kevin J. Beatt, Efrain Gaxiola,
Vankeepuran S. Srinivas, Thomas D. Stuckey
- N o v e m b e r 8 , 2 0 11
10:54 am - TCT-64. Prasugrel vs. Double
Clopidogrel to Overcome High Platelet
Reactivity Early Following a 600mg
Clopidogrel Loading Dose in Patients
Undergoing Primary Percutaneous
Dimitrios Alexopoulos
Tuesday
Cardiovascular
Therapeutics
10:15 am - TCT-80. The Effect of Drug-Eluting
Stents on Clinical and Angiographic
Outcomes in Diabetic Patients, 3 Years
Result: Multicenter Registry in Asia
Sunao Nakamura
10:28 am - TCT-81. One-Year Outcomes in Over
1,500 Patients with Diabetes Treated with
the Resolute Zotarolimus-Eluting Stent
Sigmund Silber
10:41 am - TCT-82. Impact of Diabetes on
Clinical Outcomes after Revascularization
with Everolimus- and SirolimusEluting Stents: A Substudy of the
SORT OUT IV Trial
Anders Junker
10:54 am - TCT-83. Impact of the Development
and Treatment of Critical Limb Ischemia on
Long-term Cardiac Mortality in Diabetic
Patients Treated with Percutaneous
Francesco Liistro
11:07 am - TCT-84. Glycosylated Hemoglobin
and Outcomes in Diabetic Patients with
Acute Myocardial Infarction After
Successful Revascularization
Anand Singla
11:20 am - TCT-85. Three-Year Cardiovascular
Event Rates Were Lower in Type 2 Diabetic
Patients with Pioglitazone Treatment After
Zotarolimus-Eluting Stent Implantation
Soon Jun Hong
85
Tuesday, November 8
11:33 am - TCT-86. Similar Target Lesion
Revascularization In Non-Insulin-Dependent
Diabetic Compared with Nondiabetic
Patients After Bare Metal Stenting in Lesions
Carrying a Low Risk of Restenosis
Pier Woudstra
10:54 am - TCT-94. Results of the ALSTER
Hypertension Registry: First Experience
with Renal Denervation
Martin W. Bergmann
10:28 am - TCT-101. Positive Remodeling Is
Associated with Vulnerable Coronary Plaque
Components Regardless of Clinical
Presentation: Virtual Histology-Intravascular
Ultrasound Analysis
Young Joon Hong
11:46 am - TCT-87. Urine NGAL and IL-18
Identify CI-AKI Early in Patients with DM and
CKD Undergoing Coronary Angiography/PCI
Ayesha Qureshi
11:07 am - TCT-95. Acute and Long-term
Follow-up Results of Renal Angioplasty
in Takayasu Arteritis
Amar Patnaik
11:59 am - TCT-88. Twice Daily Dosing of
Aspirin Is Biologically More Effective in
Patients with Type 2 Diabetes Mellitus and
Coronary Artery Disease
Jean-Guillaume Dillinger
11:20 am - TCT-96. Impact of Preexisting
Cerebral Ischemia Detected by Magnetic
Resonance Imaging and Angiography on
Clinical Outcomes After Coronary Artery
Bypass Graft in Patients Without
History of Stroke
Won-Jang Kim
12:12 pm - TCT-89. Impact of Hyperglycemia in
Myocardial Infarction Undergoing
David Planer
11:33 am - TCT-97. From US Pivotal Study to
1,200 Patients on Six Continents: A Global
Perspective on the Endurant Stent Graft
Brij Maini
12:30 pm - Adjourn
10:15 am-12:15 pm
Room 112
Moderators: Mark W. Burket,
Christopher J. Cooper
Discussants: Alex Abou-Chebl,
Gerald D. Dorros, David B. Jessup,
Takao Ohki
10:15 am - TCT-90. The Impact of BTK Runoff
Score on the Patency After Stenting for
SFA Lesion
Ikki Komatsu
10:28 am - TCT-91. Six-Year Outcomes
Following Endovascular Therapy with Nitinol
Stenting for TransAtlantic Inter-Society
Consensus C-D Lesions in the
Femoropopliteal Segment
Tomoharu Dohi
10:41 am - TCT-93. COMPLIANCE 360:
A Prospective, Randomized, Multicenter
Trial Comparing Balloon Angioplasty to
Diamondback 360�Orbital Atherectomy
System in Calcified Femoropopliteal Disease
Raymond Dattilo
86
program ·
11:46 am - TCT-98. Carotid Artery
Revascularization with Distal Protection in
High Surgical Risk Patients in Routine
Clinical Practice: Results of the CABANA
Safety Surveillance Program
L. Nelson Hopkins
11:59 pm - TCT-99. The SAPPHIRE Worldwide
Carotid Artery Stenting with Embolic
Protection Study: Outcomes to One-Year
with Over 7,600 Patients
12:15 pm - Adjourn
Intravascular Imaging:
Novel Insights
10:15 am-12:30 pm
Room 120
Moderators: Michael Haude, Amir Lerman
Discussants: Hector M. Garcia-Garcia,
Angela Hoye, Habib Samady, Szilard Voros
10:15 am - TCT-100. Neoatherosclerosis and
Late Stent Thrombosis After Coronary Bare
Metal Stent Implantation: An Optical
Coherence Tomography Study
Yuetsu Kikuta
10:41 am - TCT-102. Multiple Plaque Rupture,
Erosion, and Stability as Assessed by
Optical Coherence Tomography (OCT),
Angioscopy, Intravascular Ultrasound (IVUS),
and Coronary Computed Tomographic
Angiography (CT Angiography)
Yukio Ozaki
10:54 am - TCT-103. Head-to-Head Comparison
of the Neointimal Response Between
Metallic and Bioresorbable EverolimusEluting Scaffolds Using Optical
Josep Gomez-Lara
11:07 am - TCT-104. The Impact of Intravascular
Ultrasound Guidance in Routine
Conventional Lesions: Data from the
EXCELLENT Trial
Si-Hyuck Kang
11:20 am - TCT-105. Impact of Tissue Prolapse
on Short- and Long-term Clinical Outcomes
after Stent Implantation in Patients with
Acute Myocardial Infarction: An Intravascular
Ultrasound Analysis
Young Joon Hong
11:33 am - TCT-106. Fate of Sidebranches at 6,
12, and 24 Months After Implantation of
Bioresorbable Scaffolds: Assessment
with 3-Dimensional Optical
Yoshinobu Onuma
11:46 am - TCT-107. Prevalence, Distribution,
Predictors, and Outcomes of Patients
with Calcified Nodules in Native Coronary
Arteries: A Three-Vessel Intravascular
Ultrasound Analysis from PROSPECT
Yingjia Xu
11:59 am - TCT-108. Intraoperative
Shuntography for Immediate Control and
Improvement of Results of Coronary
Bypass Surgery
Bagrat Alekyan
TCT2011
Cardiovascular
Therapeutics
11:46 am - TCT-117. Off-Pump, Transapical
Placement of Artificial Chordae Tendinae
to Correct Mitral Insufficiency: European
Trial Update
Richard C. Daly
11:07 am - TCT-124. Transfemoral Treatment of
Bioprosthetic Aortic Valve Failure:
Suitability of the Medtronic CoreValve
ReValving System
Felix Woitek
12:30 pm - Adjourn
11:59 am - TCT-118. Impact of Severe Left
Ventricular Systolic Dysfunction on Clinical
and Echocardiographic Outcomes Following
Transcatheter Aortic Valve Implantation for
Severe Aortic Stenosis
Claudia Fiorina
11:20 am - TCT-125. Transcatheter Aortic Valve
Implantation for the Treatment of
Degenerative Bioprosthetic Surgical
Valves: Results from the Global VIV
(Valve-in-Valve) Registry
Danny Dvir
12:12 pm - TCT-119. Long-term Follow-up After
Alcohol Septal Ablation for Hypertrophic
Obstructive Cardiomyopathy in Young Adults
Amir-Ali Fassa
11:33 am - TCT-126. Transcatheter Valve-inValve Implantation for Failed Balloon
Expandable Transcatheter Aortic Valves
Stefan Toggweiler
12:30 pm - Adjourn
11:46 am - TCT-127. Low Preprocedural
Transaortic Gradient Predicts Adverse
Clinical Outcome After Transcatheter Aortic
Valve Implantation
Nicolas Amabile
Structural Heart
Disease Intervention
10:15 am-12:30 pm
Room 114
Moderators: Zahid Amin, Bernhard Meier
Discussants: Sheldon Goldberg,
Igor F. Palacios, Matthew J. Price
10:15 am - TCT-110. Follow-up of Patients with
Ostium Secundum Atrial Septal Defect with
Severe Pulmonary Arterial Hypertension
Undergoing Device Closure
Sudhir C. Sinha
10:28 am - TCT-111. Migraine Visual Aura With
or Without Headache: Association with Right
to Left Shunt and Assessment Following
Transcutaneous Closure
M. Khalid Mojadidi
10:41 am - TCT-112. Interim Data from
AMPLATZER�Cardiac Plug Registry
Jai-Wun Park
10:54 am - TCT-113. Safety and Efficacy of
Balloon Atrial Septostomy for Advanced
Pulmonary Hypertension in Patients
Failing Prostanoid Therapy
Brooks Kuhn
11:07 am - TCT-114. Standalone Balloon Aortic
Valvuloplasty: Indications and Outcomes
from the UK in the Transcatheter Valve Era
David Hildick-Smith
11:20 am - TCT-115. Immediate and Long-term
Results of Mitral Balloon Valvuloplasty in
Patients with Severe Pulmonary
Hypertension
Rodrigo Blanco
11:33 am - TCT-116. Long-term Follow-up After
Myocardial Contrast EchocardiographyGuided Alcohol Septal Ablation for
Hypertrophic Obstructive Cardiomyopathy
Amir-Ali Fassa
Replacement I
10:15 am-12:15 pm
Room 131
Moderators: Josep Rodes-Cabau,
John G. Webb
Discussants: Larry S. Dean,
Michael Kang-Yin Lee, Gilles Rioufol,
Thomas Walther
10:15 am - TCT-120. Midterm Outcomes
Following Transcatheter Aortic Valve
Replacement with Both Edwards SAPIEN
and Medtronic CoreValve ReValving
System�Devices According to VARC
Definitions: The Milan Experience
Gill L. Buchanan
10:28 am - TCT-121. Late Structural Integrity of
Balloon Expandable Stents Used for
Transcatheter Aortic Valve Replacement:
Assessment by Multidetector
Computerized Tomography
Alex Willson
10:41 am - TCT-122. Short- and Long-term
Safety and Effectiveness of Transcatheter
Aortic Valve Implantation in a Failing Surgical
Aortic Bioprosthesis
Ralf Mueller
Replacement with Edwards Sapien Valve for
Treatment of Degenerated Bioprosthesis:
UK Sapien User Group Experience
Vinnie Bapat
- N o v e m b e r 8 , 2 0 11
12:12 pm - TCT-109. Arterial Response to
Sirolimus-Eluting Stents with Bioabsorbable
Polymer: First IVUS Report from the
DESSOLVE-I FIM Trial
Kenji Sakamoto
Tuesday
11:59 am - TCT-128. Transaortic Transcatheter
Aortic Valve Implantation Using the Sapiens
Valve for Patients with No Optional Artery
Access: A New Promising Approach
Kentaro Hayashida
12:15 pm - Adjourn
Transcatheter Aortic
Valve Replacement II
10:15 am-12:30 pm
Room 132
Moderators: Georg Lutter, E. Murat Tuzcu
Discussants: Jorge A. Belardi, Reginald I. Low,
Terje K. Steigen
10:15 am - TCT-129. Outcome of Conservative
Management in Patients with Aortic
Valve Stenosis Ineligible for
Transcatheter Treatment
Massimo Napodano
10:28 am - TCT-130. TAVR for High-Risk
Patients with Severe Aortic Stenosis Who
Satisfy All the Criteria for Conventional
Aortic Valve Replacement: A United
Kingdom-Based Cost-Utility Analysis
John Eaton
87
Tuesday, November 8
10:41 am - TCT-131. Transfemoral Transcatheter
Aortic Valve Implantation vs. Surgical Aortic
Valve Replacement in Patients with Severe
Aortic Stenosis
Marco Barbanti
10:54 am - TCT-132. Intracardiac
Echocardiography: A New Guiding Tool for
Transcatheter Aortic Valve Replacement
Thomas Bartel
11:07 am - TCT-133. Management of
Paravalvular Leaks During and After
Transcatheter Valve Replacement
Claudia A. Martinez Bermudez
11:20 am - TCT-134. Immediate Results and
Mid-term Follow-Up of Transcatheter
Closure of Paravalvular Leaks with
Amplatzer Vascular Plug III Device
Manuel Paulo
Replacement with Edwards Sapien Valve
via Transaortic Route: European
Multicenter Experience
Vinnie Bapat
Exhibit Hall Opens
12:00 pm
Lunch will be provided.
Scientific Symposia
(Continued)
Device-Based Approaches
for Heart Failure: Recent
Developments and
New Directions
This session is not CE/CME accredited.
1:00 pm-6:20
Room 123
pm
Session I. Indwelling Pressure Monitoring
for Patients with Advanced Heart Failure
Moderators: Daniel Burkhoff, Ileana L. Piña
Discussants: Maria Rosa Costanzo,
Neal L. Eigler, JoAnn Lindenfeld
1:00 pm - Featured Lecture: Pressure
Monitoring for Patients with Advanced
Heart Failure: Past, Present, and Future
Maria Rosa Costanzo
1:15 pm - CardioMems: Device and Studies
JoAnn Lindenfeld
3:21 pm - New Therapies for Pulmonary
Arterial Hypertension
Irene M. Lang
Session III. Left Ventricular Assist Devices
Moderators: Joseph C. Cleveland,
Maria Rosa Costanzo
Discussants: Renzo Cecere,
Robert D. Dowling, Robert D.B. Jaquiss,
Francis D. Pagani, Joseph G. Rogers,
Matt Romano, Marvin J. Slepian
3:48 pm - Featured Lecture: LVADs:
State of the Art
Francis D. Pagani
4:03 pm - Temporary Left Ventricular Support
During High-Risk PCI: New Insights from
PROTECT II
Jeffrey J. Popma
4:15 pm - SynCardia
Marvin J. Slepian
4:27 pm - The REVIVE-IT Study
Matt Romano
4:39 pm - HeartMate II for “Less Sick” Patients
Joseph G. Rogers
1:27 pm - Savacor: Device and Studies
Neal L. Eigler
11:46 am - TCT-136. Twelve-Month Results from
the CoreValve Transcatheter Aortic Valve
Australia-New Zealand Study
Ian T. Meredith
4:51 pm - CircuLite: Update on the EU Clinical
Study of “Less Sick” Patients
Robert D. Dowling
1:39 pm - Chronic Pressure Monitoring in
Heart Failure: Regulatory Perspectives
Ileana L. Piña
5:03 pm - Sunshine Heart
Renzo Cecere
11:59 am - TCT-137. Comparison of Balloonexpandable and Self-expandable
Bioprosthesis for Transcatheter Aortic
Valve Implantation
Massimo Napodano
12:12 pm - TCT-138. Aortic Annulus Diameter
Determination by Multidetector Computed
Tomography: Reproducibility, Applicability,
and Implications for Transcatheter Aortic
Valve Replacement
Ronen Gurvitch
12:30 pm - Adjourn
1:51 pm - Discussion with Audience Q&A:
Pressure Sensors and Other Technologies
for Keeping Patients Out of Hospital
Session II. Update on Novel Therapies
for Heart Failure
Moderators: JoAnn Lindenfeld,
Joseph G. Rogers
Discussants: David S. Feldman,
Paul J. Hauptman, Irene M. Lang,
Serjan D. Nikolic, Paul A. Sobotka
2:06 pm - Featured Lecture: Novel Devices
for Refractory Heart Failure
William T. Abraham
2:21 pm - Role of Percutaneous Mitral Repair
in Patients with CHF
Olaf Franzen
2:33 pm - Renal Nerve Ablation (Ardian):
Potential for Heart Failure
Paul A. Sobotka
2:45 pm - CardioKinetics: Device and Studies
Serjan D. Nikolic
2:57 pm - BioControl: Device and Studies
Paul J. Hauptman
88
3:09 pm - IMPULSE Dynamics:
Device and Studies
David S. Feldman
program ·
5:15 pm - The CircuLite Percutaenous
Long-term VAD
Daniel Burkhoff
5:27 pm - The HeartWare MVAD
Andreas Brieke
5:39 pm - Right Ventricular Support:
The Need and the Devices
Joseph C. Cleveland
5:51 pm - The Berlin Heart Pediatrics VAD
Robert D.B. Jaquiss
6:20 pm - Adjourn
TCT2011
1:00 pm-6:10
Room 131
pm
1:00 pm - The FDA CREST Analysis:
Data Which Further Defines the Roles
of CEA and CAS
Peter A. Schneider
1:12 pm - Explaining the Differences Between
European and US CAS Trial Results
William A. Gray
1:24 pm - The Case for a Trial of Medical
Therapy vs. Revascularization in
Asymptomatic Patients
Thomas G. Brott
4:23 pm - The Surgical Approaches to and
Indications for Iliofemoral Venous
Obstruction
Anthony J. Comerota
3:08 pm - The Role of the Interventional
Cardiologist in Treating Acute Stroke
Stephen R. Ramee
4:33 pm - Endovascular Management of
SVC Syndrome
Hugo F. Londero
4:43 pm - Results of a Multicenter Registry of
Rheolytic Thrombectomy for DVT
Robert A. Lookstein
Session VIII. Flash Debates: Round Two
Moderators: Gary M. Ansel, Bernhard Reimers
Discussants: Thomas G. Brott,
Anthony J. Comerota, William A. Gray,
Sumaira Macdonald, Issam D. Moussa,
Peter A. Schneider
Flash Debate VI
3:31 pm - Proximal Protection Should Be Used
Whenever Anatomy and Physiology Allow!
Sumaira Macdonald
3:36 pm - The Method of Protection Has No
Meaningful Impact on CAS Outcomes!
Issam D. Moussa
Flash Debate VII
1:32 pm - Risk-Adjusted National Benchmarks
for the Performance of CAS
Jon S. Matsumura
3:45 pm - The Misinterpretation of CREST and
ICSS: CAS Remains Unproven for Standard
Surgical Risk Patients!
Anthony J. Comerota
1:40 pm - Procedure Rehearsal in CAS Can
Improve Procedural Performance and
Reduce the Learning Curve
Isabelle Van Herzeele
3:50 pm - CEA Is No Longer Justifiable in
the Standard Risk Patient Given Results
of CREST!
William A. Gray
1:48 pm - Managing the Asymptomatic
Octogenarian: Who Gets Revascularization,
and How to Reduce Adverse Outcomes?
Gary M. Ansel
1:58 pm - Complications During CAS:
Recognition and Management
2:10 pm - Managing Carotid Access from
Straight-Forward to Complex
Bernhard Reimers
2:20 pm - Is the Carotid String-Sign Off-limits
for Carotid Intervention?
Colin M. Barker
2:30 pm - Characterization of Plaque Prolapse
Following Carotid Artery Stenting by OCT
Bernhard Reimers
2:38 pm - A New Variable (High-Low) Flow
Reversal Catheter for Transcervical
Carotid Intervention
Enrique Criado
2:46 pm - Diffusion Weighted MRI Evaluation
of the Effectiveness of Proximal Protection
(MOMA) During Carotid Stenting: The
DESERVE Prospective Study
Alberto Cremonesi
Flash Debate VIII
3:59 pm - Asymptomatic Patients with Carotid
Stenosis Should Be Treated with Best
Medical Therapy Given Improvements
in Outcomes!
Thomas G. Brott
4:04 pm - The Only Randomized Data That
Exists for the Asymptomatic Patient
Dictates Revascularization!
Peter A. Schneider
Session IX. Venous Therapies
Moderators: Anthony J. Comerota,
Raghu Kolluri
Discussants: Michael D. Dake, Michael R. Jaff,
Paul H. Kramer, Hugo F. Londero,
Robert A. Lookstein, Lindsay S. Machan,
Raghotham R. Patlola, Robert M. Schainfeld,
Mohsen Sharifi
4:13 pm - Venous Anatomy and Duplex
Interpretation for the Interventionalist
Raghotham R. Patlola
4:53 pm - EVISTA-DVT Trial Results of
Endovenous Infrainguinal Stenting for DVT
Mohsen Sharifi
5:03 pm - Should Intervention for Iliofemoral
DVT Be Considered Standard of Care?
Review of the Data
Michael R. Jaff
- N o v e m b e r 8 , 2 0 11
Session VII. Cerebrovascular Intervention
Moderators: Alex Abou-Chebl,
Philip M. Meyers
Discussants: Gary M. Ansel, Colin M. Barker,
Thomas G. Brott, Alberto Cremonesi,
Enrique Criado, William A. Gray,
L. Nelson Hopkins, Jon S. Matsumura,
D. Christopher Metzger, Stephen R. Ramee,
Bernhard Reimers, Peter A. Schneider,
Isabelle Van Herzeele
2:56 pm - Current Interventional Approach
to Acute Stroke (and SAMMPRIS
in Perspective)
L. Nelson Hopkins
Tuesday
(Part 2)
Cardiovascular
Therapeutics
5:13 pm - IVC Filters 101: Indications for Use,
Removal, and Techniques
5:23 pm - The Spectrum of Ablation Options
for Office-Based Saphenous Vein Practice
Lindsay S. Machan
5:33 pm - The Elements Required to Begin a
Successful Practice in Venous Insufficiency
Paul H. Kramer
5:43 pm - Challenges to the Concept of
Chronic Cerebrospinal Venous Insufficiency
(CCSVI): What Is the Way Forward?
Roger M. Greenhalgh
6:10 pm - Adjourn
Hot Topics in Interventional
Cardiology: ACC.11 Highlights
for the Interventional, Invasive,
and General Cardiologist
1:00 pm-6:00
Room 132
pm
Session I. Surgical vs. Nonsurgical
Therapy for CAD
Moderators: James B. McClurken,
Thomas A. Ports
Andrew J. Boyle
1:00 pm - Impact of the STICH Trial on
Revascularization for LV Dysfunction
Andrew J. Boyle
1:12 pm - CABG vs. PCI for Unprotected
Left Main Disease
Edward J. McNulty
1:24 pm - Viability Studies:
Are They Worth the Cost?
Robert O. Bonow
89
Tuesday, November 8
Session II. What’s New in
Systemic Hypertension?
Moderators: Michael H. Crawford,
Patrick T. O’Gara
Discussant: Anthony E. Steimle
2:00 pm - Evaluation of the Patient
with New Hypertension
Paul A. Sobotka
2:12 pm - Current Treatment
Recommendations for Hypertension
Michael H. Crawford
2:24 pm - Hypertension Trials at ACC 2011
Anthony E. Steimle
Session III. Stroke Prevention in
Moderators: David R. Holmes Jr,
E. Murat Tuzcu
Discussants: Lee R. Guterman,
John G. Webb, Jesse Weinberger
3:00 pm - Definition of Stroke
Jesse Weinberger
3:10 pm - Stroke During TAVR,
PCI, and Surgery
John G. Webb
3:20 pm - Impact of Stroke During
Interventional Procedures
Lee R. Guterman
3:30 pm - New Devices for Stroke Prevention
Eberhard Grube
Session IV. Stroke Prevention
in Atrial Fibrillation
Moderators: Ralph G. Brindis, Byron K. Lee
Discussants: Michael D. Ezekowitz,
Peter J. Goadsby, Karl-Heinz Kuck,
Vivek Y. Reddy
4:00 pm - Importance of Stroke Prevention
in Patients with Atrial Fibrillation
Davendra Mehta
4:10 pm - Left Atrial Appendage Occlusion
Vivek Y. Reddy
4:20 pm - What Is the Role of Atrial Fibrillation
Ablation in Stroke Prevention?
Karl-Heinz Kuck
4:30 pm - Risk of Bleeding vs. Stroke,
HAS-BLED and CHADS2, and New
Antithrombotic Agents
Michael D. Ezekowitz
Session V. Genetics and
Pharmacokinetic Assessment
David J. Moliterno
Discussants: Somjot S. Brar,
Germano Di Sciascio, Paul A. Gurbel,
Dietmar Trenk
5:00 pm - Prognostic Importance of
High Platelet Reactivity
Somjot S. Brar
5:10 pm - What Might We Expect from the
TRIGGER-PCI Late BREAKING TRIAL
Presentation? Insights from Public
Domain Data
Dietmar Trenk
5:20 pm - What Is the Optimal Strategy for
Genetic Polymorphism and Platelet
Function Testing?
Paul A. Gurbel
5:30 pm - Is There a Bleeding Risk with
High Platelet Inhibition?
Germano Di Sciascio
6:00 pm - Adjourn
Identifying the High-Risk Patient
and Lesion: From Vulnerable
Plaque to Ischemia and Viability
1:00 pm-6:00
Room 124
pm
Session I. Introductory Lecture
1:00 pm - Conceptual Redesign:
Today’s Culprit vs. Future Culprits:
Ischemia Today vs. Tomorrow
Gregg W. Stone
Session II. What Makes a Coronary
Plaque Vulnerable?
Moderators: Prediman K. Shah,
Robert L. Wilensky
James A. Goldstein, Pedro R. Moreno,
Christodoulos I. Stefanadis, Yasunori Ueda,
Renu Virmani, Szilard Voros
1:10 pm - What Structural Features Predict
Plaque Vulnerability and Future Events?
New 2011 Insights
Renu Virmani
1:22 pm - What Plaque-Intrinsic Biochemical
and Molecular Features Predict Lesion
Vulnerability and Future Events?
New 2011 Insights
Robert L. Wilensky
1:34 pm - Emerging Paradigms in
Atherosclerosis: From Inflammation to
Cholesterol Metabolism
Prediman K. Shah
90
program ·
1:49 pm - 2011 Intravascular Imaging Insights
into Focal Plaque Vulnerability and
Identification: From VH-IVUS to OCT to NIRS
Gary S. Mintz
2:01 pm - 2011 Intravascular Imaging Insights
into Focal Plaque Temporal Stability
Akiko Maehara
2:11 pm - Shear Stress 1: Influences of Low
vs. High Shear Stress on Plaque Progression
Habib Samady
2:21 pm - Shear Stress 2: New Insights
from PREDICTION
Peter H. Stone
2:31 pm - Social Stress-Related Triggers of
Acute Myocardial Infarction and Sudden
Death: Examples and Mechanisms
Robert A. Kloner
2:41 pm - Is Noninvasive Imaging Useful to
Identify Vulnerable Patients for Cardiac
Arrest and MI?
Jeroen J. Bax
2:51 pm - Can MSCT Truly Identify
Vulnerable Plaque?
Udo Hoffmann
3:01 pm - How Far Away Is Noninvasive
Molecular Imaging of Vulnerable Plaque?
Farouc Jaffer
3:11 pm - Does Endothelial Dysfunction
Meaningfully Contribute to Plaque
Vulnerability or Ischemia?
Amir Lerman
3:21 pm - Can We Identify Vulnerable Patients
and Vulnerable Plaque? Do We Know
Enough to Treat High-Risk Lesions?
Discussion with Audience Q&A
Session III. Role of Ischemia in Predicting
Short-term and Late Events
Moderators: John A. Ambrose, Amir Lerman
Discussants: Sripal Bangalore, Sorin J. Brener,
Allen Jeremias, Morton J. Kern, James K. Min,
John A. Spertus, Christodoulos I. Stefanadis,
Pim A.L. Tonino
3:37 pm - Relationship Between Ischemic
Burden and Prognosis (from Death and MI
to Angina and Revascularization)
Leslee J. Shaw
3:47 pm - Might Revascularization of Ischemia
Reduce Death and MI: From Old RCTs (ACIP,
SWISSI II) to New Insights from COURAGE
William E. Boden
3:57 pm - A Reevaluation of the Importance of
Complete Revascularization
Ajay J. Kirtane
Revascularization: What Should
Be the Goal?
Morton J. Kern
TCT2011
4:27 pm - Yes, Until Proven Otherwise!
Judith S. Hochman
1:20 pm - New European Guidelines for Stroke
Prevention in Atrial Fibrillation
Peter Sick
1:30 pm - How Do the New Anticoagulants
Change the Equation of LAA Closure?
Vivek Y. Reddy
4:37 pm - No, Until Proven Otherwise!
Julinda Mehilli
Debate: Most Patients with Atrial
Fibrillation Are Good Candidates for
Anticoagulation
4:47 pm - Design, Rationale, and Status of
the FAMI II Trial
William F. Fearon
1:40 pm - Pro!
4:55 pm - Design, Rationale, and Status of
the ISCHEMIA Trial
David J. Maron
5:03 pm - Relationship Between Ischemia and
Vulnerable Plaque: An Integrated Theory
Bernard De Bruyne
5:13 pm - Is Alleviating Ischemia the Key to
Improving Cardiovascular Prognosis, and
Should This Affect the Practice of PCI
Today? Discussion with Audience Q&A
Session IV. Is Viability (or Its Assessment)
No Longer Essential?
Moderators: Daniel S. Berman, Vladimir Dzavik
Bernard J. Gersh
5:28 pm - STICH Post-Mortem: Is the Glass
Half Empty or Half Full?
Robert O. Bonow
5:38 pm - The Totally Negative STICH Viability
Substudy: Limitations and Historical Context
Bernard J. Gersh
5:48 pm - Should Patients with Severe
Coronary Artery Disease, Depressed LVEF,
and No or Minimal Inducible Ischemia
Undergo Revascularization? Discussion
with Audience Q&A
6:00 pm - Adjourn
Left Atrial Appendage Closure:
Indications, Devices,
and Techniques
1:00 pm-6:20
Room 130
pm
Session I. Background and Basics
Moderators: Peter J. Goadsby, Vivek Y. Reddy
Discussants: Paul S. Chan,
Michael D. Ezekowitz, Peter Sick
1:00 pm - Stroke Risk in Atrial Fibrillation:
Mechanisms and Frequency
Peter J. Goadsby
1:45 pm - Con!
Paul S. Chan
Session II. The Evidence: Results of
Clinical Trials
Moderators: Steven L. Almany,
Howard C. Herrmann
Discussants: David R. Holmes Jr,
Bernhard Meier, Horst Sievert
2:00 pm - Update from PROTECT AF
David R. Holmes Jr
2:10 pm - Emerging Data from Continued
Access and PREVAIL Status
Saibal Kar
2:20 pm - LAA Closure in Patients Who Cannot
Take Warfarin: Results of the ASAP Trial
Horst Sievert
2:30 pm - Update on the ACP Registries
Bernhard Meier
Session III. Imaging for LAA Closure
Moderators: Frank E. Silvestry,
Brian Whisenant
Discussants: Swaminatha V. Gurudevan,
Robert J. Siegel, Nina C. Wunderlich
3:30 pm - LAA Closure with the Watchman:
A Step-by-Step Tutorial
Zoltan G. Turi
3:40 pm - LAA Closure with the Amplatzer
Cardiac Plug: A Step-by-Step Tutorial
Jai-Wun Park
Session V. New LAA Closure Devices
and Techniques
Moderators: James B. Hermiller Jr, Peter Sick
Discussants: A. Marc Gillinov,
David W.M. Muller, Steven J. Yakubov
4:00 pm - Initial Experience with the Gen 4
Watchman: Results from the EVOLVE Trial
Horst Sievert
4:10 pm - The Coherex WaveCrest: Device
Design and Human Results to Date
David W.M. Muller
4:20 pm - SentreHEART Device: Description,
Technique, and Known Outcomes
Steven J. Yakubov
4:30 pm - Other Novel Endocardial and
Epicardial Techniques
Horst Sievert
4:40 pm - Surgical Ligation and AtriCure:
Safety and Acute/Sustained Efficacy
A. Marc Gillinov
Session VI. Difficult Cases and
Troubleshooting
Moderators: David J. Hildick-Smith,
Peter N. Ruygrok
David R. Holmes Jr, Brij Maini,
Ramon Quesada, Vivek Y. Reddy, Peter Sick,
Zoltan G. Turi, Gian Paolo Ussia,
Brian Whisenant, Stephen G. Worthley
5:00 pm - Case Presentation:
Device Embolization
Stephen G. Worthley
2:50 pm - Pre- and Post-procedural TEE
Nina C. Wunderlich
5:07 pm - Device Embolization: Frequency,
Prevention, and Management
David R. Holmes Jr
3:00 pm - Specific Echocardiographic Imaging
Approaches and Angles: A How-to Guide
Robert J. Siegel
5:14 pm - Case Presentation: DeviceAssociated Thrombus
Ramon Quesada
3:10 pm - Lessons Learned from 3-D TEE
Swaminatha V. Gurudevan
5:21 pm - Thrombus on the Device: Origins,
Frequency, and Implications for
Anticoagulation
Brian Whisenant
Session IV. Latest LAA Closure “Approved”
Device Iterations and Device-Specific
Implant Considerations
Moderators: Peter C. Block, Roger J. Laham
Discussants: Jai-Wun Park, Zoltan G. Turi
- N o v e m b e r 8 , 2 0 11
The Great Debate: OAT Was Negative: Do the
Results Extend to STEMI Between 12 and 48
Hours and CTOs with Ischemia?
1:10 pm - Bleeding from Chronic
Anticoagulation: How Large a Problem,
and Who Is at Risk?
Tuesday
4:17 pm - An Observational Study of
Ischemia-Guided vs. Non-Ischemia-Guided
Revascularization in 5,340 Patients with
Multivessel Disease
Young-Hak Kim
Cardiovascular
Therapeutics
5:28 pm - Case Presentation: Persistent LAA
Patency Despite Adequate Device Position
Brij Maini
5:35 pm - Residual Flow: What Does It Mean?
Vivek Y. Reddy
91
Tuesday, November 8
Periprocedural Stroke
Zoltan G. Turi
1:05 pm - Final Lessons from the
NEVO Program
Daniel I. Simon
2:56 pm - Progress with a Zotarolimus-Filled
Stent: Technology and Preclinical Results
Josiah N. Wilcox
5:49 pm - Stroke Early and Late After LAA
Occlusion: Thrombotic, Hemorrhagic, Air
Embolism, and Others
Maurice Buchbinder
1:13 pm - The SYNERGY Stent: Technology,
EVOLVE Design, and Future Directions
Ian T. Meredith
3:03 pm - Sirolimus Elution from a
Nanoparticle-Based Stent (Envision
Scientific): Technology and
Preclinical Results
Heleen van Beusekom
Pericardial Tamponade
Gian Paolo Ussia
6:03 pm - Effusions and
Pericardial Tamponade
Peter Sick
6:20 pm - Adjourn
Next Generation Drug-Eluting
Stents and Bioabsorbable
Scaffolds
12:15 pm-6:00
Room 104
pm
Session I. The Big Picture
Moderators: Martin B. Leon,
Patrick W. Serruys
Discussants: Ian T. Meredith,
John A. Ormiston, Manel Sabate,
Sigmund Silber
Opening Debate: The Promise of Next
Generation AntiRestenotic Devices
12:15 pm - Perspective 1: Durable Polymers
Can Be a Positive Attribute of a Stent!
Elazer R. Edelman
12:23 pm - Perspective 2: Bioabsorbable
Polymers, Polymer-Free Systems, and
Bioabsorbable Scaffolds Will Improve Late
Outcomes and Reduce the Reliance on Dual
Antiplatelet Therapy!
Stefan Verheye
12:31 pm - Perspective 3: How Can the
Current DES Results Get Any Better?
And What Kinds of Trials Will This Take?
Gregg W. Stone
Session II. Representative DES with
Bioabsorbable Polymers
Moderators: Ian T. Meredith, Stefan Verheye
Discussants: Alexandre Abizaid,
Bernard R. Chevalier, Run-Lin Gao,
Daniel I. Simon, Glenn Van Langenhove,
Robert J. Whitbourn
12:47 pm - Lessons from BioMatrix and the
LEADERS Trial at Four Years: Transitioning
into the Global Program
Patrick W. Serruys
12:57 pm - Long-term Insights from the
Nobori Stent Program
Bernard R. Chevalier
92
program ·
1:21 pm - Program Update: Micell
Crystalline Sirolimus Elution from a
Bioabsorbable Polymer
John A. Ormiston
1:29 pm - FIREHAWK Bioabsorbable
Polymer Sirolimus-Eluting Stent: Update
on the First-in-Man, TARGET I, and
TARGET II Studies
Run-Lin Gao
1:37 pm - Program Update: Voclosporin and
Corolimus Elution from a Bioabsorbable
Omega-3 Fatty Acid Carrier
1:45 pm - Program Update: Excella
Novolimus Elution from Bioabsorbable
Polymer-Coated Stents
Alexandre Abizaid
Session III. Representative
Polymer-Free DES
Moderators: Dean J. Kereiakes,
Gregg W. Stone
Discussants: Alexandre Abizaid, Didier Carrie,
Ricardo A. Costa, Run-Lin Gao,
Julinda Mehilli, Heleen van Beusekom,
Josiah N. Wilcox
Session IV. Stents Designed to
Enhance Healing
Moderators: Nicolas A.F. Chronos,
Robert S. Schwartz
Discussants: Henricus J. Duckers,
Michael Haude, Julio C. Palmaz
3:22 pm - Perspectives on the Genous
Anti-CD34 Antibody-Coated Stent: From
HEALING I/II to TRIAS HR to Use During
Primary PCI
Henricus J. Duckers
3:32 pm - A Combination Sirolimus-Eluting
Anti-CD34 Antibody-Coated Stent:
Description and REMEDEE Trial
Michael Haude
3:42 pm - Endothelial Cell Guidance:
Technological Possibilities
Julio C. Palmaz
2:05 pm - The Translumina Yukon ISAR-TEST
Family of Trials: A Synthesis of the
Long-term Trial Results
Julinda Mehilli
Session V. Bioabsorbable Scaffolds
Moderators: Jacques J. Koolen,
Ron Waksman
Hector M. Garcia-Garcia, Antoine Lafont,
Jens Flensted Lassen, Ian T. Meredith,
Patrick W. Serruys, Stefan Verheye,
Renu Virmani, Wojciech Wojakowski
2:17 pm - The BioFreedom DES: Late Results,
Technology Challenges, and Next Steps
Eberhard Grube
4:00 pm - The Promise and Challenges of
Bioabsorbable Scaffolds (As I See It)!
Renu Virmani
2:25 pm - Two-Year Results from the
VESTAsync II Randomized Trial with a
Hydroxyapatite Polymer-Free
Sirolimus-Eluting Stent
Alexandre Abizaid
4:08 pm - Imaging Bioabsorbable Scaffolds:
IVUS, VH, OCT, CTA, and More: From
Research Insights to Clinical Utility
Hector M. Garcia-Garcia
2:33 pm - PAX Polymer-Free Paclitaxel-Eluting
Technology and Clinical Trial Update
Ricardo A. Costa
2:41 pm - The Cre8 Stent (Sirolimus Elution
from Reservoirs in a Carbofilm-Coated
Stent): Device Description and
Clinical Development Program
Didier Carrie
2:49 pm - Experimental and First-in-Man Data
with the BICARE Polymer-Free Dual-Drug
(Sirolimus and Probucol)-Eluting Stent
Run-Lin Gao
4:18 pm - Measurement, Magnitude, and
Clinical Relevance of Coronary Endothelial
Dysfunction After Metallic First and Second
Generation DES
Wojciech Wojakowski
4:26 pm - Assessment and Potential Clinical
Benefits of Restored Late Endothelial
Function After Scaffold Bioabsorption
Ian T. Meredith
4:34 pm - BVS in Simple Lesions: Five-Year
Cohort A and Two-Year Cohort B Results:
Integrated Insights
Patrick W. Serruys
TCT2011
5:08 pm - ELIXIR Novolimus and Myolimus
Elution from a Fully Bioabsorbable Scaffold
Stefan Verheye
5:18 pm - AMS Redesign and Relaunch:
Lessons Applied and Current Status
Jacques J. Koolen
5:26 pm - REVA Redesign and Relaunch:
Lessons Applied and Current Status
Alexandre Abizaid
5:34 pm - ART: Progress with a Novel
Bioabsorbable PLLA Stent
Antoine Lafont
6:00 pm - Adjourn
The Valvular Heart Disease
Summit (Part 2): Mitral
Valve Therapies
1:00 pm-6:00
Room 135
pm
Session I. Guidelines and Global
Developments
Moderators: Blase A. Carabello,
Allan Schwartz
Discussants: David H. Adams,
Robert O. Bonow, James S. Gammie,
Maurice E. Sarano, Alec Vahanian
1:00 pm - Critical Appraisal of the Latest MR
Guidelines 1: Distinguishing Fact from
Evidence Level C Opinion
Robert O. Bonow
1:10 pm - Critical Appraisal of the Latest MR
Guidelines 2: A Future Wish List
David H. Adams
1:20 pm - MR Therapy Trends in the
United States (DMR and FMR) 1:
Mayo Clinic Perspectives
Maurice E. Sarano
1:30 pm - MR Therapy Trends in the
United States (DMR and FMR) 2:
Insights from the STS Database
James S. Gammie
1:40 pm - MR Therapy Trends in Europe
(DMR and FMR): Nontreatment,
MitraClip, and Surgery
Alec Vahanian
2:00 pm - How Often Is MV Repair Done
(And What Are the Predictors)?
James S. Gammie
2:10 pm - Pros and Cons of Early Surgery
in Asymptomatic MR
Allan Schwartz
2:20 pm - Long-term Durability of Valve
Repair/Replacement
Alfredo Trento
2:30 pm - MitraClip for High-Risk DMR:
Data and Perspectives
Ted Feldman
2:40 pm - MitraClip for Low-Risk DMR:
Data and Perspectives
Saibal Kar
2:50 pm - DMR Therapies: Case Presentation
Michael J. Rinaldi
Session III. Functional Mitral
Regurgitation Controversies
Moderators: Paul A. Grayburn,
Patrick T. O’Gara
Discussants: William T. Abraham,
Michael Argenziano, Steven F. Bolling,
Olaf Franzen, Samir R. Kapadia, Alfredo Trento
3:10 pm - Nonvalvular Therapies for
FMR 1: Revascularization (Efficacy
and Patient Selection)
Samir R. Kapadia
3:20 pm - Nonvalvular Therapies for
FMR 2: CRT
William T. Abraham
Debate: TODAY, the Non-revascularizable
Patient with Severe FMR Should as First-Line
Therapy be Treated with. . . .
3:30 pm - Surgery!
Steven F. Bolling
3:38 pm - MitraClip!
Olaf Franzen
3:46 pm - Medical Therapy (With or
Without CRT)!
Patrick T. O’Gara
3:54 pm - Recurrent MR After Mitral Valve
Surgery or MitraClip in FMR: Frequency,
Implications, and Management Options
Michael Argenziano
4:04 pm - FMR Therapies: Case Presentation
Alfredo Trento
Session IV. MitraClip Considerations
Moderators: Howard C. Herrmann,
Corrado Tamburino
Discussants: Olaf Franzen, Linda D. Gillam,
James B. Hermiller Jr, Saibal Kar,
Wolfgang Schillinger, Robert J. Siegel,
Frank E. Silvestry, Frederick G. St. Goar
4:29 pm - Lessons from Imaging: Patient
Selection and Procedural Guidance to
Optimize MitraClip Outcomes
Robert J. Siegel
4:39 pm - Grading MR After the MitraClip
(And Valve Interventions in General)
Frank E. Silvestry
- N o v e m b e r 8 , 2 0 11
4:58 pm - Case Review Lessons from the BVS
Program: The Good, the Bad, and the Ugly
John A. Ormiston
Session II. Degenerative Mitral
Regurgitation Controversies
Moderators: David H. Adams, Scott Lim
Case Presenter: Michael J. Rinaldi
Discussants: Ted Feldman, James S. Gammie,
Saibal Kar, Allan Schwartz, Alfredo Trento
Tuesday
4:46 pm - Special Lecture: BVS in Complex
Lesions: First Results from ABSORB Extend
Alexandre Abizaid
Cardiovascular
Therapeutics
4:49 pm - Impact of Residual MR After
Mitral Valve Surgery vs. MitraClip
Linda D. Gillam
4:59 pm - MitraClip Learning Curve: What
Have We Learned from the EU Experience?
Olaf Franzen
5:09 pm - MitraClip Use Outside of the
Standard EVEREST Clinical and
Anatomic Indications
Wolfgang Schillinger
5:19 pm - MitraClip Complications (Acute
and Chronic): Frequency, Avoidance,
and Management
Saibal Kar
5:29 pm - How Can the Current Generation
MitraClip Be Improved?
Frederick G. St. Goar
5:39 pm - Challenging MitraClip
Case Presentation
6:00 pm - Adjourn
Translational Research and
First-in-Human Studies for
Emerging Cardiovascular
Technologies
1:00 pm-6:00
Room 125
pm
Emerging DES Platforms
Moderators: Greg L. Kaluza,
Robert S. Schwartz
Elazer R. Edelman, Andrew Farb,
Aloke V. Finn, Giulio Guagliumi
1:00 pm - Experimental Strategies, Models,
and Challenges in the Evaluation of
Emerging DES Platforms (Safety
and Efficacy)
Nicolas A.F. Chronos
93
Tuesday, November 8
1:10 pm - Surrogate Endpoints in FIH DES
Trials: From OCT Surrogates of Healing to
Measures of Efficacy
Giulio Guagliumi
TAVR
Moderator: Eberhard Grube
Discussants: Andrew Farb, Aloke V. Finn,
E. Murat Tuzcu, John G. Webb, Larry L. Wood
1:20 pm - Evolving Towards Polymer-Free DES
Platforms: Balancing Efficacy and
Thrombotic Risk
Alexandre Abizaid
4:00 pm - A Technological Overview of
Emerging Aortic Valve Concepts
John W. Karanian
1:30 pm - Do Polymers on Stents Add Risk
or Safety? New Experimental Insights
Elazer R. Edelman
4:10 pm - Experimental Considerations and
Challenges in the Validation Process of
Percutaneous Valve Technologies 1:
From Design to Bench Testing
Larry L. Wood
Totally Bioabsorbable Scaffolds
Moderators: Antoine Lafont, Ron Waksman
Discussants: Andrew Farb, Syed Hossainy,
Greg L. Kaluza, John A. Ormiston
4:20 pm - Experimental Considerations and
Challenges in the Validation Process of
Percutaneous Valve Technologies 2:
Animal Models
Renu Virmani
2:00 pm - Emerging Concepts, Polymer
Formulations, and Stent Designs:
Do They Address Current Limitations
of the Technology?
Patrick W. Serruys
4:30 pm - Surrogate Endpoints for the
Validation of TAVR Safety and Efficacy
in FIH Studies
John G. Webb
2:10 pm - Mechanistic Role of Structural
Vascular Support: The Good and Bad of
Permanent vs. Temporary Scaffolds
Syed Hossainy
2:20 pm - Evaluation of Mechanical Integrity
and Degradation Patterns of Bioabsorbable
Stents in Animal Models
Greg L. Kaluza
2:30 pm - Lessons Learned from FIH
Bioabsorbable Scaffolds: The Good,
the Bad, and the Ugly
John A. Ormiston
Drug Coated Balloons
Moderators: Elazer R. Edelman,
Juan F. Granada
Discussants: Andrew Farb, Michael R. Jaff,
Greg L. Kaluza
3:00 pm - DCB Validation Strategies:
Bench Testing, In Vivo PK, and Beyond
Elazer R. Edelman
3:10 pm - First Generation DCB: Preclinical
Indications of Suboptimal Formulation
Greg L. Kaluza
Renal Artery Denervation Therapies
Moderators: Krishna J. Rocha-Singh,
Horst Sievert
Discussants: John W. Karanian,
Serge Roussel, Dierk Scheinert,
Paul A. Sobotka
5:00 pm - Experimental Pathways for the
Evaluation of Perirenal Nerve Distribution,
Density, and Quantification
Serge Roussel
5:10 pm - Preclinical Investigation of
Non-blood Pressure Related Effects of Renal
Artery Denervation (Glucose Homeostasis,
Ovarian Function, etc.)
Paul A. Sobotka
5:20 pm - New Therapeutic Alternatives
and Delivery Approaches
Horst Sievert
5:30 pm - Clinical Considerations for the
Design of FIH Clinical Studies
Krishna J. Rocha-Singh
6:00 pm - Adjourn
3:20 pm - Second Generation DCB:
Improving Dosing, Transfer Uniformity,
and Particulate Formation
Juan F. Granada
3:30 pm - Selecting the Proper
Endpoints in FIH SFA Trials: Imaging
Assessment vs. Functional
Michael R. Jaff
94
program ·
Transradial Angiography
and Intervention: From
Basic to Advanced
1:00 pm-6:00
Room 134
pm
Session I. Transradial Fundamentals I
Moderators: Ronald Caputo, Varinder P. Singh
Discussants: Francesco Burzotta,
Mauricio G. Cohen, Ian C. Gilchrist,
Martial Hamon, Samir B. Pancholy,
Jennifer A. Tremmel, Zoltan G. Turi
1:00 pm - Historical Perspectives on
Transradial PCI: Where We’ve Been
and Where We’re Headed
Zoltan G. Turi
1:10 pm - Patient Setup and Arterial Access
for Right and Left Radial (Including Tests of
Radial-Ulnar Patency)
Mauricio G. Cohen
1:20 pm - Upper Extremity Venous Access
and Procedure
Ian C. Gilchrist
1:30 pm - From Wrist to Coronaries: Basics,
Managing Loops, Tortuosity, and Spasm
Martial Hamon
1:45 pm - Diagnostic and Guide Catheter
Choices and Manipulation from the Radial
Artery for Native and Graft Vessels
Francesco Burzotta
2:00 pm - Hemostasis and Radial
Artery Patency
Samir B. Pancholy
2:10 pm - Case Presentation: Overcoming
Numerous Transradial Problems
Jennifer A. Tremmel
Session II. Transradial Fundamentals II
Moderators: Martial Hamon, Tejas Patel
Discussants: Vladimir Dzavik, Tift Mann,
Ramon Quesada, Stéphane Rinfret,
Varinder P. Singh
2:35 pm - Dealing with Complications of
the Radial Approach
Varinder P. Singh
2:45 pm - Case Presentation: A Major
Transradial Vascular Complication
Stéphane Rinfret
2:55 pm - Anticoagulation Strategies
for Transradial Diagnostic and
Interventional Cases
Tift Mann
3:05 pm - Transradial Primary PCI: Tips
and Tricks for Success
Tejas Patel
TCT2011
Special Sessions
SCAI ELM Program in
Partnership with ACC and CRF
7:00 am-1:00
Room 238
Session III. Advanced Concepts in
Transradial PCI
Moderators: Olivier F. Bertrand, Sunil V. Rao
Discussants: Asim Cheema,
Sanjay Kumar Chugh, Douglas G. Fraser,
Sudhir Rathore, Alessandro Sciahbasi
3:50 pm - The Sheathless Approach for
Transradial PCI
Douglas G. Fraser
4:00 pm - Minimizing Radial Artery Injury
Sudhir Rathore
4:10 pm - Radiation Exposure: Lessons
from the TALENT Trial
Alessandro Sciahbasi
4:20 pm - Anticipating Failure: Role of Arm
Imaging Prior to Arterial Access
Sanjay Kumar Chugh
4:30 pm - The Transradial Learning Curve
Asim Cheema
Session IV. Clincial Investigation in
Transradial PCI
Moderators: James Nolan, Marco Valgimigli
Discussants: Ivo Bernat, Olivier F. Bertrand,
Sanjit S. Jolly, Sunil V. Rao
4:55 pm - Lesson from the RIVAL Trial:
A Critical Appraisal
Sanjit S. Jolly
5:05 pm - A Randomized Trial of Radial vs.
Femoral Approaches for Primary PCI
Ivo Bernat
5:15 pm - Study of Access Site for
Enchancement of PCI for Women
(SAFE-PCI for Women)
Sunil V. Rao
5:25 pm - The EASY B2B Trial
Olivier F. Bertrand
5:35 pm - The REAL Registry and the
MATRIX Trial
Marco Valgimigli
6:00 pm - Adjourn
Please note this session is by invitation only.
pm
Program Year 1, Training Session 2
This program is supported by unrestricted
educational grants from ABIOMED,
AGA Medical, and GE Healthcare.
ELM Faculty
Srihari S. Naidu, MD (Chair)
Tyrone J. Collins, MD
Morton J. Kern, MD
Douglas Levy, MD
Michael J. Lim, MD
George W. Vetrovec, MD
Shelley Wood
ELM Mentors
George G. Dangas, MD, PhD
Cindy L. Grines, MD
Thomas K. Jones, MD
Morton J. Kern, MD
Ramon Quesada, MD
Gregg W. Stone, MD
ELM Fellows
J. Dawn Abbott, MD
Mauricio G. Cohen, MD
Allen Jeremias, MD, MSc
Navin K. Kapur, MD
Lynn Peng, MD
Duane S. Pinto, MD
Paul Sorajja, MD
Jennifer A. Tremmel, MD
Thomas M. Tu, MD
7:00 am - Breakfast
7:25 am - ELM Program Update
Srihari S. Naidu
7:30 am - Podium Presentation Skills Training
Panel
10:00 am - Intro to Working with the Media
Shelley Wood
1:00 pm - Adjourn
Japan-US Synergies for Medical
Device Innovation: A
Harmonization by Doing (HBD)
Educational Symposium
8:00 am-12:00
Room 270
pm
Part I. The Japan-US Medical
Device Landscape
Gary Thompson
Discussants: Ashley B. Boam, Andrew Farb,
Koji Ikeda, Fumiaki Ikeno, Takeshi Kimura,
Paul A. LaViolette, Shigeru Saito,
Huay Cheem Tan, Takahiro Uchida
- N o v e m b e r 8 , 2 0 11
3:25 pm - Transradial Approach for
Unprotected Left Main PCI
Vladimir Dzavik
12:00 pm - Roundtable Discussion:
Avoiding and Surmounting Obstacles
to Leadership
Tuesday
3:15 pm - Transradial Approach for Chronic
Total Occulsions
Stéphane Rinfret
Cardiovascular
Therapeutics
8:00 am - Uncertainties, Concerns, and the
Innovation Landscape: An Industry View
Paul A. LaViolette
8:10 am - MHLW/PMDA-US FDA HBD Pilot
Program Initiative
Ashley B. Boam
8:20 am - Heart Disease Speaks Both
Japanese and English: Working Together Is
Better for Patients, Better for Industry, Better
for Regulators
Shigeru Saito
Part II. Coronary Stent Innovation:
Biological Poolability East and West
Moderators: Andrew Farb, Shigeru Saito
Discussants: Keith D. Dawkins, Rié Fukaya,
Fumiaki Ikeno, Mitchell W. Krucoff,
Manuela Negoita, Thomas J. Povsic,
Huay Cheem Tan, Gary Thompson
9:00 am - Bioabsorbable Stent Platforms: The
Vision and New Questions in Eastern and
Western Patients
Richard J. Rapoza
9:10 am - Endothelial Progenitor Cell Capture:
The Vision and New Questions In Eastern
and Western Patients
Mitchell W. Krucoff
9:20 am - “Japan First”: Single Global Trials
and Other Options
Rié Fukaya
10:30 am - Media Training and Advanced
Public Speaking
Douglas Levy
95
Tuesday, November 8
Part III. Structural Heart Disease and
Devices In Japan and United States
Moderators: Koji Ikeda, Fumiaki Ikeno
Discussants: Jodi Akin, Ashley B. Boam,
Andrew Farb, Rié Fukaya, Mitchell W. Krucoff,
Manuela Negoita, David G. Reuter,
Stanton J. Rowe, Shigeru Saito,
Kazuhiro Sase, Huay Cheem Tan,
Gary Thompson, Takahiro Uchida
10:00 am - LVAD and Artificial Hearts:
Combining Postmarket Safety Information to
Support Ongoing Innovation
Kazuhiro Sase
10:10 am - TAVR: Similarities and Differences
in the United States and Japan
Jodi Akin
10:20 am - Percutaneous Therapy for Mitral
Regurgitation and Heart Failure:
Similarities and Differences In
the United States and Japan
Fumiaki Ikeno
Part IV. Peripheral Vascular Intervention,
East and West
Moderator: Ashley B. Boam
Discussants: Peter C. Block, Nabil Dib,
Andrew Farb, Neal Fearnot, Rié Fukaya
Koji Ikeda, Mitchell W. Krucoff,
Manesh R. Patel, Shigeru Saito,
Robert Thatcher
11:00 am - Japan-US Study of DES for PAD:
Lessons Learned
Neal Fearnot
11:10 am - Consensus Definitions in PAD:
A Global Need
Manesh R. Patel
11:20 am - Regulatory Issues for PAD Devices
Rié Fukaya
12:00 pm - Adjourn
Presentation Theater
South
12:30 pm-1:30 pm
Santa Rosa Valley (Exhibit Hall)
Please see page 150 for the Presentation
Theater schedule.
Special Twilight
Sessions
Drug-Eluting Stent vs.
Stent Studies
6:00 pm-8:00 pm
Room 121
Moderators: Stephen G. Ellis, Alan C. Yeung
Discussants: Bernard R. Chevalier,
Nicolas A.F. Chronos,
Jose M. de la Torre Hernandez, Jorge Gaspar,
Christoph A. Kaiser, Young-Hak Kim,
Pedro A. Lemos, Tift Mann
6:00 pm - LONG-DES IV: A Prospective,
Randomized Trial of Zotarolimus-Eluting
Stents and Sirolimus-Eluting Stents in
Patients with Long Coronary Artery Lesions
Seung-Jung Park
6:15 pm - LEADERS Four-Year: A Prospective,
Randomized Trial of a Bioabsorbable
Polymer-Based Biolimus-Eluting Stent vs.
a Durable Polymer-Based SirolimusEluting Stent
Thomas A. Ischinger
6:30 pm - SORT OUT IV 2-Year: A Prospective,
Randomized Trial of an Everolimus-Eluting
Stent and a Sirolimus-Eluting Stent
Lisette Okkels Jensen
6:45 pm - PRECOMBAT-2: A Multicenter
Case-Controlled Registry of EverolimusEluting Stents vs. Sirolimus-Eluting Stents in
Patients with Unprotected Left Main Disease
Seung-Jung Park
7:00 pm - XIENCE Prime: A Prospective,
Multicenter, Single-Arm Study of a New
Cobalt Chromium Everolimus-Eluting Stent
Marco A. Costa
7:15 pm - RIBS III: A Prospective, Multicenter,
Registry of the Use of Same or Different
Stents After Coronary Drug-Eluting Stent
Restenosis
Fernando Alfonso
7:30 pm - APICE-OCT: A Prospective,
Multicenter, Randomized Trial of
Zotarolimus-Eluting Stents and EverolimusEluting Stents in Patients with Acute
Coronary Syndromes
Alaide Chieffo
7:45 pm - A Prospective, Multicenter,
Randomized Trial of the Early Healing of
Four Types of Stents Assessed by Optical
Ladislav Groch
8:00 pm - Adjourn
How to Treat Complex Lesions
6:00 pm-8:00 pm
Room 114
Moderator: Yang-Soo Jang
Discussants: In-Ho Chae, Yun-Kyeong Cho,
Woong-Chul Kang, Byoung-Kwon Lee,
Jong-Seon Park, Sang-Yeob Yim
6:00 pm - Introduction
Yang-Soo Jang
Session I. Complex Multivessel Disease
PCI in a Diabetic Patient
6:05 pm - Case Presentation
Yun-Kyeong Cho
6:10 pm - How Would I Treat?
Sang-Yeob Yim, Byoung-Kwon Lee
6:30 pm - How Did I Treat?
Yun-Kyeong Cho
6:50 pm - Consensus
Yang-Soo Jang
Session II. Complex Disease PCI in a
STEMI Patient
6:55 pm - Case Presentation
Woong-Chul Kang
7:00 pm - How Would I Treat?
In-Ho Chae, Jong-Seon Park
7:20 pm - How Did I Treat?
Woong-Chul Kang
7:40 pm - Consensus
Yang-Soo Jang
96
program ·
TCT2011
8:00 pm - Adjourn
6:00 pm-8:00 pm
Room 113
Moderators: Run-Lin Gao,
Martin B. Leon, Gregg W. Stone
Discussants: YunDai Chen, Antonio Colombo,
Eberhard Grube, Ajay J. Kirtane,
Shuzheng Lu, Roxana Mehran, Shubin Qiao,
Bo Xu, Ruiyan Zhang
7:53 pm - Tips and Tricks in Management
of Severe PCI Complications
Ruiyan Zhang
8:00 pm - Adjourn
Challenge I. How to Treat Difficult
Bifurcation Lesions
6:00 pm - A Complex True Bifurcation Lesion
Case Presenter: Weimin Wang
6:00 pm - Opening Remarks
Juan F. Granada
6:02 pm - Interventional Cardiology in
the Russian Federation: “The Last Decade”
Bagrat Alekyan
Challenge II. How to Treat a Complex
CTO Lesion
6:24 pm - Retrograde CTO Angioplasty
Case Presenter: Lei Ge
6:41 pm - Tips and Tricks in CTO Angioplasty
Yaling Han
Challenge III. How to Treat a
Treacherous Left Main Lesion by the
Transradial Approach
7:05 pm - Tips and Tricks in Left Main
Stenting by the Transradial Approach
Yuejin Yang
6:51 pm - Case Presentation: Atypical
Use of Occluders
Alexander G. Osiev
Challenge IV. How to Manage a Difficult
Patient with STEMI
6:56 pm - Mini-Lecture: Indications and
Tips and Tricks with Occluders
Bagrat Alekyan
7:36 pm - Nightmare in the Cath Lab
Case Presenter: Haichang Wang
Programs schedule.
Difficult LAA Occlusion
Saibal Kar
Challenge V. How to Treat a Major
Complication During PCI
pm -10:00 pm
7:29 pm - Tips and Tricks During Primary
PCI for STEMI
Hongbing Yan
7:00
6:12 pm - Mini-Lecture: Device Selection
and Tips and Tricks for ASD Closure
Ziyad M. Hijazi
6:34 pm - Mini-Lecture: Tips and Tricks in
LAA Deployment
William A. Gray
Evening Programs
Atrial Septal Defect
Alexey Protopopov
6:48 pm - Distal LM Bifurcation
Case Presenter: Guosheng Fu
7:12 pm - STEMI with Large, Refractory
Thrombus Burden
Case Presenter: Lefeng Wang
8:00 pm - Adjourn
TCT Russia: Focused Session
on Endovascular and
Structural Heart Disease
6:00 pm-8:00 pm
Room 122
Moderators: Bagrat Alekyan, Juan F. Granada,
Gary S. Mintz
Discussants: Vladimir Ganyukov,
Barry T. Katzen, Zaza Kavteladze,
Alexander Nikanorov, Alexander G. Osiev,
Alexey Protopopov, Brian Whisenant
6:17 pm - Tips and Tricks in Bifurcation PCI
Michael Kang-Yin Lee
7:40 pm - Mini-Lecture: The Complex SFA
Environment: Biomechanics, Biological
Considerations, and Beyond
Alexander Nikanorov
- N o v e m b e r 8 , 2 0 11
CIT in Partnership with TCT:
Challenging Cases in
Clinical Practice
Tuesday
7:45 pm - Conclusions
Yang-Soo Jang
Cardiovascular
Therapeutics
7:13 pm - Case Presentation: Percutaneous
Repair of Thoracic Aortic Aneurysms
Vladimir Ganyukov
7:18 pm - Mini-Lecture: Tips and Tricks
During TAA Repair
Sergey A. Abugov
7:35 pm - Case Presentation: A Complex
Case of SFA Intervention
Zaza Kavteladze
97
RESEARCH
F O U N D AT I O N
Skirball Research Center
Redefining Preclinical Cardiovascular
Translational Research
The goal of translational
The Jack H. Skirball Center for Cardiovascular Research (SCCR) is a state-of-the-art
research is to bring an innovative
facility dedicated to the investigation of novel concepts, treatments, and devices.
concept into the arena of human
Our team of interventionalists, surgeons, and pathologists guide early ideas and
clinical trials. Our scientists and
physicians develop the strategies
needed to navigate and facilitate
this process.
inventions through comprehensive research programs in order to introduce practical
clinical therapies to patients.
SCCR is the starting point for technological advances that will ultimately improve
the lives of those suffering from cardiovascular disease and is defined by
innovative thinking.
Translational Research
Research Cores
• Biotechnology validation
• Emerging vascular interventions
• Independent research
• Applied cardiovascular imaging
• Professional education
• Regenerative interventional therapies
• Invention
• Interventional vascular biology
• Emerging cardiovascular concepts
TCT2011
Cardiovascular
Therapeutics
Major Halls
Main Arena............................................................................................... 100
How to Treat Theater: Coronary Artery Disease....................................... 101
How to Treat Theater: Endovascular and Structural Heart Disease.......... 102
Challenging Case Theater........................................................................ 103
International Society-Sponsored Case Theater........................................ 103
Maintenance of Certification (MOC) Course........................... 104
Core Training Curriculum in Clinical Research.......................................... 104
Deep Dive: Stroke Prevention Therapies.................................................. 105
Innovative Surgical Techniques and Technologies.................................... 106
International Debating Chamber: Interventional Cardiology on Trial......... 106
Presentation Theaters..................................................................... 155
TCT for Surgeons............................................................... 106, 111, 114
Lunchtime Sessions
Hot Topics................................................................................................ 107
Learn the Technique................................................................................. 109
Aortic Endografts and Aneurysm Repair ................................................. 111
Integrating IVUS and FFR to Improve PCI Outcomes............................... 112
Next Generation Transcatheter Mitral Valve Therapies............................. 112
Clinical Cardiovascular Genetics and the
Era of Personalized Medicine................................................................... 114
Focus on India: Interactive Case Review and Panel Discussion............... 115
Korean Interventional Summit.................................................................. 116
Special Circulation Journal Session: The Most Important
Interventional Papers from the Last Year.................................................. 116
san francisco, ca
Partnership Session: JIM at TCT.............................................................. 115
·
Featured Clinical Research III. Drug-Eluting Stents,
Drug-Coated Balloons, and PCI Pharmacology....................................... 115
November 9, 2011
Valvular and Structural Heart Disease...................................................... 114
the Moscone Center
Optimizing Use of Today’s Antithrombotic and Antiplatelet
Drugs in ACS, PCI, and Atrial Fibrillation.................................................. 113
Wednesday
Breakfast Meetings........................................................................... 152
99
Breakfast Meetings
7:00
am -8:00 am
Meetings schedule.
Main Arena
Moderators: Martin B. Leon, Gregg W. Stone
Plenary Session I. Live Cases I
Live Case Moderator: Martin B. Leon
Live Case Co-Moderator: Martyn R. Thomas
Live Case Discussants: Alaide Chieffo,
Ulrich J. Gerckens, Sheldon Goldberg,
John McB. Hodgson, Thomas K. Jones,
Takeshi Kimura, Jan Kovac, John A. Ormiston,
Jeffrey J. Popma, E. Murat Tuzcu,
Stephen G. Worthley
8:00 am - St Thomas’ Hospital
8:45 am - NewYork-Presbyterian Hospital/
New York, NY
Plenary Session II.
Transcatheter Aortic
Valve Replacement
Moderators: Robert O. Bonow,
Michael J. Mack
Discussants: Blase A. Carabello,
Eberhard Grube, D. Craig Miller,
Allan Schwartz
9:30 am - Spotlight Lecture: Complications
After TAVR: Achilles’ Heel or Manageable
in the Future?
Martin B. Leon
TCT Interventional Corner I. The Future of
TAVR: Cautious vs. Rapid Adoption
Discussants: Craig R. Smith, E. Murat Tuzcu
9:45 am - A Surgeon’s Perspective
Craig R. Smith
9:55 am - The Interventionalist’s Viewpoint
E. Murat Tuzcu
10:05 am - Discussion and Rebuttal
10:15 am - Synthesis
Patrick T. O’Gara
Plenary Session III.
TCT 2011 Revolutions
Moderator: Gregg W. Stone
10:20 am - TCT 2011 Welcome
Martin B. Leon, Gregg W. Stone
program ·
Focus on PCI Pharmacology and
Stent Thrombosis II
12:15 pm - RAPID GENE: A
Prospective, Randomized
Trial of Prasugrel vs.
Clopidogrel in CYP2C19*2
Carriers Identified by Rapid
Point-of-Care Genotyping
10:40 am - TCT 2011 Keynote Address:
The Future of Humankind
Michio Kaku
Plenary Session IV. TCT 2011
Career Achievement Award
8:00 am-6:00 pm
Esplanade Ballroom
100
10:25 am - Incidence and Epidemiology
of Cardiovascular Disease: A National
(and International) Success Story
Lee Goldman
11:15 am - Presentation of the TCT 2011
Career Achievement Award
Award Presenter: Martin B. Leon
Award Recipient: Eric J. Topol
Plenary Session V. Late
Breaking Clinical Trials and
First Report Investigations I
Moderator: E. Magnus Ohman
Discussants: Dominick J. Angiolillo,
Laurent Bonello, David P. Faxon,
Paul A. Gurbel, Neal S. Kleiman,
David F. Kong, Roxana Mehran,
Shamir R. Mehta, Michelle O’Donoghue,
Derek So, Gregg W. Stone,
Jurrien M. Ten Berg, Eric J. Topol,
Dietmar Trenk
Focus on PCI Pharmacology and
Stent Thrombosis I
11:30 am - ADAPT-DES: A
Large-Scale, Prospective,
Examining the Relationship
of Platelet Responsiveness
to Stent Thrombosis
After DES Implantation
Gregg W. Stone
11:40 am - DESERT: A
Large-Scale, Multicenter,
Case-Controlled Study
Examining the Predictors of
Stent Thrombosis
Ron Waksman
11:50 am - PARIS: A
Large-Scale, Prospective,
Studying the Patterns of
and Reasons for
Nonadherence to
Antiplatelet Agents in Stented Patients
Roxana Mehran
Strengths, Limitations, and Implications
of These Studies
Derek So
12:25 pm - TRIGGER-PCI: A
Trial of Prasugrel vs.
Clopidogrel in ClopidogrelHyporesponsive Patients
with Stable Ischemic Heart
Disease Undergoing Percutaneous
Dietmar Trenk
12:35 pm - BRIDGE: A
Prospective, Double-Blind,
Multicenter, Randomized
Placebo-Controlled Trial of
Intravenous Cangrelor
in Patients Awaiting
Surgery
Dominick J. Angiolillo
of These Studies
Plenary Session VI.
Live Cases II
Live Case Moderator: Gregg W. Stone
Live Case Co-Moderator: Patrick W. Serruys
Live Case Discussants:
W. Randolph Chitwood Jr, Alain G. Cribier,
Marc D. Feldman, Eberhard Grube,
Ajay J. Kirtane, Jean-Claude Laborde,
Michael J. Mack, Ian T. Meredith,
Jonathan M. Tobis, Olaf Wendler,
Stephan Windecker
1:00 pm - St. Paul’s Hospital/University
of British Columbia
Vancouver, Canada
1:45 pm - University of Colorado Health
Sciences Center
Denver, CO
Plenary Session VII. Coronary
Revascularization Updates
Moderators: Bernard J. Gersh,
Joseph F. Sabik
Discussants: William E. Boden,
Ralph G. Brindis, David J. Cohen,
Mark Andrew Hlatky, Ajay J. Kirtane,
David J. Maron, Harry R. Phillips,
David Taggart
TCT2011
2:30 pm - Strengths, Limitations, and the
Raison d’Être for Appropriateness Criteria
Manesh R. Patel
TCT Interventional Hot Topic II. Chronic
Cerebrospinal Venous Insufficiency
(CCSVI) for Multiple Sclerosis
5:30 pm - Chronic Cerebrospinal Venous
Insufficiency (CCSVI) for Multiple Sclerosis
Michael D. Dake
5:45 pm - Current Perspectives and
Future Expectations
Barry T. Katzen
6:00 pm - Adjourn
3:05 pm - Spotlight Lecture: Clinical
Decision-Making in Patients with
Multivessel and Left Main Disease
David E. Kandzari
Plenary Session VIII.
Live Cases III
Live Case Co-Moderator: Hans Krankenberg
Live Case Discussants: Steven R. Bailey,
Rafael Beyar, Giancarlo Biamino,
Bernard R. Chevalier, Run-Lin Gao,
Michel Henry, Lindsay S. Machan,
Ashok Seth, Ron Waksman,
Michael H. Wholey, Jay S. Yadav
3:30 pm - University of California, Davis
Medical Center
Sacramento, CA
4:15 pm - Cedars-Sinai Medical Center
Los Angeles, CA
Plenary Session IX.
Endovascular Horizons
Moderators: Barry T. Katzen, Jeffrey W. Olin
Discussants: Michael R. Jaff,
Lindsay S. Machan, Harry R. Phillips,
Stephen R. Ramee, Krishna J. Rocha-Singh,
Paul A. Sobotka, Adam Witkowski
TCT Interventional Hot Topic I.
Transcatheter Renal Nerve Denervation
for Refractory Hypertension
5:00 pm - Transcatheter Renal Nerve
Denervation for Refractory Hypertension
Henry Krum
5:15 pm - Current Perspectives and
Future Expectations
Murray D. Esler
How to Treat Theater:
Coronary Artery
Disease
8:00 am-6:00
Hall D
pm
Intervention I
Moderator: Patrick W. Serruys
Co-Moderator: Stephen G. Ellis
8:00 am - Bifurcation (Left Main and Non-Left
Main) Technique 1: What Have We Learned
from Randomized Trials?
Leif Thuesen
8:15 am - Bifurcation (Left Main and Non-Left
Main) Technique 2: What Have We Learned
from Clinical Experience?
Antonio Colombo
Live Cases: Left Main
and Bifurcation I
Live Case Moderator: Patrick W. Serruys
Live Case Co-Moderator: Stephen G. Ellis
Live Case Discussants: Didier Carrie,
Michael J. Cowley, John S. Douglas Jr,
Dietmar H. Glogar, Michalis Hamilos,
Jens Flensted Lassen, Michael S. Lee,
Alfredo Rodriguez, Teguh Santoso
8:30 am - ICPS Institut Hospitalier
Jacques Cartier
Massy, France
9:15 am - Cedars-Sinai Medical Center
Los Angeles, CA
10:00 am - Discussion: What Have We
Learned from These Cases?
Intervention II
Moderator: Antonio Colombo
Co-Moderator: David G. Rizik
10:15 am - Integrated Clinical Trial Insights
into the Appropriateness of Left Main
Intervention
Patrick W. Serruys
10:30 am - Assessing Patients for Left Main
PCI: Practicalities and Limitations of
Risk Scores
Corrado Tamburino
Live Cases: Left Main
and Bifurcation II
- N o v e m b e r 9 , 2 0 11
2:40 pm - The Appropriateness of PCI
Procedures: Insights, Limitations and
Recommendations from a
Registry-Based Analysis
Paul S. Chan
Wednesday
TCT Interventional Corner II.
The Appropriate Use of
Appropriateness Criteria
Cardiovascular
Therapeutics
Live Case Moderator: Antonio Colombo
Live Case Co-Moderator: David G. Rizik
Live Case Discussants: Francesco Burzotta,
Kenneth Chin, Andrejs Erglis,
Daljeet S. Gambhir, Jorge Gaspar,
Ran Kornowski, Shu-Kin Li,
Keith G. Oldroyd, Marco Valgimigli
New York, NY
12:15 pm - Discussion: What Have We
12:30 pm - Break
Chronic Total Occlusion I
Moderator: Kenneth Chin
Co-Moderator: Shigeru Saito
1:30 pm - CTO Clinical Decision-Making:
Incorporating Myocardium at Risk, Ischemia,
and Completeness of Revascularization into
a Framework to Guide Revascularization
Gerald S. Werner
1:45 pm - Emerging Antegrade Tools,
Techniques, and Approaches for CTO
Recanalization and Procedural Success
J. Aaron Grantham
Live Cases: Chronic
Total Occlusion I
Live Case Moderator: Gerald S. Werner
Live Case Co-Moderator: Carlo Di Mario
Live Case Discussants: Mauro Carlino,
Keiichi Igarashi, Toshiya Muramatsu,
Robert T. Pyo, Sudhir Rathore, Shigeru Saito,
Georgios Sianos, Bradley H. Strauss,
Craig A. Thompson
2:00 pm - NewYork-Presbyterian Hospital/
New York, NY
101
Chronic Total Occlusion II
Moderator: David E. Kandzari
Co-Moderator: S. Chiu Wong
3:45 pm - Emerging Retrograde Tools,
Techniques, and Approaches for CTO
Recanalization and Procedural Success
Craig A. Thompson
4:00 pm - Complications of Complex PCI:
Contrast Nephropathy, Perforations,
Vascular Compromise, and
Radiation Toxicity
Roxana Mehran
Live Cases: Chronic
Total Occlusion II
Live Case Moderator: David E. Kandzari
Live Case Co-Moderator: S. Chiu Wong
Live Case Discussants: Yaron Almagor,
Alfredo R. Galassi, Jonathan M. Hill,
Jacques J. Koolen, Ashwin Balachand Mehta,
Sunao Nakamura, Stéphane Rinfret,
R. Michael Wyman, Masahisa Yamane
4:15 pm - Toyohashi Heart Center
Toyohashi, Japan
6:00 pm - Adjourn
Endovascular
and Structural
HEart Disease
8:00 am-6:00
Hall D
pm
Transcatheter Valve Therapies I
Moderator: Thomas Walther
Co-Moderator: Ganesh Manoharan
8:00 am - Aortic Stenosis: Pathology,
Pathophysiology, Natural History, Balloon
Aortic Valvuloplasty, and Surgical Therapies
Patrick T. O’Gara
8:15 am - TAVR 1: Case Selection
Considerations: Anatomic and
Clinical Factors
Samir R. Kapadia
102
program ·
Live Cases: Transcatheter
Valve Therapies I
Live Case Moderator: Thomas Walther
Live Case Co-Moderator: Ganesh Manoharan
Live Case Discussants: Stephen J.D. Brecker,
Gill L. Buchanan, Gregory P. Fontana,
Azeem Latib, Michael Kang-Yin Lee, Brij Maini,
Oscar A. Mendiz, Wesley R. Pedersen,
Corrado Tamburino, William A. Zoghbi
8:30 am - St. Paul’s Hospital/University
of British Columbia
Vancouver, Canada
1:45 pm - Navigating Femoropopliteal
Intervention: So Many Choices,
So Little Data
Thomas Zeller
Live Cases: Iliac and SFA
Live Case Moderator: Gary M. Ansel
Live Case Co-Moderator:
Live Case Discussants: Herbert D. Aronow,
Mark C. Bates, Fernando Cura,
Lawrence A. Garcia, Erich Minar, Alex Powell,
Luigi Salemme, David P. Slovut,
Craig M. Walker
2:00 pm - University of California,
Sacramento, CA
Transcatheter Valve Therapies II
2:45 pm - Auckland City Hospital
Moderator: Joseph E. Bavaria
Co-Moderator: Todd M. Dewey
10:15 am - TAVR 2: Results of TAVR in High
Surgical Risk and Inoperable Patients
Samir R. Kapadia
10:30 am - TAVR 3: Next Generation TAVR
Systems and Novel Accessory Devices
(to Reduce Complications)
Eberhard Grube
Live Cases: Transcatheter Valve
Therapies II
Live Case Moderator: Joseph E. Bavaria
Live Case Co-Moderator: Craig R. Smith
Live Case Discussants: Michael J. Davidson,
Victor Guetta, Rebecca Tung Hahn, Petr Kala,
Axel Linke, Neil E. Moat, Igor F. Palacios,
David Paniagua, Augusto D. Pichard
10:45 am - St. Paul’s Hospital/University
of British Columbia
Vancouver, Canada
11:30 am - ICPS Institut Hospitalier
Jacques Cartier
Massy, France
Aortic and Renal/
Mesenteric Intervention
Moderator: John H. Rundback
Co-Moderator: Mark W. Burket
3:45 pm - Renal Intervention Status Before
the CORAL Results: The “Prequel”
Michael R. Jaff
4:00 pm - EVAR Indications, Patient Selection,
and Outcomes: What Are the Remaining
Controversies?
Roger M. Greenhalgh
Live Cases: Aortic and
Renal/Mesenteric
Live Case Moderator: John H. Rundback
Live Case Co-Moderator: Mark W. Burket
Live Case Discussants: Robert M. Bersin,
Alessandro S. Bortone, Hugo F. Londero,
James F. McKinsey, Takao Ohki,
Juan C. Parodi, Rahul S. Patel, On Topaz,
Marco V. Wainstein
12:30 pm - Break
4:15 pm - University of California,
Sacramento, CA
Iliac and SFA Intervention
5:00 pm - Auckland City Hospital
Moderator: Gary M. Ansel
Co-Moderator: Craig M. Walker
1:30 pm - The Conversion from Surgical to
Endovascular Revascularization for Iliac
Occlusive Disease Is Nearly Complete:
What Are the Remaining Challenges?
Hans Krankenberg
6:00 pm - Adjourn
TCT2011
Challenging Case Theater
pm
Endovascular I
Moderators: Greg Mishkel, Jeffrey W. Olin
James P. Burke
9:00 am - Use of a Reentry Catheter in
Chronic Total Occlusion of Infrarenal Aorta
Taehoon Kim
9:12 am - Innovative Technique to Facilitate
Endovascular Repair of Giant Arch and
Descending Aortic Aneurysms
George Joseph
9:24 am - Double Distal Protection for Carotid
and Vertebral Arteries in a Brachiocephalic
Artery Occlusion
Eijiro Hayashi
9:36 am - Bilateral Carotid Stenting by
Transradial Approach
Luis Fernando Campos
9:48 am - Alternative Contrast Media for
Endovascular Therapy of a Patient with
Kidney Disease
Iwaki Taku
Complex and Unusual Interventions
Moderators: Graham A. Cassel,
Raimund A. Erbel
Discussants: Pawel E. Buszman,
Nicola Corvaja
10:00 am - Multiorgan Resuscitation
Using Multimodality Support
Benjamin Yang
10:12 am - Have a Closer Look. . . .
Jaclyn Chi Lin Chan
10:24 am - Hemodynamic Support in
Cardiogenic Shock Complicated By
Behnam Tehrani
10:36 am - To Pull or Not to Pull . . .
Too Hard on a Wire
Narasimharaj Rajendra
10:48 am - A Novel Approach to IVC
Filter Thrombosis
Rahul Sakhuja
Thrombotic Complications
Moderators: Theodore A. Bass,
Michael J. Cowley
Discussants: John A. Ambrose,
Muzaffer Degertekin
11:12 am - Practicing Safe Stenting:
Simultaneous Embolic Protection In
Bifurcation Vein Graft Intervention
Eric Fuh
11:24 am - The Use of Nicorandil in a Case
of No Reflow in RCA with Occluded LAD
Seung Uk Lee
11:36 am - A Fractured Balloon Interrupting
LAD Flow
Jae-Hwan Lee
11:48 am - Acute Occlusion in a Giant
Coronary Aneurysm Treated with
Covered Stents
Katsuyuki Hasegawa
12:00 - Break
Moderators: Kirk N. Garratt, Manel Sabate
Discussants: Daniel J. Blackman,
Robert J. Freedman Jr
2:00 pm - Myocardial Infarction Following
Intracardiac Injection of Metallic Mercury
Izabela Wojtkowska
2:12 pm - Retrieval of a Ruptured and
Detached Balloon During Primary PCI
Vit Reznicek
2:24 pm - Cardiogenic Shock in a
Postpartum Woman
Gianfranco Aprigliano
3:48 pm - Exploring New Interventional
Frontiers in Congenital Heart Disease
Werner Budts
Chronic Total Occlusion I
Moderators: Kevin J. Beatt, Angela Hoye
Discussants: M. Nicholas Burke, Oktay Ergene
4:00 pm - Modified Rendezvous Technique
for CTO During Retrograde PCI
Bin Zhang
4:12 pm - Retrograde Approach for a CTO
via a Gastroepiploic Artery Graft
Yoshiaki Mibiki
4:24 pm - Coronary Perforation During
Antegrade and Retrograde Subintimal
Tracking for Right Coronary CTO
Yuichi Ujiie
4:36 pm - Only 10 ml Contrast Media Used for
CTO PCI of the RCA Using Retrograde
Approach in a Patient with Chronic
Kidney Disease
Ryosuke Kametani
4:48 pm - Kissing-Wire Technique for a Totally
Occluded Ostial LAD with Retrograde
Approach from a SVG in the
Descending Aorta
Masashi Fujino
5:00 pm - Adjourn
International Society-Sponsored
Case Theater
8:00 am-6:00
Hall D
pm
2:36 pm - Percutaneous Device Closure of
Left Ventricular Free Wall Rupture
Harinder Bali
The Intersection of PCI and CABG
Sponsored by the Belgian Working Group of
2:48 pm - Failed Repeated Thrombolysis
Requiring Left Ventricular Assist Device
Gilbert Tang
Moderators: Suzanne Pourbaix,
Adult Congenital Heart Disease I
Moderators: Ralf J. Holzer, John F. Rhodes
Discussants: Bruce Bowers, Jon C. George
3:00 pm - Transcatheter Closure of a Large
ASD from the Femoral Vein in a Patient
with Budd-Chiari Syndrome
Shreepal Jain
3:12 pm - Percutaneous Closure of an
Aorto-Pseudoaneurysm Fistula and Left
Ventricular Pseudoaneurysm
Josef Toussaint
3:24 pm - Management of Catheter-Associated
Right Atrial Thrombus During Percutaneous
Mitral Valve Paravalvular Leak Closure
Ethan Korngold
3:36 pm - Transjugular Tricuspid
Valve-in-Valve Replacement
Hellmuth Weich
- N o v e m b e r 9 , 2 0 11
9:00 am-5:00
Hall D
11:00 am - Mechanical and Pharmacological
Approach to Extensive Saphenous Vein
Graft Thrombus
Ethan Korngold
Wednesday
Challenging Case
Multiplex
Cardiovascular
Therapeutics
9:00 am - Case 1: CABG After Failed/
Complicated PCI
Claude Hanet
9:15 am - Case 2: PCI/TAVR for When
CABG/AVR Is Impossible
Walter Desmet
9:30 am - Case 3: PCI for Late CABG Failure
Paul Vermeersch
9:45 am - Case 4: Mixed Revascularization
by CABG and PCI
Erwin Schroeder
PCI Complications
Sponsored by the Chinese Society
of Cardiology
Moderator: Run-Lin Gao
Discussants: Xianghua Fu, Yaling Han,
Yuejin Yang, Yujie Zhou
103
10:00 am - Case 1: Osteofascial Compartment
Syndrome After PCI via Transradial
Approach
Lang Li
10:15 am - Case 2: Simple Lesion,
Complicated Result
Jian Liu
10:30 am - Case 3: The Trap of RCA Stenosis
with Aneurysmal Dilation
Xuebo Liu
10:45 am - Case 4: Stent Loss During LAD
PCI: Cause and Treatment
Qi Zhang
Navigating Complex Coronary Bifurcation
Lesion Treatment
Sponsored by the Nordic-Baltic Study Group
of Interventional Cardiology
Moderator: Leif Thuesen
Discussants: Knut Endresen,
Jens Flensted Lassen, Terje K. Steigen,
Simon Walsh
11:00 am - Case 1: Threatened Occlusion of
the Main Vessel During Two-Stent
Bifurcation Procedure
Jaakko Niemela
Lead Discussant: Simon Walsh
Moderators: Dariusz Dudek, Adam Witkowski
Discussants: Robert J. Gil, Maciej Lesiak,
Andrzej J. Ochala, Krzysztof Reczuch
3:30 pm - Case 3: Valve-in-Valve Technique for
Optimization of a Complicated CoreValve
TAVR Case
Maciej Dabrowski
3:45 pm - Case 4: TAVR and Complex PCI in
a Patient with Breast Cancer
Pawel Kleczynski
Complications in Interventional Cardiology
Sponsored by the Swedish Working Group
on PCI, Swedish Society of Cardiology
4:00 pm - Case 1: Cardiogenic Shock Induced
by a Pacemaker Implant in a Patient with
Multiple CTOs
Matthias Götberg
11:45 am - Case 4: When a Chronic Total
Occlusion Turns into a Bifurcation Lesion
Evald H. Christiansen
Lead Discussant: Terje K. Steigen
4:15 pm - Case 2: From an LAD Lesion to
a Left Main Complication
Jason Stewart
2:00 pm - Case 1: When It Rains, It Pours
Christoph A. Kaiser
2:15 pm - Case 2: Vascular Nightmare
Following TAVR
Stephane Noble
2:30 pm - Case 3: Stable—But for How Long?
Peter Wenaweser
2:45 pm - Case 4: Valve in Ring:
Disappointing Result or Not?
Roberto Corti
program ·
6:00 pm - Adjourn
3:15 pm - Case 2: Bifurcation Stenting
in a Patient with NSTE-ACS and
Pulmonary Edema
Aleksander Araszkiewicz
11:30 am - Case 3: Using FFR for DecisionMaking of Sidebranch Stenting
Indulis Kumsars
Lead Discussant: Knut Endresen
Moderators: Stéphane Cook, Franz R. Eberli,
Giovanni B. Pedrazzini, Ulrich Sigwart,
Philip M. Urban
5:45 pm - Case 4: Complicated RCA CTO
Rosli Mohd Ali
Maintenance of
Certification
(MOC) Course
Moderator: Goran K. Olivecrona
Discussants: Mikael Danielewicz,
Lars Hellsten, Ulf Jens Jensen,
Thomas Kellerth
Valve Complications
Sponsored by the Swiss
Society of Cardiology
5:30 pm - Case 3: Occlusion of the Abdominal
Aorta After Coronary Angiography
Yudi Her Oktaviano
3:00 pm - Case 1: Intraaortic Balloon Pump
Counterpulsation During PCI in a Very
High-Risk Patient with NSTE-ACS
Radoslaw Parma
11:15 am - Case 2: Minimizing Multiple Stent
Layers in Bifurcation Stenting
Miroslaw Ferenc
Lead Discussant: Jens Flensted Lassen
12:00 pm - Break
104
Challenging Cases in Coronary and Aortic
Valve Interventions
Sponsored by the Association on
Cardiovascular Interventions of the
Polish Cardiac Society
4:30 pm - Case 3: Cardiac Arrest in a Patient
Transferred Between PCI Centers with a
Wire Across the Lesion
Jacob Odenstedt
4:45 pm - Case 4: Takotsubo Cardiomyopathy:
Hemodynamic Compromise When Treated
as a Conventional Acute Coronary Syndrome
Berglind Libungan
PCI Complications: Nightmare Scenarios
Sponsored by the ASEAN Federation
of Cardiology
Moderators: Kenneth Chin,
Thosaphol Limpijankit
Discussants: Sarana Boonbaichaiyapruck,
Teguh Santoso, Wasan Udayachalerm
5:00 pm - Case 1: Thrombus During Coiling
of a Coronary Pulmonary Fistula
Timothy C. Dy
5:15 pm - Case 2: Stuck Rotablator Burr—
Really Stuck!
Wacin Buddhari
8:00 am-2:00
Room 103
pm
8:00 am - Welcome and Introduction
George D. Dangas
8:05 am - Interventional Cardiology 2011
Update Module Review
Moderator: Tayo A. Addo
Duane S. Pinto
10:00 am - Break
Charles E. Chambers
Discussants: Tayo A. Addo,
12:00 pm - Interventional Cardiology 2009
George D. Dangas
Charles E. Chambers
2:00 pm - Adjourn
Morning Spotlight
Sessions
Core Training Curriculum in
Clinical Research
8:00 am-12:00
Room 134
pm
Session I. How to Establish and Maintain
a Successful Research Program
Moderators: David A. Cox, Giora Weisz
Discussants: Ravit Barkama, Bruce R. Brodie,
Kate Dalton, Timothy D. Henry,
James B. Hermiller Jr, David E. Kandzari,
Roxana Mehran, Lauren T. Privitera,
Ron Waksman
8:00 am - Welcome and Introduction:
Objectives of the Section
Giora Weisz
TCT2011
8:15 am - The Guiding Principles:
Standards to Be Followed
Ravit Barkama
8:35 am - The Perfect Site: Enroll More, Keep
Quality and Morale High, and Costs Down!
8:50 am - Investigator-Initiated Research:
How Do You Start?
Ron Waksman
9:00 am - Industry-Sponsored Research:
How Do You Succeed?
David E. Kandzari
11:20 am - Muddy Waters: Intent-to-Treat vs.
Per-Protocol Analyses
Ajay J. Kirtane
11:35 am - Benefits and Pitfalls of CostEffectiveness Analyses
David J. Cohen
11:50 am - Final Words
Donald Cutlip, Ajay J. Kirtane
12:00 pm - Adjourn
Deep Dive: Stroke
Prevention Therapies
8:00 am-12:00
Room 135
pm
9:10 am - The Screening Process: A Painful
But Essential Step
David A. Cox
Session I. Stroke Demographics
Moderators: William A. Gray, Mark Reisman
Discussant: L. Nelson Hopkins
9:20 am - Informed Consent: Follow the Rules
Kate Dalton
8:00 am - The Opportunity for Prevention:
Mechanisms and Incidence of Cardiac and
Atheroembolic Stroke
L. Nelson Hopkins
9:30 am - Quality Control: Investigator’s
Responsibilities
Timothy D. Henry
9:40 am - How to Handle Monitoring
Visits and Audits
Roxana Mehran
Session II. Clinical Trial Interpretation:
Pitfalls and Practical Lessons
Moderators: Donald Cutlip, Ajay J. Kirtane
Discussants: Somjot S. Brar,
Davide Capodanno, David J. Cohen,
Sanjay Kaul, Mitchell W. Krucoff, Helen Parise,
John L. Petersen, Stuart J. Pocock,
John A. Spertus
10:20 am - Randomized Trials vs.
Observational Studies: Both Are Good,
Both Can Be Bad
Roxana Mehran
10:35 am - Practicalities and Misapplications
of Composite Endpoints in Clinical Trials
Stuart J. Pocock
10:50 am - Importance of Adequately Powered
Studies in Clinical Medicine: Case Studies
Sanjay Kaul
11:05 am - Noninferiority Exposed:
Uses and Abuses
Donald Cutlip
9:20 am - Not All Asymptomatic Lesions Are
the Same: Objective Measures of the
Higher-Risk Lesion
Issam D. Moussa
9:28 am - Medical Therapy: Do the Data
Support Not Intervening in the Severe
Asymptomatic Carotid Lesion?
Peter A. Schneider
9:36 am - Surgery for the Asymptomatic
Carotid Stenosis: Randomized Trial
Evidence-Based Medicine
Roger M. Greenhalgh
9:44 am - Carotid Stenting and the
Asymptomatic Patient: Can It Be Advocated
for Prevention of Stroke?
James P. Zidar
9:52 am - Surgery vs. Carotid Stenting for the
Symptomatic Patient: Why Is There Such
Discrepant Data on Safety?
William A. Gray
10:02 am - Intracranial Atherosclerosis:
Evaluation, Therapeutic Options,
and Outcomes
Philip M. Meyers
Session II. Atrial Fibrillation
Moderators: William A. Gray, Mark Reisman
Discussants: Michael D. Ezekowitz,
L. Nelson Hopkins, Vivek Y. Reddy,
Peter N. Ruygrok
Session IV. Patent Foramen Ovale
Moderators: Zahid Amin,
Paul H. Kramer, Mark Reisman,
Jonathan M. Tobis
8:10 am - The Brave New World of
Antithrombotic Therapy for Stroke
Prevention in Atrial Fibrillation
10:27 am - Screening for the PFO-Related
Stroke: Is There a Best Method?
Paul H. Kramer
8:25 am - Surgical Approaches to Preventing
Stroke in Atrial Fibrillation: Rhythm Ablation
and Appendage Exclusion
A. Marc Gillinov
10:35 am - A Critical Appraisal of CLOSURE I
and Status Report on RESPECT
and REDUCE
Jonathan M. Tobis
8:40 am - Electrophysiologic Ablation for Atrial
Fibrillation: Methods and Efficacy
Vivek Y. Reddy
10:45 am - Does the Device Matter? The
Landscape of Current and Future PFO
Closure Devices
Mark Reisman
8:52 am - Transcatheter Atrial Appendage
Occlusion: From the Watchman Proof
of Concept to Emerging Next
Generation Devices
Peter N. Ruygrok
10:55 am - Is Migraine a Separate
Consideration When Assessing the
Patient with PFO and Stroke?
Session III. Carotid and
Intracranial Therapy
Moderators: Michael R. Jaff, Robert D. Safian
Discussants: William A. Gray,
Roger M. Greenhalgh, Philip M. Meyers,
Issam D. Moussa, Peter A. Schneider,
James P. Zidar
- N o v e m b e r 9 , 2 0 11
8:25 am - Improving Efficiencies with the
IRB, Budgets, and Contracts
Lauren T. Privitera
Wednesday
8:05 am - How to Establish Clinical Research
in Your Hospital: The Essential First Steps
Bruce R. Brodie
Cardiovascular
Therapeutics
Session V. The Great Stroke Debates
Moderators: Peter C. Block, John M. Lasala
Discussants: Joseph P. Carrozza Jr,
Christopher B. Granger,
David J. Hildick-Smith, Peter Sick
Progress in Anticoagulant Therapy Will
Obsolete Left Atrial Appendage Occlusion
11:20 am - Pro!
Christopher B. Granger
105
11:28 am - Con!
Peter Sick
11:36 am - Discussion and Vote
First-Time PFO Strokes Should
Not Be Closed
11:40 am - Pro!
11:48 am - Con!
11:56 am - Discussion and Vote
12:00 pm - Adjourn
Innovative Surgical Techniques
and Technologies
8:00 am-12:00 pm
Room 133
Co-sponsored by the American Association
for Thoracic Surgery
Session I. Coronary Artery Disease
Moderators: Johannes Bonatti,
John D. Puskas
Discussant: Husam H. Balkhy
8:00 am - When Is Off-Pump the
Right Choice?
John D. Puskas
9:35 am - Transapical Closure of
Paravalvular Leaks
Mathew Williams
Session III. Aneurysmal Disease
Moderators: W. Randolph Chitwood Jr,
Allan Stewart
Discussant: Grayson H. Wheatley
9:55 am - Composite Bioroot: Is Anyone Too
Young for a Tissue Valve?
Allan Stewart
10:05 am - Hybrid Therapy for Aneurysms
Grayson H. Wheatley
Session IV. Atrial Fibrillation
Moderators: Michael Argenziano,
Timothy J. Gardner
Discussants: Husam H. Balkhy,
A. Marc Gillinov
10:20 am - Is There an Indication for
Stand-Alone Surgical AF Treatment—And
Why Are We Not Seeing These Patients?
Michael Argenziano
10:30 am - Hybrid Surgical and Percutaneous
AF Ablation
Husam H. Balkhy
8:10 am - Robotic Approaches Really Work!
Johannes Bonatti
10:40 am - Concomitant Surgical Ablation:
What Is the Right Procedure?
A. Marc Gillinov
8:20 am - Anastamotic Connectors:
Is There a Role?
Husam H. Balkhy
10:50 am - The Left Atrial Appendage:
A Surgical Target?
A. Marc Gillinov
Session II. Valvular Heart Disease
Moderators: Neil E. Moat, Mathew Williams
Discussants: Michael Argenziano,
Thierry A. Folliguet, James S. Gammie,
A. Marc Gillinov, Francesco Maisano,
Vinod H. Thourani
Session V. Heart Failure
Moderators: William E. Cohn, Ulrich P. Jorde
Discussants: Robert E. Michler, Amit Patel
8:35 am - Sutureless Surgical Aortic
Valve Replacement
Thierry A. Folliguet
8:45 am - Is There a Role for the Apicoaortic
Conduit in the TAVR Era?
James S. Gammie
8:55 am - Apical Closure Devices
Vinod H. Thourani
9:05 am - Surgery After Failed MitraClip
Procedures: A Critical Appraisal
Michael Argenziano
11:10 am - LVADs of Tomorrow
William E. Cohn
11:20 am - Destination Therapy: Will This
Ever Be a Reality?
Ulrich P. Jorde
11:30 am - The Future of CABG and SVR
in CHF After STICH
Robert E. Michler
11:40 am - Stem Cell Therapy: The Role
of Surgery and Surgeons
Amit Patel
12:00 pm - Adjourn
9:15 am - Robotic Mitral Repair:
A Step Forward?
A. Marc Gillinov
9:25 am - Transapical Mitral Repair
with Artificial Chords
Francesco Maisano
106
program ·
International Debating
Chamber: Interventional
Cardiology on Trial
Sponsored by the British Cardiovascular
Intervention Society
8:00 am-11:55
Room 104
am
8:00 am - Introduction, Session Outline,
and Goals
Mark A. de Belder
Conflagration I. Early PCI for a
Patient with Stable CAD
Moderators: Mark A. de Belder,
William E. Boden
Discussants: Steven R. Bailey,
Adrian P. Banning, Daniel S. Berman,
William E. Boden, Bernard De Bruyne,
Cindy L. Grines, Philip M. Urban,
David O. Williams
8:03 am - Session and Participant Introduction
Mark A. de Belder, William E. Boden
8:06 am - Case Presentation Introduction:
A Patient with New Onset Moderate Angina
Undergoes Early Angiography and PCI
Keith G. Oldroyd
Motion: Medical Treatment Is the First-Line
Treatment for Patients with Stable Angina
with Revascularization Reserved for
Uncontrolled Symptoms
8:09 am - For: The Evidence Is Clear: To Do
Otherwise Is Potentially Harmful and Costly!
Judith S. Hochman
8:19 am - Against: We’ve Moved on: Ischemia/
FFR Guided Revascularization Will Achieve
the Best Outcomes for Patients!
Dean J. Kereiakes
8:29 am - Jury Deliberations (Issue in
General and Patient Specific)
8:49 am - Panel Discussion and Audience Vote
8:52 am - Case Presentation Conclusion:
Procedural and Late Patient Outcomes
Keith G. Oldroyd
8:55 am - Final Judicial Sentence and
Take-Home Messages
Mark A. de Belder, William E. Boden
Conflagration II. Duration of Dual
Antiplatelet Therapy for Patients
Undergoing PCI with DES
Moderators: Anthony H. Gershlick,
C. Michael Gibson
Discussants: Alison L. Calver, Nick Curzen,
Laura Mauri, Matthew T. Roe, Manel Sabate,
Gary L. Schaer, Bonnie H. Weiner,
Azfar G. Zaman
Frederick Feit, Anthony H. Gershlick
TCT2011
Motion: The Guidelines Are Wrong: We Do Not
Need Prolonged Dual Antiplatelet Therapy
for Most Patients Undergoing PCI with DES
9:16 am - Against: The Longer and More
Potent DAPT the Better!
Daniel I. Simon
9:46 am - Panel and Audience Vote
Patricia J. Best
Take-Home Messages
Anthony H. Gershlick, C. Michael Gibson
Conflagration III. TAVR in the Not So
High-Risk Surgical Candidate
Moderators: Lars G. Svensson,
Martyn R. Thomas
Discussants: Yaron Almagor,
Adrian P. Banning, Daniel J. Blackman,
Mark W. Connolly, Michael J. Mullen,
Uday Trivedi, Hugo Vanermen, Olaf Wendler
Lars G. Svensson, Martyn R. Thomas
A Moderate-Risk Aortic Stenosis Patient
Refuses Surgical Aortic Valve Replacement
Roberto Corti
Motion: With Appropriate Informed Consent,
TAVR Should Be Considered for ModerateRisk Patients Who Prefer the Lesser
Invasive Approach
10:03 am - For: The Outcomes Are Good—Let
the Patient Have the Say!
Brian Whisenant
10:13 am - Against: Has Civilization Lost
Its Mind?!
Robert A. Guyton
Roberto Corti
Conflagration IV. Arterial Access and
Pharmacological Approach to PCI
Moderators: Warren J. Cantor, Nick Curzen
Discussants: Robert J. Applegate,
Bagrat Alekyan, Sripal Bangalore,
Daniel J. Blackman, Ronald Caputo,
Anthony H. Gershlick, Luis A. Guzman,
Martial Hamon, James Nolan,
Marco V. Wainstein, Bernhard Witzenbichler
10:56 am - Session and Participant
Introduction
Warren J. Cantor, Nick Curzen
10:59 am - Case Presentation: A Patient with
STEMI Undergoes Radial Access with
Heparin Anticoagulation Only (No Bivalirudin
or GP IIb/IIIa Inhibitor) and with
Thrombus Aspiration
Goran K. Olivecrona
Motion: Radial Access and Thrombus
Aspiration Are the New Standard of Care for
Primary PCI in STEMI—The Type of
Anticoagulation Is Less Important
11:02 am - For: Radial Access Prevents Most
Bleeding, and Thrombus Aspiration Is More
Effective Than Any Antiplatelet Agent!
Sanjit S. Jolly
11:12 am - Against: Bivalirudin Has the
Highest Level of Evidence on Both
Continents, and Is the Only Proven
Default Therapy!
Frederick Feit
Procedural and Patient Outcomes
Goran K. Olivecrona
Take-Home Messages
Warren J. Cantor, Nick Curzen
12:00 pm - Adjourn
Presentation Theaters
12:15
pm -1:15 pm
Theater schedule.
Lunchtime Activities
Hot Topics
ACC Fellows Session I. Advanced Training
in Valvular Heart Disease
12:15 pm-1:50 pm
Room 131
- N o v e m b e r 9 , 2 0 11
9:06 am - For: To Prescribe DAPT in Most
Patients for More Than Six Months Is Cruel
and Unusual Punishment!
Marco Valgimigli
Take-Home Messages
Lars G. Svensson, Martyn R. Thomas
Wednesday
A Patient Undergoes Elective PCI with DES
and Is Prescribed DAPT Indefinitely
Patricia J. Best
Cardiovascular
Therapeutics
Advanced Training in Valvular Heart Disease
Moderators: Vasilis Babaliaros,
Wesley R. Pedersen
Discussants: Raoul Bonan, Mathew Williams
12:15 pm - Essentials of Mitral Valvuloplasty
Wesley R. Pedersen
12:30 pm - Essentials of Aortic Valvuloplasty
Samin K. Sharma
12:45 pm - Essentials of Percutaneous
Mitral Valve Repair
Raoul Bonan
1:00 pm - Essentials of Transcatheter Aortic
Valve Replacement
Vasilis Babaliaros
1:15 pm - Working with Cardiothoracic
Surgeons
Mathew Williams
1:45 pm - Adjourn
Career Development for the
“New” Interventionalist
12:15 pm-1:45 pm
Room 130
Moderator: Manish A. Parikh
Discussants: Navin K. Kapur, Sahil A. Parikh,
Matthew J. Price, Michael J. Rinaldi,
Uma S. Valeti, James P. Zidar
Manish A. Parikh
12:20 pm - Getting Started in an Academic
Group Practice: What to Do and What
Not to Do
James P. Zidar
12:30 pm - Getting Started in a University
Practice: What to Do and What Not to Do
Navin K. Kapur
12:40 pm - Building a Niche: How to Transition
from the “New” Interventionalist to the
“Expert” Group
Michael J. Rinaldi
107
12:50 pm - Tips, Tricks, and Rookie Mistakes
When Starting as an Interventionalist:
Discussion with Audience Q&A
Session III. Preparing for the Future:
The TAVR Example
Moderator: Harry R. Phillips
12:55 pm - The BARI-2D Trial: Is the
Revascularization Glass Really Empty?
Frederick Feit
1:00 pm - Balancing Multiple Skills:
Building a Portfolio
Uma S. Valeti
1:22 pm - Hybrid Rooms, Logistics,
Interdepartmental Cooperation: Incremental
Steps or the All-in Approach?
William F. Fearon
1:03 pm - Which Diabetic Patients with
Multivessel and Left Main Disease Should
Undergo PCI in 2011?
Donald Cutlip
1:11 pm - Which Diabetic Patients with
Multivessel and Left Main Disease Should
Undergo CABG in 2011?
Joseph F. Sabik
1:10 pm - Practical Implications of Health
Care Reform
Randel Richner
1:20 pm - Juggling Clinical Practice and
Clinical Research
Matthew J. Price
1:30 pm - Ten Things to Do in Your First Five
Years to Grow Your Career
Manish A. Parikh
1:50 pm - Adjourn
Cath Lab Directors Roundtable: Managing
the Present, Preparing for the Future
12:15 pm-1:45 pm
Room 125
Moderator: Kishore J. Harjai
Discussants: Simon R. Dixon, Stephen G. Ellis,
Peter S. Fail, Cindy L. Grines,
William W. O’Neill, Harry R. Phillips,
David Jonathan Sahn, Ron Waksman,
Bonnie H. Weiner
12:15 pm - Introduction and Session Goals
Kishore J. Harjai
Session I. PCI Appropriateness and
Unnecessary Procedures
Moderator: Cindy L. Grines
12:18 pm - The Issue and Implications:
The Pandora’s Box of PCI
William W. O’Neill
12:25 pm - The Challenges of Credentialing
and Peer Review
Stephen G. Ellis
Session II. Resource Utilization and Metrics
Moderator: Stephen G. Ellis
12:47 pm - Efficiency Metrics in the Cath Lab:
Focus on Costs, Equipment Utilization,
and On-Time Starts
Peter S. Fail
12:52 pm - Cost vs. Quality in the Cath Lab:
A Fork in the Road?
Bonnie H. Weiner
12:57 pm - Integrating Clinical Research in a
Busy Lab: Is it Worth it?
Ron Waksman
1:02 pm - STEMI Metrics: The Pitfalls of
Door-to-Balloon Time
Kishore J. Harjai
1:42 pm - Closing Remarks
Kishore J. Harjai
1:45 pm - Adjourn
Diabetes and Cardiovascular Disease:
New Therapeutic Approaches
12:15 pm-1:45 pm
Room 124
New Therapeutic Approaches
Moderators: Michael E. Farkouh,
Frederick Feit
Michael E. Farkouh
12:17 pm - Diabetes and Coronary Large/Small
Vessel Arteriopathy: Truths and Myths
Robert S. Schwartz
12:24 pm - Optimal Periprocedural and
Chronic Medical Therapy in the Diabetic:
Agents and Goals
J. Dawn Abbott
Case I. The Patient with Diabetes, Coronary
Artery Disease, and Silent Ischemia:
Medical Therapies and the Decision
Whether to Revascularize
Frederick Feit
Discussants: Carlo Briguori, Donald Cutlip,
Efrain Gaxiola, Margaret B. McEntegart
12:32 pm - Case Presentation Introduction:
Patient Presentation and Diagnostic
Testing (Pre-angiography)
Kevin J. Beatt
12:35 pm - The Discussion: Optimizing Medical
Therapy, Whether to Cath and Revascularize
12:43 pm - Case Presentation Conclusion:
Management and Long-term Outcomes of
This Patient
Kevin J. Beatt
12:47 pm - General Discussion: Optimal
Risk-Factor Management in Diabetic
Patients, and Triggers for Noninvasive and
Invasive Coronary Screening
Frederick Feit
Discussants: J. Dawn Abbott,
Aaron D. Kugelmass, Norman E. Lepor,
Margaret B. McEntegart, Robert S. Schwartz,
Vankeepuran S. Srinivas
108
program ·
1:19 pm - Stent Selection in Diabetic Patients:
Rationale and Design of the TUXEDO Trial
Upendra Kaul
Case II. PCI vs. CABG in the Patient with
Diabetes Requiring Revascularization
Frederick Feit
Discussants: Donald Cutlip,
A. Pieter Kappetein, Joseph F. Sabik
1:27 pm - Case Presentation Introduction:
A Complex Diabetic and the Heart
Team Discussion
David H. Adams, Samin K. Sharma
1:30 pm - The Heart Team Discussion:
How Would We Have Managed This Patient?
1:38 pm - Case Presentation Conclusion:
The Revascularization Decision and
Patient Outcomes
David H. Adams, Samin K. Sharma
1:42 pm - Concluding Remarks
Frederick Feit
1:45 pm - Adjourn
Guidelines and Appropriateness
Criteria Discussions: PCI in the
United States and Europe
12:15 pm-1:45 pm
Room 123
PCI in the United States and Europe
Moderators: Kurt Huber, Glenn N. Levine,
Manesh R. Patel
Discussants: Eric R. Bates, Paul S. Chan,
Timothy D. Henry, Michel R. Le May,
Maurizio Menichelli, John D. Puskas,
Erick Schampaert, Thomas D. Stuckey,
David Taggart, Corrado Tamburino,
Holger Thiele
12:15 pm - Highlights of the Latest US PCI and
CABG Guidelines
Glenn N. Levine
12:30 pm - Highlights of the Latest European
PCI Guidelines (Including NSTEMI
and STEMI)
Kurt Huber
TCT2011
1:00 pm - General Discussion
OK, What Training Do I Need to Be a Focused
Interventional . . . Expert?
1:15 pm - Valve Therapy
Samir R. Kapadia
1:00 pm - Case 1: A Patient with Unprotected
Left Main Coronary Artery Disease
Corrado Tamburino
1:05 pm - Discussion: What Do the
US/EU Guidelines and Appropriateness
Criteria Say?
Paul S. Chan, Kurt Huber, Erick Schampaert,
David Taggart
1:15 pm - Case 2: A Patient with STEMI 60
Minutes from the Nearest Cath Lab
Timothy D. Henry
12:15 pm-1:45 pm
Room 132
Moderators: Todd J. Brinton, Paul Yock
Discussants: Peter J. Fitzgerald,
Howard M. Holstein, Ross A. Jaffe,
Joshua Makower, James R. Shay
1:20 pm - Discussion: What Do the
US/EU Guidelines and Appropriateness
Criteria Say?
Discussants: Eric R. Bates, Michel R. Le May,
Maurizio Menichelli, Thomas D. Stuckey,
Holger Thiele
1:45 pm - Adjourn
Physician Training Requirements for
the “Interventional Futurist”
12:15 pm-1:45 pm
Room 102
Moderators: Doff B. McElhinney,
Mark Reisman
Samir R. Kapadia, Michael J. Lim,
Ganesh Manoharan, Jeffrey J. Popma,
12:15 pm - New Interventional (and Surgical)
Skill Sets: Multifocal Access (Transseptal,
Transapical, and Endovascular Plus
Transvascular) and Implants (Clamshells,
Plugs, Clips, and Valves)
Mark Reisman
12:30 pm - Mastering New Imaging Modalities:
Echo, CT, and Beyond
Michael J. Lim
OK: I’m a . . . and I Want to Become an
“Interventional Futurist”: What’s Next?
12:45 pm - Fellow-in-Training
Jeffrey J. Popma
12:50 pm - Practicing (Primarily)
Coronary Interventionalist
Ganesh Manoharan
1:30 pm - Hypertension Therapy
1:45 pm - Adjourn
So You Think You Have a Great Idea?
An Inventor’s Workshop
Sponsored by Stanford Biodesign
12:15 pm - Introduction and Goals
Paul Yock
12:18 pm - Secret Sauce: The Right
Clinical Need
Todd J. Brinton
12:32 pm - Assessing the Market (Without
Hiring an MBA)
Ross A. Jaffe
12:46 pm - IP 101: Is Your Device Patentable?
James R. Shay
1:00 pm - The New Regulatory Logic for CE
Mark and FDA Approval
Howard M. Holstein
1:14 pm - Strategy Assessment: Is This a
Product or a New Company?
Joshua Makower
1:28 pm - Getting Real: Practical Next Steps
Peter J. Fitzgerald
1:42 pm - Wrap-up
Paul Yock
1:45 pm - Adjourn
Special JACC Session: How to Write and
Evaluate Medical Journal Articles
12:15 pm-1:45 pm
Room 133
Moderators: Anthony N. DeMaria,
Sotirios Tsimikas
Discussant: David J. Moliterno
12:15 pm - How to Write Publishable Papers
(with Examples of Dos and Don’ts)
Anthony N. DeMaria
12:45 pm - How to Evaluate a Research Paper:
What Constitutes a Good Review?
Sotirios Tsimikas
- N o v e m b e r 9 , 2 0 11
Applying the US and EU Guidelines and
Appropriateness Criteria (from
Revascularization Decisions to
Pharmacotherapy)
12:55 pm - Practicing or In-Training Surgeon
Michael J. Davidson
Wednesday
12:45 pm - Highlights of the Appropriateness
Use Criteria, and How to Apply Them in
Daily Practice
Manesh R. Patel
Cardiovascular
Therapeutics
1:15 pm - How to Enhance Your Paper
Through Electronic Media
David J. Moliterno
1:45 pm - Adjourn
Learn the Technique
Acute Stroke Intervention
12:15 pm-1:45 pm
Room 112
Session I. Flash Lectures
Moderators: L. Nelson Hopkins,
Philip M. Meyers
Stephen R. Ramee
12:15 pm - Essential Anatomy for Stroke
Intervention
L. Nelson Hopkins
12:23 pm - Patient Selection: Clinical
and Imaging
Philip M. Meyers
12:31 pm - Current Technical Options for
Successful Revascularization
Stephen R. Ramee
12:39 pm - Complication Avoidance and
Management
Alex Abou-Chebl
How to Train Non-Neurointerventionalists
for Stroke Intervention
Session II. Case Presentations
Moderators: L. Nelson Hopkins,
Philip M. Meyers
Stephen R. Ramee
12:55 pm - Successful Merci
Stephen R. Ramee
1:05 pm - Successful Penumbra
Alex Abou-Chebl
1:15 pm - Successful Stentriever (Solitaire)
L. Nelson Hopkins
109
1:25 pm - Complication: Hemorrhage
Post-Revascularization
Philip M. Meyers
1:35 pm - Complication:
Procedural Perforation
L. Nelson Hopkins
1:45 pm - Adjourn
Complex Congenital Intervention
12:15 pm-1:45 pm
Room 120
Moderators: Ziyad M. Hijazi, John F. Rhodes
Ralf J. Holzer, Eric Horlick, Frank F. Ing,
Carlos Pedra
12:15 pm - Coarctation of the Aorta:
Techniques for Stent Implantation
Elchanan Bruckheimer
12:25 pm - Two Illustrative Cases of
Coarctation Stent Placement: One
Uncomplicated and One Complex
Eric Horlick
12:45 pm - Coronary AV Fistulas:
Treatment Techniques
John F. Rhodes
12:55 pm - Two Illustrative Fistula Occlusion
Cases: One Uncomplicated and One
Complex
Ziyad M. Hijazi
12:45 pm - A Case Series of DES In-Stent
Restenosis (with Insights from
Intracoronary Imaging)
Fausto Feres
1:00 pm - A Case Series of Late DES
Thrombosis (with Insights from
Intracoronary Imaging)
Fernando Alfonso
1:15 pm - A Case Series of Embolized Stents
and Other Devices
John S. Douglas Jr
1:30 pm - A Case Series of Vascular
Complications: Radial and Femoral
Robert J. Applegate
1:45 pm - Adjourn
Day-to-Day Use of IVUS
12:15 pm-1:45 pm
Room 121
Moderators: John McB. Hodgson,
Gary S. Mintz
12:15 pm - Why We Need IVUS in the OCT Era
12:20 pm - How to Perform IVUS: Right and
Wrong (Case Examples)
John McB. Hodgson
12:40 pm - Lesion and Plaque Assessment
with IVUS Techniques (Case Examples)
1:15 pm - Paravalvular Mitral Leaks:
Indications for Treatment and Outcomes
Zoltan G. Turi
1:00 pm - IVUS for Stent Optimization
Including Bifurcation PCI (Case Examples)
Brian Courtney
1:25 pm - Two Illustrative Cases:
One Uncomplicated and One
Complex Transapical LV Closure
Thomas Walther
1:20 pm - Use of IVUS in the Recognition,
Evaluation, and Management of PCI
Complications (Case Examples)
1:40 pm - Take-Home Messages for
Your Day-to-Day Work
John McB. Hodgson
1:45 pm - Adjourn
Coronary Complication
Management (Part 1)
12:15 pm-1:45 pm
Room 122
John S. Douglas Jr, Fausto Feres,
Jose P.S. Henriques
12:15 pm - A Case Series of Coronary
Perforations: Causes and Management
1:45 pm - Adjourn
Left Main Intervention
12:15 pm-1:45 pm
Room 111
Moderators: David J. Hildick-Smith,
David E. Kandzari
Session I. The Syntax Score
12:15 pm - How to Calculate the Syntax Score
(Step by Step): It’s Not So Hard
Philippe Genereux, Tullio Palmerini
12:30 pm - A Case Series of Refractory
Intracoronary Thrombosis and No-Reflow
Jose P.S. Henriques
110
program ·
Session II. Management of the Distal Left
Main Bifurcation
Provisional Stenting with Crossover
Is Usually Possible
Discussants: Remo Albiero,
Davide Capodanno, Nick Curzen,
Bon-Kwon Koo
12:27 pm - Case 1: You Might Not Have
Thought So in This Case
Remo Albiero
12:33 pm - Case 2: You Might Not Have
Thought So in This Case
Davide Capodanno
12:39 pm - Case 3: Use of FFR to Avoid
the Left Circumflex Entirely
Bon-Kwon Koo
12:45 pm - Case 4: Use of IVUS to Simplify
and Optimize Left Main PCI
Nick Curzen
The Planned Two-Stent Technique
Discussants: Alaide Chieffo, Andrejs Erglis,
Issam D. Moussa, Paul S. Teirstein
12:51 pm - Case 5: TAP/T: When to
Choose and How to Do
Paul S. Teirstein
12:57 pm - Case 6: Crush/Mini-Crush: When
to Choose and How to Do
Alaide Chieffo
1:03 pm - Case 7: Culotte: When to Choose
and How to Do
Andrejs Erglis
1:09 pm - Case 8: SKS/V/Y: When to Choose
and How to Do
Issam D. Moussa
The Complex Distal Left Main
Discussants: David E. Kandzari, Brij Maini,
Keith G. Oldroyd, Teguh Santoso
1:15 pm - Case 9: LM Rotational Atherectomy
Keith G. Oldroyd
1:21 pm - Case 10: Provisional vs.
Prophylactic Hemodynamic Support
Brij Maini
1:27 pm - Case 11: A Complex Distal Left Main
Trifurcation (Three Important Branches)
Antonio Colombo
1:33 pm - Case 12: The Restenotic Distal Left
Main Segment
David E. Kandzari
1:39 pm - Case 13: An Unforgettable Left Main
PCI Complication
Teguh Santoso
1:45 pm - Adjourn
TCT2011
12:25 pm - Retrograde CTO PCI via Epicardial
Collaterals; Primary Lesion Crossing with
Wire Externalization
Tony J. DeMartini
12:35 pm - Retrograde CTO PCI, Reverse
CART with Wire Externalization
Yaron Almagor
12:45 pm - Retrograde CTO PCI, IVUS-Guided
Reverse CART with Wire Externalization
Masahisa Yamane
12:55 pm - Retrograde CTO PCI, Traditional
CART Technique
Georgios Sianos
1:05 pm - Retrograde CTO PCI Requiring Wire
Snaring for Externalization
J. Aaron Grantham
1:05 pm - What Infrastructure Is Required for
TAVR Complication Management?
Todd M. Dewey
1:15 pm - Case 4: Aortic Insufficiency
Post-TAVR
Ulrich J. Gerckens
1:25 pm - Incidence, Mechanism, Treatment,
and Consequences of Aortic Insufficiency
Following TAVR
Martyn R. Thomas
1:45 pm - Adjourn
Transseptal Puncture: A How-to Guide
12:15 pm-1:48 pm
Room 110
Moderators: Ted Feldman,
Howard C. Herrmann
Discussants: Peter C. Block,
Eulogio J. Garcia, Paul H. Kramer,
Karl-Heinz Kuck, Stefan Sack
12:15 pm - Basic Transseptal Technique
and Indications
Ted Feldman
1:15 pm - Retrograde CTO PCI: Complication
Management (Collateral Perforation)
Alfredo R. Galassi
12:30 pm - Case 1: Transseptal Puncture
for Mitral Balloon Valvuloplasty with
ICE Guidance
Howard C. Herrmann
1:25 pm - Retrograde CTO PCI: Complication
Management (Donor Vessel Thrombosis)
Masahisa Yamane
for MitraClip Repair 1
Ted Feldman
for Pulmonary Vein Isolation
Karl-Heinz Kuck
1:45 pm - Adjourn
Transcatheter Aortic Valve Replacement
12:15 pm-1:45 pm
Room 114
Moderators: Ulrich J. Gerckens,
Martyn R. Thomas
Discussants: Todd M. Dewey, Nicolo Piazza,
Alec Vahanian
12:15 pm - Case 1: Vascular Access
Site Complication
Stephan Windecker
12:25 pm - Managing the Vascular Access
Site in TAVR
Ulrich J. Gerckens
12:35 pm - Case 2: Valve Embolization
Nicolo Piazza
12:45 pm - Optimal Deployment Techniques
in TAVR
Alec Vahanian
1:00 pm - Imaging Guidance of Transseptal
Puncture Location
Howard C. Herrmann
for MitraClip Repair 2
Peter C. Block
for LAA Occlusion
Stefan Sack
for Paravalvular Leak Closure
Eulogio J. Garcia
1:48 pm - Adjourn
Afternoon Spotlight
Sessions
Aortic Endografts and
Aneurysm Repair
2:00 pm-6:00 pm
Room 134
Sponsored by the International
Society of Endovascular Specialists
Session I. Abdominal Aortic Aneurysm
Repair (EVAR) Part 1
Moderators: Jacques Busquet,
Christopher K. Zarins
Discussants: Clifford J. Buckley,
Frank J. Criado, Barry T. Katzen,
Zvonimir Krajcer
- N o v e m b e r 9 , 2 0 11
12:15 pm - Retrograde CTO PCI via Septal
Collaterals; Primary Lesion Crossing with
Wire Externalization
Stéphane Rinfret
12:55 pm - Case 3: Hemodynamic Collapse
During TAVR
Martyn R. Thomas
Wednesday
Retrograde CTO Approach
12:15 pm-1:45 pm
Room 113
Moderators: Carlo Di Mario,
Craig A. Thompson
Discussants: Yasushi Asakura,
Tony J. DeMartini, Alfredo R. Galassi,
Stéphane Rinfret, Georgios Sianos,
Masahisa Yamane
Cardiovascular
Therapeutics
2:00 pm - EVAR Triumphs and Defeats:
Critical Appraisal of the First 20 Years
of the Endograft Era
Frank J. Criado
2:10 pm - Are There Meaningful Differences
Among the Current Aortic Endografts
to Allow Customization to Specific
Patient Anatomy?
Clifford J. Buckley
2:20 pm - EVAR Devices: The Next Five Years
Barry T. Katzen
2:30 pm - EVAR in the Future: Maximizing
Device Durability to Minimize the Need for
Surveillance and Reinterventions
2:40 pm - Role of EVAR in Treatment of
Ruptured Aneurysms (RAAA): Current Status
2:50 pm - What Are the Impediments to Wider
Adoption of Percutaneous EVAR?
Zvonimir Krajcer
Session II. Abdominal Aortic Aneurysm
Repair (EVAR) Part 2
Moderators: Barry T. Katzen, Zvonimir Krajcer
Discussants: Jacques Busquet,
Tyrone J. Collins, Robert A. Lookstein,
Kenneth Ouriel
3:15 pm - Optimal Management of the Small
AAA: Can Early EVAR Be Justified?
Kenneth Ouriel
3:25 pm - Indications for Intervention and
Techniques for Treatment of
Post-EVAR Endoleaks
Barry T. Katzzen
3:35 pm - Contrast CTA Surveillance Is an
Embattled and Increasingly Controversial
Practice: What Are the Alternatives?
Robert A. Lookstein
111
3:45 pm - Aneurysmal Common Iliac Arteries:
Current Guidelines and Considerations for
Extension into the External Iliac
Jacques Busquet
3:55 pm - Renal Artery Stenosis and AAA:
Optimal Timing of Treatment?
Tyrone J. Collins
Session III. Endograft Thoracic Aortic
Repair (TEVAR)
Moderators: Frank J. Criado, Rodney White
Discussants: Timothy A.M. Chuter,
W. Anthony Lee, Christoph A. Nienaber,
Grayson H. Wheatley
4:20 pm - TEVAR Access Issues
and Techniques
Grayson H. Wheatley
4:30 pm - TEVAR Devices: State of the Art
and Unmet Needs for 2011
Michael D. Dake
4:40 pm - Hybrid Solutions for TAA Involving
the Aortic Arch
Grayson H. Wheatley
4:50 pm - Does the Expansion of On-Label
Indication for TEVAR Devices Matter?
Frank J. Criado
5:00 pm - Branch-Vessel Strategies During
Endovascular Treatment of Juxta-Visceral
and Thoracoabdominal Aneurysms:
Chimneys, Snorkels, and Periscopes
W. Anthony Lee
5:10 pm - Update on Endovascular Repair of
Acute Type B Aortic Dissection: Challenges
and Possible Solutions
Christoph A. Nienaber
5:20 pm - Branched Endograft Solutions for
the Thoracoabdominal Aorta
Timothy A.M. Chuter
5:30 pm - TEVAR Strategies for Treatment of
Aortic Catastrophes: Emerging Evidence and
Evolving Practices
Rodney White
6:00 pm - Adjourn
Integrating IVUS and FFR to
Improve PCI Outcomes
2:00 pm-6:05
Room 104
pm
Session I. The Basics and Intermediate
Lesion Assessment
Moderators: Bernard De Bruyne,
John McB. Hodgson
Discussants: William F. Fearon,
Hector M. Garcia-Garcia, Morton J. Kern,
Massoud A. Leesar, Gilles Rioufol
112
program ·
2:00 pm - How I Use IVUS in the Cath Lab
and Why: Basics, Practice, and Pitfalls
Gilles Rioufol
2:15 pm - What Is Radiofrequency IVUS,
and How Might It Be Used Clinically in the
Cath Lab?
2:30 pm - How I Use FFR in the Cath Lab and
Why: Basics, Practice, and Pitfalls
Morton J. Kern
2:45 pm - FFR vs. IVUS for Assessment of
LMCA and Non-LMCA Intermediate Lesions:
Concordance, Discord, and How/When
to Choose
John McB. Hodgson
3:00 pm - FIRST: Correlation Between
Radiofrequency Intravascular Ultrasound
and Fractional Flow Reserve Parameters
in Patients with Intermediate
Coronary Stenoses
Ron Waksman
Practicalities of IVUS and FFR and
Their Cutoff Values
Session II. Stump the IVUS/FFR Experts:
Case Presentations
Moderators: Morton J. Kern, Gary S. Mintz
Discussants: Wacin Buddhari,
Ricardo A. Costa, Jose de Ribamar Costa Jr,
Michalis Hamilos, Sandeep Nathan,
Huay Cheem Tan, Pim A.L. Tonino
3:25 pm - Case 1: IVUS and FFR in
Intermediate Lesions
Massoud A. Leesar
3:35 pm - Case 2: IVUS and FFR in
Tandem Lesions
William F. Fearon
3:45 pm - Case 3: One or More Artifacts
Habib Samady
3:55 pm - Case 4: IVUS and FFR in Acute
Coronary Syndromes
Colin Berry
Session III. IVUS/FFR Uses During PCI
Moderators: Carlo Di Mario,
Discussants: Lisette Okkels Jensen,
Bon-Kwon Koo, Massoud A. Leesar,
Matthew J. Price, Satoru Sumitsuji
4:05 pm - Use of IVUS During CTO
Intervention (with Case Examples)
Satoru Sumitsuji
4:15 pm - Use of IVUS and FFR in LMCA
Interventions: When to Treat, How to Treat,
Outcomes, and Clinical Decision-Making
Matthew J. Price
4:25 pm - Role of IVUS After Stent
Implantation: Optimization, Complications,
and Predictors of Early and Late Events
Massoud A. Leesar
4:35 pm - Role of FFR After Stent Implantation:
Optimization, Sidebranch Assessment in
LMCA and Non-LMCA Lesions, and More
Bon-Kwon Koo
4:45 pm - Assessment of In-Stent Restenosis
and Thrombosis (with Case Examples)
Lisette Okkels Jensen
Session IV. Clinical Strategies
Moderators: William F. Fearon,
Massoud A. Leesar
Discussants: David J. Cohen,
Bernard De Bruyne, Gary S. Mintz,
Ajit Mullasari
5:10 pm - How I Integrate Selective Use of
FFR and IVUS in the Cath Lab and Why
Ajit Mullasari
5:20 pm - IVUS and IVUS/VH in Acute
Coronary Syndromes: How to Interpret
and Apply PROSPECT to Clinical Care
Gary S. Mintz
5:30 pm - FFR in Multivessel Disease:
A Practical Approach Based on FAME,
SYNTAX, and COURAGE
Bernard De Bruyne
5:40 pm - Cost-Effectiveness of PCI vs. CABG
in Multivessel CAD: Implications of an
FFR-Guided Strategy
David J. Cohen
6:05 pm - Adjourn
Next Generation Transcatheter
Mitral Valve Therapies
2:00 pm-6:00
Room 135
pm
Session I. The Challenges of CatheterBased Therapies for Mitral Regurgitation
Moderators: Maurice Buchbinder,
A. Marc Gillinov
Discussants: Paul A. Grayburn,
A. Pieter Kappetein, Robert J. Siegel,
Renu Virmani
2:00 pm - A Noninvasive
Cardiologist’s Perspective
Paul A. Grayburn
2:08 pm - An Echocardiographer’s Perspective
Robert J. Siegel
2:16 pm - A Surgeon’s Perspective
A. Pieter Kappetein
TCT2011
2:40 pm - Cardiac Dimensions Carrillon XE2:
Foundational Results and Design Iteration
Toward a Pivotal Clinical Trial
Steven L. Goldberg
2:52 pm - Lessons from a Therapy on Hold:
The Edwards Monarc (EVOLUTION I and II)
Jan Harnek
3:00 pm - Lessons from a Therapy on Hold:
Viacor PTMA
Stefan Sack
3:08 pm - Coronary Sinus Annuloplasty Plus:
Progress with Mitral Cerclage
Robert J. Lederman
Session III. Second Shot on Goal: Direct
Annuloplasty Devices
Moderators: Ted Feldman,
Howard C. Herrmann
Lutz Buellesfeld, Richard R. Heuser,
Karl-Heinz Kuck, Francesco Maisano,
Jason H. Rogers
3:26 pm - Guided Delivery Systems’
Accucinch: Device Description, Procedure,
and Latest Patient Results
Joachim Schofer
3:40 pm - Mitralign Bident: Current
Device, Procedure, and Up-to-Date
Clinical Outcomes
Lutz Buellesfeld
4:52 pm - The Cardiosolutions Mitra-Spacer
Anson Cheung
5:02 pm - The Valtech V-Chordal System
Francesco Maisano
Session V. Fourth Shot on Goal:
Transcatheter Mitral Valve Replacement
Moderators: Karl-Heinz Kuck,
Joachim Schofer
Discussants: Howard C. Herrmann,
Georg Lutter, Michael J. Mack
5:20 pm - Progress with Transcatheter
Mitral Valve Replacement 1: EndoValve
Howard C. Herrmann
Mitral Valve Replacement 2: CardiAQ
Michael J. Mack
Mitral Valve Replacement 3: The
Lutter Bioprosthesis
Georg Lutter
6:00 pm - Adjourn
Optimizing Use of Today’s
Antithrombotic and Antiplatelet
Drugs in ACS, PCI, and
Atrial Fibrillation
2:00 pm-6:05
Room 102
pm
Debate: Point-of-Care Testing Should
Dictate Selection of ADP Inhibitor
2:36 pm - Pro: Platelet Assays/Genotyping
Are Useful!
David Antoniucci
2:44 pm - Con: Relying on Platelet Assays/
Genotyping Is Misleading and
Potentially Harmful!
Sanjay Kaul
2:52 pm - Do Glycoprotein IIb/IIIa Inhibitors
Still Have a Role in Selected Patients?
Neal S. Kleiman
Session II. Optimal Anticoagulant Therapy
in ACS and PCI
Moderators: Deepak L. Bhatt,
E. Magnus Ohman
Discussants: Kurt Huber, Stefan K. James,
David F. Kong, Steven V. Manoukian,
Julinda Mehilli, Shamir R. Mehta,
Gregg W. Stone, George W. Vetrovec
3:17 pm - Patient Selection for Bivalirudin:
In Whom Should It Be Required vs. Preferred
vs. May Not Be Necessary?
Gregg W. Stone
3:29 pm - Enoxaparin: Safe and Cost-Effective
for All ACS and PCI Patients!
Stefan K. James
3:41 pm - Heparin Alone Is Still the Most
Widely Used Antithrombin Regimen—and
Rightly So!
Julinda Mehilli
3:51 pm - Fondaparinux Has a Role in
the Right Patient
Shamir R. Mehta
4:02 pm - RF-Based Mitral Annuloplasty:
QuantumCor
Richard R. Heuser
Session I. Optimal Antiplatelet Therapy in
ACS and PCI
Moderators: Dominick J. Angiolillo,
David J. Moliterno
Discussants: David Antoniucci,
Germano Di Sciascio, Stefan K. James,
Sanjay Kaul, Neal S. Kleiman,
Shamir R. Mehta, Victor L. Serebruany,
Sigmund Silber, Jurrien M. Ten Berg
Session III. Chronic Anticoagulation in
Patients with Atrial Fibrillation
Moderators: Christopher B. Granger,
Matthew T. Roe
Discussants: Andrea Abizaid,
Piera Capranzano, James H. Chesebro,
Michael D. Ezekowitz, Stefan K. James,
David F. Kong, Jeffrey J. Rade,
Freek W.A. Verheugt
4:16 pm - The Valtech Catheter-Based
Cardioband
Francesco Maisano
2:00 pm - Role of Clopidogrel: Who Benefits,
What Dose, and Pre- or Post-PCI?
Shamir R. Mehta
4:28 pm - Micardia Dynoplasty: Progress
Toward a Percutaneously Adjustable
Mitral Ring
Maurice Buchbinder
2:12 pm - Role of Prasugrel: Who Benefits,
Who Doesn’t, and What Are the Risks and
Contraindications?
Sigmund Silber
4:16 pm - Patient Selection Considerations
for the Oral Thrombin Inhibitor Dabigatran:
Safety, Efficacy, Contraindications,
and Caveats
4:30 pm - The Millepede Percutaneous
Annuloplasty Ring
Jason H. Rogers
2:24 pm - Role of Ticagrelor: Who Benefits,
Who Doesn’t, and What Are the Risks and
Contraindications?
Stefan K. James
3:50 pm - HIFU-Based Mitral
Annuloplasty: ReCor
Karl-Heinz Kuck
- N o v e m b e r 9 , 2 0 11
Session II. First Shot on Goal: Coronary
Sinus Annuloplasty Devices
Moderators: Jason H. Rogers, Alec Vahanian
Discussants: Stephen G. Ellis,
Steven L. Goldberg, Jan Harnek,
Robert J. Lederman
Session IV. Third Shot on Goal:
Other Approaches
Moderators: Olaf Franzen,
Discussants: Anson Cheung,
Francesco Maisano
Wednesday
2:24 pm - A Pathologist’s Perspective
Renu Virmani
Cardiovascular
Therapeutics
4:26 pm - Patient Selection Considerations
for the Oral Direct Factor Xa Inhibitor
Rivaroxaban: Safety, Efficacy,
Contraindications, and Caveats
Freek W.A. Verheugt
113
4:36 pm - Patient Selection Considerations for
the Oral Direct Factor Xa Inhibitor Apixaban:
Safety, Efficacy, Contraindications,
and Caveats
4:46 pm - Perspectives on the “New”
Anticoagulants for Nonvalvular Atrial
Fibrillation: When Is Warfarin Acceptable
and Cost-Effective?
Matthew R. Reynolds
4:56 pm - Strategies for the Patient Requiring
Aspirin, Clopidogrel, and Chronic
Anticoagulation
David F. Kong
Session IV. Emerging Novel Therapies
Moderators: C. Michael Gibson,
Frans Van de Werf
Discussants: Deepak L. Bhatt, Kirk N. Garratt,
David J. Moliterno, Freek W.A. Verheugt,
Pascal Vranckx
5:21 pm - The Clinical Potential for
Intravenous ADP Receptor Blockers
(and Lessons Learned to Date)
Deepak L. Bhatt
5:36 pm - The Clinical Potential for PAR-1
Inhibitors (and Lessons Learned to Date)
David J. Moliterno
6:05 pm - Adjourn
Surgical, Interventional, and
Hybrid Procedures (Part 2):
Valvular and Structural
Heart Disease
2:00 pm-6:00
Room 133
pm
Session I. Transfemoral vs. Transapical
Access for TAVR
Moderators: Axel Linke, Thomas Walther
Discussants: Gregory P. Fontana, Jan Kovac,
Neil E. Moat, Mathew Williams
2:00 pm - Transapical Is the Preferred
Approach—Even if Suitable for Transfemoral!
Thomas Walther
2:08 pm - Transfemoral (Whenever Feasible)
Is the Preferred Approach!
Jan Kovac
114
Session II. TAVR Potpourri
Moderators: Nicolo Piazza, Mathew Williams
Discussants: Anson Cheung, Eberhard Grube,
Larry L. Wood
2:40 pm - Valve-in-Valve for Failed
Bioprosthetic Valves
Anson Cheung
2:50 pm - TAVR Trends in Europe and
What We Might Expect in the United
States (Post-Approval)
Larry L. Wood
Session V. Structural Heart Disease
Moderators: Gregory P. Fontana,
Samir R. Kapadia
Discussants: Roger J. Laham,
Michael J. Mullen
5:24 pm - PFO: When Is Surgical or
Percutaneous Closure Indicated?
Michael J. Mullen
3:00 pm - TAVR: Parade of Next
Generation Devices
Eberhard Grube
5:34 pm - Periventricular Closure of
Septal Defects
Samir R. Kapadia
5:44 pm - Surgical and Percutaneous Options
to Close the Left Atrial Appendage:
What Really Works?
Roger J. Laham
Session III. Transcatheter Mitral
Valve Procedures
Moderators: A. Marc Gillinov, Alfredo Trento
Discussants: Michael J. Davidson, Scott Lim,
Neil E. Moat, Joachim Schofer
3:18 pm - Multidisciplinary Approach to
Mitral Valve Disease
Neil E. Moat
3:28 pm - MitraClip: Trends in Europe
Francesco Maisano
3:38 pm - Training Surgeons to Do the
MitraClip Procedure
Scott Lim
3:48 pm - Are Surgical Options Preserved After
Transcatheter Mitral Valve Procedures?
Michael J. Davidson
3:58 pm - Beyond MitraClip: Parade of
Transcatheter Mitral Valve Devices
Joachim Schofer
Session IV. Valve Surgery
Moderators: A. Marc Gillinov, Neil E. Moat
Steven F. Bolling, W. Randolph Chitwood Jr,
James S. Gammie, Lars G. Svensson
6:00 pm - Adjourn
Special Twilight
Sessions
Clinical Cardiovascular
Genetics and the Era of
Personalized Medicine
6:00 pm-8:00 pm
Room 120
Moderators: W. Craig Hooper,
H. Robert Superko
Discussants: Colin M. Barker,
James H. Chesebro, Robert Roberts,
John Sninsky, George Wells
6:00 pm - Tools for Genomics and
Pathophysiological Targets for
James H. Chesebro
4:16 pm - Minimally Invasive Mitral Repair:
How I Do It
A. Marc Gillinov
6:15 pm - Is Genetic Testing for Clopidogrel
Hyporesponsiveness Ready for Prime Time?
Colin M. Barker
4:26 pm - Artificial Chords: How I Do It
Steven F. Bolling
4:36 pm - Aortic Valve Repair: How I Do It
Lars G. Svensson
2:16 pm - If Transfemoral Is Not Available,
Alternative Vascular Access Is Preferable
to Transapical!
Neil E. Moat
4:46 pm - Who Should Have a Mitral
Valve Replacement—Even If the
Valve Is Repairable?
James S. Gammie
2:24 pm - Stop the Turf Battle: A Collaborative
Heart Team Should Decide! (Case Examples)
Mathew Williams
4:56 pm - The Tricuspid Valve: When Should
It Be Repaired?
W. Randolph Chitwood Jr
program ·
5:06 pm - Update on NIH-Sponsored Mitral
Regurgitation Trials
Michael Argenziano
6:30 pm - Use of Genetic Markers in Families
with a History of Coronary Artery Disease
H. Robert Superko
6:45 pm - 9p21: Risk Marker or Gene
Dose Severity?
Robert Roberts
TCT2011
7:00 pm - BIOSOLVE I: A Prospective Study
of a Paclitaxel-Eluting Bioabsorbable
Magnesium Stent in Patients with Coronary
Artery Disease
Raimund A. Erbel
7:15 pm - Multi-SNP Analysis: Risk Prediction
Better Than Framingham and ARIC?
George Wells
7:15 pm - SeQuent Please World Wide:
A Large-Scale Registry Study of a
Paclitaxel-Coated Balloon in Native
Coronary Artery Lesions
Jochen Wöhrle
7:30 pm - Genetics of VTE Risk
and Comorbidities
W. Craig Hooper
7:45 pm - Discussion: Current and Future
Directions of Genomic-Directed
8:00 pm - Adjourn
Featured Clinical Research III.
Drug-Eluting Stents,
Drug-Coated Balloons,
and PCI Pharmacology
6:00 pm-8:00 pm
Room 124
Bruno Scheller
Discussants: Jorge A. Belardi, Rafael Beyar,
Kishore J. Harjai, Oscar A. Mendiz,
Expedito E. Ribeiro, Francesco Saia,
Tabassome Simon, Peter Wenaweser
6:00 pm - MOST: A Prospective, Multicenter,
Case-Control-Matched Study Investigating
the Causes of Stent Thrombosis Using
Optical Coherence Tomography and
Platelet Function Testing
Guido Parodi
6:15 pm - A Prospective, Randomized Trial of
Prasugrel vs. Double-Dose Clopidogrel in
Myocardial Infarction and Clopidogrel
Hyporesponsiveness
Dimitrios Alexopoulos
6:30 pm - SPICE: A Prospective, Randomized
Trial of Four Antacid Strategies in Patients
Receiving Clopidogrel
Jean-Pierre Dery
6:45 pm - ACCEL-BLEED: A Prospective Study
Examining the Relationship Between Platelet
Reactivity and Bleeding Events After
Young-Hoon Jeong
7:30 pm - PEPPER FIM: A Prospective,
Multicenter, Registry of a Paclitaxel-Coated
Balloon for Treatment of Coronary Bare
Metal or Drug-Eluting Stent Restenosis
Christoph Hehrlein
7:45 pm - A Prospective, Multicenter Registry
of a Paclitaxel-Coated Balloon for Treatment
of Femoropopliteal Arterial Disease
Antonio Micari
Session III. TAVR Session: Success,
Failures, and Tips and Tricks
Moderator: Antonio Colombo
Discussants: Jean-Claude Laborde,
Martin B. Leon
7:15 pm - CoreValve from the Master
Jean-Claude Laborde
7:30 pm - Sapien from the Master
Martin B. Leon
8:00 pm - Adjourn
Focus on India: Interactive Case
Review and Panel Discussion
6:00 pm-8:00 pm
Room 131
Moderators: Ajay J. Kirtane, Manish A. Parikh
Discussants: Sirish M Hiremath,
Sreenivas Arramraju Kumar,
Ashwin Balachand Mehta, Keyur H. Parikh,
Ashok Seth
6:00 pm - Introductions
6:05 pm - Case 1: Coronary Artery Disease
Intervention Complication
8:00 pm - Adjourn
Partnership Session: JIM at TCT
6:20 pm - Case 2: Complex Peripheral Arterial
6:00 pm-8:00
Room 122
pm
Session I. Drug-Coated Balloons: Should
They Be Used for Coronary In-Stent
Restenosis and Bifurcations?
Moderator: Jean-Claude Laborde
Juan F. Granada
6:00 pm - No, DES and PTCA Are Fine for
Most: DCB Are Unlikely to Work and/or May
Not Be Safe!
Juan F. Granada
6:10 pm - Yes, I Challenge the Rationale to
Add Extra Metal: In Some Conditions,
“a Drug and a Balloon” Will Be Better!
Antonio Colombo
- N o v e m b e r 9 , 2 0 11
7:00 pm - Translation of Genomics into Clinical
Care: Quality and Strength of Evidence for
Clinical Practice Improvements in Advance
of Guidelines
John Sninsky
Wednesday
Cardiovascular
Therapeutics
6:35 pm - Case 3: Peripheral Arterial Disease
6:50 pm - Dinner Break
Discussants: Vinay Bahl, Upendra Kaul,
Pratap Kumar, Samuel K. Mathew
7:15 pm - Case 4: Complex Structural Heart
7:30 pm - Case 5: Structural Heart Disease
7:45 pm - Closing Remarks
8:00 pm - Adjourn
Session II. Challenging PCI: Selected
Case Reviews
Commentators: Ted Feldman,
Eulogio J. Garcia, Augusto D. Pichard
6:30 pm - Really Diffuse Disease
Augusto D. Pichard
6:45 pm - A Really Tough Bifurcation Lesion
Antonio Colombo
7:00 pm - Complex In-Stent Restenosis
Carlo Di Mario
115
Korean Interventional
Cardiology Summit
6:00 pm-8:00 pm
Hilton San Francisco
Golden Gate 1, Lobby Level
333 O’Farrell St, San Francisco, CA
Moderators: Joo-Young Yang, Jung-Han Yoon
Panelists: Jae-Keon Chae, Tae-Soo Kang,
Young-Hoon Kim, Young-Youp Koh,
Sung-Jin Oh, Woo-Jung Park, Eun-Seok Shin
6:00 pm - Welcome Address
Joo-Young Yang
6:05 pm - EES vs. First Generation DES:
Are There Any Differences? Evidence
from Meta-analyses
Kyung-Woo Park
6:40 pm - Audience Q&A
6:50 pm - Break
Case Studies
7:00 pm - Case 1: Multivessel Treatment
7:10 pm - Case 2: Bifurcation Disease
7:20 pm - Case 3: Left Main Disease
7:30 pm - Case 4: Long Lesion Disease
7:40 pm - Case 5: Small Vessel Disease
7:50 pm - Closing Thoughts and
Take-Home Messages
Jung-Han Yoon
8:00 pm - Adjourn
Special Circulation Journal
Session: The Most Important
Interventional Papers from
the Last Year
6:00 pm-8:00 pm
Room 121
Moderators: David P. Faxon, David O. Williams
Theodore A. Bass, Jane A. Leopold
David P. Faxon
6:02 pm - Evaluation of the Second Generation
of a Bioresorbable Everolimus-Eluting
Vascular Scaffold for Treatment of De Novo
Coronary Artery Stenosis: Six-Month Clinical
and Imaging Outcomes
Patrick W. Serruys
Moderator: Theodore A. Bass
Discussants: J. Dawn Abbott, David P. Faxon,
Jane A. Leopold, Patrick W. Serruys,
David O. Williams
6:20 pm - Incidence and Predictors of Early
and Late Mortality After Transcatheter Aortic
Valve Implantation in 663 Patients with
Corrado Tamburino
Moderator: David P. Faxon
Theodore A. Bass, Jane A. Leopold,
Corrado Tamburino, David O. Williams
6:40 pm - Platelet Reactivity and
Cardiovascular Outcomes After
A Time-Dependent Analysis of the
Gauging Responsiveness with a VerifyNow
P2Y12 Assay: Impact of Thrombosis and
Safety (GRAVITAS) Trial
Matthew J. Price
Moderator: J. Dawn Abbott
Discussants: Theodore A. Bass,
Bernard De Bruyne, David P. Faxon,
Jane A. Leopold, David O. Williams
7:00 pm - Difference in Tissue Characteristics
Between Early and Very Late Restenosis
After Bare Metal Stent Implantation: An
Optical Coherence Tomography Study
Maoto Habara
Moderator: David O. Williams
Lead Discussant: Jane A. Leopold
Theodore A. Bass, David P. Faxon,
Maoto Habara
116
program ·
7:20 pm - Simple or Complex Stenting for
Bifurcation Coronary Lesions: A PatientLevel Pooled Analysis of the Nordic
Bifurcation Study and the British
Bifurcation Coronary Study
Moderator: J. Dawn Abbott
Discussants: Theodore A. Bass,
David P. Faxon, David J. Hildick-Smith,
Jane A. Leopold, David O. Williams
7:40 pm - Validation of Intravascular
Ultrasound-Derived Parameters with
Fractional Flow Reserve for Assessment
of Coronary Stenosis Severity
Gary S. Mintz
Moderator: Jane A. Leopold
Theodore A. Bass, David P. Faxon,
Gary S. Mintz, David O. Williams
7:58 pm - Concluding Remarks
David O. Williams
8:00 pm - Adjourn
Evening Programs
7:00
pm -10:00 pm
Programs schedule.
TCT2011
Cardiovascular
Therapeutics
Wednesday
Educational Activities
- N o v e m b e r 9 , 2 0 11
C a r d i o va s C u l a r
researCh
F o u n d at i o n
Save the Dates
Save the dates for these upcoming meetings sponsored
by the Cardiovascular Research Foundation.
p-c-i Live with TCT
Complex PCI: A Live
Case Demonstration
Course with Left Main,
Bifurcation, and
CTO Interventions
Gi2 with TCT
TCT Russia
April 11-13, 2012
XIV Moscow International
Course on Endovascular
Therapies
February 23-25, 2012
Fellows Course
December 9, 2011
New York Marriott Marquis
April 19-22, 2012
Mandarin Oriental Hotel
New York, NY
Loews Miami Hotel
December 1-2, 2011
Munich, Germany
Annual Pulse of
the City Gala
New York, NY
CIT in Partnership with TCT
São Paulo, Brazil
Moscow, Russia
Transcatheter Valve Therapies
(TVT) 2012
Miami, FL
June 2-5, 2012
Conference on Cell Therapy
March 15-18, 2012
Angioplasty Summit-TCTAP
for Cardiovascular Disease
Beijing, China
April 25-28, 2012
January 26-27, 2012
Vivien and Seymour Milstein
Family Heart Center
NewYork-Presbyterian/Columbia
University
Medical Center
Optimizing PCI Outcomes:
Seoul, South Korea
Evolving Paradigms
TCT Mediterranean 2012
March 2012
May 4-5, 2012
ACC.12/i2 Summit
The Grand Resort
Chicago, IL
New York, NY
Limassol, Cyprus
May 28-30, 2012
Westin Seattle
Seattle, WA
Transcatheter Cardiovascular
Therapeutics (TCT) 2012
October 22-26, 2012
Miami Beach Convention Center
Miami, FL
ACC.11/i2 Summit with TCT
March 24-27, 2012
Chicago, IL
R E S E A R C H F O U N D AT I O N
passion for innovation
w w w . t c t c o n f e r e na c
e.com
117
P L E A S E
J O I N
U S
F O R
Honoring
Elizabeth Nabel, MD
Mehmet Oz, MD
And Special Guests
for Championing Women’s Heart Health
F R I D AY, D E C E M B E R 9 , 2 0 11
M A N DA R I N O R I E N TA L · T I M E W A R N E R C E N T E R
8 0 C O L U M B U S C I R C L E · N E W YO R K , N Y
Cocktails, Dinner, and Dancing
For more information about the gala or the women’s heart health summit,
please contact Irma Damhuis at 646-434-4690 or [email protected].
118
final program ·
TCT2011
Cardiovascular
Therapeutics
Major Halls
Main Arena............................................................................................... 120
How to Treat Theater: Endovascular and Structural Heart Disease...........122
International Society-Sponsored Case Theater.........................................123
Maintenance of Certification (MOC) Course........................... 124
Special Sessions
FDA Town Hall Meeting.............................................................................125
From Clinical Trials Evidence to Clinical Practice:
Unraveling the Issues............................................................................... 126
Next Generation Transcatheter Aortic Valve Therapies............................. 126
Optimizing Primary PCI for STEMI (Part 1): The Systems Approach........ 127
Tough Calls in the Cath Lab: Are You Up to the Challenge?......................127
Presentation Theaters..................................................................... 160
Lunchtime Sessions
Hot Topics................................................................................................ 128
Thursday
Learn the Technique..................................................................................129
Drug-Coated Balloons: Clinical Data and Applications............................ 132
Next Generation Optical Intravascular Imaging:
OCT and NIR Spectroscopy..................................................................... 133
Partnership Session: Brazilian Society of Interventional
Cardiology (SBHCI) and Gi2: Transcatheter Aortic Valve
Replacement and Complex Coronary Intervention................................... 134
Partnership Session: p-c-i Live in Partnership with TCT: Practical
Aspects of Coronary, Valvular, and Electrophysiologic Interventions........ 134
san francisco, ca
·
Optimizing Primary PCI for STEMI (Part 2):
Drugs, Devices, and Technique.................................................................133
the Moscone Center
Deep Dive: Interventional Hypertension................................................... 131
November 10, 2011
Practicalities and Pitfalls of Platelet Function Testing.............................. 135
TCT Mediterranean...................................................................................135
119
Breakfast Meetings
7:00
am -8:00 am
Meetings schedule.
Plenary Session XII. TCT 2011
Inspirational Address and the
TCT 2011 Thomas J. Linnemeier
Spirit of Interventional
Cardiology Young
Investigator Award
Main Arena
8:00 am-6:00 pm
Esplanade Ballroom
Plenary Session X.
Live Cases IV
Live Case Co-Moderator: Horst Sievert
Live Case Discussants: Elchanan Bruckheimer,
David J. Cohen, Dariusz Dudek,
Raimund A. Erbel, Chaim S. Lotan,
Daniel J. McCormick, Gary S. Mintz,
Robert D. Safian, Alec Vahanian,
Brian Whisenant, Alan C. Yeung
8:00 am - Mayo Clinic
Rochester, MN
8:45 am - Cardiovascular Centre,
ZNA Middelheim
Antwerp, Belgium
Plenary Session XI. Adjunctive
Pharmacology Considerations
Dean J. Kereiakes
Discussants: Deepak L. Bhatt,
Laurent Bonello, James H. Chesebro,
Dmitriy N. Feldman, C. Michael Gibson,
Michelle O’Donoghue, Dirk Sibbing,
Daniel I. Simon
TCT Interventional Corner III.
The Clinical Utility of Platelet
Resistance and Genetic Testing
9:30 am - Selective but Important Value!
Matthew J. Price
9:40 am - Research-Only Tool!
Jean-François Tanguay
9:50 am - Discussion and Rebuttal
10:00 am - Synthesis
Ajay J. Kirtane
10:05 am - Spotlight Lecture: Evidence-Based
Pharmacotherapy Recommendations for
PCI, NSTEMI, and STEMI: The Forest
and the Trees
Gregg W. Stone
10:45 am - TCT 2011 Inspirational Address:
A Story of Despair, Hope, and Recovery
in Japan
Shigeru Saito
11:00 am - TCT 2011 Thomas J. Linnemeier
Spirit of Interventional Cardiology Young
Investigator Award
Award Presenter: Gregg W. Stone
Award Finalists: Masaki Awata,
Davide Capodanno, Thomas T. Tsai,
Robert W. Yeh
Plenary Session XIII. Late
First Report Investigations II
Focus on Transcatheter Aortic
Valve Replacement
Moderator: Jean-Claude Laborde
Discussants: David J. Cohen,
A. Pieter Kappetein, Martin B. Leon,
Raj Makkar, Ian T. Meredith, Robert E. Michler,
Neil E. Moat, William W. O’Neill,
Jeffrey J. Popma, Matthew R. Reynolds,
Martyn R. Thomas, Leif Thuesen
11:15 am - PARTNER Cohort
B Two-Year:
A Prospective, Randomized
Trial of Transcatheter Aortic
Valve Replacement vs.
Standard Therapy in
Patients with Inoperable Aortic Stenosis
Raj Makkar
A QOL: Qualityof-Life Analysis from a
Surgical Aortic Valve Replacement in
High-Surgical-Risk Patients with
Aortic Stenosis
David J. Cohen
10:20 am - Spotlight Lecture: Novel Adjunctive
PCI/ACS Pharmacologic Strategies
and Agents: Have We Reached a
Biologic Plateau?
Harvey D. White
120
program ·
A CE: Cost-Effectiveness
Analysis from a
Surgical Aortic Valve Replacement in
High-Surgical-Risk Patients with Aortic
Stenosis
Matthew R. Reynolds
11:41 am - STACCATO: A
Trial of Transapical
Replacement vs. Surgical
Aortic Valve Replacement
in Low-Surgical-Risk Elderly Patients
with Aortic Stenosis
Leif Thuesen
11:51 am - Roundtable Discussion:
of These Studies
Focus on Primary PCI in STEMI
Moderator: Eric R. Bates
Discussants: John A. Bittl, Bruce R. Brodie,
Frederick Feit, Martial Hamon, Sanjit S. Jolly,
Ajay J. Kirtane, Harry R. Phillips,
Enrico Romagnoli, Richard Smalling,
Pieter R. Stella
12:15 pm - RIFLE STEACS: A
Trial of Radial vs. Femoral
Vascular Access in Patients
with ST-Segment Elevation
Enrico Romagnoli
12:25 pm - MUSTELA: A
Trial of Thrombectomy vs.
No Thrombectomy in
Patients with ST-Segment
Elevation Myocardial
Infarction and Thrombus-Rich Lesions
Anna Sonia Petronio
12:35 pm - DEB-AMI: A
Trial of Paclitaxel-Coated
Balloons plus Bare Metal
Stents vs. PaclitaxelEluting Stents vs. Bare
Metal Stents Alone in Patients with
Pieter R. Stella
TCT2011
Live Case Co-Moderator: Bernard De Bruyne
Live Case Discussants: Maurice Buchbinder,
Ted Feldman, Howard C. Herrmann,
David J. Hildick-Smith, Thomas A. Ischinger,
Allen Jeremias, Dean J. Kereiakes,
Sameer Mehta, John F. Rhodes,
Joachim Schofer, Gerhard C. Schuler
New York, NY
1:45 pm - Scripps Green Hospital
La Jolla, CA
Plenary Session XV. Clinical
Trials: The Cornerstone of
Evidence-Based Medicine
Moderators: Patrick W. Serruys,
Gregg W. Stone
Discussants: Donald Cutlip,
Dean J. Kereiakes, Michael J. Mack,
Roxana Mehran, Helen Parise, Sunil V. Rao,
Freek W.A. Verheugt, Pascal Vranckx,
Stephan Windecker
TCT Interventional Corner IV. Clinical
Trial Design and Interpretation
2:30 pm - Randomized Trials Remain
the Gold Standard!
Gregg W. Stone
2:40 pm - Registries Are an Invaluable
and Indispensable Tool!
Ralph G. Brindis
2:50 pm - Discussion and Rebuttal
3:00 pm - Synthesis
Peter Juni
3:05 pm - Spotlight Lecture: Common Sense
Interpretation of Increasingly Sophisticated
Statistics: Recent Case Study Examples
Stuart J. Pocock
Plenary Session XVI.
Live Cases VI
Live Case Co-Moderator: Liliana R. Grinfeld
Live Case Discussants: John D. Carroll,
Charles J. Davidson, Larry S. Dean,
Olaf Franzen, Eulogio J. Garcia,
Anthony H. Gershlick, Steven L. Goldberg,
Joshua M. Hare, Sigmund Silber,
Daniel I. Simon, Rod H. Stables
4:15 pm - Scripps Green Hospital
La Jolla, CA
Plenary Session XVII. Structural
Heart Disease Controversies
Moderators: Michael J. Mullen,
Jonathan M. Tobis
Howard C. Herrmann, Eric Horlick,
Stamatios Lerakis, Brad I. Munt,
Ramon Quesada, Peter Sick, David E. Thaler,
Brian Whisenant
TCT Interventional Hot Topic III.
PFO Closure for Stroke Prevention
and Migraine Treatment
5:00 pm - The Clinical Needs (and Data)
Are Compelling!
John D. Carroll
5:10 pm - Evidence for Efficacy Is
Sorely Lacking!
Thomas G. Brott
5:20 pm - Discussion and Rebuttal
TCT Interventional Hot Topic IV. Left Atrial
Appendage Closure for Stroke Prevention
5:30 pm - Spotlight Lecture: Comprehensive
Update on LAA Closure: Rationale,
Indications, Clinical Trials (Completed
and Ongoing), and Technologies
Vivek Y. Reddy
6:00 pm - Adjourn
Coronary Artery
Disease
8:00 am-6:00
Hall D
pm
Complex and Unusual Cases I
Moderator: George D. Dangas
Co-Moderator: Richard A. Schatz
8:00 am - Drivers of Revascularization in
Stable Coronary Artery Disease:
A Balanced Approach
John A. Spertus
8:15 am - Revascularization Guidance in
Patients with Diabetes Mellitus
Ajay J. Kirtane
Live Cases: Complex and
Unusual Cases I
Live Case Moderator: George D. Dangas
Live Case Co-Moderator: Richard A. Schatz
Live Case Discussants: Steven L. Almany,
John A. Ambrose, Christoph A. Kaiser,
Henning Kelbaek, Karel T. Koch,
Karl-Heinz Kuck, Norman E. Lepor,
Giora Weisz, Peter Wenaweser
8:30 am - Scripps Green Hospital
La Jolla, CA
9:15 am - Mayo Clinic
Rochester, MN
10:00 am - Discussion: What Have We Learned
from These Cases?
- N o v e m b e r 1 0 , 2 0 11
Plenary Session XIV.
Live Cases V
3:30 pm - Swedish Health Services
Seattle, WA
Thursday
of These Studies
Cardiovascular
Therapeutics
Multivessel Disease I
Moderator: Maurice Buchbinder
Co-Moderator: Erick Schampaert
10:15 am - Next Generation Drug-Eluting
Stents Today and Tomorrow: Evolution
or Revolution?
Stephan Windecker
10:30 am - How to Use FFR in Clinical
Practice: From Basic to Advanced
Bernard De Bruyne
Live Cases:
Multivessel Disease I
Live Case Moderator: Maurice Buchbinder
Live Case Co-Moderator: Erick Schampaert
Live Case Discussants: Sripal Bangalore,
Giulio Guagliumi, Yaling Han,
Michael A. Kutcher, Detlef G. Mathey,
Michael Mooney, Giuseppe M. Sangiorgi,
Pim A.L. Tonino, Haichang Wang
10:45 am - Cardiovascular Centre
ZNA Middelheim
Antwerp, Belgium
11:30 am - Scripps Green Hospital
La Jolla, CA
12:15 pm - Discussion: What Have We Learned
from These Cases?
12:30 pm - Break
Complex and Unusual Cases II
Moderator: Jeffrey J. Popma
Co-Moderator: Morton J. Kern
1:30 pm - Optimal Therapies in STEMI: Timing
Issues, Pharmacotherapy, Stents, and More
Bruce R. Brodie
1:45 pm - Optimal Therapies in NSTEMI:
Timing Issues, Pharmacotherapy,
Stents, and More
Frans Van de Werf
121
Unusual Cases II
Live Case Moderator: Jeffrey J. Popma
Live Case Co-Moderator: Morton J. Kern
Live Case Discussants: Chales E. Chan,
Valerian Fernandes, Bon-Kwon Koo,
James R. Margolis, Jack L. Martin,
Samuel K. Mathew, Miodrag C. Ostojic,
Abhiram Prasad, Frederic S. Rensic
2:00 pm - Asan Medical Center
Seoul, South Korea
2:45 pm - First Affiliated Hospital of Nanjing
Medical University
Beijing, China
from These Cases?
Multivessel Disease II
Moderator: James B. Hermiller Jr
Co-Moderator: Patrick L. Whitlow
3:45 pm - How Can PCI Outcomes in
Multivessel Disease Be Improved?
Jeffrey J. Popma
4:00 pm - Dual Antiplatelet Therapy
Conundrums: Loading, Duration, Agents,
and Point-of-Care Testing
Dean J. Kereiakes
Live Cases: Multivessel
Disease II
Live Case Moderator: James B. Hermiller Jr
Live Case Co-Moderator: Patrick L. Whitlow
Live Case Discussants: David Antoniucci,
Kevin J. Beatt, Yoon Sin Chong,
Marco A. Costa, Aaron D. Kugelmass,
Harry R. Phillips, Jorge F. Saucedo,
Sotirios Tsimikas, Yongjian Wu
4:15 pm - Asan Medical Center
Seoul, South Korea
5:00 pm - First Affiliated Hospital of Nanjing
Medical University
Beijing, China
from These Cases?
6:00 pm - Adjourn
Endovascular
and Structural
HEart Disease
8:00 am-6:00
Hall D
pm
Intervention I
Moderator: Peter A. Schneider
Co-Moderator: Sumaira Macdonald
8:00 am - Carotid Artery Stenting and
Endarterectomy: Individualized Patient
Decision-Making
Jay S. Yadav
8:15 am - Identifying the At-Risk Patient with
Asymptomatic Critical Carotid Stenosis: A
Neurology Perspective
Wade S. Smith
Live Cases: Carotid and
Neurovascular I
Live Case Moderator: Peter A. Schneider
Live Case Co-Moderator: Sumaira Macdonald
Live Case Discussants: Lee R. Guterman,
R. Stefan Kiesz, D. Christopher Metzger,
Issam D. Moussa, Antonios A. Polydorou,
Amit Segev, Maarten J. Suttorp,
Mark H. Wholey, Jose M. Wiley
8:30 am - Mirano General Hospital
Mirano, Italy
New York, NY
10:00 am - Discussion: What Have We Learned
from These Cases?
Intervention II
Moderator: Jay S. Yadav
Co-Moderator: Roger M. Greenhalgh
10:15 am - Differentiating Between Proximal
and Distal Embolic Protection Devices:
Patient Selection and Outcomes
Sumaira Macdonald
10:30 am - What Are the Optimal Design
Attributes for a Carotid Stent? Review of
the Current Options and Future Directions
Peter A. Schneider
Live Cases: Carotid and
Neurovascular II
Live Case Moderator: Jay S. Yadav
Live Case Co-Moderator:
Roger M. Greenhalgh
Live Case Discussants: J. Michael Bacharach,
Enrique Criado, Peter S. Fail, Zvonimir Krajcer,
Thosaphol Limpijankit, Flavio L. Ribichini,
Peter A. Schneider, Eugenio Stabile,
Adam Witkowski
10:45 am - Mirano General Hospital
Mirano, Italy
New York, NY
from These Cases?
12:30 pm - Break
Adult Congenital I
Moderator: John M. Lasala
Co-Moderator: Michael J. Mullen
1:30 pm - After CLOSURE I, When
Should a PFO Be Closed in 2011?
Paul H. Kramer
1:45 pm - Paravalvular Leaks: Device Options,
Current Results, and Future Directions
Eulogio J. Garcia
Live Cases: Adult Congential I
Live Case Moderator: Eric Horlick
Live Case Co-Moderator: Michael J. Mullen
Live Case Discussants: Zahid Amin,
Nirat Beohar, Ralf J. Holzer, John M. Lasala,
Eustaquio Maria Onorato, Carlos Pedra,
Ramon Quesada, Peter Sick, Thomas M. Tu
2:00 pm - Rush Center for Congenital and
Structural Heart Disease at Rush University
Medical Center
Chicago, IL
New York, NY
from These Cases?
Adult Congenital II
Moderator: Elchanan Bruckheimer
Co-Moderator: Frank F. Ing
3:45 pm - Left Atrial Appendage Closure:
Devices and Results
Peter N. Ruygrok
3:55 pm - The Large ASD: Device or Surgery?
John F. Rhodes
4:05 pm - Current Experience with
Transcatheter Pulmonic Valves
Doff B. McElhinney
122
program ·
TCT2011
4:15 pm - Rush Center for Congenital and
Structural Heart Disease at Rush University
Medical Center
Chicago, IL
5:00 pm - Swedish Health Services
Seattle, WA
from These Cases?
6:00 pm - Adjourn
Challenging Case
Multiplex
9:00 am-5:00
Hall D
pm
Coronary Miscellaneous
Moderators: Simon R. Dixon,
Jonathan D. Marmur
Discussants: Stephen P. Hoole, Takashi Kubo
9:00 am - Retrieval of an Entangled Diagnostic
Catheter in the Femoral Artery:
An Innovative Solution
Ming Ming Sim
10:12 am - Retrograde Approach for a
Left Main Ostial Occlusion
Masaaki Okutsu
10:24 am - Left Main Coronary Artery
Thrombus: Now What?
10:36 am - Bifurcation PCI Complicated
by Coronary Rupture
Jai-Wun Park
10:48 am - Early Stenosis of a Gortex Graft
to the Left Main Coronary Artery with
Rescue Angioplasty
Luis Jhonathan Uribe Gonzalez
Chronic Total Occlusion II
Moderators: Mauro Carlino, S. Chiu Wong
Discussants: Lei Ge, Talib Majwal
11:00 am - Rotablation for an Undilatable CTO
Lesion Using the Rendezvous Technique
Chao-Feng Liao
11:12 am - CTO Intervention with Minimum
Use of Contrast Media
Yoshiki Uehara
11:24 am - An Innovative Approach to
Facilitate True Lumen Reentry from
Subintimal Track in CTO
Jon C. George
11:36 am - A Challenging Chronic
Total Occlusion
Vinny Ram
11:48 am - Left Main Chronic Total Occlusion
with Retrograde Coronary Intervention
Qi Zhang
12:00 pm - Break
9:12 am - Novel Treatment of an Emboli-Prone
Coronary Atherosclerotic Aneurysm
Corey Foster
Transcatheter Valve Therapies:
Aortic and Mitral
Moderators: Jan Kovac, Stefan Sack
Discussants: Flavio L. Ribichini, Amit Segev
9:24 am - Percutaneous Retrieval of an
Entrapped and Transected Rotablator
Burr Using a Snare Device
Toru Mazaki
2:00 pm - TAVR in a Patient with Aortoiliac
Endoprosthesis and Severely Tortuous
Bilateral External Iliac Arteries
Flavio L. Ribichini
9:36 am - Complex High Risk Rotational
Atherectomy Supported by Extracorporeal
Membrane Oxygenation
Marco Magalhaes
2:12 pm - Transfemoral TAVR for
Aortic Regurgitation
Philipp Kahlert
9:48 am - Removal of a Fractured Angioplasty
Guidewire Using Microcatheter and
Microsnare Technique
Min-Woong Kim
Moderators: Andrejs Erglis, Rod H. Stables
Discussants: Mitsuyasu Terashima,
Hiroyoshi Yokoi
10:00 am - Unprotected Left Main Bifurcation
Restenosis Treated with Double
Stenting Technique
Marco V. Wainstein
2:24 pm - Urgent Bailout Reimplantation
of the Sapien Aortic Valve: The Price of
a Single Heart Beat
Ran Kornowski
2:36 pm - Percutaneous Bioprosthesis
Implantation in a Mitral Ring by
Anterograde Approach
Anna Sonia Petronio
2:48 pm - Modified Technique of Balloon Mitral
Valvotomy for Severe Submitral Stenosis
Arunkumar Panneerselvam
Endovascular II
Moderators: Tyrone J. Collins, Erich Minar
Discussants: Thomas O. McNamara,
Rahul S. Patel
3:00 pm - Unusual Vascular Access for
Exclusion of a Large Traumatic Aorta
Pseudoanuerysm
Raul Rios-Mendez
3:12 pm - Transcatheter Aspiration for
Superior Mesenteric and Celiac Arterial
Thromboembolism
Rie Sasaki
3:24 pm - Massive Pulmonary Embolism
Treatment with Thrombolysis via DrugDelivery Catheter
Michael Nuyles
- N o v e m b e r 1 0 , 2 0 11
Live Case Moderator: Elchanan Bruckheimer
Live Case Co-Moderator: Frank F. Ing
Live Case Discussants: Hans R. Figulla,
Vivek Gupta, Samir R. Kapadia,
Kapildeo Lotun, Doff B. McElhinney,
Srihari S. Naidu, Ali Oto, Peter N. Ruygrok,
Steven J. Yakubov
Thursday
Live Cases: Adult Congential II
Cardiovascular
Therapeutics
3:36 pm - Unusual Case of Subclavian
Steal Syndrome
Kishore Sadanand
3:48 pm - Dual Injection to Facilitate
Intervention of an Occluded Posterior
Tibial Artery
Prakash Krishnan
Transcatheter Valve Therapies: Aortic
Moderators: Nirat Beohar, Augusto D. Pichard
Discussants: Mark Goldberger,
Ghada W. Mikhail
4:00 pm - Repositioning of an Embolized
Sapien XT Valve with an Inoue-Balloon
Catheter via Left Subclavian Artery Access
Hans R. Figulla
4:12 pm - TAVR: An Unusual Complication
Dan Ioanes
4:24 pm - Repositioning of a CoreValve
During TAVR Due to Low Implantation
P. Patsalis
4:36 pm - Transcatheter Aortic Valve
Implantation Following Thoracic
Endovascular Repair with Vascular
Surgery Bailout
Uzoma Ibebuogu
4:48 pm - PCI in a TAVR Patient
Massimo Mancone
5:00 pm - Adjourn
Case Theater
8:00 am-6:00
Hall D
pm
Cath Lab Nightmares
Sponsored by the Brazilian Society
Moderators: Mauricio R. Barbosa,
Marcelo Queiroga
Discussants: Jose Ary Boechat,
Fabio S. Brito, Valter C. Lima, Carlos Pedra
123
8:00 am - Case 1: Congenital - Intervention
in an Early Failing Fontan
Carlos Pedra
Approach to Tough Bifurcation Lesions
Sponsored by the Colegio Argentino de
Cardioangiologia Intervencionista
3:30 pm - Case 3: Decisions, Decisions,
Decisions: Not Your Everyday STEMI Case
Jose P.S. Henriques
8:15 am - Case 2: TAVR - Accidental
Repositioning of a Misplaced CoreValve
Dimytri Siqueira
Moderators: Oscar A. Mendiz,
Ruben A. Piraino
Discussants: Jorge A. Belardi,
Liliana R. Grinfeld
3:45 pm - Case 4: High Thrombotic and
Bilateral Occlusions in STEMI: Staging
Approach with a Self-Expanding Stent
Gillian A. Jessurun
8:30 am - Case 3: PCI - Preventing Distal
Embolization During SVG Intervention
Adriano Caixeta
8:45 am - Case 4: Intervention in a
Calcified Lesion
Paulo Caramori
Decision-Making in STEMI
Sponsored by the Cardiovascular
Intervention Association of Thailand
Moderator: Sarana Boonbaichaiyapruck
Discussants: Wacin Buddhari, Kenneth Chin,
Sameer Mehta, Huay Cheem Tan
11:00 am - Case 1: Provisional Stent and
TAP Technique
Daniel H. Berrocal
11:15 am - Case 2: Crush and
Mini-Crush Technique
Marcelo Halac
11:30 am - Case 3: Simultaneous
Kissing Stents
Gustavo Lev
11:45 am - Case 4: Culotte Technique
Jorge H. Leguizamon
9:00 am - Case 1: STEMI of the Inferior Wall
(Issues: Aspiration, Reperfusion Arrhythmias,
Stent Decisions)
Sarana Boonbaichaiyapruck
12:00 pm - Break
9:15 am - Case 2: STEMI of the Anterior Wall
(Issues: Vascular Access and Anticoagulation)
Moderators: Anthony Fung, Merril L. Knudtson
Discussants: Vladimir Dzavik,
Michel R. Le May, Erick Schampaert,
9:30 am - Case 3: STEMI of the Anterior Wall
(Issues: Tandem Lesions, Direct Stenting,
Imaging, and FFR)
9:45 am - Case 4: STEMI Due to Multivessel
Stent Thrombosis with Shock (Issues:
Thrombectomy, Multivessel Intervention,
Possible CABG)
SPANK the PCI Technique
Sponsored by the Canadian Association
2:00 pm - Case 1: What’s Wrong with
This CTO PCI Technique?
Lead Discussant: Jean-François Tanguay
This Bifurcation PCI Technique?
Sam Radhakrishnan
Lead Discussant: Vladimir Dzavik
PCI Complications and Innovative
Bailout Solutions
Sponsored by the Cardiology
Society of India
This Left Main PCI Technique?
Eric A. Cohen
Lead Discussant: Erick Schampaert
Moderator: Samuel K. Mathew
Discussants: Sameer Indravadan Dani,
Ajit Menon, Ajit Mullasari, Dev B. Pahlajani
This STEMI PCI Technique?
Albert W. Chan
Lead Discussant: Michel R. Le May
10:00 am - Case 1: Severe CatheterInduced Dissection
Samuel K. Mathew
10:15 am - Case 2: A Totally
Unexpected Nightmare
Upendra Kaul
10:30 am - Case 3: Stent Dislodgement
in the Left Main
Amal Kumar Banerjee
10:45 am - Case 4: Truly Undilatable Lesions
Ashok Seth
Complex Cases in ACS: Focus on
Primary PCI
Sponsored by the Dutch Society of
Moderators: Peter den Heijer, Jan J. Piek
Discussants: Marek Grygier,
Jose P.S. Henriques, Richard Smalling,
Jochen Wöhrle
3:00 pm - Case 1: A Complex STEMI:
When, What, and How
Jeroen Vos
3:15 pm - Case 2: Primary PCI in STEMI
with a Self-Deploying Stent
Karel T. Koch
124
program ·
Complex PCI: Managing Complications
and Achieving Optimal Outcomes
Sponsored by the Cardiac Society
of Australia and New Zealand
Moderator: Darren L. Walters
Discussants: John A. Ormiston,
Ajay Radheshyam Sinhal, Stephen G. Worthley
4:00 pm - Case 1: Making the Simple Complex
Robert J. Whitbourn
4:15 pm - Case 2: Difficulty Crossing
the Lesion?
Mark W.I. Webster
4:30 pm - Case 3: Atherectomy of the
Left Main Trifurcation
David W.M. Muller
4:45 pm - Case 4: Stent Thrombosis After
Left Main Stem Simultaneous Kissing Stents
Nigel Jepson
AMI Intervention: Focus on the Left
Main Coronary Artery
Sponsored by the Czech Working Group
of Interventional Cardiology of the Czech
Society of Cardiology
Moderator: Petr Kala
Discussants: Viktor Kocka, Pavel Cervinka,
Roman Stipal, Michael Zelizko
5:00 pm - Case 1: STEMI and Transradial PCI
of the Left Main Coronary Artery
Ivo Bernat
5:15 pm - Case 2: Acute Left Main Coronary
Artery Occlusion Treated with PCI
Martin Mates
5:30 pm - Case 3: Complex PCI in STEMI
Post-CABG
Josef Bis
5:45 pm - Case 4: Unusual Case of
Primary PCI
Miroslav Brtko
6:00 pm - Adjourn
Maintenance of
Certification
(MOC) Course
8:00 am-2:00
Room 103
pm
TBA
TCT2011
10:00 am - Break
12:00 pm - Interventional Cardiology 2009
Moderator: Emmanouil S. Brilakis
Charles E. Chambers
2:00 pm - Adjourn
Special Sessions
FDA Town Hall Meeting
8:00 am-5:00
Room 102
pm
Part I. Cardiovascular Medical Device
Innovation: Barriers and Solutions
Session I. Cardiovascular Device
Innovation in the United States: Scope of
the Problem: Regulatory, Industry,
and Physician-Scientist Perspectives
Moderators: Paul A. LaViolette, Paul Yock
Discussants: Rick Anderson, Ralph G. Brindis,
Keith D. Dawkins, Jo Carol Hiatt,
Aaron V. Kaplan, Frank Litvack,
Bray Patrick-Lake, Campbell Rogers,
Sean Salmon, Daniel G. Schultz,
Charles A. Simonton, John B. Simpson,
Ron Waksman, Bram D. Zuckerman
8:00 am - Regulatory Science, Innovation and
the Public Health: Our Leading Imperative
Vicki Seyfert-Margolis
8:12 am - Medical Device Innovation:
Balancing Risk with Speed to Market
William H. Maisel
8:24 am - Costs Too High, Incentives Too Low:
Has the United States Lost Its Leading
Position in Innovation?
Paul A. LaViolette
8:36 am - The Pace of US Innovation:
A Venture Capital Perspective
Peter J. Fitzgerald
8:48 am - Viewpoints from a “Humble”
Physician-Inventor
Julio C. Palmaz
9:45 am - Break
Session II. Cardiovascular Device Innovation
Solutions: Think Tank Approach
John B. Simpson
Discussant: Richard S. Stack
Moderators: Aaron V. Kaplan,
Session V. New DES Indications
Underway: Left Main Coronary
Artery Intervention
10:00 am - Restoring an Ecosystem in Crisis:
A Series of Suggestions
Mitchell W. Krucoff
Moderators: A. Pieter Kappetein,
Mitchell W. Krucoff
Discussants: Keith D. Dawkins,
James B. Hermiller Jr, Jeffrey B. Jump,
John D. Puskas
10:15 am - Possible Premarket vs.
Postmarket Concepts and Solutions
Andrew Farb
2:10 pm - Critical Trial Design: Lessons
Learned for a Left Main Stent Study
Martin B. Leon
10:30 am - Parallel Review: Alignment
Between Federal Agencies
Jyme H. Schafer
2:15 pm - FDA Talking Points
Ashley B. Boam
10:45 am - The 510(k) Process Redesign 1:
Modification or Reboot?
William Vodra
11:00 am - The 510(k) Process Redesign 2:
Modification or Reboot?
William H. Maisel
12:00 pm - Break
Part II. Interventional Hot Topics
Session III. Catheter-Based Treatment
for Hypertension
Moderators: Roxana Mehran,
Robert S. Schwartz
Discussants: Michael A. Kutcher, Semih Oktay,
Horst Sievert, Christian M. Spaulding
1:00 pm - FDA Perspectives
Kenneth J. Cavanaugh Jr
1:05 pm - Industry Perspectives 1
Martin T. Rothman
Keith D. Dawkins
1:15 pm - Physician-Scientist Perspectives
Deepak L. Bhatt
Session IV. AMI Therapies
Discussants: C. Michael Gibson,
Gonzague Issenmann, Kevin Larkin
1:35 pm - FDA Perspectives 1
Andrew Farb
1:40 pm - FDA Perspectives 2
Catherine P. Wentz
1:45 pm - Industry Perspectives
Keith D. Dawkins
Bernard J. Gersh
- N o v e m b e r 1 0 , 2 0 11
Charles E. Chambers
Thursday
Moderator: Emmanouil S. Brilakis
Discussants: Tayo A. Addo, Robert T. Pyo
Cardiovascular
Therapeutics
Charles A. Simonton
Session VI. New DES Indications
Underway: Bifurcations
Moderators: Roxana Mehran, Terje K. Steigen
Discussants: Isabelle Martin, David G. Rizik,
Sean Salmon
2:40 pm - Critical Trial Design: Lessons
Learned for a Bifurcation Stent Study
Martin B. Leon
2:45 pm - FDA Talking Points
Andrew Farb
Aaron V. Kaplan
Session VII. Addressing “Off-Label Use”
Expansion: The CTO Example
Moderators: Aaron V. Kaplan,
Craig A. Thompson
Discussants: Ashley B. Boam,
Dennis Donohoe, Gary C. Johnson,
David F. Kong, Chad Kugler,
Charles A. Simonton, Bradley H. Strauss
Ashley B. Boam
Gary C. Johnson
Charles A. Simonton
Session VIII. Next Generation DES (Including
Bioabsorbable Scaffolds): Proving Safety
and Efficacy
Moderators: Ian T. Meredith, Gregg W. Stone
Discussants: Dennis Donohoe,
Mitchell W. Krucoff, Motasim Sirhan,
Josiah N. Wilcox
3:40 pm - FDA Perspectives 1: Preclinical
Duane S. Pinto
125
3:45 pm - FDA Perspectives 2: Clinical
Andrew Farb
Charles A. Simonton
Gregg W. Stone
Session IX: Left Atrial Appendage Occlusion
Moderators: Aaron V. Kaplan, Vivek Y. Reddy
Discussants: Steven L. Alman, Ashley B. Boam,
Albert W. Chan, Saibal Kar, Pam Simons
Part i. With Significant Clinical Data
Panel III. TAVR in High-Risk Aortic Stenosis:
The PARTNER Trial
Moderator: Roxana Mehran
Discussants: Bernard J. Gersh, Peter Juni,
Sanjay Kaul, Laura Mauri, Helen Parise,
Duane S. Pinto, Stuart J. Pocock,
Craig R. Smith
8:00 am - Needs and Expectations for
Future TAVR Systems
Martin B. Leon
9:24 am - The Trial and the Issues
Stuart J. Pocock
Richard J. Linder
Panel IV. Does Ticagrelor “Work” in
North America? The PLATO Trial
Discussants: Bernard J. Gersh, Peter Juni,
Sanjay Kaul, Laura Mauri, Helen Parise,
Duane S. Pinto, Stuart J. Pocock,
John A. Spertus
Ted Feldman
David F. Kong
Heather L. Agler
Keith D. Dawkins
5:00 pm - Adjourn
Morning Spotlight
Sessions
Panel V. The DAPT Conundrum
Discussants: Ashley B. Boam,
Bernard J. Gersh, Peter Juni, Sanjay Kaul,
Laura Mauri, Helen Parise, Duane S. Pinto,
Stuart J. Pocock
From Clinical Trials Evidence
to Clinical Practice:
Unraveling the Issues
Laura Mauri
8:00 am-11:45
Room 133
Panel VI. The Great P Value Debate
Moderator: Helen Parise
Discussants: Somjot S. Brar, Sanjay Kaul,
Ajay J. Kirtane, David F. Kong,
Dean J. Kereiakes, Roxana Mehran
pm
Featured Lecture
8:00 am - Interpreting Clinical Trial Evidence:
Lost in Translation
Sanjay Kaul
Panel I. Routine Early Angioplasty
After Fibrinolysis
Moderator: Stuart J. Pocock
Discussants: Mark Andrew Hlatky, Peter Juni,
Sanjay Kaul, Roxana Mehran, Helen Parise,
Stephan Windecker
Peter Juni
Panel II. Left Main DES vs. CABG:
The EXCEL Trial
Moderator: Stuart J. Pocock
Discussants: Mark Andrew Hlatky, Peter Juni,
Sanjay Kaul, Roxana Mehran, Helen Parise,
Stephan Windecker
Helen Parise
126
program ·
Debate: Alpha and the “Magical”
P < 0.05 Threshold
11:00 am - P Values Are Important—and
Significant!
Stuart J. Pocock
11:12 am - Down with P Values!
Peter Juni
11:45 pm - Adjourn
Next Generation Transcatheter
Aortic Valve Therapies
8:00 am-12:00
Room 135
pm
Session I. New and Novel Transcatheter
Aortic Valve Systems
Moderators: Lutz Buellesfeld, Martin B. Leon
Discussants: Joerg Kempfert, Rudiger Lange,
Ganesh Manoharan, Ian T. Meredith,
Joachim Schofer, Hendrik Treede
8:10 am - Results from the Symetis
Transapical TAVR System
Joerg Kempfert
8:22 am - Results from the Jena Valve
Hendrik Treede
8:34 am - Results from the Ventor Embracer
Rudiger Lange
8:46 am - Results from the Direct Flow
Transfemoral TAVR System
Joachim Schofer
8:58 am - The LOTUS Valve and the REPRISE
Clinical Trial Program
Ian T. Meredith
9:10 am - Results from the St. Jude’s
Medical Transfemoral TAVR System
Ganesh Manoharan
Part ii. First-in-Human Use and Preclinical
Concepts
9:45 am - Heart Leaflet Technology
Gerhard C. Schuler
9:49 am - AngioScore Valvuloplasty System
Gary Gershony
9:53 am - Valve Medical
Martin B. Leon
9:57 am - Colibri
Bernard R. Chevalier
10:01 am - InterValve Valvuloplasty System
Wesley R. Pedersen
Session II. Cerebral Protection Devices
Moderators: Joseph E. Bavaria,
Samir R. Kapadia
Discussants: Ulrich J. Gerckens,
Christoph K. Naber, Pieter R. Stella
10:15 am - Confronting the TAVR Stroke Issue:
Background, Reality, and Potential Impact of
Cerebral Protection
Samir R. Kapadia
10:25 am - Early Clinical Experiences Using
the SHEF Deflector
Pieter R. Stella
the Embrella Deflector
Ulrich J. Gerckens
the Claret Cerebral Filter
Christoph K. Naber
TCT2011
11:15 am - The Landscape of Transarterial
“Large Hole” Vascular Closure Devices
Peter J. Fitzgerald
11:27 am - The Landscape of Transapical
“Large Hole” Closure Devices
Michael J. Mack
11:39 am - A Primer on the New Expandable
Sheath Technologies
Antonio Colombo
12:00 pm - Adjourn
Optimizing Primary PCI
for STEMI (Part 1):
The Systems Approach
8:00 am-12:00
Room 104
pm
Session I. Timely Reperfusion Across
STEMI Systems
Moderators: William J. French,
Bernard J. Gersh
Discussants: Kenneth W. Baran, Eric R. Bates,
Christian W. Hamm, Christian Juhl Terkelsen
8:00 am - Important New Benchmarks from
the 2011 ACC/AHA STEMI Guidelines
Eric R. Bates
8:10 am - Contrasting the European and
Current ACC/AHA STEMI Guidelines
Christian W. Hamm
8:20 am - System Delays and Mortality
Christian Juhl Terkelsen
8:30 am - Bypassing the ER at the STEMI
Center: Trading-Off Speed vs. False
Activations
Kenneth W. Baran
8:40 am - STEMI Networks: Potentials
and Pitfalls
Bernard J. Gersh
Session II. Adjunctive Pharmacology
and Interventional Issues
Moderators: Cindy L. Grines,
Christian W. Hamm
Discussants: Bruce R. Brodie,
Warren J. Cantor, Stefan K. James,
Sigmund Silber
9:05 am - Integrating Fibrinolysis into a
Hospital Transfer System
Warren J. Cantor
11:35 am - Expansion of Primary PCI in
Europe: The Stent for Life Project
Carlo Di Mario
Debate: Use of More Potent ADP
Receptor Antagonists
9:25 am - STEMI Systems Should Encourage
Prasugrel, Preferably Given Upstream!
Sigmund Silber
9:35 am - STEMI Systems Should Encourage
Ticagrelor, Preferably Given Upstream!
Stefan K. James
Session III. Optimizing Appropriate
Cath Lab Activation
Moderators: Kishore J. Harjai, Henry H. Ting
Discussants: William J. French,
Christopher B. Granger, Timothy D. Henry,
Ivan C. Rokos, Christian M. Spaulding
10:00 am - Appropriate Cath Lab Activation:
Optimizing ECG Interpretation
Ivan C. Rokos
10:10 am - Insights from the North Carolina
Cath Lab Activation Registry (CLAR)
10:20 am - Challenging ECG and Coronary
Anatomy at 4 am
William J. French
Debate: Treatment of the Cardiac
Arrest Patient
10:30 am - Hypothermia and
Emergent Catheterization Is Only
Indicated for Resuscitated Ventricular
Tachycardia/Fibrillation!
Christian M. Spaulding
10:40 am - Hypothermia and Emergent
Catheterization Is Also Indicated for
Resuscitated Pulseless Electrical
Activity and Asystole!
Timothy D. Henry
Session IV. Quality Improvement
Strategies and Health Policy Issues
for STEMI Systems
Moderators: Alice K. Jacobs, Ivan C. Rokos
Discussants: Carlo Di Mario, Laura Mauri,
Henry H. Ting
11:05 am - ACTION Registry-GWTG and
Quality Improvement in Mission: Lifeline
Ivan C. Rokos
12:00 pm - Adjourn
Tough Calls in the Cath Lab:
Are You Up to the Challenge?
8:00 am-12:00
Room 134
pm
Session I. Clarifying Hemodynamics
Moderators: Morton J. Kern, Zoltan G. Turi
Discussants: Blase A. Carabello,
Walter Desmet, James A. Goldstein, Ali Oto,
Paul Sorajja, Patrick L. Whitlow
- N o v e m b e r 1 0 , 2 0 11
Session III. Vascular Closure Devices
Moderators: Nicolas van Mieghem,
Mathew Williams
Peter J. Fitzgerald, Michael J. Mack
9:15 am - Pharmacoinvasive Strategies:
When Are They Indicated?
Bruce R. Brodie
Thursday
Cardiovascular
Therapeutics
8:00 am - A Patient with Moderate Aortic
Stenosis and Poor LV Function: Is it
Hemodynamically Severe or Not?
Michael S. Lee
8:15 am - A Patient with Severe Neck
Distension and a Little Pericardial Fluid:
What’s the Diagnosis?
Thomas M. Tu
8:30 am - A Patient with Pulmonary
Hypertension: Is It Worth Assessing for
Vasodilator Response?
Irene M. Lang
8:45 am - A Patient with Hypertrophic
Cardiomypathy—or Not?
Carey D. Kimmelstiel
Session II. Demystifying Structural Heart
Disease Hemodynamics
Moderators: Ted Feldman, Gerhard C. Schuler
Discussants: Jeroen J. Bax, Larry S. Dean,
Eulogio J. Garcia, Saibal Kar,
Andrew D. Michaels, Martyn R. Thomas
9:00 am - What’s Wrong with This
Prosthetic Valve?
Stefan Sack
9:15 am - Is This Percutaneous Mitral
Valve Repair Going Well or Not?
Francesco Maisano
11:15 am - First Medical Contact-to-Balloon
Times: Metrics, Caveats, and Incentives
Henry H. Ting
9:30 am - Is This Percutaneous Aortic
Valve Replacement Going Well or Not?
Nicolo Piazza
11:25 am - Public Reporting of PCI Mortality:
The Massachusetts Experience
Laura Mauri
9:45 am - Is This Cardiac Assist Device
Improving Hemodynamics or Not?
Srihari S. Naidu
127
Session III. Angiographic Bewilderment
(Part 1): Cardiac Angiography
Moderators: Jeffrey J. Popma,
Patrick L. Whitlow
Discussants: Sorin J. Brener, Ecaterina Cristea,
Ralf J. Holzer, Pedro A. Lemos,
Bonnie H. Weiner, Brian Whisenant
10:00 am - Should I Close This Shunt?
Lynn Peng
10:15 am - How Exactly Is This (Anomaly)
Supplying Blood to the Heart?
Frederick Feit
10:30 am - Where Is That Blood Going on the
LV Gram (Aneurysm, Diverticulum,
Fistular, Other)?
Ricardo A. Costa
10:45 am - What’s Wrong with This Aorta?
Takao Ohki
Presentation Theaters
12:15
pm -1:15 pm
Theater schedule.
Lunchtime Sessions
Hot Topics
ACC Fellows Session II. Advanced Training
in Structural (Non-valve) Heart Disease
12:15 pm-1:45 pm
Room 133
Moderators: Zahid Amin, Jonathan M. Tobis
Discussants: Vivek Y. Reddy, Paul Sorajja
1:45 pm - Adjourn
Chronic Kidney Disease and
Contrast Nephropathy
12:15 pm-1:45 pm
Room 130
Debates and Case Dilemmas
Moderators: Antonio L. Bartorelli,
Somjot S. Brar, Roxana Mehran
Discussants: Steven R. Bailey,
Otavio Berwanger, Carlo Briguori,
Charles J. Davidson, Augusto D. Pichard,
Daniel I. Simon
12:15 pm - A Patient with Chronic Kidney
Disease Requiring Complex PCI and TAVR
Antonio L. Bartorelli
12:15 pm - Essentials of PFO Closure
Jonathan M. Tobis
Debate I. N-Acetylcysteine: Effective or
No Better than Placebo?
12:25 pm - Pro!
Somjot S. Brar
12:35 pm - Essentials of ASD/VSD Closure
Zahid Amin
12:30 pm - Con!
Otavio Berwanger
Session IV. Angiography Bewilderment
(Part 2): Peripheral Angiography
Moderators: Stephen R. Ramee,
Thomas Zeller
Discussants: Thomas A. Ischinger,
R. Stefan Kiesz, Robert A. Lookstein,
Daniel J. McCormick, Greg Mishkel,
Raghotham R. Patlola
12:55 pm - Essentials of Paravalvular
Leak Closure
Paul Sorajja
11:00 am - A Patient with Carotid Stenosis
Plus an Intracerebral Unknown
Lee R. Guterman
1:35 pm - Open Q&A Session
Debate III. Contrast Removal (Hemofiltration
and Coronary Sinus Aspiration)
11:15 am - A Patient with a Malfunctioning
Dialysis Shunt
John A. Bittl
11:30 am - A Patient with Renal Artery
Stenosis and a Renal Parenchymal Disorder
Mehdi H. Shishehbor
11:45 am - A Patient with Abdominal Pain,
Anemia, and a Vascular Disorder
Michael J. Rinaldi
12:00 pm - Adjourn
1:15 pm - Essentials of Left Atrial
Appendage Closure
Peter Sick
1:45 pm - Adjourn
ACC Practitioners Session: Innovations to
Manage, Maintain, and Expand Your
Clinical Practice
12:15 pm-1:45 pm
Room 132
E. Murat Tuzcu
Discussants: Prakash Krishnan,
Manish A. Parikh, Krishna J. Rocha-Singh
12:15 pm - Aortic Valve Interventions
E. Murat Tuzcu
12:30 pm - Structural Heart
Disease Interventions
Ted Feldman
12:45 pm - Endovascular Interventions
Prakash Krishnan
1:00 pm - Hypertension Initiatives
1:15 pm - Quality Control and
Manish A. Parikh
128
program ·
Debate II. Matched Hydration/Diuresis
(RenalGuard System)
12:40 pm - Pro!
Carlo Briguori
12:45 pm - Con!
Daniel I. Simon
12:55 pm - Pro!
Steven R. Bailey
1:00 pm - Con!
Augusto D. Pichard
Debate IV. Contrast-Type Matters and
Sodium Bicarbonate Helps
1:10 pm - Pro!
Somjot S. Brar
1:17 pm - Con!
Charles J. Davidson
1:40 pm - The Final Word: Preventive
Strategies That Work and Don’t
Somjot S. Brar
1:45 pm - Adjourn
TCT2011
STEMI and NSTEMI
12:15 pm - 2011 STEMI Guidelines:
What’s New?
Frederick Kushner
12:30 pm - 2011 Focused Update for
NSTEMI/UAP
John A. Ambrose
12:45 pm - Recommendations for the
Management of the Resuscitated
Cardiac Arrest Patient: Should PCI Be
Performed Routinely?
Margaret B. McEntegart
1:00 pm - Role of GP IIb/IIIa Inhibitor Therapy
in the Era of Bivalirudin and DAPT
David X. Zhao
1:15 pm - Indications in 2011 for
(1) Fibrinolytic Therapy, and (2) Timing of
Transfer After Fibrinolytic Therapy for STEMI
Jacqueline E. Tamis-Holland
1:30 pm - Case Presentation: Clinical
Decision-Making
David O. Williams
1:45 pm - Adjourn
Minimizing and Managing Cath
Lab Complications
12:15 pm-1:45 pm
Room 125
Moderators: Stephen Balter, Cindy L. Grines,
David A. Cox, Robert D. Safian
12:15 pm - Coronary Dissections
(Including Guiding Catheter Complications)
Robert J. Applegate
12:30 pm - Vascular Access Complications
(Including Retroperitoneal Bleeds)
Robert D. Safian
12:45 pm - Distal Embolization and No-Reflow
Cindy L. Grines
1:00 pm - Perforations and
Cardiac Tamponade
David A. Cox
1:30 pm - Excessive Radiation Complications
Stephen Balter
1:45 pm - Adjourn
Optimizing Care for Women with
Cardiovascular Disease
12:15 pm-1:45 pm
Room 123
Bonnie H. Weiner
John A. McPherson, Eugenia Nikolsky,
Anna Sonia Petronio, Jennifer A. Tremmel
12:15 pm - Facility Management: Developing
a Multidisciplinary Procedural Venue
(Hybrid or Conventional ORs/Cath Labs
and Equipment/Inventory)
Alan Lumsden
12:30 pm - Staffing Challenges: Integrating
the “Team” (Interventionalists, Surgeons,
Anesthesia, Echo, Techs, Nurses)—What
a Mess!
Sam Radhakrishnan
How It’s Done in the “Real World”:
Meet the Successful Models
12:15 pm - Introduction and Goals
Alexandra J. Lansky
12:45 pm - St. Paul’s Hospital,
Vancouver, Canada
Sandra Lauck
12:20 pm - Coronary and Microvascular
Disease in Women: Diagnostic
Challenges and Prognosis
Jennifer A. Tremmel
Columbia University Medical Center,
New York, NY
Marian C. Hawkey, Mathew Williams
12:30 pm - Coronary Fibromuscular Dysplasia:
An Under-Recognized Cause of ACS
in Women
1:07 pm - University of Toronto,
Toronto, Canada
Eric Horlick
12:45 pm - Bleeding Complications in Women
Undergoing Revascularization: Implications
and Prevention
Eugenia Nikolsky
1:00 pm - TAVI and Percutaneous Mitral
Valve Therapy Outcomes in Women:
The European Experience
Anna Sonia Petronio
1:15 pm - Peripheral Vascular Disease
in Women: Prevalence, Prognosis,
and Therapies
J. Dawn Abbott
1:30 pm - Case Presentation: A Woman
with Challenging Heart Disease
John A. McPherson
1:45 pm - Adjourn
The Evolving Cath Lab: Facility and
Staffing Considerations
12:15 pm-1:45 pm
Room 131
Moderators: Ganesh Manoharan,
Mathew Williams
Discussants: Martin B. Leon,
Sam Radhakrishnan
- N o v e m b e r 1 0 , 2 0 11
Moderators: Alice K. Jacobs,
Frederick Kushner, David O. Williams
Discussants: John A. Ambrose,
Margaret B. McEntegart,
Jacqueline E. Tamis-Holland, David X. Zhao
1:15 pm - Peripheral and Structural
Complication Smorgasbord
Thursday
Guideline Directions and Controversies:
STEMI and NSTEMI
12:15 pm-1:45 pm
Room 124
Cardiovascular
Therapeutics
1:18 pm - Intermountain Medical Center,
Salt Lake City, UT
Brian Whisenant
1:30 pm - Sweeping Changes in the Dynamic
Interventional Global Landscape
Martin B. Leon
1:45 pm - Adjourn
Learn the Technique
Acute Infarct Angioplasty and
Cardiogenic Shock
12:15 pm-1:45 pm
Room 120
Moderators: Brij Maini, Thomas D. Stuckey,
Discussants: Dariusz Dudek, Ran Kornowski,
Roger J. Laham
12:15 pm - How to Perform Left Main PCI
in STEMI (Two Cases)
12:30 pm - When and How to Use Aspiration
and Thrombectomy Devices (Two Cases)
Dariusz Dudek
12:45 pm - How to Perform PCI in Cardiogenic
Shock (Two Cases)
Thomas D. Stuckey
1:00 pm - When to Treat Multiple
Vessels in Patients With and Without
Shock (Two Cases)
Ran Kornowski
129
1:15 pm - When and How to Use Impella in
STEMI (Two Cases)
Brij Maini
1:30 pm - Unusual Complications of
Hemodynamic Support Devices (Two Cases)
Roger J. Laham
1:45 pm - Adjourn
Alcohol Septal Ablation
12:15 pm-1:45 pm
Room 110
Moderators: John S. Douglas Jr,
Srihari S. Naidu
Discussants: Ali E. Denktas, Michael A. Fifer,
Christopher D. Nielsen, Ulrich Sigwart
12:15 pm - Choosing the Patient: Symptoms,
Anatomy, and Hemodynamics
Srihari S. Naidu
12:25 pm - Tools of the Trade: Selecting
Guides, Wires, Balloons, and Alcohol Dose
John S. Douglas Jr
12:35 pm - Myocardial Contrast
Echocardiography: How to Perform It
and What to Look for
Christopher D. Nielsen
12:45 pm - Multiple Septals: How to
Choose the Right Ones
Case Presenter: Ulrich Sigwart
1:00 pm - Borderline Anatomy:
Deciding Whether to Proceed
Case Presenter: Michael A. Fifer
1:15 pm - Procedural Complications
Case Presenter: Ali E. Denktas
1:35 pm - Access for Treating Peripheral
Vascular Disease: Complications and
Their Management
Richard R. Heuser
1:00 pm - Case Review 2: How to
Perform the Mini-Crush Technique in a
Complex Bifurcation
Ioannis Iakovou
1:45 pm - Adjourn
1:15 pm - Case Review 3: How to Perform the
Culotte Technique in a Complex Bifurcation
Carlo Di Mario
1:30 pm - Case Review 4: How to Perform the
Simultaneous Kissing Stent Technique in a
Complex Bifurcation
Sorin J. Brener
1:45 pm - Adjourn
Complication Management (Part 2)
12:15 pm-1:45 pm
Room 122
Moderators: Nick Curzen, Richard R. Heuser,
John R. Laird Jr
Discussants: Rajesh M. Dave, James D. Joye,
Thomas O. McNamara, Craig A. Thompson,
Gerald S. Werner, R. Michael Wyman
Session I. Complications Associated
with Treating Coronary CTOs: A Series
of Case Reviews
12:15 pm - Complications Arising During
the Antegrade Approach to CTOs
Craig A. Thompson
12:25 pm - Complications Arising During
the Retrograde Approach to CTOs
R. Michael Wyman
12:35 pm - Perforations Associated with CTO
Treatment: All Types
Gerald S. Werner
1:30 pm - HCM and Aortic Stenosis:
Is Ablation Ever Right?
Case Presenter: Srihari S. Naidu
12:45 pm - Minimizing Complications
Associated with Treating CTOs
Richard R. Heuser
Session II. Peripheral Vascular
Complications: Cases, Examples,
and Tips and Tricks
1:45 pm - Adjourn
Complex Bifurcations
12:15 pm-1:45 pm
Room 113
Moderator: Issam D. Moussa
Discussants: Sorin J. Brener, Alaide Chieffo,
Ricardo A. Costa, Carlo Di Mario,
Ioannis Iakovou
12:15 pm - What Is a “Complex Bifurcation”?
Issam D. Moussa
12:30 pm - How to Perform Provisional
Stenting in Complex Bifurcations:
A Roadmap for Success
Alaide Chieffo
130
12:45 pm - Case Review 1: What to Do
When the Sidebranch Occludes During
Provisional Stenting?
Ricardo A. Costa
program ·
12:55 pm - Complications Associated
with Aortoiliac Intervention
John R. Laird Jr
1:05 pm - Complications Associated with
Femoropopliteal Intervention
James D. Joye
1:15 pm - Infrapopliteal Intervention:
Complications and Their Treatment
Thomas O. McNamara
1:25 pm - Complications Associated with
Treating Critical Limb Ischemia
Rajesh M. Dave
Day-to-Day Use of FFR
12:15 pm-1:45 pm
Room 121
Session I. Clinical Applications of FFR
Moderators: Bon-Kwon Koo,
Massoud A. Leesar
Discussants: Takashi Akasaka,
Michalis Hamilos, Allen Jeremias
12:15 pm - How to Integrate FAME, SYNTAX,
COURAGE, and PROSPECT into
Daily Practice
Bernard De Bruyne
12:27 pm - Why FFR in Left Main and
Bifurcation Lesions?
Bon-Kwon Koo
Session II. The Art and Technique of FFR
Measurement: Case Review Session
Moderators: Bon-Kwon Koo,
Massoud A. Leesar
12:50 pm - FFR in Bifurcation Lesions
Massoud A. Leesar
1:00 pm - FFR in Complex Lesions
Pim A.L. Tonino
1:10 pm - FFR in Acute Coronary Syndromes
Habib Samady
1:20 pm - FFR in Left Main Stenosis
Gregory R. Giugliano
1:30 pm - FFR in Tandem Lesions
William F. Fearon
1:40 pm - Take-Home Messages
Bon-Kwon Koo, Massoud A. Leesar
1:45 pm - Adjourn
Percutaneous Edge-to-Edge Mitral
Valve Repair
12:15 pm-1:45 pm
Room 111
Step I. TTE and TEE Pre-procedural
Assessment to Identify Appropriate Mitral
Valve Pathology for the MitraClip
Moderators: James B. Hermiller Jr,
Scott Lim
Discussant: Neil J. Weissman
12:15 pm - Case 1: Degree of MR Assessment
Neil J. Weissman
12:23 pm - Case 2: Complex
Degenerative Pathology
Neil J. Weissman
TCT2011
Moderators: James B. Hermiller Jr, Scott Lim
Discussant: Gorav Ailawadi
12:38 pm - Case 2: How to Gain Height
After Inferior Transseptal
Gorav Ailawadi
Step III. Transseptal Puncture for the
MitraClip
Discussant: Francesco Maisano
12:45 pm - Case 1: How to Puncture the
Bulging Septum
Francesco Maisano
12:53 pm - Case 2: How to Puncture the
Floppy Septum
Francesco Maisano
Step IV. Steering/Guidance/Grasping
of Leaflets
1:00 pm - Case 1: Using 2-D TEE to
Guide the Clip
Scott Lim
1:08 pm - Case 2: Using 3-D TEE to
Guide the Clip
Scott Lim
Step V. MR Evaluation Post-Clip and Decision
for Second Clip
Discussant: Olaf Franzen
1:15 pm - Case 1: 2+ MR and Mild
Inflow Gradient
Olaf Franzen
1:23 pm - Case 2: Getting Fooled by
Residual MR
Olaf Franzen
Step VI. Dealing with Complications
Discussant: Richard Smalling
1:30 pm - Case 1: Stuck in Chords
Richard Smalling
1:38 pm - Case 2: The Unexpected
Richard Smalling
1:45 pm - Adjourn
Transradial Intervention
12:15 pm-1:45 pm
Room 112
Moderators: Philippe Genereux, Tift Mann
Discussants: Ivo Bernat, Olivier F. Bertrand,
Vladimir Dzavik, Ian C. Gilchrist, Tak W. Kwan,
Ramon Quesada, Sunil V. Rao
Philippe Genereux, Tift Mann
12:45 pm - Laser and Radiofrequency Ablation
for Superficial Venous Disease
Jose M. Wiley
12:28 pm - Bifurcation Stenting with 6 Fr Guide
Vladimir Dzavik
12:51 pm - Acute Deep Venous Thrombosis 1
Mahmood K. Razavi
12:37 pm - Subacute Radial Occlusion Treated
with Transient Ulnar Compression
Ivo Bernat
12:57 pm - Acute Deep Venous Thrombosis 2
Anthony J. Comerota
12:46 pm - PCI via Radial Access in STEMI
Olivier F. Bertrand
12:55 pm - Ad Hoc NSTEMI PCI with Switch
to Bivalirudin
Sunil V. Rao
1:04 pm - TRI in the Post-CABG Patient:
Left Radial Access and Setup
Tift Mann
1:13 pm - Techniques to Traverse Difficult Arm/
Shoulder/Ascending Aorta Anatomy
Ian C. Gilchrist
1:22 pm - Management of Radial
Complications
Philippe Genereux
1:31 pm - CTO PCI via Transradial Access:
Setup and Technique
Ramon Quesada
Philippe Genereux, Tift Mann
1:45 pm - Adjourn
Venous Disease Intervention
12:15 pm-1:45 pm
Room 114
Session I. Core Concepts
Moderators: Raghu Kolluri,
Mahmood K. Razavi
12:15 pm - Venous Anatomy, Physical Exam,
and Assessment
Raghu Kolluri
12:23 pm - Evidence Supporting Ablative
Therapies in Superficial Venous Disease
Anthony J. Comerota
12:28 pm - Evidence Supporting Intervention
in Acute Proximal Deep Venous Thrombosis
Greg Mishkel
12:35 pm - Evidence Supporting Intervention
in Chronic Venous Occlusions
Mahmood K. Razavi
12:40 pm - Evidence for Interventional
Management of Submassive and Massive
Pulmonary Emboli
Lawrence Hofmann
Session II. The Cases
Moderators: Raghu Kolluri,
Mahmood K. Razavi
Discussants: Anthony J. Comerota,
Lawrence Hofmann, Greg Mishkel,
Jose M. Wiley
1:03 pm - Upper Extremity Central
Venous Occlusion
Greg Mishkel
1:09 pm - Chronic Deep Venous Thrombosis
Mahmood K. Razavi
1:15 pm - Complications of Venous
Intervention
Greg Mishkel
- N o v e m b e r 1 0 , 2 0 11
12:30 pm - Case 1: How to Get Coaxial
After Anterior Transseptal
Gorav Ailawadi
12:19 pm - Complex PCI Using 7 Fr
Sheathless Technique
Tak W. Kwan
Thursday
Step II. Mechanics and Knobs of the
MitraClip System
Cardiovascular
Therapeutics
1:21 pm - Pulmonary Embolism
Lawrence Hofmann
1:27 pm - Something You Don’t See Everyday
Raghu Kolluri
1:45 pm - Adjourn
Afternoon Spotlight
Sessions
Deep Dive: Interventional
Hypertension
2:00 pm-6:00
Room 135
pm
Part I. Hypertension Overview
Moderators: John Flack, C. Venkata S. Ram
Discussants: Prakash Deedwania,
Maurizio Menichelli, Addison A. Taylor
2:00 pm - Demographics and Epidemiology
of Hypertension: End-Organ Effects and
Clinical Consequences
C. Venkata S. Ram
2:15 pm - Monitoring and Measuring Blood
Pressure: Defining the Resistant (Refractory)
Hypertensive Patient
Addison A. Taylor
2:30 pm - Standard Hypertension Therapy:
Guidelines for Optimal Pharmacotherapy,
Diet, and Lifestyle Modifications
John Flack
2:45 pm - Current Approaches to Resistant
Hypertension: Clinical Workup and
Treatment Strategies
Henry Black
131
3:00 pm - Hypertension Centers of Excellence:
A Team Approach Improves Outcomes
John Flack
5:30 pm - Future Research Targets for Renal
Denervation Therapy: Heart Failure and
Sleep Apnea
Henry Krum
3:15 pm - Role of the Kidney and
RAAS Activation in Hypertension
Prakash Deedwania
3:30 pm - Sympathetic Nervous System
Activation and Hypertension
Prakash Deedwania
3:45 pm - Moderated Panel Discussion:
Focus on Resistant Hypertension: Magnitude
of the Problem and Therapeutic Challenges
Part II. Interventional Hypertension Therapy
Moderators: Deepak L. Bhatt, Horst Sievert
Discussants: Robert Kieval, Henry Krum,
Felix Mahfoud, Christopher D. Owens
4:00 pm - Background and Rationale for
Renal Denervation Therapy in
Refractory Hypertension
Henry Krum
4:15 pm - Latest Results from Renal
Denervation Therapy in Refractory
Hypertension: The Symplicity HTN-1
and Symplicity
HTN-2 Trials
Horst Sievert
4:30 pm - Lessons Learned and Trial Design
for the United States Pivotal Symplicity
HTN-3 Trial
Deepak L. Bhatt
4:45 pm - The CVRx Implantable Carotid Sinus
Modulation System to Treat Refractory
Hypertension: Rationale and Clinical
Trial Results
Robert Kieval
5:00 pm - Adventitial Drug-Induced Renal
Artery Denervation in Refractory
Hypertension: Preclinical Experience and
First-in-Human Status Update (MERCATOR)
Christopher D. Owens
132
5:45 pm - Moderated Panel Discussion: Pitfalls
and Promise for Ardian and Other DeviceBased Therapies for Refractory Hypertension
6:00 pm - Adjourn
Drug-Coated Balloons:
Clinical Data and Applications
2:00 pm-6:00
Room 133
pm
Session I. Specific Devices and
Latest Results
Detlef G. Mathey
Discussants: Giancarlo Biamino,
Bodo Cremers, Hans Krankenberg,
Bruno Scheller, Karl Ludwig Schulte,
Pieter R. Stella, Thomas Zeller
2:00 pm - Paccocath: Technology Overview
and Latest Peripheral Data
Thomas Zeller
2:15 pm - Paccocath Cotavance/SeQuent
Please: Latest Coronary Data
Bruno Scheller
Critical Appraisal of the Paccocath
Technology and Results
2:39 pm - Eurocor: Technology Overview
and Latest Peripheral Data
Karl Ludwig Schulte
2:49 pm - Eurocor: Latest Coronary Data
Pieter R. Stella
Critical Appraisal of the Eurocor Technology
and Results
3:03 pm - Invatec: Technology Overview and
Latest Peripheral Data
Giancarlo Biamino
3:13 pm - Invatec: Latest Coronary Data
Bodo Cremers
Critical Appraisal of the Invatec Technology
and Results
3:27 pm - Pantera Lux: Technology and Data
Ralph Toelg
5:15 pm - Impact of Renal Denervation
Therapy on Glucose Metabolism, Insulin
Resistance, and Diabetes
Felix Mahfoud
3:37 pm - Lutonix: Technology Overview and
Latest Peripheral Data
Hans Krankenberg
program ·
3:45 pm - Lutonix: Latest Coronary Data
Patrick W. Serruys
Critical Appraisal of the Lutonix Technology
and Results
4:01 pm - Progress with a Drug-Coated
Angiosculpt
Gary Gershony
4:11 pm - Unique Coatings and Novel
Carrier-Systems to Enable a SirolimusBased Drug-Coated Balloon: Descriptions
and Preclinical Data
Greg L. Kaluza
4:21 pm - PERFECT Stent Study 12-Month
Results: Paclitaxel-coated Balloon Plus
Endothelial Progenitor Cell Capturing Stents
in De Novo Coronary Artery Disease
Jochen Wöhrle
Discussants: Gary Gershony, Greg L. Kaluza,
Ralph Toelg, Jochen Wöhrle
Session II. Case Reviews: Complex
Drug-Coated Balloon Cases
Moderators: Alessandro S. Bortone,
Upendra Kaul
Discussants: Jorge Gaspar, Barry T. Katzen,
Alfredo Rodriguez, Konstantinos Spargias,
4:48 pm - Peripheral Case 1
Giuseppe M. Sangiorgi
4:56 pm - Peripheral Case 2
Robert A. Byrne
5:04 pm - Coronary Case 1
Azeem Latib
5:12 pm - Coronary Case 2
Tian-Hai Koh
Session III. Summary Statements
Moderators: Ron Waksman, Thomas Zeller
5:20 pm - Evidence-based Medicine Synthesis
2011: DCBs for Peripheral Arterial
Applications: Promise, Caveats, and
Recommendations for Further Development
Hans Krankenberg
5:35 pm - Evidence-based Medicine Synthesis
2011: DCBs for Coronary Arterial
Applications: Promise, Caveats, and
Recommendations for Further Development
Bruno Scheller
5:50 pm - The Last Word: “Top Five Facts”
That May Kill This Technology— If We’re
Not Careful!
Juan F. Granada
6:00 pm - Adjourn
TCT2011
2:00 pm-6:15
Room 134
pm
2:00 pm - The World of 3-D OCT
Patrick W. Serruys
2:15 pm - Introduction to OCT Image
Interpretation
Guillermo Tearney
2:27 pm - Pre-intervention OCT Cases 1
Konstantinos Toutouzas
2:37 pm - Pre-intervention OCT Cases 2
Hiroyuki Okura
2:47 pm - Post-intervention OCT Cases 1
Marco A. Costa
2:57 pm - Post-intervention OCT Cases 2
Francesco Prati
3:07 pm - Stent Failure OCT Cases 1
Gilles Rioufol
3:17 pm - Stent Failure OCT Cases 2
Maria D. Radu
3:27 pm - Next Generation OCT and Beyond
Brett E. Bouma
3:37 pm - Discussion Panel: OCT Image
Interpretation: What Is Certain and
What Is Not
Session II. NIRS Image Interpretation: Case
Presentations and Panel Interpretations
Moderators: James A. Goldstein,
Morton J. Kern
Hector M. Garcia-Garcia, Henning Kelbaek,
Brij Maini, Pedro R. Moreno, Evelyn S. Regar,
Giora Weisz
3:52 pm - NIR Spectroscopy and Image
Interpretation (with Integrated IVUS):
Beneath the Pixels
James E. Muller
4:05 pm - Pre-intervention NIR Cases 1
Brij Maini
4:15 pm - Pre-intervention NIR Cases 2
David G. Rizik
4:25 pm - Post-intervention NIR Cases
Session III. Clinical Potential of
Intravascular Optical Imaging
Moderators: Gary S. Mintz, Patrick W. Serruys
Discussants: Fernando Alfonso, YunDai Chen,
Marc D. Feldman, Peter J. Fitzgerald,
Giulio Guagliumi, Michael Joner, Takashi Kubo
4:45 pm - Angiography Alone is Not Sufficient
for Cath Lab Decision-Making: The Need for
Direct Coronary Imaging
James A. Goldstein
4:55 pm - Optical Imaging in Acute
Coronary Syndromes
Atsushi Tanaka
5:10 pm - Optical Imaging to Guide
Interventions
Junya Shite
5:25 pm - Optical Imaging to Prevent and
Assess Immediate Stent Complications
Evelyn S. Regar
5:35 pm - Optical Imaging to Prevent and
Assess Late Stent Complications
Giulio Guagliumi
5:50 pm - In-Stent Neoatherosclerosis:
Pathologic Validation, Imaging Insights,
and Clinical Findings
Gary S. Mintz
6:00 pm - Panel Discussion: Intravascular
Optical Imaging: What Is Needed to Further
the Clinical Adoption of These Technologies?
6:15 pm - Adjourn
Optimizing Primary PCI for
STEMI (Part 2): Drugs, Devices,
and Techniques
2:00 pm-6:15
Room 104
pm
Session I. Management of Thrombus
Moderators: Bruce R. Brodie, Chaim S. Lotan
Discussants: David Antoniucci,
Francesco Burzotta, Joost Daemen,
Holger Thiele
2:00 pm - Does Aspiration Really Reduce
Mortality? A Critical Appraisal
Francesco Burzotta
2:10 pm - Rheolytic Thrombectomy:
Explaining the Differences Between AiMI
and JETSTENT
David Antoniucci
2:20 pm - Intracoronary Glycoprotein IIb/IIIa
Platelet Inhibitors: A New Way to Give
an Old Drug
Holger Thiele
2:30 pm - Stent Thrombosis After Primary PCI:
Frequency, Predictors, and Strategies
to Prevent
Joost Daemen
Session II. Procedural Management
Choices During Primary PCI for STEMI:
A Series of Flash Debates
Moderators: Petr Kala, Harvey D. White
Discussants: Graham A. Cassel,
Giuseppe De Luca, Sameer Mehta,
Fayaz Shawl, Marco V. Wainstein,
Flash Debate I. DES Should Be Used Liberally
in STEMI Patients Treated with Primary PCI
- N o v e m b e r 1 0 , 2 0 11
Session I. OCT Image Interpretation: Case
Presentations and Panel Interpretations
Moderators: Giulio Guagliumi, Evelyn S. Regar
Discussants: Takashi Akasaka,
Francesco Burzotta, Marco A. Costa,
Carlo Di Mario, Sheldon Goldberg,
Maria D. Radu, Neil J. Weissman
4:35 pm - Discussion Panel: NIRS Imaging and
Clinical Applications: What Is Certain and
What Is Not
Thursday
Next Generation Optical
Intravascular Imaging:
OCT and NIR Spectroscopy
Cardiovascular
Therapeutics
2:50 pm - Pro: The Data Couldn’t Be
More Solid!
Somjot S. Brar
2:58 pm - Con: Little to Gain and a Lot
to Lose!
Bruce R. Brodie
Flash Debate II. Transradial Should Be the
Preferred Access Route in STEMI Patients
3:10 pm - Pro: Eliminate Bleeding, Improve
Outcomes (and Patient Comfort)!
Marco Valgimigli
3:18 pm - Con: Bivalirudin Plus Femoral
Access Preserves My Options—and
Is Faster!
David A. Cox
Flash Debate III. Bivalir udin Is the New
Standard of Care for Primary PCI
3:30 pm - Pro: It Has the Highest Level of
Evidence in Both the EU and US Guidelines!
Michel R. Le May
3:38 pm - Con: Heparin (Unfractionated or
LMWH) Plus GP IIb/IIIa Inhibitors Are Better!
Sanjit S. Jolly
Session III. Primary PCI Technique
and Challenges
Moderators: Cindy L. Grines, Marco Valgimigli
Discussants: Simon R. Dixon, Elvin Kedhi,
Ajay J. Kirtane, Michael Mooney,
William W. O’Neill, Manesh R. Patel,
Pascal Vranckx
3:50 pm - Management of (Left and Right
Ventricular) Cardiogenic Shock
During Primary PCI: 2011 Approaches
and Outcomes
Simon R. Dixon
4:00 pm - Use of Impella During
Cardiogenic Shock
133
4:08 pm - Rationale for Left Ventricular
Unloading with Impella to Reduce Infarct
Size: The MINI-AMI Trial
Ajay J. Kirtane
4:15 pm - Use of Intraaortic Balloon
Counterpulsation Before or After Primary
PCI in High-Risk STEMI: From PAMI-2 to
CRISP-AMI
Manesh R. Patel
4:25 pm - Management of STEMI Patients
with Multivessel Disease: From
Current Recommendations to
the COMPARE-ACUTE Trial
Elvin Kedhi
4:35 pm - Considerations for STEMI Patients
Taking Oral Anticoagulants
Pascal Vranckx
4:43 pm - Benefits of Hypothermia in Cardiac
Arrest Survivors—and Practical
Recommendations
Michael Mooney
Session IV. Approaches to Reperfusion
Injury and Enhancing Myocardial Recovery
Moderators: Mitchell W. Krucoff, Holger Thiele
Discussants: Thomas Engstrom, David Erlinge,
Christopher B. Granger, Robert A. Kloner,
Frans Van de Werf
5:05 pm - Reperfusion Injury in 2011: Does It
Exist, and What Can We Do About It?
Robert A. Kloner
5:15 pm - Failed Approaches to Reduce Infarct
Size, and Why Do They Keep Failing?!
5:25 pm - Potential for Improved Myocardial
Reperfusion with a PTFE Net-Covered Stent:
Rationale and MASTER Trial Design
Dariusz Dudek
5:33 pm - Intracoronary Adenosine During
Primary PCI: Are the Data Strong Enough to
Recommend Routine Use?
Frans Van de Werf
5:43 pm - Studies of Hypothermia to
Reduce Infarct Size
David Erlinge
Complex Coronary Intervention Great Cases
Special Twilight
Sessions
Partnership Session: Brazilian
Society of Interventional
Cardiology (SBHCI) and Gi2:
Replacement and Complex
6:00 pm-8:00
Room 123
pm
6:00 pm - Opening Remarks
Moderators: Andrea Abizaid, Gregg W. Stone
Session I. Transcatheter Aortic Valve
Replacement
Moderators: Mauricio R. Barbosa,
Carlos Pedra
Discussants: Fabio S. Brito,
Augusto D. Pichard, E. Murat Tuzcu
6:05 pm - How to Start a TAVR Program: From
Fundamentals, to Training, to Putting
Together the Valve Team
Augusto D. Pichard
8:00 pm - Adjourn
p-c-i Live in Partnership with
TCT: Practical Aspects of
Coronary, Valvular, and
Electrophysiologic Interventions
6:00 pm-8:00
Room 122
pm
6:00 pm - Introduction to PCI Live
Moderators: Martin B. Leon, Sigmund Silber
6:10 pm - PCI vs. Bypass Surgery:
The European View: State of the Art
Sigmund Silber
6:20 pm - Edited Case Presentation:
Highly Proximal LAD in a Diabetic Patient
Jochen Wöhrle
TAVR Great Cases
Discussants: Luiz Antonio Carvalho,
Pedro A. Lemos, Jose Armando Mangione,
Augusto D. Pichard
6:45 pm - Case 1: Unusual Unexpansion of
CoreValve Surgically Explanted
Rogerio Sarmento-Leite
6:53 pm - Case 2: Valve-in-Valve
Augusto D. Pichard
7:01 pm - Case 3: No Vascular Access
Magaly Arrais dos Santos
6:01 pm - Novel Approaches to Reduce Infarct
Size: Cyclosporin, Preconditioning, and
Postconditioning
Thomas Engstrom
7:09 pm - Complex Lesion Morphologies:
Left Main and Acute MI
Davide Capodanno
program ·
7:52 pm - Case 3: Bioabsorbable Scaffold
Jose de Ribamar Costa Jr
6:25 pm - SBHCI Recommendations for TAVR
Case Selection
Fabio S. Brito
7:19 pm - New DES Technologies Including
Fully Bioabsorbable Scaffolds
Alexandre Abizaid
134
7:44 pm - Case 2: Acute MI
Marco V. Wainstein
6:15 pm - How to Avoid the Most Common
Complications: Vascular, Bleeding, and
Stroke
E. Murat Tuzcu
Session II. Complex Coronary Intervention
Moderators: Expedito E. Ribeiro,
Amanda G.M.R. Sousa
Davide Capodanno
6:15 pm - Adjourn
7:36 pm - Case 1: Left Main
Marco A. Perin
Session I. Coronary Intervention
Moderators: Jochen Cremer, Sigmund Silber
Discussants: Wolfgang Bocksch,
Juerg Gruenenfelder, Kurt Huber,
Florin Laubenthal, Gerald S. Werner,
Jochen Wöhrle
5:53 pm - Effects of Pressure-Controlled
Intermittent Coronary Sinus Occlusion on
Myocardial Reperfusion: Preparing for
PREPARE-RAMSES
Jan J. Piek
Discussants:
Marcelo Jose de Carvalho Cantarelli,
Fausto Feres,
Gilberto Lahorgue Nunes, Marco V. Wainstein
Session II. Valvular Intervention
Moderators: Hans R. Figulla,
Friedrich W. Mohr
Discussants: Wolfgang Bocksch,
Juerg Gruenenfelder, Kurt Huber,
Joachim Schofer, Horst Sievert,
Gerald S. Werner
6:45 pm - TAVI vs. Traditional Aortic Valve
Implantation: The European View:
State of the Art
Hans R. Figulla
6:55 pm - Edited Case Presentation:
Aortic Stenosis in a 60-Year-Old Patient
Wolfgang Bocksch
Joachim Schofer
TCT2011
7:30 pm - Edited Case Presentation: Persistent
Atrial Fibrillation in a Young Patient
Thorsten Lewalter
Ernst Vester
8:00 pm - Adjourn
Practicalities and Pitfalls of
Platelet Function Testing
6:00 pm-8:00 pm
Room 120
Paul A. Gurbel, Matthew J. Price
Discussants: Laurent Bonello,
Dirk Sibbing, Tabassome Simon,
Jurrien M. Ten Berg
6:00 pm - Platelet Reactivity and Outcomes
After PCI: Current State of the Evidence
Dominick J. Angiolillo
Assessing the Prognostic and Predictive
Value of Platelet Function Testing
in Patients Undergoing PCI: Is It a
Meaningful Test?
6:10 pm - Viewpoint 1: Perhaps, but with
Little Clinical Use!
Jurrien M. Ten Berg
6:22 pm - Viewpoint 2: Yes, If You Know
How to Interpret the Test!
Paul A. Gurbel
6:44 pm - Platelet Function Testing in the
Low-Risk Patient: Lessons Learned From
GRAVITAS and TRIGGER-PCI
Matthew J. Price
6:56 pm - Incorporating Platelet Function
Testing into a Practical Clinical Pathway
Laurent Bonello
7:18 pm - Optimizing Platelet Inhibition to
Prevent Bleeding Complications with Platelet
Function Testing (Timing of Surgery After
DAPT Discontinuation; Long-term
Antiplatelet Therapy Management):
Are We There Yet?
Dirk Sibbing
TCT Mediterranean
7:05 pm - A Distal Left Main Bifurcation
Mohamed Sobhy
6:00 pm-8:00 pm
Room 121
Roxana Mehran
6:00 pm - Welcome and Introduction:
Goals and Plans for TCT in the
Mediterranean Region
George D. Dangas
Session I. Imaging/FFR Update in the
Mediterranean Region: State of the Union
Moderators: Panayiotis Avraamides,
George D. Dangas
Discussants: Dariusz Dudek, Oktay Ergene,
Zaza Kavteladze, Nicholas N. Kipshidze,
Milan A. Nedeljkovic, Konstantinos Toutouzas,
Dobrin Vassilev
6:05 pm - Case Presentation: Invasive Imaging
Solves a Dilemma
Konstantinos Toutouzas
6:10 pm - How I Use IVUS/VH in
Clinical Practice
Nicholas N. Kipshidze
6:15 pm - How I Use OCT in Clinical Practice
Dariusz Dudek
6:20 pm - How I Use FFR in Clinical Practice
Milan A. Nedeljkovic
Session II. TAVR in the Mediterranean
Region: Investigations and
Clinical Penetration
Moderators: Chaim S. Lotan,
Gennaro Sardella
Discussants: Christos Christou,
Ghada W. Mikhail, Anna Sonia Petronio,
Boris Starcevic, Corrado Tamburino
7:10 pm - Approach to Bifurcations: How to
Choose Between a Provisional vs. Planned
Two Stent Strategy
Archimides Sanati
7:15 pm - Approach to Left Main Disease:
Who Should Have PCI Rather Than CABG?
Andrejs Erglis
- N o v e m b e r 1 0 , 2 0 11
7:20 pm - Ablation vs. Medical Treatment in
Atrial Fibrillation: The European View:
State of the Art
Ernst Vester
8:00 pm - Adjourn
Session III. Left Main and Bifurcations: The
Mediterranean Experience
Moderators: Thierry Corcos, Aleksander Ernst
Discussants: Ibrahim R. Al-Rashdan,
Andrejs Erglis, Georges Ghanem,
Archimides Sanati, Mohamed Sobhy
7:30 pm - Synthesizing the Assessment of
Genotype and Phenotype in the PCI Patient
Tabassome Simon
Thursday
Session III. Electrophysiologic Intervention
Moderators: Juerg Gruenenfelder,
Thorsten Lewalter
Discussants: Kurt Huber, Karl-Heinz Kuck,
Florin Laubenthal, Ernst Vester,
Gerald S. Werner
Cardiovascular
Therapeutics
Session IV. Complex PCI:
Tackling the Complications
Antonios A. Polydorou
Discussants: Ozgen Dogan, Ahmed Magdy,
Luigi Salemme, Giuseppe M. Sangiorgi
7:30 pm - Case Presentation 1:
A Severe Perforation
Luigi Salemme
No Reflow
Ahmed Magdy
Stent Thrombosis
Giuseppe M. Sangiorgi
Closing Remarks and Future Plans
8:00 pm - Adjourn
Evening Programs
7:00
pm -10:00 pm
Please see page 161 for Evening
Programs schedule.
6:35 pm - Case Presentation: A Typical
TAVR Case in My Hospital
Ghada W. Mikhail
6:40 pm - TAVR Tips and Tricks for Case
Selection and Technique
Corrado Tamburino
6:50 pm - How to Avoid Stroke and Bleeding
Complications in TAVR
Anna Sonia Petronio
135
TCT Comes to Miami in 2012
Save the date
OCTOber 22-26, 2012
Mi ami Bea ch Co nv en tion Cent er
MiaMi, florida
w w w. t ct con f e re n c e . c o m
TCT2011
Cardiovascular
Therapeutics
Major Halls
Main Arena............................................................................................... 138
How to Treat Theater: Endovascular and Structural Heart Disease.......... 139
International Society-Sponsored Case Theater........................................ 140
Controversies in Interventional Cardiology: The Skeptic’s Corner............ 140
Difficult Patients in Interventional Cardiology:
The Art of Clinical Decision-Making......................................................... 141
TAVR Site Readiness: Organizing and Training
Your Site to Prepare for TAVR................................................................... 142
Friday
the Moscone Center
·
san francisco, ca
November 11, 2011
137
Friday, November 11
Breakfast Meetings
7:00
am -8:00 am
Meetings schedule.
10:30 am - State of the Subspecialty: Dynamic
Changes in Resource Allocation, Physician
Training, and Socioeconomic Imperatives
John C. Lewin
Plenary Session XX. TCT 2011
Geoffrey O. Hartzler Master
Clinical Operator Award
Main Arena
8:00 am-3:00 pm
Esplanade Ballroom
Plenary Session XVIII.
Live Cases VII
Live Case Co-Moderator: Antonio Colombo
Live Case Discussants: Mauricio Cohen,
Efrain Gaxiola, J. Aaron Grantham,
Reginald I. Low, Brad I. Munt,
Christoph A. Nienaber, Raghotham R. Patlola,
Stephen R. Ramee, Mahmood K. Razavi,
Peter C. Smits, Christopher K. Zarins
8:00 am - University Hospital Bonn
Bonn, Germany
8:45 am - Park Hospital Leipzig
Leipzig, Germany
Plenary Session XIX.
Interventional TCT-ACC
Masters Collection
Moderators: Ralph G. Brindis, Gregg W. Stone
Discussants: Simon R. Dixon,
Juan F. Granada, Liliana R. Grinfeld,
Jose P.S. Henriques, Neal S. Kleiman,
David W.M. Muller, Marc E. Shelton,
Frans Van de Werf, Glenn Van Langenhove,
David O. Williams
9:30 am - Evolution of Diagnosis and
Treatment of Vulnerable Plaque: From
PROSPECT to the High-Risk Plaque Project
Valentin Fuster
9:50 am - Improving Outcomes in the
High-Risk STEMI Patient: Systems,
Cells, and Devices
Cindy L. Grines
10:50 am - Presentation of the TCT 2011
Geoffrey O. Hartzler Master Clinical
Operator Award
Award Presenters: Martin B. Leon,
Gregg W. Stone
Award Recipient: Horst Sievert
Plenary Session XXI. Late
First Report Investigations III
Focus on Novel Drug-Eluting Stents and
Drug-Coated Balloons
Discussants: Alexandre Abizaid, Didier Carrie,
Antonio Colombo, Stéphane Cook,
Joost Daemen, Juan F. Granada,
Michael Haude, Michael Joner, Laura Mauri,
Ian T. Meredith, Harald Rittger,
Patrick W. Serruys
11:00 am - EVOLVE: A
Trial of Two Dose
Formulations of a
Bioabsorbable PolymerBased Everolimus-Eluting
Stent vs. a Durable Polymer-Based
Everolimus-Eluting Stent
Ian T. Meredith
11:10 am - REMEDEE: A
Trial of a Combination
Bioabsorbable PolymerBased Anti-CD34 Antibody
Sirolimus-Eluting Stent vs.
a Durable Polymer-Based PaclitaxelEluting Stent
Michael Haude
11:20 am - NEXT: A
Trial Comparing Cre8, a
Polymer-Free
Stent Eluting Sirolimus, to
a Paclitaxel-Eluting Stent
10:10 am - Vascular Restoration with
Bioabsorbable Drug-Eluting Stents Are
the Future! The Science Behind the Dream
Patrick W. Serruys
138
program ·
Didier Carrie
11:30 am - PEPCAD-DES: A
Trial of a PaclitaxelCoated Balloon vs.
Uncoated Balloon
Angioplasty in Patients with
Restenosis of Drug-Eluting Stents
Harald Rittger
11:40 am - Roundtable Discussion:
of These Studies
Focus on Optimal PCI
Moderator: Michalis Hamilos
Discussants: Jozef Bartunek, Justin Davies,
Andrejs Erglis, William F. Fearon,
John McB. Hodgson, Henning Kelbaek,
Morton J. Kern, Gary S. Mintz,
Keith G. Oldroyd, Mark Reisman,
Gert Richardt, Pim A.L. Tonino,
11:55 am - TWENTE: A
Trial of Zotarolimus-Eluting
Stents and EverolimusEluting Stents in Patients
with Coronary Artery
Disease
12:05 pm - ROTAXUS: A
Trial of High-Speed
Rotational Atherectomy
Prior to Paclitaxel-Eluting
Stent Implantation in
Complex Calcified Coronary Artery Lesions
Gert Richardt
12:15 pm - ADVISE:
Validation of a
Vasodilator-Independent
Measure of Coronary
Fractional Flow Reserve
Justin Davies
of These Studies
Focus on Peripheral Vascular Disease
Moderator: Thomas Zeller
Discussants: J. Michael Bacharach,
Subhash Banerjee, Robert M. Bersin,
Peter S. Fail, Michel Henry, Raghu Kolluri,
Hans Krankenberg, D. Christopher Metzger,
Stephen R. Ramee, Mahmood K. Razavi,
Joachim Schofer, Mark H. Wholey,
Jay S. Yadav
TCT2011
Carotid Stenting
Klaudija Bijuklic
of These Studies
Plenary Session XXII.
TCT 2011 Highlights and
Take-Home Messages
Moderators: Martin B. Leon, Gregg W. Stone
Discussants: John A. Bittl, David J. Cohen,
Antonio Colombo, Michael J. Cowley,
Dariusz Dudek, Ajay J. Kirtane,
Roxana Mehran, Gary S. Mintz,
Jeffrey W. Moses, Manish A. Parikh,
Patrick W. Serruys
1:10 pm - TCT 2011 Late Breaking Trials
Critique and Interpretation
Gregg W. Stone
3:00 pm - Adjourn
Coronary Artery
Disease
8:00 am-12:30
Hall D
pm
Live Case Moderator: Jeffrey W. Moses
Live Case Co-Moderator: Rajesh M. Dave
Live Case Discussants: Daniel H. Berrocal,
Pawel E. Buszman, Edoardo Camenzind,
Louis A. Cannon, Lei Ge, Jan J. Piek,
Duane S. Pinto, George W. Vetrovec,
Wojciech Wojakowski
8:30 am - Piedmont Heart Institute
Atlanta, GA
Complex and Unusual Cases IV
Moderator: Ajay J. Kirtane
Co-Moderator: Kirk N. Garratt
10:15 am - The Exploding World of
Intravascular Imaging: Rational Assimilation
into Today’s Cath Lab Environment
Gary S. Mintz
10:30 am - Radial vs. Femoral Access
Revisited: Major Distinction or Much
Ado About Nothing?
Martial Hamon
Live Cases: Complex
and Unusual Cases IV
Live Case Moderator: Ajay J. Kirtane
Live Case Discussants: Periklis Davlouros,
Mark A. de Belder, Kirk N. Garratt,
Ioannis Iakovou, Hyo-Soo Kim,
Young-Hak Kim, Guy LeClerc,
Masato Nakamura, Massimo Napodano,
Andrzej J. Ochala, Vincent J. Pompili
10:45 am - Quebec Heart and Lung Institute
Quebec City, Canada
8:00 am - Spontaneous and Periprocedural
Myocardial Infarctions: Definition,
Ascertainment Alternatives (High-Sensitivity
Troponins and Imaging), and Implications
Harvey D. White
8:15 am - Periprocedural Hemorrhagic
Complications and Mortality:
Linkage or Causality?
Frederick Feit
8:15 am - MitraClip Results in Degenerative
and Functional Mitral Regurgitation:
Identifying Appropriate Patients
Live Cases: Transcatheter
Valve Therapies III
Live Case Moderator: Ted Feldman
Live Case Co-Moderator: Alec Vahanian
Live Case Discussants: Vinay K. Bahl,
Jorge A. Belardi, Raoul Bonan,
Paul T.L. Chiam, Jan Harnek,
Stamatios Lerakis, Francesco Maisano,
Konstantinos Spargias, Pieter R. Stella
8:30 am - Quebec Heart and Lung Institute
Quebec City, Canada
Bonn, Germany
Chronic Limb Ischemia
and Unusual Cases
Moderator: Robert M. Schainfeld
Co-Moderator: Tyrone J. Collins
10:15 am - The Role of Drug-Eluting
Stents and Drug-Coated Balloons in
Robert A. Lookstein
10:30 am - The “Holistic” Approach to
Salvaging Tissue in Critical Limb Ischemia
John R. Laird Jr
Bonn, Germany
Live Cases: Chronic Limb
Ischemia and Unusual Cases
Live Case Moderator: Robert M. Schainfeld
Live Case Co-Moderator: Tyrone J. Collins
Live Case Discussants: Rajesh M. Dave,
Richard R. Heuser, Prakash Krishnan,
Greg Mishkel, Alexander Nikanorov,
Rahul S. Patel, Gary L. Schaer,
Mehdi H. Shishehbor, James P. Zidar
12:30 pm - Adjourn
Complex and Unusual Cases III
Moderator: Jeffrey W. Moses
Co-Moderator: Rajesh M. Dave
8:00 am - Mitral Regurgitation: Pathology,
Pathophysiology, Natural History, and
Surgical Therapies
Alec Vahanian
Endovascular
and Structural
HEart Disease
8:00 am-12:30
Hall D
pm
- N o v e m b e r 1 1 , 2 0 11
12:50 pm - PROFI: A
Trial of Proximal Balloon
Occlusion vs. Distal Filter
Embolic Protection in
Patients Undergoing
Unusual Cases III
Friday
12:40 pm - COBRA: A
Trial of Cryoplasty vs.
Conventional Balloon
Postdilatation of Nitinol
Stents in the Superficial
Femoral Artery of Patients with Diabetes
Mellitus
Subhash Banerjee
Cardiovascular
Therapeutics
10:45 am - Park Hospital Leipzig
Leipzig, Germany
12:30 pm - Adjourn
Transcatheter Valve
Therapies III
Moderator: Ted Feldman
Co-Moderator: Alec Vahanian
139
Friday, November 11
Challenging Case
Multiplex
9:00 am-12:00
Hall D
pm
Aortic Intervention
Moderators: J. Michael Bacharach,
Jacques Busquet
Discussants: Mirko Doss, Takao Ohki
9:00 am - Iatrogenic Aortic Dissection
Benjamin Scott
9:12 am - Percutaneous Transcatheter
Closure of Paravalvular Aortic Leak
Piotr Pysz
9:24 am - Difficulties with a Horizontal
Aortic Root
Pak Hei Chan
9:36 am - Percutaneous Repair of an Aorta
to Right Ventricular Fistula
Bryan Cogar
9:48 am - Endovascular Revascularization
of Bald Aortic Arch
Sanjay Tyagi
11:24 am - Intraoperative Pulmonary
Artery Stenting in Aortoarteritis:
A Hybrid Procedure
Kapil Rangan
11:36 am - Closure of Traumatic Muscular
Interventricular Septal Defect
Carlos Balestrini
Moderators: Oscar A. Mendiz,
Jamil Abdalla Saad
Discussants: Alexandre Abizaid, Jorge Gaspar,
Jose L. Leiva-Pons, Stephan Windecker
11:48 am - Transcatheter Closure of
Perimembranous Ventricular Septal Defect
Apostolos Tzikas
10:00 am - Case 1: An Unforgettable Coronary
Complication, Saved
Jorge Antonio Mayol Almera
12:00 pm - Adjourn
10:15 am - Case 2: An Unforgettable
Peripheral Arterial Complication, Saved
Alejandro O. Palacios
Case Theater
8:00 am-12:00
Hall D
pm
Complex and Unusual Issues in
STEMI Intervention
Sponsored by the Singapore Cardiac Society
Moderators: Tian-Hai Koh, Swee Guan Teo
Discussant: Charles Chan
8:00 am - Case 1: Left Main PCI During STEMI
Aaron Wong
10:30 am - Case 3: An Unforgettable
Interventional Congenital Heart Disease
Complication, Saved
Carlos Pedra
10:45 am - Case 4: An Unforgettable TAVR
Complication, Saved
Fabio S. Brito
Management of Thrombus During
PCI and STEMI
Sponsored by the Italian Society of
Invasive Cardiology
8:15 am - Case 2: A Complication During
Primary PCI
Adrian Low
Moderator: Giulio Guagliumi
Discussants: Bagrat Alekyan,
David Antoniucci, Antonio L. Bartorelli
8:30 am - Case 3: IVUS Evaluation of the
Infarct Site During STEMI
Paul Ong
11:00 am - Case 1: Clinical Impact of
Thrombus Composition in STEMI
Massimo Fineschi
10:00 am - Challenging
Pseudoaneurysm Closure
Robert Huang
8:45 am - Case 4: What Can Go Wrong During
PCI of a Branch Occlusion in STEMI?
Chin Chee Tang
11:15 am - Case 2: Imaging Guidance
for Thrombus Removal
Francesco Saia
10:12 am - Management of a Ruptured
Pseudoaneurysm of Transplanted
Renal Artery
Narenda N. Khanna
Demanding and Unusual Noncoronary
Cardiovascular Interventions
Sponsored by the Mexican Society
of Cardiology
11:30 am - Case 3: Manual and Mechanical
Thrombus Aspiration: Tricks and Pitfalls
Gennaro Sardella
10:24 am - Endovascular Treatment of Acute
Critical Hand Ischemia Using a Novel
Infusion Balloon Catheter
Salman A. Arain
Moderator: Jorge Gaspar
Discussants: Jose Luis Assad Morel,
Jose L. Leiva-Pons, Homero A. Ramirez,
Alfredo Rodriguez
10:36 am - Endovascular Repair of a Large
Thrombotic Carotid Pseudoaneurysm
Narenda N. Khanna
9:00 am - Case 1: A Large Aortic Aneurysm
After Stenting for Aortic Coarctation
Guering Eidt-Lidt
10:48 am - Challenging Treatment of an
Innominate Artery and Ostial Right
Common Carotid
Tarun Madan
9:15 am - Case 2: Challenges of Patent
Ductus Arteriosus Closure in the
Adult Patient
Carlos Zabal
Endovascular III
Moderators: Luigi Salemme, Craig M. Walker
Discussants: Alan Lumsden,
Pedro Martinez-Clark
Adult Congenital Heart Disease II
Moderators: Eric Horlick, Michael J. Mullen
Discussants: Phillip A. Horwitz, Lynn Peng
11:00 am - To Close or Not to Close an Atrial
Septal Defect in Ischemic Cardiomyopathy
Thomas Bartel
9:30 am - Case 3: Challenges of ASD
Closure in the Adult Patient
Jose Luis Lazaro Castillo
9:45 am - Case 4: The Endovascular Approach
for the “Nutcracker Syndrome”—Surgery No
Longer Needed?
Jorge Gaspar
11:12 am - Complex Coiling of Remote
Arteriovenous Malformations
Matthew Bunte
140
My Worst Complication and My Best Save
Sponsored by the Latin America Society of
program ·
11:45 am - Case 4: DES vs. Self-Expanding
BMS When Thrombus is Present
Davide Capodanno
12:00 pm - Adjourn
Morning Spotlight
Sessions
Controversies in
Interventional Cardiology:
The Skeptic’s Corner
8:00 am-12:00
Room 104
pm
Panel I. Interventional Cardiology and
Surgery Crossroads
Moderators: Sanjay Kaul, William W. O’Neill
Mark W. Connolly, Luis A. Guzman,
Michael A. Kutcher, Michel R. Le May,
Jean-Claude Laborde, Robert E. Michler,
Thomas A. Ports
TCT2011
Commonly Held View II. Ad Hoc PCI Is
Appropriate for Triple-Vessel Disease
in Stable Angina
8:22 am - Contrarian Position: Europe Has it
Right: All Patients Should Have an Informed
Discussion Prior to PCI—Especially Those
with Triple-Vessel Disease!
Flavio L. Ribichini
Commonly Held View III. Mitral Regurgitation
Is an Interventional Cardiology Disease
8:44 am - Contrarian Position: Interventional
Devices Will Never Be Able to Manage the
Spectrum of Mitral Pathology!
David H. Adams
Commonly Held View VIII. FFR Should
Be Required for PCI in Stable CAD
10:34 am - Contrarian Position: People Who
Make These Statements Don’t Take Care of
Patients—or Read the Literature Carefully!
Jeffrey W. Moses
Commonly Held View IX. Dual Antiplatelet
Therapy Should Be Continued for More
Than Six Months After DES
10:56 am - Contrarian Position:
Evidence-Based Nonsense!
Fausto Feres
Commonly Held View X. CTA Should Be
the Initial Screening Test for Coronary
Artery Disease
11:18 am - Contrarian Position: Don’t Be
Seduced by Pictures: Anatomy Is Less
Critical Than Function and Perfusion!
Leslee J. Shaw
Commonly Held View IV. TAVR for Aortic
Stenosis Changes Everything
12:00 pm - Adjourn
9:06 am - Contrarian Position: More Strokes,
Vascular Complications, Unknown
Durability—Slow Down!
D. Craig Miller
Difficult Patients in
Interventional Cardiology:
The Art of Clinical
Decision-Making
Commonly Held View V. Carotid Artery
Stenting Is Standard of Care for
Asymptomatic Carotid Artery Disease
9:28 am - Contrarian Position: CEA Reigns If
Preventing Stroke Is Your Goal!
Michael J. Reardon
Panel II. Interventional Cardiology
Moderators: Eric R. Bates, Mark Reisman
Discussants: Albert W. Chan, Donald Cutlip,
Upendra Kaul, Michael A. Kutcher,
Chaim S. Lotan, John A. Ormiston,
Abhiram Prasad, Jonathan M. Tobis
Commonly Held View VI. PFO Closure
Has a Future
9:50 am - Contrarian Position: Time to Close
the Book on PFO Closure!
Darren L. Walters
8:00 am-12:05
Room 134
pm
Clinical Decisions I. The “Poor Responder”
to Clopidogrel
Moderators: John A. McPherson,
Shamir R. Mehta
Discussants: Laurent Bonello, Somjot S. Brar,
Paul A. Gurbel, Michelle O’Donoghue,
Matthew J. Price, Dirk Sibbing,
Tabassome Simon, Daniel I. Simon
Point-Counterpoint
8:00 am - Pro: Point-of-Care Assays for
Clopidogrel Responsiveness Offer Important
Clinical Information and Should Be Used!
Paul A. Gurbel
8:10 am - Con: Point-of-Care Assays for
Clopidogrel Responsiveness Have Not Been
Shown to be Useful and May Be Misleading!
Daniel I. Simon
Commonly Held View VII. Bioabsorbable
Stents Are the Future
10:12 am - Contrarian Position: Drug-Eluting
Bioabsorbable Stents Will Introduce More
Problems Than They Solve!
Renu Virmani
8:20 am - Clinical Potential and Uses of
Genetic Assays to Assess Responsiveness
to Pharmacotherapy in Cardiology
Michelle O’Donoghue
8:30 am - Case Presentation: A Patient with
Successful PCI for Stable Angina with
Clopidogrel Hyporesponsiveness
Matthew J. Price
8:55 am - Summary Comments: Clinical
Decision-Making Today and Tomorrow
John A. McPherson, Shamir R. Mehta
Clinical Decisions II. The Angiographically
Indeterminate Lesion: Using Adjunctive
Imaging to Guide PCI
Alan C. Yeung
Case Presenter:
Discussants: Jose de Ribamar Costa Jr,
Michael Haude, Michael J. Lim, James K. Min,
Gary S. Mintz, Szilard Voros, Gerald S. Werner
- N o v e m b e r 1 1 , 2 0 11
8:00 am - Contrarian Position: CABG Provides
More Durable Relief Than PCI and Is More
Widely Applicable!
Mark W. Connolly
Friday
Commonly Held View I. Left Main PCI
Will Make CABG Obsolete
Cardiovascular
Therapeutics
9:00 am - The Role of CT to Screen for and
Assess Intermediate Lesions at Risk for
Ischemia or Plaque Rupture
Szilard Voros
9:08 am - Grayscale IVUS for Assessment of
Indeterminate Lesions: When Is It Useful?
Jose de Ribamar Costa Jr
9:16 am - The Emerging Role of VH-IVUS,
OCT, and NIRS for Assessment of
Indeterminate Lesions
Gary S. Mintz
9:24 am - FFR for Assessment of
Indeterminate Lesions: Strengths Yes,
but Know the Limitations
Gerald S. Werner
9:32 am - Case Presentation: Management
of a Patient with Conflicting Clinical and
Imaging/FFR Data
Alexandra J. Lansky, Alan C. Yeung
Clinical Decisions III. Revascularization
in Patients with Depressed Left
Ventricular Function
Moderators: Sanjay Kaul, Manish A. Parikh
Discussants: John A. Bittl, Larry S. Dean,
Vladimir Dzavik, Robert J. Freedman Jr,
Norman E. Lepor, Mauro Moscucci,
Richard Smalling, David X. Zhao
Point-Counterpoint
10:02 am - There Is a Strong Rationale for
Revascularization in Patients with Heart
Failure (and Patients Benefit)!
Richard Smalling
141
Friday, November 11
10:12 am - Don’t STICH Me! The Data for
Revascularization in Patients with Depressed
Ventricular Function is Weak!
Sanjay Kaul
10:22 am - What Should Prompt
Revascularization Decisions in Heart Failure:
Ischemia, Viability, Symptoms, or Other?
Vladimir Dzavik
10:32 am - Case Presentation: A Patient
with Severe Heart Failure and Coronary
Artery Disease
Manish A. Parikh
Sanjay Kaul, Manish A. Parikh
Clinical Decisions IV. Contemporary
Management of Stable Coronary
Artery Disease
Moderators: John S. Douglas Jr,
Jeffrey W. Moses
Discussants: David A. Cox, Allen Jeremias,
David J. Maron, Binoy K. Singh,
Rod H. Stables, Pim A.L. Tonino,
Bonnie H. Weiner
Point-Counterpoint
11:02 am - Position 1: Based on What We
Know Today, Medical Therapy is Sufficient
for Most Patients with Stable CAD!
David J. Maron
11:12 am - Position 2: Functionally-Guided
Revascularization Is the Best Way to
Improve Symptoms and Potentially
Save Lives!
Pim A.L. Tonino
11:22 am - Position 3: Ultraconservatism Is
Harming Patients: Follow the Evidence
and Common Sense!
Jeffrey W. Moses
11:32 am - Case Presentation: A Stable
Symptomatic Patient with CAD
Giora Weisz
John S. Douglas Jr
12:05 pm - Adjourn
TAVR Site Readiness:
Organizing and Training Your
Site to Prepare for TAVR
8:00 am-12:00
Room 135
pm
Session I. Components of a Successful
TAVR Program
Moderators: Marian C. Hawkey,
Mathew Williams
Discussants: Joseph E. Bavaria,
Michael Guiry, Sandra Lauck, Scott Lim,
Kristen Skelton, E. Murat Tuzcu
8:00 am - The Heart Valve Team 1:
Concept, Culture, and Commitment
E. Murat Tuzcu
8:10 am - The Heart Valve Team 2:
Physician and Nonphysician Contributors
Sandra Lauck
8:20 am - Procedural Environment 1:
A Dedicated Facility (Hybrid Room
or Otherwise)
Mathew Williams
8:30 am - Procedural Environment 2:
Staffing, Stocking, Training, and Scheduling
Michael Guiry
8:40 am - TAVR Site Qualification Standards:
Recommended Site and Physician Expertise
and Volume Requirements
Kristen Skelton
8:52 am - Best Practice Guidelines for
Managing TAVR Patients: Providing for
Optimal Patient Care Before, During,
and After TAVR is Essential!
Scott Lim
9:04 am - Hospital Administration Must Be
Onboard: Experiences and Suggestions
Joseph E. Bavaria
9:14 am - Panel Discussion: Components of
a TAVR Program
Session II. The Critical First Step:
Case Screening and Triaging to
Optimal Therapies
Moderators: Sandra Lauck, Scott Lim
Rebecca Tung Hahn, Jonathon A. Leipsic,
Augusto D. Pichard, Nicolas van Mieghem,
Mathew Williams
9:34 am - Organizing and Implementing
a Multidisciplinary Valve Clinic
Michael J. Davidson
Advanced Noninvasive Imaging is a Must!
9:44 am - Basic Echo Requirements for
TAVR Screening
Rebecca Tung Hahn
9:54 am - Basic CTA Requirements for
TAVR Screening
Jonathon A. Leipsic
142
program ·
Case Distribution Expectations from a
Busy TAVR Practice
10:04 am - Experiences from Washington
Hospital Center
Augusto D. Pichard
10:12 am - Experiences from Columbia
Mathew Williams
10:20 am - Identifying High-Risk and
Inoperable TAVR Patients: Risk Algorithms,
Documentation, and Tips and Tricks
Nicolas van Mieghem
10:32 am - Panel Discussion: Case Screening
and Triaging for TAVR
Session III. Managing Patients, Families,
and Referring Physicians
Moderators: Michael Guiry, Raj Makkar
Discussants: Marian C. Hawkey,
10:47 am - How to Develop a Thriving TAVR
Referral Practice: The West Coast Offense
Raj Makkar
10:57 am - Communicating with Patients,
Families, and Referring Physicians:
Managing Expectations in Ultra-Sick
AS Patients
11:07 am - Education and Training at All Levels
Is Critical! This is a “New Ballgame”
Marian C. Hawkey
11:17 am - Panel Discussion: TAVR
Practice Building
Session IV. Successful TAVR Models
Moderators: Martina Kelly Speight,
Augusto D. Pichard
Discussants: Raoul Bonan,
Ganesh Manoharan, E. Murat Tuzcu
A Successful TAVR Organizational Model. . . .
11:27 am - From Europe
Ganesh Manoharan
11:35 am - From Canada
Raoul Bonan
11:43 am - From the United States
E. Murat Tuzcu
11:51 am - Panel Discussion: Success
Lessons from Around the World
12:00 pm - Adjourn
TCT2011
Cardiovascular
Therapeutics
Friday
C a r d i o va s C u l a r
researCh
F o u n d at i o n
- N o v e m b e r 1 1 , 2 0 11
Clinical Trials Center
Experts in Protocol Design,
Data Management, Core
Laboratories, Indicated Judication
and Regulatory Support
Medical research is a continuum
The Clinical Trials Center (CTC) sets the standard for conducting clinical research,
that begins with a promising
offering a full spectrum of interventional and pharmacological evaluations with
concept and concludes with proving
the safety and efficacy of a new
therapy in a controlled clinical
trial. CRF’s Clinical Trials Center
provides comprehensive
and complete trial design,
evaluation, and analysis services.
unmatched expertise. The CTC combines the comprehensive knowledge of
leading physicians and technologists to streamline the research process from
Phase I through Phase IV trials.
The CTC provides the full spectrum of services needed for successful clinical
research, including clinical and regulatory strategy, protocol and database
development, statistical analysis, safety surveillance, and core laboratory
capabilities. This full portfolio of abilities means our clients can have a tailored
research plan that meets their needs.
143
RESEARCH
F O U N D AT I O N
Center for Education
Improving Patient Outcomes
Through Worldwide Medical
Programming
For more information, contact:
STRATEGIC PLANNING · MEETING LOGISTICS
Johnnie White, CMP
PROGRAM DEVELOPMENT · FACULTY MANAGEMENT
Executive Director,
Tel: 646-434-4392
POST-MEETING RECONCILIATION ·MARKETING AND BRANDING
E-mail: [email protected]
GRAPHIC DESIGN · WEB SITE DEVELOPMENT
Lisa Hathaway Stella
VIDEO AND INTERACTIVE MEDIA · E-LEARNING
Director,
Industry Relations
Tel: 646-434-4343
E-mail: [email protected]
CRF is certified to accredit programs for
continuing medical education (CME).
TCT2011
Cardiovascular
Therapeutics
Evening Programs.................................................................................... 146
Tuesday, November 8
Breakfast Meetings.................................................................................. 147
Presentation Theater South...................................................................... 150
Presentation Theater North...................................................................... 155
Presentation Theater North...................................................................... 160
Friday, November 11
Satellites
Monday, November 7
the Moscone Center
·
san francisco, ca
November 7-11, 2011
Satellite Symposia
Monday, November 7
EARCH ·
F
N
Padova University Hospital
Padova, Italy
Matthew T. Roe, MD, MHS
Duke Clinical Research Institute
Durham, NC
CULAR ·
R
O
AS
ES
ARDIO
· C
V
Evening Programs
Ran Kornowski, MD
UN
D AT I
O
Knights of the Roundtable 2011: Defending
and Challenging AMI Therapies
Hilton San Francisco, Imperial Ballroom/
Franciscan Room
Sponsored by Cardiovascular
Research Foundation
Supported through educational grants
from Abbott Vascular, AstraZeneca,
Medtronic CardioVascular, and TherOx, Inc.
(as of October 1, 2011)
This activity has been approved for
AMA PRA Category 1 Credit™
Dietmar Trenk, PhD
Herz-Zentrum Bad Krozingen
Charite University Medicine Berlin
Campus Benjamin Franklin
Berlin, Germany
Stephen D. Wiviott, MD
Boston, MA
Agenda
7:00 pm - Dinner Reception
Chairs
Mayo Clinic
Rochester, MN
Cindy L. Grines, MD
Royal Oak, MI
Gregg W. Stone, MD
New York, NY
Faculty
Eric R. Bates, MD
Ann Arbor, MI
Bruce R. Brodie, MD
Greensboro, NC
David A. Cox, MD
Lehigh Valley Hospital
Bethlehem, PA
Jan-Henk E. Dambrink, MD, PhD
Isala Klinieken
Zwolle, The Netherlands
University of Leicester
Sanjay Kaul, MD
Los Angeles, CA
Should Clopidogrel, Ticagrelor, or
Prasugrel Be Used in Most Cases of Primary
PCI (and Is Preloading Important)?
Moderator: Cindy L. Grines
Discussants: Eric R. Bates,
Anthony H. Gershlick, Sanjay Kaul,
Ajay J. Kirtane, Matthew T. Roe,
Gregg W. Stone, Dietmar Trenk,
Stephen D. Wiviott
8:00 pm - Case Presenter
Dietmar Trenk
8:10 pm - Opinionated Position Statement
Stephen D. Wiviott
8:18 pm - Roundtable Discussion
Panel
When Should Thrombectomy Be Performed
During Primary PCI and How?
Discussants: Bruce R. Brodie, David A. Cox,
Jan-Henk E. Dambrink, Cindy L. Grines,
Ajay J. Kirtane, Ran Kornowski,
Massimo Napodano, Bernhard Witzenbichler
Bernard J. Gersh
Massimo Napodano
Panel
New York, NY
146
program ·
T r a n s c a t h ete r C a r d i o v a s c u l a r T h e r a pe u tic s
When Should Multivessel Revascularization
Be Performed During Primary PCI?
Moderator: Bernard J. Gersh
Discussants: Eric R. Bates, Bruce R. Brodie,
David A. Cox, Anthony H. Gershlick,
Sanjay Kaul, Ran Kornowski,
Massimo Napodano, Dietmar Trenk
Ran Kornowski
Cindy L. Grines
Panel
Should Patients with STEMI Presenting
12 to 48 Hours After Symptom Onset Be
Emergently Revascularized?
Discussants: Eric R. Bates,
Jan-Henk E. Dambrink, Bernard J. Gersh,
Anthony H. Gershlick, Cindy L. Grines,
Sanjay Kaul, Matthew T. Roe,
Jan-Henk E. Dambrink
Eric R. Bates
Panel
10:00 pm - Adjourn
Innovation in the Management and
Treatment of Vascular Disease:
2012 and Beyond
Hilton San Francisco, Grand Ballroom A
Sponsored by Covidien
Chair
Michael R. Jaff, DO
Boston, MA
Faculty
Joseph Broderick, MD
University of Cincinnati
Cincinnati, OH
Senator Bill Frist, MD
Nashville, TN
James D. Joye, DO
El Camino Hospital
Mountain View, CA
Sacramento, CA
Mark A. Turco, MD
Chief Medical Officer,
Covidien Vascular Therapies
Takoma Park, MD
TCT2011
Agenda
8:00 pm - Introduction, Covidien
Vascular Therapies
Mark A. Turco
Overview of the Elixir Medical Programs
8:10 pm - Keynote: An Insider’s Crystal Ball
Look into Health Reform: Trends That
Impact Innovation
Senator Bill Frist
8:00 pm - Drug-Eluting Stents with
Durable (DESyne™) and Biodegradable
(DESyne™ BD) Polymers
8:07 pm - Drug-Eluting Bioresorbable Scaffold
(DESolve™)
8:30 pm - Antirestenosis Therapies:
The Changing PAD Landscape
John R. Laird Jr
8:15 pm - DESyne™ Randomized Clinical Trial
Two-Year Results
Venous Vascular
8:25 pm - DESyne™ BD Randomized Clinical
Trial Primary Endpoint Results
8:45 pm - Into the Blue:
Endovenous Intervention
James D. Joye
8:35 pm - IVUS Insights with DESyne™
and DESyne™ BD
Neurovascular
9:00 pm - Acute Stroke Intervention:
Data and Trends
Joseph Broderick
9:15 pm - Q&A Session
Panel
9:30 pm - Adjourn
Chairs
São Paulo, Brazil
Martin B. Leon, MD
New York, NY
Faculty
Peter Fitzgerald, MD, PhD
Stanford University Hospital
Palo Alto, CA
ZNA Middleheim Hospital
Antwerp, Belgium
Agenda
8:00 pm - Welcome and Introductions
Alan B. Lumsden
8:05 pm - Building the Room: A Business Case
Alan B. Lumsden
8:15 pm - Visit to the Hybrid Room
Alan B. Lumsden
DESolve™ Bioresorbable Scaffold
8:20 pm - Hybrid Aortic Cases
Michael J. Reardon
8:45 pm - Preclinical Experience with
the DESolve™ Bioresorbable Scaffold
8:30 pm - Hybrid Coronary Cases
Mahesh K. Ramchandani
8:55 pm - Clinical Experience with the
DESolve™ FIM Study
8:40 pm - Hybrid Ablation Procedures
Basel Ramlawi
9:05 pm - DESolve™ Nx Clinical Trial
8:50 pm - Percutaneous Aortic Valves:
If I Knew Then What I Know Now
Neal S. Kleiman
Discussion
9:15 pm - Take-Home Message
Innovating Vascular Restoration: Clinical
Experience with Elixir’s Durable and
Biodegradable Polymer DES, and
Bioresorbable Scaffold Platforms
Hilton San Francisco, Continental
Ballroom 6-9
Sponsored by Elixir Medical
Michael J. Reardon, MD
Vascular Center
Houston, TX
9:30 pm - Adjourn
- N o v e m b e r 7 - 11 , 2 0 11
Peripheral Vascular
Clinical Experience with the DESyne™
and DESyne™ BD Novolimus-Eluting DES
Basel Ramlawi, MD
Vascular Center
Houston, TX
Satellite Symposia
Agenda
Cardiovascular
Therapeutics
9:00 pm - Advanced Imaging and Navigation
Alan B. Lumsden
9:30 pm - Adjourn
Hybrid Room Design and Utilization:
Lessons Learned
Ballroom 1-4
Sponsored by Methodist DeBakey Heart
and Vascular Center
Supported through an educational grant
from The Methodist Hospital
Chairs
Neal S. Kleiman, MD
Vascular Center
Houston, TX
Tuesday, November 8
Breakfast Meetings
Optimizing PCI Outcomes in Complex
Patients: Role of Pharmacology and
Hemodynamic Support
The Moscone Center, Room 112
Sponsored by ABIOMED Inc. and
The Medicines Company
Chair
New York, NY
Alan B. Lumsden, MD
Vascular Center
Houston, TX
Faculty
Faculty
University of Miami
Miami, FL
Mahesh K. Ramchandani, MD
Vascular Center
Houston, TX
Neal S. Kleiman, MD
Methodist DeBakey Heart and Vascular Center
Houston, TX
www . tctc o n f e r ence . c o m
147
Satellite Symposia
ES
EARCH ·
F
O
ARDIO
· C
V
CULAR ·
R
N
N
ARDIO
· C
V
CULAR ·
R
Acute Kidney Injury: Effect of Contrast
Media—Does It Really Matter?
Research Foundation
8:00 am - Adjourn
AS
AS
EARCH ·
F
Panel
8:00 am - Adjourn
ES
7:30 am - Lessons from PROTECT-II:
Role of Hemodynamic Support with
Impella and Complex Case Review
7:50 am - Q&A Session
Panel
O
7:15 am - Assessing the Risk and Targeting
the Pharmacologic Treatment: The Role
of Direct Thrombin Inhibitors
George D. Dangas
7:35 am - Discussion: Impact of TAVR in
Your Center and “Unique” Aspects of the
Western United States
Panel
D AT I
7:00 am - Understanding the Management
Challenges of the Complex Patient
Undergoing PCI
Neal S. Kleiman
7:25 am - Site Readiness: Top 10 General
Requirements to Be a Successful
Heart Team
Gregory P. Fontana
UN
6:30 am - Breakfast
O
Agenda
Supported through an educational
grant from Guerbet
UN
D AT I
O
Preparing for a Transcatheter AVR Program
and Heart Valve Team in Your Center:
The Nuts and Bolts (Western United States)
Research Foundation
grant from Edwards Lifesciences
Praveen Mehrotra, MD
Boston, MA
Tomokuki Suzuki, MD
Sakakibara Heart Institute
Tokyo, Japan
Lorraine Choi, MD
UTMB
Galveston, TX
Richard Solomon, MD
University of Vermont
Burlington, VT
Agenda
6:30 am - Breakfast
7:00 am - Welcome and Introductions
Mathew Williams
Agenda
7:03 am - Percutaneous Extraction of Pacing
Leads from the Left Coronary Artery and
Left Ventricle
Sammy Elmariah, Praveen Mehrotra
6:30 am - Breakfast
7:18 am - Q&A and Discussion
7:00 am - Tutorial on Contrast Media
Richard Solomon
7:22 am - Successful Recanalization of Left
Coronary Artery Dissection Involved with
Type A Acute Aortic Dissection
Tomokuki Suzuki, Yusuke Watanabe
7:10 am - Acute Kidney Injury:
Prevention and Risks
Somjot S. Brar
7:05 am - Takeaway Lessons from the
PARTNER Trial
D. Craig Miller
7:20 am - Contrast-Induced Nephropathy:
Does the Type of Contrast Media Matter?
One-Year Outcomes of the ICON Study
Usman Baber
7:41 am - Aortocaval Fistula: A Case of
Rapidly Deteriorating Course, Diagnosis, and
Endovascular Treatment
Lorraine Choi, Gilani Syed
7:15 am - Review of Balloon-Expandable TAVR
Technology, Procedural Tips, and the
“Special” Role of the Heart Team
Raj Makkar
7:30 am - Case Presentation with Q&A
Somjot S. Brar
Discussants: Usman Baber, Richard Solomon
8:00 am - Adjourn
148
Sammy Elmariah, MD
Boston, MA
Faculty
Faculty
Raj Makkar
scholarship winners
Gilani Syed, MD
UTMB
Galveston, TX
Somjot S. Brar, MD
Kaiser Permanente
Los Angeles, CA
6:30 am - Breakfast
Mathew Williams, MD
New York, NY
Roxana Mehran, MD
New York, NY
Raj Makkar, MD
Los Angeles, CA
Agenda
Chair
Chair
Chair
D. Craig Miller, MD
Stanford, CA
grant from Medtronic CardioVascular
Yusuke Watanabe, MD
Paris, France
Usman Baber, MD
New York, NY
Los Angeles, CA
Innovative Hybrid Therapy for Treatment
of Complex Cardiovascular Lesions:
Collaborative Care Case Reviews
Sponsored by Cardiovascular Research
Foundation
program ·
8:00 am - Adjourn
TCT2011
Chair
Martin B. Leon, MD
New York, NY
Faculty
Antonio Colombo, MD
Milan, Italy
Agenda
6:30 am - Breakfast
7:00 am - Introduction and Objectives
Martin B. Leon
7:05 am - Cre8 Polymer-Free DES Features
and Preclinical Results
Alexandre Abizaid
7:20 am - Cre8 Polymer-Free DES Clinical Plan
Antonio Colombo
Moderator: Martin B. Leon
Antonio Colombo
7:50 am - Take-Home Messages
Martin B. Leon
8:00 am - Adjourn
3-D-Guided Interventions for Structural
Heart and Complex PCI Procedures
Sponsored by GE Healthcare
Faculty
Weill Cornell Medical Centerr
New York, NY
Ashok Tirouvanziam, MD
University Hospital of Nantes
Nantes, France
Alan Yeung, MD
Palo Alto, CA
Agenda
6:30 am - Breakfast
7:00 am - Transcatheter Valve Implantation:
3-D Rendering to Guide Valve Replacement
Ashok Tirouvanziam
Juan F. Granada, MD
New York, NY
7:50 am - Adjourn
Sander IJsselmuiden, MD
Dordrecht
Dordrecht, The Netherlands
PCI Optimization with FFR and OCT
Sponsored by St. Jude Medical
Alan Yeung, MD
Stanford University
Stanford, CA
Chair
Agenda
Marco A. Costa, MD, PhD
University Hospitals, Case Western
Reserve University
Cleveland, OH
6:30 am - Breakfast
Faculty
Bernard De Bruyne, MD, PhD
Cardiovascular Center Aalst
Aalst, Belgium
Agenda
6:30 am - Breakfast
7:00 am - FFR and OCT to Determine
PCI Appropriateness
Marco A. Costa
7:10 am - OCT: Clinical Updates and
Case Presentations
Marco A. Costa
7:25 am - FFR: Clinical Updates and
Case Presentations
Bernard De Bruyne
Moderator: Marco A. Costa
Discussant: Bernard De Bruyne
8:00 am - Adjourn
Solving the Sizing Dilemma Using a
Self-Apposing Stent: STEMI Clinical
Program in Europe and the United States
Sponsored by STENTYS S.A.
Chairs
La Jolla, CA
Roxana Mehran, MD
New York, NY
Faculty
Don Cutlip, MD
Harvard Clinical Research Institute
Cambridge, MA
Peter Fitzgerald, MD
Stanford University
Stanford, CA
7:00 am - Introduction
Maurice Buchbinder
7:02 am - Self-Apposing Technology: From
Product Design to Imaging-Based Evidence
Peter Fitzgerald
7:12 am - One-Year Clinical Results in STEMI:
APPOSITION I and II
Sander IJsselmuiden
- N o v e m b e r 7 - 11 , 2 0 11
São Paulo, Brazil
7:25 am - Imaging in Complex Coronary
Artery Interventions
Alan Yeung
Satellite Symposia
Future DES Technology, Today: Cre8
Sponsored by CID SpA
Cardiovascular
Therapeutics
7:20 am - Ongoing and Future Clinical
Evaluations: APPOSITION III and IV
TBA
7:30 am - US Clinical Trial and IDE:
Strawman Protocol of the
APPOSITION V Study
Don Cutlip
Panel
8:00 am - Adjourn
A Paradigm Shift In Bifurcations: Tryton
Experience in the United States and Europe
Sponsored by Tryton Medical, Inc.
Chairs
Cardiovascular Medicine Clinic
Stanford, CA
Thierry Lefèvre, MD
Massy, France
Faculty
Yaron Almagor, MD
Jesselson Heart Center
Jerusalem, Israel
Antonio Bartorelli, MD
Centro Cardiologico
Monzino, Italy
David Foley, MD
Beaumont Hospital
Dublin, Ireland
Maciej Lesiak, MD
University Hospital
Poznan, Poland
149
Satellite Symposia
7:23 am - IVUS Assessment In Bifurcations
and Case Review
Antonio Bartorelli
7:32 am - Long-term Experience:
The Dublin Series
David Foley
7:41 am - Left Main Treatment: A New Era?
Maciej Lesiak
7:50 am - Discussion and Conclusion
Moderators: William F. Fearon, Thierry Lefèvre
8:00 am - Adjourn
Treating the Complex Lesion:
Techniques and Technology for
Left Mains and Bifurcations
Sponsored by Volcano Corporation
Chairs
Saibal Kar, MD
Los Angeles, CA
Brian Whisenant, MD
Intermountain Medical Center
Salt Lake City, UT
Faculty
Shephal Doshi, MD
Pacific Heart Institute
Santa Monica, CA
David Muller, MD
St. Vincent’s Hospital
Darlinghurst, Australia
Vivek Reddy, MD
New York, NY
Chair
Agenda
David Rizik, MD
Scottsdale Healthcare
Phoenix, AZ
12:30 pm - LAA Occlusion in the
Treatment of Atrial Fibrillation:
An Electrophysiologist’s Perspective
Vivek Reddy
Agenda
6:30 am - Breakfast
David Rizik
7:05 am - Bifurcation Strategies and
Techniques
7:20 am - Side Branch Options and
the Role of FFR
7:35 am - Left Main PCI: Assessment
and Approaches
8:00 am - Adjourn
ARDIO
· C
V
CULAR ·
R
N
O
7:14 am - Tryton Clinical Data Overview
and Real-World Cases
Yaron Almagor
AS
EARCH ·
F
7:05 am - The Tryton IDE Study:
A First in Man in the United States
William F. Fearon
Controversies in LAA Occlusion
as a Treatment for A-Fib Patients
The Moscone Center
Presentation Theater South,
Santa Rosa Valley (Located in
the Exhibit Hall)
Sponsored by Coherex, Inc.
ES
Thierry Lefèvre
Evening Programs
D AT I
Lunchtime Sessions
UN
Presentation Theater South
6:30 am - Breakfast
O
Agenda
Drug-Coated Balloons: An Emerging
Breakthrough Technology
Ballroom 6-9
Research Foundation
Supported through educational grants from
Abbott Vascular, Boston Scientific
Corporation, Cook Medical, Lutonix,
MEDRAD Interventional, Medtronic
CardioVascular (as of October 1, 2011)
Chairs
Juan F. Granada, MD
Orangeburg, NY
William A. Gray, MD
New York, NY
Gregg W. Stone, MD
New York, NY
Faculty
12:40 pm - The “Novel Anticoagulants:”
A Reality Check
Brian Whisenant
Gary M. Ansel, MD
Columbus, OH
12:50 pm - Imaging Techniques for
LAA Closure
Saibal Kar
Antonio Colombo, MD
Milan, Italy
1:00 pm - What LAA Closure Might Look
Like in a Busy EP Practice
Shephal Doshi
Andrew Farb, MD
Silver Spring, MD
1:10 pm - Coherex WaveCrest Case
Summary with 45-Day Follow-up
David Muller
Dierk Scheinert, MD
Park-Krankenhaus
Leipzig, Germany
1:20 pm - Q&A Discussion
Panel
Bruno Scheller, MD
University of Saarland
Homburg, Germany
1:30 pm - Adjourn
Pieter R. Stella, MD, PhD
Department of Heart and Lungs
Utrecht, The Netherlands
Renu Virmani, MD
Gaithersburg, MD
150
program ·
TCT2011
8:45 pm - Impact of Coating Formulation and
Antiproliferative Choices on Drug Transfer
and Tissue Pharmacokinetics
Bruno Scheller
Panel
9:00 pm - Regulatory Challenges to DCB
Development and Validation in the
United States
Andrew Farb
Panel
9:15 pm - Tissue Safety Studies: Similarities
and Critical Differences Between DCB and
DES Technologies
Renu Virmani
Panel
9:30 pm - Clinical Trial Design for DCB Above
and Below the Knee: What Are the Endpoints
and Challenges to Completion?
Gary M. Ansel
Panel
9:45 pm - Future Generation DCB Platforms
Juan F. Granada
Panel
10:00 pm - Adjourn
ARDIO
· C
V
N
O
Panel
D AT I
8:30 pm - Similarities and Differences
in Today’s DCB Technologies
William A. Gray
UN
Panel
TAVR Has Arrived: Pillars of Success
Hilton San Francisco, Grand Ballroom AB
Research Foundation
from Edwards Lifesciences
Chairs
Martin B. Leon, MD
New York, NY
Craig R. Smith, MD
New York, NY
Faculty
Philadelphia, PA
Alain G. Cribier, MD
Rouen, France
Todd M. Dewey, MD
Medical City Dallas
Dallas, TX
Philadelphia, PA
Samir R. Kapadia, MD
The Cleveland Clinic Foundation
Cleveland, OH
The Christ Hospital
Cincinnati, OH
Scott Lim, MD
UVA Medical Center
Charlottesville, VA
Michael J. Mack, MD
The Heart Hospital Baylor Plano
Plano, TX
D. Craig Miller, MD
Stanford, CA
University of Miami
Miami, FL
Washington, DC
Allan Schwartz, MD
New York, NY
La Jolla, CA
Vinod H. Thourani, MD
Atlanta, GA
E. Murat Tuzcu, MD
The Cleveland Clinic Foundation
Cleveland, OH
Alec Vahanian, MD
Hôpital Bichat
Paris, France
Thomas Walther, MD
Kerckhoff Klinik Bad Nauheim
- N o v e m b e r 7 - 11 , 2 0 11
8:15 pm - The Potential for Peripheral DCBs:
Why Aren’t Other Therapeutic Alternatives
(ie, DES) Sufficient?
Dierk Scheinert
O
Panel
CULAR ·
R
EARCH ·
F
8:00 pm - The Potential for Coronary DrugCoated Balloons (DCBs): Indications,
Opportunities, and Challenges
Gregg W. Stone
AS
ES
Satellite Symposia
Agenda
Cardiovascular
Therapeutics
Olaf Wendler, MD, PhD
Mathew Williams, MD
New York, NY
Agenda
INTRODUCTION
Martin B. Leon, Craig R. Smith
PART I. APPROPRIATE CASE SELECTION
8:00 pm - Choosing the Best Patients for
TAVR: Today and Tomorrow
Michael J. Mack
8:15 pm - Panel Discussion: TAVR Case
Selection and Considerations
Moderators: Martin B. Leon, Craig R. Smith
Discussants: Scott Lim, Michael J. Mack,
D. Craig Miller, William W. O’Neill,
Allan Schwartz, Alec Vahanian
PART II. THE HEART TEAM aND SITE READINESS
8:30 pm - Forming a Heart Team and
Preparing Your Site for Success: Not
“Business as Usual”
E. Murat Tuzcu
8:45 pm - Panel Discussion: Evolving the
Heart Team Concept
Discussants: Joseph E. Bavaria,
Alain G. Cribier, Todd M. Dewey,
Howard C. Herrmann, Dean J. Kereiakes,
E. Murat Tuzcu, Olaf Wendler
151
Satellite Symposia
PART III. OPTIMIZING CLINICAL OUTCOMES
9:00 pm - Best TAVR Practice Standards
Today and Future Expectations
Martyn R. Thomas
9:15 pm - Panel Discussion: Best Clinical
Practices and Future Enhancements
Discussants: Samir R. Kapadia,
Augusto D. Pichard, Paul S. Teirstein,
Martyn R. Thomas, Vinod H. Thourani,
Thomas Walther, Mathew Williams
9:30 pm - Adjourn
Emerging Paradigms and New Frontiers in
Science and Application of Antithrombotic
Interventions for High-Risk ACS
Ballroom 1-4
Sponsored by University of Massachusetts
Medical School
grant from sanofi-aventis
8:40 pm - Radial vs. Femoral Access for PCI in
the Setting of NSTE-ACS: Implications for
Anticoagulation Management—Does Mode
of Access Matter?
Sunil V. Rao
9:05 pm - Novel Anticoagulants for High-Risk
ACS: Rationale and Study Designs Focused
on the Safety and Efficacy of Factor Xa
Inhibition in the Setting of NSTE-ACS
David P. Faxon
9:30 pm - TCT Director Keynote Address:
Contemporary and Evolving Approaches
to Optimizing Outcomes in High-Risk ACS:
A Near Future Vision Statement Focused
on Advances in Anticoagulation
Gregg W. Stone
9:50 pm - Chair’s Summary on the Future of
Anticoagulation for High-Risk ACS in the
Setting of PCI
Deepak L. Bhatt
10:00 pm - Adjourn
Breakfast Meetings
Faculty
David P. Faxon, MD
Harvard Medical School
Boston, MA
Ron Waksman, MD
Cardiovascular Research Institute
Washington, DC
Bern, Switzerland
Agenda
6:30 am - Breakfast
7:00 am - Welcome and Opening Remarks
Ron Waksman
7:05 am - Relevance of Vascular Healing
in DES with Bioabsorbable vs.
Permanent Polymers
Michael Joner
7:20 am - Clinical Utility of a Bioabsorbable
Polymer on a Modern Stent Platform with
Hybrid Coating
Stephan Windecker
7:30 am - Overview of Clinical Experience
with a DEB Releasing Paclitaxel from a
BTHC Excipient
Ralph Toelg
7:40 am - Lessons Learned about a
Bioabsorbable Metallic Scaffold: Update
from the BIOSOLVE-I Trial
Michael Haude
Chair
Deepak L. Bhatt, MD
Harvard Medical School
Boston, MA
Ralph Toelg, MD
Herz-Kreislauf-Zentrum
Management of Complex Patients:
How the Recent Data May Affect our
Approach to Patients
from ABIOMED, Inc.
7:50 am - Closing Remarks
Panel
8:00 am - Adjourn
Sunil V. Rao, MD
Durham, NC
Treating Chronic Total Occlusions:
Advanced Technology and Techniques
Sponsored by Boston Scientific
Agenda
Faculty
Gregg W. Stone, MD
Columbia University Medical School
New York, NY
Please visit www.tctconference.com for
the latest agenda.
Tony Das, MD
Presbyterian Heart Institute
Dallas, TX
Agenda
Nonpermanent Vascular Therapies:
Are They the Future of
Vascular Intervention?
Sponsored by BIOTRONIK
Dierk Scheinert, MD
Heart Center Leipzig
Leipzig, Germany
Faculty
7:00 am - The Landscape of Tools and
Techniques for Crossing Difficult Lesions
Tony Das
8:00 pm - Emerging Strategies for Optimizing
Outcomes in High-Risk ACS: Look at
Where We’ve Been and What the Frontier
Looks Like—From Anticoagulation to
Stent Selection
Deepak L. Bhatt
8:15 pm - The Evolution of AnticoagulationBased Interventions in PCI: From UFH and
LMWH to Direct Thrombin and Factor Xa
Inhibition—What Have the Trials Taught Us?
Where Will the New Breakthroughs Come?
Deepak L. Bhatt
Michael Haude, MD
Neuss, Germany
Michael Joner, MD
Deutsches Herzzentrum München
München, Germany
Agenda
6:30 am - Breakfast
7:25 am - TruePath™ CTO Device: The Next
Frontier for Intraluminal Crossing
Dierk Scheinert
Panel
8:00 am - Adjourn
152
program ·
CULAR ·
R
O
N
EARCH ·
F
UN
D AT I
O
and Heart Valve Team in Your Center: The
Nuts and Bolts (Midwestern United States)
Foundation
from Edwards Lifesciences
Chair
Lars G. Svensson, MD, PhD
Cleveland, OH
Faculty
Todd M. Dewey, MD
Medical City Dallas Hospital
Dallas, TX
Samir Kapadia, MD
Cleveland, OH
Agenda
6:30 am - Breakfast
Lars G. Svensson
7:05 am - Takeaway Lessons from
the PARTNER Trial
Lars G. Svensson
7:15 am - Review of Balloon Expandable
TAVR Technology, Procedural Tips and
the “Special” Role of the Heart Team
Samir Kapadia
7:25 am - Site Readiness: Top 10
General Requirements to Be a
Successful Heart Team
Todd M. Dewey
7:35 am - Discussion: Impact of TAVR in
Your Center and “Unique” Aspects of
the Midwestern United States
Panel
The Emergence of Peripheral
Drug-Coated Balloons
Sponsored by Lutonix, Inc.
Chair
Gary Ansel, MD
Riverside Hospital
Columbus, OH
Gregg W. Stone, MD
New York, NY
Faculty
São Paulo, Brazil
Antonio Colombo, MD
Milan, Italy
Dariusz Dudek, MD, PhD
Jagiellonian University
Krakow, Poland
Eberhard Grube, MD
Bonn, Germany
Chaim S. Lotan, MD
Hadassah University Hospital
Jerusalem, Israel
Federico Piscione, MD, PhD
University of Naples Federico II
Naples, Italy
Ashok Seth, MD, PhD
Escorts Heart Institute and Research Centre
New Delhi, India
Sigmund Silber, MD
Heart Center at the Isar
Munich, Germany
Agenda
6:30 am - Breakfast
7:00 am - Unmet Needs, MGuard,
and the MASTER Trial
Gregg W. Stone
Moderator: Chaim S. Lotan
7:15 am - MGuard in Acute MI:
Three-Year Follow-up
Federico Piscione
Panel
7:25 am - MGuard for Complex Lesions
Antonio Colombo
8:00 am - Adjourn
7:35 am - Challenging MGuard Cases
TBA
7:55 am - Take-Home Messages
Gregg W. Stone
8:00 am - Adjourn
Chair
Faculty
Juan F. Granada, MD
New York, NY
Kingsport, TN
Dierk Scheinert, MD
Heart Center Leipzig/Park Hospital
Leipzig, Germany
Renu Virmani, MD
Gaithersburg, MD
- N o v e m b e r 7 - 11 , 2 0 11
Thrombus Management in STEMI with
MGuard Micro-Mesh Technology:
Complex Lesions and the MASTER Trial
Sponsored by InspireMD
Satellite Symposia
AS
ES
ARDIO
· C
V
TCT2011
Cardiovascular
Therapeutics
Agenda
6:30 am - Breakfast
Gary Ansel
7:05 am - The Perceived Paradox of DrugCoated Balloons (DCB)
Juan F. Granada
7:17 am - DCB Insights from the
Preclinical Model
Renu Virmani
7:32 am - The Moxy™ Drug-Coated Balloon
and the LEVANT 2 Trial
7:42 am - Technique and Procedure Lessons
from DCB Clinical Trials
Dierk Scheinert
8:00 am - Adjourn
Management of Thrombus in STEMI
Interventions: Discussion and Debate on
the Role of AngioJet Thrombectomy and
Manual Aspiration
Sponsored by MEDRAD Interventional
Faculty
Careggi Hospital
Florence, Italy
Bruce R. Brodie, MD
Greensboro, NC
153
Satellite Symposia
Giuseppe De Luca, MD, PhD
Eastern Piedmont University
Novara, Italy
AHEPA University Hospital
Thessaloniki, Greece
Agenda
6:30 am - Breakfast
7:00 am - Introduction and Overview of
Aspiration and Mechanical Thrombectomy
Trials and STEMI Guidelines
Bruce R. Brodie
7:10 am - Importance and Classification of
Coronary Thrombus Burden
Georgios Sianos
7:20 am - JETSTENT and SMART PCI Trials:
Impact on STEMI Interventions
David Antoniucci
7:30 am - Updated Meta-analysis on
Thrombectomy in STEMI
Giuseppe De Luca
7:25 am - Left Main Case
Panel
7:40 am - A Complex Bifurcation Case
Panel
7:55 am - Conclusion and
Take-Home Messages
Panel
8:00 am - Adjourn
Advanced Imaging for TAVR
Sponsored by Paieon Inc.
Chair
Martin B. Leon, MD
New York, NY
Faculty
7:40 am - Discussion and Debate:
AngioJet or Aspiration or Dual Strategy?
Panel
Peter Block, MD
Emory University
Atlanta, GA
8:00 am - Adjourn
Los Angeles, CA
Bifurcation Lesion Treatment Dilemmas:
Solutions with the Experts
Sponsored by MINVASYS
Chairs
São Paulo, Brazil
Roxana Mehran, MD
New York, NY
Faculty
Jacques Berland, MD
Clinique Saint Hilaire
Rouen, France
Bruno Garcia Del Blanco, MD
Hospital Vall d'Hebron
Barcelona, Spain
Azeem Latib, MD
Milan, Italy
Agenda
6:30 am - Breakfast
Panel
7:05 am - Provisional Approach Technique:
Step by Step
Panel
154
7:10 am - A True Bifurcation Case
Panel
program ·
Penn Heart and Vascular Center
Philadelphia, PA
Ran Kornowski, MD
Raj Makarr, MD
Los Angeles, CA
Mathew Williams, MD
New York, NY
Agenda
6:30 am - Breakfast
7:00 am - Welcome
Panel
7:03 am - Valve-in-Valve for Severe AR
After TAVR
Howard C. Herrmann
7:21 am - Edwards SAPIEN Valve Positioning
Implantation: Multicenter Evaluation with
Clinical and Anatomical Correlates
Ran Kornowski
7:39 am - TAVR Postdeployment Analysis
Mathew Williams
7:57 am - Closing
Panel
8:00 am - Adjourn
Coronary Laser Atherectomy in
the 21st Century
Sponsored by Spectranetics
Chair
On Topaz, MD
Charles George Veterans Affairs
Medical Center
Asheville, NC
Faculty
Luc Bilodeau, MD
Montreal, Quebec
Arthur Lee, MD
Kaiser Permanente
Santa Clara, CA
Antonis Pratsos, MD
Bryn Mawr Hospital
Philadelphia, PA
Agenda
6:30 am - Breakfast
7:00 am - Excimer Laser: Correlation Between
Basic Science and Clinical Utilization
On Topaz
7:12 am - Integrating Laser Atherectomy
into Today’s Environment of Complex PCI
Arthur Lee
7:24 am - Use of Excimer Laser for Complex
and Uncrossable Lesions
Luc Bilodeau
7:36 am - Current Experience and
Challenging Cases
Antonis Pratsos
Panel
8:00 am - Adjourn
Advanced Tools and Techniques for
Challenging Lower Extremity
Revascularizations
Sponsored by Terumo Medical Corporation
Chairs
Nelson Lim Bernardo, MD
Washington Cardiology Center
Washington, DC
TCT2011
7:55 am - Questions from the Audience
and Closing Remarks
Carlo Di Mario
Agenda
8:00 am - Adjourn
6:30 am - Breakfast
7:00 am - Welcome
Presentation Theater North
Lunchtime Sessions
7:05 am - Femoro-Popliteal Arterial
Occlusive Disease
7:30 am - Below-the-Knee Arterial
Occlusive Disease
8:00 am - Adjourn
Guide Extension: Making Impossible Cases
Possible and Difficult Cases Easier
Sponsored by Vascular Solutions, Inc.
Chair
Carlo Di Mario, MD, PhD
São Paulo, Brazil
Faculty
Pawel E. Buszman, MD
American Heart of Poland
Katowice, Poland
Faculty
Douglas G. Fraser, MD
Manchester Heart Centre
Manchester, United Kingdom
Sameer I. Dani, MD
Apollo Hospital International Ltd.
Ahmedabad, India
Mid America Heart Institute
Kansas City, MO
Upendra Kaul, MD
New Delhi, India
North Cascade Cardiology
Bellingham, WA
Martin B. Leon, MD
New York, NY
Agenda
6:30 am - Breakfast
Carlo Di Mario
1:08 pm - Future of DES: A Call for MitsuMerilimus-Eluting Coronary Stent
Martin B. Leon
1:16 pm - Floor Discussion
1:21 pm - Adjourn
Chair
Ricardo Costa, MD
São Paulo, Brazil
Aravinda Nanjundappa, MD
Charleston Area Medical Center
Charleston, WV
1:00 pm - Complex Cases with BioMime
Upendra Kaul
Ashok Seth, DSc
New Delhi, India
Third Division of Cardiology
Katowice, Poland
Agenda
Atrial Fibrillation and Uncontrolled
Hypertension: What Interventional
Cardiologists Need to Know
The Moscone Center,
Sonoma Valley (Located in Hall D)
Sponsored by The Society for Cardiovascular
Angiography and Interventions
- N o v e m b e r 7 - 11 , 2 0 11
7:55 am - Q&A Discussion
Panel
A Decade of Stent Design: DES Evolution
The Moscone Center,
Sponsored by Meril Life Sciences Pvt. Ltd.
12:52 pm - meriT-2 Extension in Brazil: A Deep
Look into BioMime Behavior - IVUS, OCT,
and Endothelial Function Tests
Ricardo Costa
Satellite Symposia
Jihad Mustapha, MD
West Michigan Heart
Grand Rapids, MI
Cardiovascular
Therapeutics
from Abbott Vascular, ABIOMED,
AstraZeneca, Boston Scientific,
Daiichi Sankyo Lilly, Medtronic, and Merck
Chairs
Alaide Chieffo, MD
Milan, Italy
Roxana Mehran, MD
Mount Sinai Hospital
New York, NY
Faculty
VA Boston Healthcare System and
Brigham and Women's Hospital
Boston, MA
7:05 am - History of Guide Extension and
Principles of Action
Douglas G. Fraser
12:15 pm - Evolution of Novel DES
Technologies: An Introduction
Alexandre Abizaid
David Holmes, MD
Mayo Clinic
Rochester, MN
7:15 am - Guide Extension Utility for
Stent Delivery
Carlo Di Mario
12:20 pm - Polish Clinical Experience with
Novel Hybrid Stent Design: NexGen
Pawel E. Buszman
Henry Krum, MD
Monash University
7:25 am - CTO Uses of Guide Extension
William L. Lombardi
12:28 pm - Complex Cases with NexGen
Wojciech Wojakowski
7:35 am - Guide Extension in Retrograde
Vein Graft PCI
J. Aaron Grantham
12:36 pm - meriT-1 Final Angiographic Analysis
and >18 Months of Follow-up
Sameer I. Dani
Julinda Mehilli, MD
Deutsches Herzzentrum
Munich, Germany
7:45 am - Guide Extension Benefit in
Peripheral Interventions
Aravinda Nanjundappa
12:44 pm - meriT-2 BioMime in
Complex Patients
Ashok Seth
A. Sonia Petronio, MD
University of Pisa
Pisa, Italy
Vivek Y. Reddy, MD
New York, NY
155
Satellite Symposia
Agenda
Roxana Mehran
12:20 pm - Case 1: Patient with Pulmonary
Edema and Uncontrolled Hypertension
Julinda Mehilli
12:30 pm - Renal Artery Stenting:
In Whom and When?
Deepak L. Bhatt
12:35 pm - Renal Artery Denervation:
In Whom and When?
Henry Krum
12:40 pm - Panel Discussion
Moderator: Alaide Chieffo
12:45 pm - Case 2: Patient with
Recurrent Atrial Fibrillation
A. Sonia Petronio
12:55 pm - Pharmacotherapy and
Ablation Therapy: Which and Why?
Vivek Reddy
1:00 pm - LAA Occlusion: When and Why?
David Holmes
1:05 pm - Panel Discussion
1:10 pm - Adjourn
Lunchtime Sessions
12:30 pm - How Does OCT Help Understand
Plaque Progression and Changes Following
DES Placement?
Masataka Nakano
Bifurcation Case Reviews:
12:45 pm - Clinical Lessons from OCT
Takagi Akasaka
8:45 pm - Case 2: Do Angle and Anatomy
Influence Outcomes in Bifurcation Stenting?
Achim Buettner
Renu Virmani
1:15 pm - Adjourn
Evening Programs
Reducing Late Stent Thrombosis:
Does BA9™ Technology Benefit Your
Patients Long-term?
Hilton San Francisco
Dinner Reception (7:00 pm-8:00 pm):
Franciscan Room
Evening Program (8:00 pm-9:35 pm):
Imperial Ballroom
Sponsored by Biosensors International
Chair
Inselspital Bern
Bern, Switzerland
Jacques Berland, MD
Clinique Saint Hilaire
Rouen, France
Faculty
OCT: Comparisons to Histology
The Moscone Center
the Exhibit Hall)
Sponsored by St. Jude Medical
São Paulo, Brazil
Faculty
Achim Buettner, MD
Herz-Zentrum
Takagi Akasaka, MD
Wakayama, Japan
Aloke V. Finn, MD
Atlanta, GA
Masataka Nakano, MD
Gaithersburg, MD
Renu Virmani, MD
Gaithersburg, MD
12:15 pm - Course Welcome, Overview,
and Objectives
Renu Virmani
12:16 pm - ACS: Plaque Morphology
and Progression
Aloke V. Finn
program ·
Keith G. Oldroyd, MD
West of Scotland Regional Heart
and Lung Center
Glasgow, Scotland
8:55 pm - Where Dedicated Bifurcation Stents
Can Benefit Your Patients: Axxess™:
The Self-Expanding Bifurcation Biolimus
A9-Eluting Stent
Alexandre Abizaid
Panel
9:25 pm - Take-Home Message
Jacques Berland
9:35 pm - Adjourn
Navigating the Evolving Opportunities
for the Interventional Cardiologist
Chair
Ted Feldman, MD
NorthShore University Health System,
NorthShore Cardiology
Skokie, IL
Faculty
Keith Dawkins, MD
Boston Scientific
Natick, MA
Saibal Kar, MD
Los Angeles, CA
Monash Heart Southern Health
Clayton, Australia
Chesley (Sully) B. Sullenberger III
Pilot, US Airways Flight 1549
Danville, CA
Agenda
Agenda
8:00 pm - Embracing the Future Lancscape
of Interventional Medicine
Keith Dawkins
8:00 pm - Welcome and Opening Remarks
Stephan Windecker
8:05 pm - The Impact of Patient and Lesion
Complexity on Long-term Clinical Outcomes
Antonio L. Bartorelli
Agenda
156
University of Milan
Milan, Italy
8:35 pm - Case 1: Is There Still a Role
for Provisional Stenting?
Keith G. Oldroyd
8:20 pm - Very Long-term Outcomes with
Biolimus A9 from an All-Comers Randomized
Clinical Trial: LEADERS Four-Year Data
Stephan Windecker
8:10 pm - Left Atrial Appendage Closure
in Patients with Atrial Fibrillation
Saibal Kar
8:25 pm - The Future of Transcatheter
Aortic Valve Replacement
Ian T. Meredith
CULAR ·
R
N
Faculty
Philip B. Adamson, MD
Oklahoma Heart Hospital
Oklahoma City, OK
O
William T. Abraham, MD
Ohio State University
Columbus, OH
D AT I
Chair
Optimal Antiplatelet Therapy in Patients
Undergoing PCI: A Case-Based Roundtable
with the Experts
Ballroom 1-4
Foundation
from AstraZeneca
Chairs
Clinical Cases: Management Dilemmas
8:50 pm - Case 1: Complex Coronary
Case with Multiple Stents
George D. Dangas
8:57 pm - Case 2: Post-PCI Patient
with Bleeding
David J. Moliterno
Deepak L. Bhatt, MD
VA Boston Healthcare System,
Brigham and Women’s Hospital,
and Harvard Medical School
Boston, MA
9:05 pm - Expert Panel Case Discussion
Discussants: Deepak L. Bhatt,
George D. Dangas, Paul A. Gurbel,
Stefan K. James, David J. Moliterno,
Matthew J. Price
Roxana Mehran, MD
New York, NY
9:25 pm - Words of Wisdom:
The Five Important Points to Take Home
Stefan K. James
Faculty
9:30 pm - Adjourn
Atlanta, GA
New York, NY
Warren L. Strickland, MD
Huntsville Hospital
Huntsville, AL
Paul A. Gurbel, MD
Baltimore, MD
Breakfast Meetings
Stefan K. James, MD
Uppsala Clinical Research Center
Uppsala, Sweden
Management of Complex Patients,
Expanding Your Practice: Latest
Technologies, Applications and CostEffectiveness Considerations
Sponsored by ABIOMED, Inc
Agenda
8:00 pm - Current Methods and Limitations
of Assessing the Development of Acute
Decompensated Heart Failure
Philip B. Adamson
8:20 pm - CHAMPION Trial Results
William T. Abraham
8:40 pm - Potential Benefits and Value of
Pressure-Guided Hemodynamic
Management
Warren L. Strickland
9:00 pm - Integration of this New Technology
into Today’s Cardiology Practice
David E. Kandzari
9:30 pm - Adjourn
University of Kentucky
Lexington, KY
Scripps Clinic
La Jolla, CA
Chair
Agenda
George W. Vetrovec, MD
VCU Medical Center
Richmond, VA
Faculty
8:00 pm - Welcome
Roxana Mehran
Brij Maini, MD
Pinnacle Health and Vascular Institute
Harrisburg, PA
8:05 pm - Recommendations for DAPT in PCI
Patients: A Mini-Review of ACC/AHA/ESC
PCI Guidelines
Deepak L. Bhatt
8:12 pm - The Pharmacodynamic Platform for
Improved Antiplatelet Regimens: Is There
Any Role of Platelet Inhibition Assessment
and Genetic Testing?
Paul A. Gurbel
8:20 pm - The Landscape of Antiplatelet
Agents: Which Drug for Whom?
Roxana Mehran
- N o v e m b e r 7 - 11 , 2 0 11
Prevention of Heart Failure Hospitalizations
with Wireless, Implantable Pulmonary
Artery Pressure Monitoring
Ballroom 6-9
Sponsored by CardioMEMs
UN
9:30 pm - Adjourn
O
EARCH ·
F
8:50 pm - Leading Through Change
Chesley (Sully) B. Sullenberger III
8:35 pm - Discussion Topic: Why Choose
One Drug Over Another (Safety, Efficacy,
or Cost)?
Moderator: Deepak L. Bhatt
Discussants: George D. Dangas,
Paul A. Gurbel, Stefan K. James,
Roxana Mehran, David J. Moliterno,
Matthew J. Price
Satellite Symposia
AS
ES
8:40 pm - Considerations for the
Interventionalist as We Look to the Future
Ted Feldman
ARDIO
· C
V
TCT2011
Cardiovascular
Therapeutics
Winthrop University Hospital
Mineola, NY
Agenda
6:30 am - Breakfast
7:00 am - The Emerging Field of
Percutaneous Circulatory Support:
How It May Change Our Practice
George W. Vetrovec
157
Satellite Symposia
7:30 am - Emerging Clinical Applications
of Hemodynamic Support: Case Reviews
Srihari S. Naidu
Ashish Pershad, MD
Heart and Vascular Center of Arizona
Phoenix, AZ
7:40 am - Cost-Effectiveness of
Revascularization in High-Risk Patients
Undergoing PCI with Impella
Brij Maini
Michael Wyman, MD
Torrance Memorial Medical Center
Torrance, CA
Agenda
6:30 am - Breakfast
7:00 am - Are Stents as Good as We Think?
Outcomes in Challenging PCI Subsets
Louis Cannon
8:00 am - Adjourn
New Era in CTO PCI: The Hybrid
Approach and BridgePoint Medical
Sponsored by BridgePoint Medical
Chairs
Aaron Grantham, MD
Saint Luke’s Mid America Heart and
Vascular Institute
Kansas City, MO
William Lombardi, MD
PeaceHealth St. Joseph Medical Center
Bellingham, WA
Craig Thompson, MD
Yale University School of Medicine
New Haven, CT
Faculty
Tony DeMartini, MD
Springfield Memorial Hospital
Springfield, IL
158
program ·
Panel
Panel
7:40 am - Antegrade Dissection Re-entry:
Tips and Tricks to Improve Success and
Procedural Efficiency
Ashish Pershad
Moderator: William Lombardi
8:00 am - Adjourn
Panel
8:00 am - Adjourn
AS
CULAR ·
R
EARCH ·
F
Moderator: Louis Cannon
7:15 am - Review of Balloon Expandable
TAVR Technology, Procedural Tips and
the “Special” Role of the Heart Team
Augusto D. Pichard
7:35 am - Discussion: Impact of TAVR in Your
Center and “Unique” Aspects of the
Eastern United States
Panel
ES
7:25 am - New Clinical Research on
Bioabsorbable Drug Delivery: Perspectives
from the EVOLVE Clinical Trial Program
Ian T. Meredith
7:05 am - Takeaway Lessons from
the PARTNER Trial
Howard C. Herrmann
7:20 am - Hybrid Approach:
A New Algorithm for Treating CTOs
Michael Wyman
Moderator: Aaron Grantham
ARDIO
· C
V
Monash Heart Southern Health
Clayton, Australia
Augusto D. Pichard
Panel
N
Louis Cannon, MD
Michigan Heart and Vascular Specialists
Petoskey, MI
6:30 am - Breakfast
7:25 am - Site Readiness: Top 10 General
Requirements to Be a Successful
Heart Team
Joseph E. Bavaria
O
Chairs
7:00 am - Broadening the Antegrade
Approach: When You Can’t or Don’t
Want to Go Retrograde
Tony DeMartini
Moderator: Craig Thompson
D AT I
Lessons from New Data in
Coronary Stenting
6:30 am - Breakfast
UN
8:00 am - Adjourn
Agenda
O
Panel
Agenda
and Heart Valve Team in Your Center:
The Nuts and Bolts (Eastern United States)
Research Foundation
grant from Edwards Lifesciences
Chair
Washington, DC
Faculty
Philadelphia, PA
Philadelphia, PA
Robotic-Assisted PCI: User Experience in
Daily Practice
Sponsored by Corindus Vascular Robotics
and Philips Healthcare
Chairs
Joseph Carrozza, MD
Steward St. Elizabeth’s Medical Center
Boston, MA
Peter Fitzgerald, MD
Stanford, CA
Faculty
Ronald Caputo, MD
SJH Cardiology Associates
Liverpool, NY
Kingsport, TN
New York, NY
Giora Weisz, MD
New York, NY
Agenda
6:30 am - Breakfast
7:00 am - Opening Remarks
Moderators: Joseph Carrozza, Peter Fitzgerald
TCT2011
Faculty
Faculty
Jorge Gaspar, MD
Mexico City, Mexico
7:10 am - High-Volume Operator Experience
with Robotic-Assisted PCI
Ian Menown, MD
Craigavon, Ireland
Michaël Angioi, MD
University Hospital Nancy
Nancy, France
7:18 am - How Cardiovascular Robotics
Is Changing PCI
Jeffrey W. Moses
7:34 am - Beyond PCI: Robotics for Structural
Heart Disease Procedures
Peter Fitzgerald
Moderator: Joseph Carrozza
8:00 am - Adjourn
The Identification and Treatment of
Venous Insufficiency: A New Frontier
for Cardiology Practices
Sponsored by Covidien Vascular Therapies
Chairs
James D. Joye, DO
El Camino Hospital
Mountain View, CA
Paul H. Kramer, MD
Liberty Cardiovascular Specialists
Liberty, MO
Agenda
6:30 am - Breakfast
7:00 am - Identification of Venous
Insufficiency: Disease State
James D. Joye, Paul H. Kramer
7:15 am - Treatment of Venous Insufficiency:
RF Ablation
Karl-Ludwig Schulte, MD
Berlin, Germany
Agenda
Antonio Serra, MD
Barcelona, Spain
7:00 am - Five-Year Follow-up After
Titanium-Nitride-Oxide-Coated Stents vs.
Paclitaxel-Eluting Stents in Acute Myocardial
Infarction: The TITAX AMI Trial
Petri Tuomainen
Agenda
6:30 am - Breakfast
Sigmund Silber
7:02 am - Part 1: Are DEB an Option for
Diabetic Patients? DEAR: Results of the
Argentinean Experience
Alfredo Rodriguez
Diabetic Patients? Valentines Trial I: Update
on Subgroups
Sigmund Silber
7:22 am - Experiences with DIOR® DEB in the
National Institute of Cardiology (Mexico City)
Jorge Gaspar
7:29 am - Periphery, First Experiences,
and Colombian Results, Announcement
of Activation and First Results of
Randomized Studies
Karl-Ludwig Schulte
De Novo Lesions? Focus on DEB Plus
CoCr-Stent (MAGICAL™)
Mohd Ali Rosli
De Novo Lesions? Focus on DEB Only
(Valentines Trial II)
Ian Menown
7:30 am - Future Technologies and Innovations
in the Treatment of Venous Insufficiency
De Novo Lesions? Focus on DEB in Small
Vessels (Spanish Multicenter Registry)
Antonio Serra
Panel
8:00 am - Adjourn
8:00 am - Adjourn
Petri Tuomainen, MD
Kuopio Hospital
Kuopio, Finland
6:30 am - Breakfast
7:15 am - A Randomized Comparison Of
Titan2 BAS With Xience V EES in Acute
Coronary Syndrome Patients: The BASEACS Trial 18-Month Follow-up
Pasi Karjalainen
7:30 am - Coronary Angioplasty with the
Titan2 Bio Active Stent in Acute Myocardial
Infarction Patients: The CATS-AMI Large
Scale Registry
Michaël Angioi
7:45 am - Optical Coherence Tomography
(OCT) Findings After Titan2 and Xience V
Stents Implantations After 18 Months of
Follow-up: The BASE-OCT Trial
Pasi Karjalainen
8:00 am - Adjourn
True Vessel Characterization: Implications
for Increasing Stenting Safety and
Preventing Coronary Events
Sponsored by InfraReDx, Inc
Chair
Royal Oak, MI
Faculty
Rotterdam, NL
New Frontiers in DEB Technologies
Sponsored by Eurocor GmbH
Titanium-Nitride-Oxide Bio Active Stent
Technology: The Evidence-Based Medicine
to Fight Restenosis Safely Over Time
Sponsored by Hexacath
Gregg W. Stone, MD
New York, NY
Chairs
Chair
6:30 am - Breakfast
Mohd Ali Rosli, MD
Pasi Karjalainen, MD
Satakunta Central Hospital
Pori, Finland
7:00 am - Introduction and Symposium:
Learning Objectives
James A. Goldstein
Sigmund Silber, MD, PhD
Munich, Germany
- N o v e m b e r 7 - 11 , 2 0 11
7:26 am - Integrating the CorPath 200 System
into the Cath Lab Workflow
Ronald Caputo
Alfredo Rodriguez, MD
Satellite Symposia
7:02 am - Overview of the CorPath 200
System and the PRECISE Trial
Giora Weisz
Cardiovascular
Therapeutics
Agenda
159
Satellite Symposia
7:05 am - Optimizing PCI Outcomes Through
Multimodality Imaging (Integrated IVUS,
OCT, and/or NIR Spectroscopy)
Patrick W. Serruys
Faculty
Agenda
Michael Haude, MD
Neuss, Germany
6:30 am - Breakfast
7:20 am - Optimizing PCI Outcomes:
Detection of Lesions at Risk for Distal
Embolization Complications
James A. Goldstein
Durham, NC
7:05 am - Overcoming Barriers to FFR Daily
Use - Is It Possible to Obtain Adenosine
Free FFR?
Morton J. Kern
7:35 am - Detection of Vulnerable Plaques:
Are We Close to Clinical Applicability?
Gregg W. Stone
8:00 am - Adjourn
STEMI: Door to Balloon or Door to Device?
Sponsored by MAQUET Cardiovascular
Ulf Landmesser, MD
University Hospital Zurich
Zürich, Switzerland
Steven W.L. Lee, MD
The University of Hong Kong
Queen Mary Hospital, Hong Kong
Roxana Mehran, MD
New York, NY
Agenda
6:30 am - Breakfast
Chair
Ralph Brindis, MD
University of San Francisco Medical Center
San Francisco, CA
7:00 am - Introduction to a New
Category of Stents
Martin B. Leon
7:05 am - Why Our Patients Need It
Roxana Mehran
Faculty
Eric R. Bates, MD
University of Michigan Health System
Ann Arbor, MI
Dorian L. Beasley, MD
Indiana University Health
Indianapolis, IN
Manesh R. Patel, MD
Durham, NC
Richard W. Smalling, MD
Memorial Hermann Heart and Vascular
Institute, University of Texas
Houston, TX
Agenda
Please visit www.tctconference.com for
the latest agenda.
The New Combo Dual Therapy Stent
Sponsored by OrbusNeich
São Paulo, Brazil
Martin B. Leon, MD
New York, NY
7:15 am - Randomized REMEDEE
Study Design
Michael Haude
7:30 am - Pro-healing Stent Coverage
Assessment by OCT
Steven W.L. Lee
7:45 am - Ongoing and Planned
Clinical Investigations
Discussants: Mitchell W. Krucoff,
Ulf Landmesser
7:50 am - Adjourn
Breaking Down Barriers to FFR Adoption:
Introducing iFR, a Vasodilator Independent
Measure of Fractional Flow Reserve
Sponsored by Volcano Corporation
Morton J. Kern, MD
University of California Irvine
Orange, CA
Faculty
Justin Davies, MD, PhD
Imperial College
Javier Escaned, MD, PhD
Hospital Clínico San Carlos
Madrid, Spain
160
program ·
7:20 am - Introduction to iFR, a New
Pressure-Derived Vasodilator Free Measure
of Fractional Flow Reserve
Justin Davies
7:40 am - The Future of FFR and the
Functional Management of your Patients
Javier Escaned
7:50 am - Closing Comments and
Audience Q&A
Morton J. Kern
8:00 am - Adjourn
Presentation Theater North
Lunchtime Sessions
7:10 am - The Technology Behind the
Combo Dual Therapy Stent
Alexandre Abizaid
Chair
Chairs
Morton J. Kern
The Future of the Cath Lab:
Managing Complexity for Improved
Safety and Outcomes in CTO, TAVI,
and Carotid Intervention
The Moscone Center,
Sonoma Valley (Located in Hall D)
Sponsored by Cardiovascular Learning
Network, a NACCME Initiative
from ACIST Medical Systems
This activity has been approved for AMA
PRA Category 1 Credit™
Approved for 1 AMA PRA Category 1 Credit,
1.0 Contact Hour for Nurses, and 1 ARRT
Category A CE Credit
Chair
Roxana Mehran, MD
New York, NY
Faculty
Sacramento, CA
Weill Cornell Medical Center
New York, NY
TCT2011
12:15 pm - Case Review
Gerry Wilkins
8:18 pm - Importance of Ischemia
Pre- and Post-Revascularization
Leslee J. Shaw
Panel
Panel
12:45 pm - Case Review
Adrian Low
8:33 pm - Importance of Complete
Revascularization
Bernard J. Gersh
Panel
1:15 pm - Adjourn
Yujie Zhou, MD
Beijing An Zhen Hospital
Beijing, China
ARDIO
· C
V
N
O
Monash Medical Center
Victoria, Australia
grant from Gilead Sciences
Chair
Giora Weisz, MD
New York, NY
Faculty
Jeroen J. Bax, MD
Leiden University Medical Center
Leiden, The Netherlands
Faculty
Mayo Clinic
Rochester, MN
Guosheng Fu, MD
Sir Run Run Shaw Hospital
Hangzhou, China
Leslee J. Shaw, PhD
Atlanta, GA
Yangsoo Jang, MD
Yonsei University College of Medicine
Seoul, South Korea
Gregg W. Stone, MD
New York, NY
Adrian Low, MD
National University Hospital of Singapore
Singapore
Panel
9:03 pm - Management of Patients with
Incomplete Revascularization
Giora Weisz
Panel
9:30 pm - Adjourn
AS
CULAR ·
R
EARCH ·
F
Chairs
Ischemia, Viability, and Complete
Revascularization in CAD:
What Really Matters?
Hilton San Francisco, Continental Ballroom
Research Foundation
8:48 pm - Vulnerable Plaque:
The Wild Card Factor
Gregg W. Stone
ES
Complex PCI: Asia-Pacific Approaches
The Moscone Center,
the Exhibit Hall)
Sponsored by Medtronic
D AT I
Lunchtime Sessions
UN
CULAR ·
R
O
Please visit www.tctconference.com for the
latest agenda.
AS
EARCH ·
F
Agenda
Evening Programs
ES
MEDRAD Interventional® Long-term
Clinical Data of Paccocath® Technology,
Preclinical Evidence, and Planned
Cotavance® Peripheral Study Designs
The Moscone Center,
Sponsored by MEDRAD Interventional
Panel
ARDIO
· C
V
1:15 pm - Adjourn
Panel
N
Panel
8:03 pm - Importance of Baseline
Myocardial Viability
Jeroen J. Bax
O
12:45 pm - Carotid Intervention
John R. Laird Jr
Agenda
Gregg W. Stone
- N o v e m b e r 7 - 11 , 2 0 11
12:35 pm - Chronic Total Occlusion
Jeffrey W. Moses
Gerry Wilkins, MD
Dunedin Hospital
Dunedin, New Zealand
D AT I
12:25 pm - Transcathether Aortic
Valve Interventions
Roxana Mehran
Hyo Soo Kim, MD
Seoul, South Korea
Agenda
UN
12:15 pm - Managing Complexity for
Improved Safety and Outcomes: Practical
Methods and Tools for the Operator in
Complex Cases
Roxana Mehran
Sharad Shetty, MD
Royal Perty Hospital
Perth, Australia
O
Lunch with be provided for all
symposium attendees
Satellite Symposia
Agenda
Cardiovascular
Therapeutics
Preparing the Interventionalist for
the Future: An Interactive Workshop
Research Foundation
from Medtronic CardioVascular
Chairs
William A. Gray, MD
New York, NY
Martin B. Leon, MD
New York, NY
161
Satellite Symposia
ARDIO
· C
V
N
UN
D AT I
O
John D. Carroll, MD
University of Colorado Denver
Aurora, CO
O
VA Boston Healthcare System and
Boston, MA
CULAR ·
R
EARCH ·
F
Faculty
AS
ES
CardioVascular Center Frankfurt,
Sankt Katharinen
Frankfurt, Germany
At the Razor’s Edge: Establishing
a New Standard of Care in Acute
Hilton San Francisco, Imperial Ballroom/
Franciscan Room
Research Foundation
grant from Multiple Commercial Supporters
Michael J. Davidson, MD
Boston, MA
Saibal Kar, MD
Los Angeles, CA
Kerckhoff Clinic
Alan B. Lumsden, MD
Vascular Center
Houston, TX
Gregg W. Stone, MD
NewYork-Presbyterian Hospital/Columbia
New York, NY
Faculty
New York, NY
Boston, MA
Sam Radhakrishnan, MD
Schulich Heart Center, Sunnybrook Hospital
Toronto, Canada
Mathew Williams, MD
New York, NY
Agenda
Chairs
C. Michael Gibson, MD
Boston, MA
Paul A. Gurbel, MD
Baltimore, MD
Roxana Mehran, MD
Mount Sinai Hospital
New York, NY
8:00 pm - Facility and Staffing Considerations
Alan B. Lumsden
Panel
8:40 pm - Physician Training Requirements for
the “Interventional Futurist”
William A. Gray
Panel
9:20 pm - New Patients for New
Interventional Therapies
Horst Sievert
8:52 pm - The Evolution of Antiplatelet
Therapy During Primary PCI
Shamir Mehta
9:08 pm - Clopidogrel, Prasugrel and
Ticagrelor During Primary PCI:
Pharmacokinetic and
Pharmacodynamic Differences
Paul A. Gurbel
9:24 pm - Clopidogrel, Prasugrel and
Ticagrelor During Primary PCI:
Clinical Outcomes
C. Michael Gibson
Establishing a New Standard of Care in
Moderators: Gregg W. Stone
Discussants: C. Michael Gibson,
Paul A. Gurbel, Roxana Mehran,
Shamir Mehta, Harvey D. White
10:00 pm - Adjourn
Friday, November 11
Shamir Mehta, MD, MSc
Hamilton Health Sciences
Hamilton, Canada
Breakfast Meetings
Harvey D. White, DSc
Green Lane Cardiovascular Service,
First-in-Man Chronic Total Occlusion
Crossing Using the Directional
OCT-Guided Ocelot CTO Catheter
Sponsored by Avinger, Inc.
Gregg W. Stone
8:04 pm - The Evolution of Reperfusion
Therapies: From Thrombolysis to
PCI (and From Slow to Fast)!
Harvey D. White
8:20 pm - The Evolution of Catheter-Based
Therapies in STEMI: From Balloons to
Drug-Eluting Stents and Mechanical
Approaches to Thrombus
Christian W. Hamm
Panel
10:00 pm - Adjourn
program ·
Agenda
162
8:36 pm - The Evolution of Antithrombin
Therapy During Primary PCI
Roxana Mehran
Faculty
Sean F. Janzer, MD
Mainline Health, Bryn Mawr Hospital
Bryn Mawr, PA
John B. Simpson, MD, PhD
CEO, Founder, Avinger Inc
Redwood City, CA
Christian Vande Velde
Garmin Cervelo Pro Cycling Team
Lemont, IL
Agenda
6:30 am - Breakfast
7:00 am - From the Tour de France to TCT
Christian Vande Velde
TCT2011
7:35 am - First-in-Man Chronic Total Occlusion
Crossing Using the Directional OCT-Guided
Ocelot CTO Catheter
John B. Simpson
Moderator: Sean F. Janzer
CULAR ·
R
O
N
EARCH ·
F
UN
D AT I
O
Guidewire Design and Selection:
A User’s Guide
Research Foundation
7:30 am - Hydrophilic and Support Wires
Ajay J. Kirtane
7:40 am - CTO Wires: Antegrade and
Retrograde Approaches
Craig A. Thompson
7:50 am - Discussion and Audience Q&A
Panel
8:00 am - Adjourn
Management of Complex Patients,
Award Winning Case Presentations
Research Foundation
from ABIOMED, Inc.
Use of Intraaortic Balloon Counterpulsation
in Percutaneous Aortic Valve Procedures
and Complex PCI: Selected Cases
Foundation
from MAQUET Cardiovascular.
Moderators
Duane S. Pinto, MD, MPH
Boston, MA
Jose M. Wiley, MD
New York, NY
Scholarship Winners
Chairs
Gill Buchanan, MD
Milan, Itlay
from Abbott Vascular and Medtronic
CardioVascular
Roxana Mehran, MD
New York, NY
Vinod Patel, MD
New York, NY
Theodore L. Schreiber, MD
Cardiovascular Consultants
Warren, MI
Alice Perlowski, MD
Evanston Hospital, NorthShore University
Health System
Chicago, IL
Chairs
New York, NY
Martin B. Leon, MD
New York, NY
Faculty
Christopher E. Buller, MD
Vancouver General Hospital
Vancouver, Canada
scholarship winners
Gopi Manthripragada, MD
UCLA
Moorpark, CA
Faramarz Tahrani, MD
Sacramento, CA
Michael Tempelhof, MD
Chicago, IL
Agenda
6:30 am - Breakfast
Yale New Haven Hospital
New Haven, CT
7:00 am - Building an Impella
Program Confirmed
Theodore L. Schreiber
Agenda
7:15 am - Impella Assisted High
Risk Unprotected LM PCI
Faramarz Tahrani
6:30 am - Breakfast
Martin B. Leon
7:05 am - Anatomy and Design of Coronary
Guidewires 101: Engineering for the
Interventionalist
7:15 am - Applied Use of Coronary
Guidewires: Basic Principles
Martin B. Leon
7:25 am - Q&A
- N o v e m b e r 7 - 11 , 2 0 11
AS
ES
ARDIO
· C
V
8:00 am - Adjourn
Case Presentations
Satellite Symposia
7:20 am - Understanding Biological and
Mechanical Markers to Cross CTOs Using
Optical Coherence Tomography
Sean F. Janzer
Cardiovascular
Therapeutics
Agenda
6:30 am - Breakfast
7:00 am - The Vital Role of IABP in a Rare
Case of Left Main Thrombotic Occlusion
Following Balloon Aortic Valvuloplasty
Gill Buchanan
7:15 am - Q&A
7:20 am - Intraaortic Balloon Pump
Counterpulsation for Hemodynamic Collapse
Implantation
Alice Perlowski
7:35 am - Q&A
7:40 am - Complex PCI with IABP Support
in a Patient with Hypoplastic Aorta
Vinod Patel
7:55 am - Q&A
8:00 am - Adjourn
7:30 am - Impella as a Bridge to the First
Successful Utilization of the HeartWare
Assist Device for Biventricular Failure in
North America
Michael Tempelhof
7:40 am - Q&A
7:45 am - A Second Chance
Gopi Manthripragada
7:55 am - Q&A
8:00 am - Adjourn
163
Women’s Heart
Health Summit
Satellite Symposia
In Pursuit of Excellence:
Improving Cardiovascular
Outcomes in Women
In PursuIt of ExcEllEncE:
Improving Cardiovascular
Outcomes in Women
friday, December 9, 2011
11:00 am-2:00 pm
The Princeton Club
15 West 43rd Street
New York, NY
SummIt ChaIr
Roxana Mehran, MD
KEynotE addrESS
Cindy L. Grines, MD
Please join us for a special luncheon program featuring prominent experts in
research, academia, and health policy as we examine the importance of gender in
cardiovascular disease research. The Summit will address the state of heart disease
in women: what has been achieved and how can we fill the gaps in the future.
For more information or to register,
please visit www.pulsegala.org/womensheartsummit
164
program ·
TCT2011
Cardiovascular
Therapeutics
A Passion for Innovation
Satellite Symposia
RESEARCH
F O U N D AT I O N
- N o v e m b e r 7 - 11 , 2 0 11
Pioneering New Therapies for
the Treatment of Heart Disease
More than 81 million people live with heart disease
worldwide. Many of them will benefit from
interventional procedures developed or refined by
the Cardiovascular Research Foundation (CRF) . . . .
WE INVESTIGATE
Early Stage Technologies During Preclinical Research
WE EVALUATE
Promising New Therapies by Designing and Implementing
Multiple Phases of Human Clinical Trials
WE EDUCATE
Medical Professionals and the Public to Enhance
Patient Outcomes
165
493 - 512
4 4
8
4 86 5 4
8
92
7
4
49 91
0
89
697 - 710
Congenital Heart Disease and Acquired Structural Defects
711 - 726
Valvular Heart Disease - Aortic
727 - 794
Valvular Heart Disease - Mitral
795 - 807
431
4 40
6
0
40 5
39
4
8
40
39
3
9
40 400
1
2
40
495
494
CORONARY
39
0
3 39
3 95 4 3
9
6
93
3
39 92
1
39
7
382-389 (8 posters) Unstable Anginaand NSTEMI
354
355
341 346
347
350
342
345
348
349
343
344
353
338
363 356
357
358
385
389
14 15
3 4 4 08
3
382
8
4
6
41
384
388
2
09
41 11
387
383
04
4
41
407-415 (9 posters) Heart Disease in the Elderly
364
365
373 366
367
368
340 351
372 369
362 359
370
360
352
371
361
339
328-381 (54posters) - STEMI Poster
328 337
329
330
32
320 7
32
3225
3261
32
331 336
332
333
30
2981
3027
29
30
296 3
30
3069
3105
30
31
304 1
31
312 9
3183
31
31
3147
3009
29
3087
30
2165
31
3243
32
290-327 (38poster faces) - Left Main and
226 235 236 245
247 252
246 253
256 257
255 258
254 259
262 263
261 264
260 265
267 268
266 269
1106
1107
2045
20
2012
20
2078
20
186
191
190
193
189
194
188
195
196
187
183
1854
18
176
1827
17
169
164
1685
16
1750
17
1818
17
158
161
1609
15
1632
16
1676
16
1741
17
151
1809
17
1732
17
152
197
206
209
192
153
200
210
211
212
215
154
1989
19
203
2134
21
155
150 - 191 (42posters faces) - Adjunct Pharmacology
156
1197
1198
1199
1200
1201
1202
1203
1204
1205
1206
1207
1208
1209
1210
1211
1212
1213
1214
1215
1216
1217
1218
1219
150
270
271
272
1220
270-280(11 poster faces) Chronic Total Occlusion
277 276
280 273
279
274
278
275
334 335
290
282 281
288 287 286 285
225
227 234 237 244
248 251
281-289 poster faces) - In-stent Restenosis and
Drug-eluting Balloons
224
228 233 238 243
230 231 240 241
le,
rbab
229 232 239 242 249 250
abso udies
- Bio tent St
ces)
S
er fa e Metal
r
post
(78 and Ba
,
-269
192 Eluting
gDru
223
222
221
220
284 283
289
291
292
293
294
295
379
380
381
376
377
378
374
375
416-425(10 poster faces) Heart Disease in Women
416
417
418 425
421
422
420
423
419
424
434
433
432
436
435
428
429
430
426
427
426 - 437 (11 posters) - Heart Disease in Diabetics
496
493
48
84
Structural
8
44
44 7
45 9
44
0
44
1
45 4 44 6
44 5
11 2
03 4
0
1
0 5 5 505
2 5 5 497
51
50
9
1
06
98
50 08
50 00
75
94
5
5
50
49
493 - 512 (20 posters) - Contrast Nephropathy and
Chronic Kidney Disease
621 - 696
Physiologic Lesion Assessment
1133
1132
Endovascular
CHALLENGING CASES
602 - 620
Intravascular Imaging: IVUS, OCT, Spectroscopy, and Other
1131
1130
468 - 492
Contrast Nephropathy and Chronic Kidney Disease
OTHER
Coronary Angiography and CTA
1129
1128
554 - 601
1127
1126
437 - 467
Cardiogenic Shock, Heart Failure, and Hemodynamic Support
0
4
4
44 9
4 1
4
43
2
43
3
44 43 8
7
Imaging
1125
1124
543 - 553
Peripheral Vascular Intervention (non carotid, non neurovascular)
1123
1122
513 - 542
Carotid and Neurovascular Intervention
1121
CHALLENGING
Basic Science, Animal Models and Preclinical Studies
390 - 406 (17 posters) PCI Outcomes
426 - 436
1102
1103
416 - 425
Heart Disease in Diabetics
1104
1105
407 - 415
Heart Disease in Women
1108
1109
390 - 406
Heart Disease in the Elderly
1110
1111
382 - 389
PCI Outcomes
1112
1113
328 - 381
Unstable Angina and NSTEMI
t Failure,
290 - 327
STEMI Posters
1114
1115
281 - 289
Left Main and Bifurcation Stenting
1116
1117
270 - 280
In-stent Restenosis and Drug-Eluting Balloons
cience, Animal Models and Preclinical Studies
192 - 269
Chronic Total Occlusion
1118
1119
150 - 191
Bioabsorbable, Drug-Eluting, and Bare Metal Stent Studies
1120
Adjunct Pharmacology
40
7
# A b s t r a ct s
C atag o r i e s
# Abstracts
150 - 191
192 - 269
270 - 280
281 - 289
290 - 327
328 - 381
382 - 389
390 - 406
407 - 415
416 - 425
426 - 436
437 - 467
468 - 492
493 - 512
513 - 542
543 - 553
554 - 601
219
218
217
216
157
program ·
166
602 - 620
621 - 696
697 - 710
711 - 726
727 - 794
795 - 807
Poster abstract Map
Coronary
Other
1101
1150
1151
4
46
46 3
46 5
46
6
46
7
46 0 46 2
46 1
CHALLENGING CASES
4 46
47 70 9 4
86
1
4
47
47 85
24
4
73
3
53
1164
39
85
53
Cardiovascular
Therapeutics
TCT2011
778
779
777 760
761
762
758
759
734 745
744
741
743
742
728
729
730
731
795 - 807 (13 posters) - Valvular
Heart Disease - Mitral
780
781
782
776 763
764
765
802 801
783
784
785
727 - 794 (68 posters) - Valvular Heart Disease - Aortic
766
757
733
732
767
748
746
747
756 749
750
751
797 796
798
795
807
786
787
788
775 768
769
770
803 800
804
799
805
806
789
790
791
691
690
686 679
687 678
688 677
STRUCTURAL
657 658
656
659
647
644
663 662
674 675
673
676
664
661
653 654
652
655
651
648
IMAGING
660
643
570
569
573 568
571
572
577 564
574 567
575
566
576
565
563
581 559
578 562
579
561
580
560
582 558
583
557
584
556
554
585 555
ENDOVASCULAR
1196
1194
1195
1192
1193
1190
1191
1188
1189
1186
1187
1184
1185
1182
1183
1180
1181
1178
1179
1176
1177
1174
1175
1172
1173
1170
1171
1178
1169
1166
1167
1165
735 740
792
774 771
755 752
727
793
772
753
739
738
794
773
754
736
737
704 - 719 (16 posters) - Congenital Heart Disease & Aquired Structural Defects
720
721
722
723
724
725
726
711
718
717
716
715
714
713
712
719
692
685 680
646 645
637 638
636
639
627
624
553
549 546
550
545
551
544
552 543
641 642
640
623
622 621
650 649
670 671
669
672
668
665
667 666
710
709
708
707
706
705
704
697
698
699
700
701
702
703
697- 710 (14 posters) - Physiology Lesion assessment
693
684 681
689
694
683 682
633 634
632
635
631
628
626 625
610 611
612
609
616
613
630 629
606 607
605
608
620
617
615 614
695
696
604
619 618
589 598
588
599
587
600
548 547
590 597
602- 620 (19 posters) Coronary Angiography and CTA
595
594
603
602
5 52
5 52
52 27 8 5
51 19 0 5
2
13
6
8
1
5
5
52
51
52 22
51 14
55
75
3
5
24
16
513 - 542 (30 posters)
5
5 42
3
7
5
54 41
0
1162
1163
5 52
53 30 9 5
36
1
5
53 35
4
2
1160
1161
53
586 601
Peripheral Vascular Intervention (non coraotid,
non neurovascular 554 - 601 (48 posters)
1154
1155
4 47
47 78 7 4
84
9
4
48
48 83
04
2
81
8
1144
1143
1142
1141
1140
1139
1138
1137
1136
1148
1149
6
45
45 5
45 7
45
8
45
9
45 2 45 4
45 3
621 - 696 (76 posters) - Intravascular Imaging:
IVUS, OCT, Spectroscopy, and Other
593
596
592
591
543-553 (11 posters) - Carotid and
Neurovascular Intervention
1156
1157
R
1145
1135
1134
1146
1147
G CASES
1158
1159
46
1152
1153
167
437 - 467 (31 posters) - Basic
468- 492(25 posters) - Cardiogenic Shock, Hea
and Hemodynamic Support
Moscone Center Map
168
program ·
TCT2011
TCT Advisory
Faculty
Lounge
Presentation theater
North - Sonoma Valley
Endovascular/
Structural
Theater
Cardiovascular
Therapeutics
Right Theater:
International
Society Case
Theater
Presentation
Theater North:
Sonoma Valley
Cath Lab of
the Future
computer
computer
PW
PW
PW
computer
PW
Presentation theater
North - Napa Valley
PW
Partnership
Pavilion
computer
Hands
on Heart
Presentation
Theater
North:
Napa Valley
Left Theater:
Challenging
Case Theater
Physcian
Attendee
Lounge
Coronary
Theater
169
Visit the ACC booth, located in the North Hall Concourse,
Lower Level in the CRF Partner Pavilion, to learn more about
the ACC’s Interventional Cardiology offerings including:
•
Membership in the ACC and the Interventional Scientific Section
•
ACC.12 and the ACC-i2 with TCT Interventional Learning
Pathway
• Journal of the American College of Cardiology (JACC ) and
JACC: Interventions
•
ACC’s Interventional Clinical Collection in collaboration with
TCTMD on CardioSource.org
Plus, stop by the booth in order for your chance to win free
registration and housing to ACC.12, where you’ll experience
the ACC’s passion for science, education and networking!
Don’t miss Hot Topics in Clinical Cardiology:
ACC.11 Highlights for the Interventional,
Invasive and General Cardiologist on Nov. 8
from 1:00 – 6:00 p.m. in room 132.
©2011 American College of Cardiology X11109
Launching January 2012
THE POWER OF
COLLABORATION
Take a sneak peek
PILOT ISSUE AT:
Booth 2334
in association with
11-1624
Ultra-modern ISO 13485 & cGMP
Qualified Manufacturing facility.
Over 10,000Sq Ft of Class 10,000Sq Ft
clean rooms; with all key process
conducted under Class 100 LAF.
EtO Sterilization & all microbial
QA Tests conducted in-house.
Tip to Hub manufacturing of Stent
systems and PTCA balloons is
done in-house.
Meril Life Sciences Pvt. Ltd.,
Muktanand Marg, Chala, Vapi 396 191. Gujarat. India.
T + 91 260 3052 100 F + 91 260 3052 125 E [email protected] W www.merillife.com
A9114-9161-A1-4A00 © 2011 Siemens Medical Solutions USA, Inc.
Visit us
at TCT,
Booth 916
Are you ready for the long run?
The road to Sustainable Cardiovascular Care is here.
www.usa.siemens.com/cardiovascular
The dynamics of our healthcare system may be changing
but the need for high-quality care for every individual
patient remains the same. You need to be able to
provide the best possible care for an increasing number
of patients—efficiently—not just today but for years
to come.
technology, and support to enable sounder decisions,
safer procedures, stronger operations, and smarter
investments. Helping you deliver quality outcomes
affordably, again and again.
That’s Sustainable Cardiovascular Care.
Through its longstanding commitment to innovation and
technological integration, Siemens Healthcare is helping
cardiovascular care move forward. Providing the systems,
Answers for life.
The XIENCE® V and XIENCE nano™
Everolimus Eluting Coronary
Stent on the MULTI-LINK VISION®
or MULTI-LINK MINI VISION®
Delivery System
INDICATIONS
The XIENCE V Everolimus Eluting Coronary
Stent System (XIENCE V stent) is indicated for
improving coronary luminal diameter in patients
with symptomatic heart disease due to de novo
native coronary artery lesions (length ≤ 28 mm)
with reference vessel diameters of 2.25 mm to
4.25 mm.
CONTRAINDICATIONS
The XIENCE V stent is contraindicated for use in
patients:
• Whocannotreceiveantiplateletand/oranticoagulant therapy
• Withlesionsthatpreventcompleteangioplasty
balloon inflation or proper placement of the
stent or stent delivery system
• Withhypersensitivityorcontraindicationto
everolimus or structurally-related compounds,
cobalt, chromium, nickel, tungsten, acrylicpolymers or fluoropolymers.
WARNINGS
• Ensurethattheinnerpackagesterilebarrierhas
not been opened or damaged prior to use.
• Judiciouspatientselectionisnecessary
because device use has been associated with
stent thrombosis, vascular complications, and/
or bleeding events.
• Thisproductshouldnotbeusedinpatients
who are not likely to comply with the
recommended antiplatelet therapy.
PRECAUTIONS
• Stentimplantationshouldonlybeperformed
by physicians who have received appropriate
training.
• Stentplacementshouldbeperformedat
hospitals where emergency coronary artery
bypass graft surgery is accessible.
• Subsequentrestenosismayrequirerepeat
dilatation of the arterial segment containing the
stent. Long-term outcomes following repeat
dilatation of the stent are presently unknown.
• Risksandbenefitsshouldbeconsideredin
patients with severe contrast agent allergies.
• Careshouldbetakentocontroltheguiding
catheter tip during stent delivery, deployment
and balloon withdrawal. Use fluoroscopy to
avoid arterial damage.
• Stentthrombosisisalow-frequencyevent
thatisfrequentlyassociatedwithmyocardial
infarction (MI) or death.
• WhenDESareusedoutsidethespecified
Indications for Use, patient outcomes may
differ from the results observed in the
XIENCE V SPIRIT family of trials.
• ComparedtousewithinthespecifiedIndications
forUse,theuseofDESinpatientsandlesions
outside of the labeled indications may have an
increased risk of adverse events, including stent
thrombosis, stent embolization, MI or death.
• Orallyadministeredeverolimuscombinedwith
cyclosporine is associated with increased
serum cholesterol and triglycerides levels.
• Apatient’sexposuretodrugandpolymeris
proportional to the number of and total length
of implanted stents. See Instructions for Use
for current data on multiple stent implantation.
• SafetyandeffectivenessoftheXIENCEV
stent have not been established for subject
populations with the following clinical settings:
• Patientswithpriortargetlesionorin-stent
restenosis related brachytherapy, patients
in whom mechanical atherectomy devices
or laser angioplasty devices are used
simultaneously, women who are pregnant
or lactating, men intending to father children,
pediatric patients, unresolved vessel thrombus
at the lesion site, coronary artery reference
vessel diameters < 2.25 mm or > 4.25 mm
or lesion length > 28 mm, lesions located in
saphenous vein grafts, unprotected left main
coronary artery, ostial lesions, chronic total
occlusions, lesions located at a bifurcation
or previously stented lesions, diffuse disease
orpoorflow(TIMI<1)distaltotheidentified
lesions,excessivetortuosityproximaltoor
within the lesion, recent acute myocardial
infarction (AMI) or evidence of thrombus
in target vessel, moderate or severe lesion
calcification,multivesseldiseaseandin-stent
restenosis.
• Everolimushasbeenshowntoreducethe
clearance of some prescription medications
when it was administered orally along with
cyclosporine (CsA). Formal drug interaction
studies have not been performed with the
XIENCE V stent because of limited systemic
exposuretoeverolimuselutedfromXIENCEV.
• Everolimusisanimmunosuppressiveagent.
Consideration should be given to patients
taking other immunosuppressive agents or
who are at risk for immune suppression.
• Oraleverolimususeinrenaltransplantpatients
and in patients treated for advanced renal cell
carcinoma was associated with increased
serum cholesterol and triglycerides that in
somecasesrequiredtreatment.
• Non-clinicaltestinghasdemonstratedthatthe
XIENCE V stent, in single and in overlapped
configurationsupto68mminlength,isMR
Conditional. It can be scanned safely under the
conditions in the Instructions for Use.
• TheXIENCEVstentshouldbehandled,
placed, implanted and removed according to
the Instructions for Use.
POTENTIAL ADVERSE EVENTS
Adverse events (in alphabetical order) which may
be associated with coronary stent use in native
coronary arteries include but are not limited to:
• Abruptclosure,Accesssitepain,hematoma,
or hemorrhage, Acute myocardial infarction,
Allergic reaction or hypersensitivity to
contrast agent or cobalt, chromium, nickel,
tungsten, acrylic and fluoropolymers; and
drug reactions to antiplatelet drugs or contrast
agent, Aneurysm, Arterial perforation and
injury to the coronary artery, Arterial rupture,
XIENCEV,XIENCEnano,MULTI-LINKVISIONandMULTI-LINKMINIVISION
are trademarks of the Abbott Group of Companies.
©2011 Abbott. All rights reserved. AP2935460-US Rev. A 09/11
Arteriovenousfistula,Arrhythmias,atrialand
ventricular, Bleeding complications, which
mayrequiretransfusion,Cardiactamponade,
Coronary artery spasm, Coronary or stent
embolism, Coronary or stent thrombosis,
Death,Dissectionofthecoronaryartery,Distal
emboli (air, tissue or thrombotic), Emergent
or non-emergent coronary artery bypass
graft surgery, Fever, Hypotension and/or
hypertension, Infection and pain at insertion
site, Injury to the coronary artery, Ischemia
(myocardial), Myocardial infarction (MI), Nausea
and vomiting, Palpitations, Peripheral ischemia
(due to vascular injury), Pseudoaneurysm, Renal
Failure, Restenosis of the stented segment of
the artery, Shock/pulmonary edema, Stroke/
cerebrovascular accident (CVA), Total occlusion
of coronary artery, Unstable or stable angina
pectoris, Vascular complications including at
theentrysitewhichmayrequirevesselrepair,
Vessel dissection.
Adverse events associated with daily oral
administration of everolimus to organ transplant
patients include but are not limited to:
• Abdominalpain(includingupperabdominal
pain);Anemia;Angioedema;Anorexia;
Asthenia;Constipation;Cough;Delayed
woundhealing/fluidaccumulation;Diarrhea;
Dyslipidemia(includinghyperlipidemiaand
hypercholesterolemia);Dyspnea;Dysgeusia;
Dyspepsia;Dysuria;Dryskin;Edema
(peripheral);Epistaxis;Fatigue;Headache;
Hematuria; Hyperglycemia (may include
new onset of diabetes); Hyperlipidemia;
Hyperkalemia; Hypertension; Hypokalemia;
Hypomagnesemia; Hypophosphatemia;
Increased serum creatinine; Infections and
serious infections: bacterial, viral, fungal,
and protozoal infections (may include herpes
virus infection, polyoma virus infection
which may be associated with BK virus
associated nephropathy, and/or other
opportunistic infections); Insomnia; Interaction
with strong inhibitors and inducers of
CY3PA4; Leukopenia; Lymphoma and other
malignancies (including skin cancer); Male
infertility (azospermia and/or oligospermia);
Mucosal inflammation (including oral
ulceration and oral mucositis); Nausea;
Neutropenia; Non-infectious pneumonitis;
Pain:extremity,incisionsiteandprocedural,
andback;Proteinuria;Pruritus;Pyrexia;Rash;
Stomatitis; Thrombocytopenia; Thrombotic
microangiopathy (TMA)/Thrombotic
thrombocytopenic purpura (TTP)/Hemolytic
uremic syndrome (HUS); Tremor; Urinary tract
infection; Upper respiratory tract infection;
Vomiting.
• Livevaccinesshouldbeavoidedandclose
contact with those that have had live vaccines
should be avoided. Fetal harm can occur when
administered to a pregnant woman. There
may be other potential adverse events that are
unforeseen at this time.
Prior to use, please reference the Instructions for
Use at www.AbbottVascular.com/ifu for more
information on indications, contraindications,
warnings, precautions and adverse events.
Advance your vascular procedures.
We believe there are no limits to what you can do—whether you’re treating
aortic disease, preventing pulmonary embolism or fighting PAD.
That’s why we offer more than just proven vascular products.
With Cook Medical, you can:
EMBOLIC THERAPIES
ENDOVASCULAR
AORTIC REPAIR
LEAD MANAGEMENT
• Expand your interventional skill set.
• Partner with a leader in physician-driven innovation.
Cook Medical—Working with you to improve patient outcomes.
LEG THERAPIES
PULMONARY EMBOLISM
PREVENTION
RENAL THERAPIES
STRUCTURAL HEART
ACCESS
Download the CRF Meetings App for iPhone and iPad to get mobile access to TCT 2011.
© COOK 2011
• Rely on our experienced team of specialists.
PI-BADV-TCTP-EN-201109
• Share best practices with physicians worldwide.
Everolimus Eluting
Coronary Stent System
Because
I put
safety first
I use XIENCE.
Chosen with conviction
Contact your Abbott Vascular sales representative for more information.
Indications: The XIENCE V® Everolimus Eluting Coronary Stent System (XIENCE V® stent) is indicated
for improving coronary luminal diameter in patients with symptomatic heart disease due to de novo native
coronary artery lesions (length ≤ 28 mm) with reference vessel diameters of 2.25 mm to 4.25 mm.
For Important Safety Information, see page 176.
Source: SPIRIT III 2-year and SPIRIT II 2-year stent thrombosis rates from XIENCE V® IFU.
For more information, visit our website at www.AbbottVascular.com
©2011 Abbott. All rights reserved. AP2935460-US Rev. A 09/11
TCT 2011
Visit us at booth 1017

program - CardioFocus

Transcription

Similar documents

Print this article - International Education and Research Journal

Desktop Network PCI Card

LTR 13 Abridged

Descarga (PDF 12.8Mb)

Evidence of the Role of Physical Activity and Cardiorespiratory

Front Matter - Circulation Research

Pre-Sports Cardiac Evaluation